WO2023005682A1 - Method for analyzing targeted exposure group of environmental pollutants in plasma, and use thereof - Google Patents
Method for analyzing targeted exposure group of environmental pollutants in plasma, and use thereof Download PDFInfo
- Publication number
- WO2023005682A1 WO2023005682A1 PCT/CN2022/105848 CN2022105848W WO2023005682A1 WO 2023005682 A1 WO2023005682 A1 WO 2023005682A1 CN 2022105848 W CN2022105848 W CN 2022105848W WO 2023005682 A1 WO2023005682 A1 WO 2023005682A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- phosphate
- acid
- phthalate
- mobile phase
- bis
- Prior art date
Links
- 239000003344 environmental pollutant Substances 0.000 title claims abstract description 49
- 238000000034 method Methods 0.000 title claims abstract description 48
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 63
- 238000001514 detection method Methods 0.000 claims abstract description 61
- 238000011084 recovery Methods 0.000 claims abstract description 60
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims abstract description 51
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 50
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims abstract description 38
- 238000004458 analytical method Methods 0.000 claims abstract description 30
- 238000000605 extraction Methods 0.000 claims abstract description 30
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 26
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims abstract description 20
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims abstract description 19
- 235000019253 formic acid Nutrition 0.000 claims abstract description 19
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 claims abstract description 15
- 239000007789 gas Substances 0.000 claims abstract description 14
- 239000006228 supernatant Substances 0.000 claims abstract description 13
- 238000004885 tandem mass spectrometry Methods 0.000 claims abstract description 13
- 239000000203 mixture Substances 0.000 claims abstract description 9
- 230000008014 freezing Effects 0.000 claims abstract description 5
- 238000007710 freezing Methods 0.000 claims abstract description 5
- 239000012046 mixed solvent Substances 0.000 claims abstract description 5
- -1 photoinitiators Substances 0.000 claims description 114
- 150000002500 ions Chemical class 0.000 claims description 72
- 239000000575 pesticide Substances 0.000 claims description 72
- 150000001875 compounds Chemical class 0.000 claims description 39
- 239000012963 UV stabilizer Substances 0.000 claims description 32
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 claims description 25
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 claims description 24
- 238000004949 mass spectrometry Methods 0.000 claims description 22
- 239000002904 solvent Substances 0.000 claims description 22
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 19
- 239000003963 antioxidant agent Substances 0.000 claims description 19
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 claims description 18
- 238000000889 atomisation Methods 0.000 claims description 18
- 239000012965 benzophenone Substances 0.000 claims description 17
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical class C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 claims description 16
- 238000010828 elution Methods 0.000 claims description 16
- 239000000178 monomer Substances 0.000 claims description 16
- 239000003993 organochlorine pesticide Substances 0.000 claims description 16
- 239000004014 plasticizer Substances 0.000 claims description 15
- 239000000047 product Substances 0.000 claims description 15
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 claims description 14
- 239000002917 insecticide Substances 0.000 claims description 14
- 239000004973 liquid crystal related substance Substances 0.000 claims description 14
- 150000001408 amides Chemical class 0.000 claims description 13
- 238000005119 centrifugation Methods 0.000 claims description 13
- 239000004305 biphenyl Substances 0.000 claims description 12
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims description 12
- 239000007864 aqueous solution Substances 0.000 claims description 11
- 239000004202 carbamide Substances 0.000 claims description 11
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 10
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 10
- 150000005691 triesters Chemical class 0.000 claims description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 9
- 101000610640 Homo sapiens U4/U6 small nuclear ribonucleoprotein Prp3 Proteins 0.000 claims description 9
- 101001110823 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) 60S ribosomal protein L6-A Proteins 0.000 claims description 9
- 101000712176 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) 60S ribosomal protein L6-B Proteins 0.000 claims description 9
- 102100040374 U4/U6 small nuclear ribonucleoprotein Prp3 Human genes 0.000 claims description 9
- 235000010290 biphenyl Nutrition 0.000 claims description 9
- 239000004009 herbicide Substances 0.000 claims description 9
- BSDQITJYKQHXQR-UHFFFAOYSA-N methyl prop-2-eneperoxoate Chemical compound COOC(=O)C=C BSDQITJYKQHXQR-UHFFFAOYSA-N 0.000 claims description 9
- 231100000719 pollutant Toxicity 0.000 claims description 9
- 239000000326 ultraviolet stabilizing agent Substances 0.000 claims description 9
- WURBVZBTWMNKQT-UHFFFAOYSA-N 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-one Chemical compound C1=NC=NN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 WURBVZBTWMNKQT-UHFFFAOYSA-N 0.000 claims description 8
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 claims description 8
- 239000005695 Ammonium acetate Substances 0.000 claims description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 8
- 229910019142 PO4 Inorganic materials 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 8
- 235000019257 ammonium acetate Nutrition 0.000 claims description 8
- 229940043376 ammonium acetate Drugs 0.000 claims description 8
- VEMKTZHHVJILDY-UXHICEINSA-N bioresmethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 VEMKTZHHVJILDY-UXHICEINSA-N 0.000 claims description 8
- 238000002347 injection Methods 0.000 claims description 8
- 239000007924 injection Substances 0.000 claims description 8
- 239000010452 phosphate Substances 0.000 claims description 8
- 239000011734 sodium Substances 0.000 claims description 8
- 229910052708 sodium Inorganic materials 0.000 claims description 8
- 229930185605 Bisphenol Natural products 0.000 claims description 7
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 claims description 7
- 150000001565 benzotriazoles Chemical class 0.000 claims description 7
- TWFZGCMQGLPBSX-UHFFFAOYSA-N carbendazim Chemical compound C1=CC=C2NC(NC(=O)OC)=NC2=C1 TWFZGCMQGLPBSX-UHFFFAOYSA-N 0.000 claims description 7
- 150000005690 diesters Chemical class 0.000 claims description 7
- 239000000284 extract Substances 0.000 claims description 7
- 239000000417 fungicide Substances 0.000 claims description 7
- 125000005498 phthalate group Chemical class 0.000 claims description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims description 6
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims description 6
- 230000002378 acidificating effect Effects 0.000 claims description 6
- PXKLMJQFEQBVLD-UHFFFAOYSA-N bisphenol F Chemical compound C1=CC(O)=CC=C1CC1=CC=C(O)C=C1 PXKLMJQFEQBVLD-UHFFFAOYSA-N 0.000 claims description 6
- FLKPEMZONWLCSK-UHFFFAOYSA-N diethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 claims description 6
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 claims description 6
- JLYXXMFPNIAWKQ-UHFFFAOYSA-N gamma-hexachlorocyclohexane Natural products ClC1C(Cl)C(Cl)C(Cl)C(Cl)C1Cl JLYXXMFPNIAWKQ-UHFFFAOYSA-N 0.000 claims description 6
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 claims description 6
- 239000003987 organophosphate pesticide Substances 0.000 claims description 6
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 claims description 6
- RDYMFSUJUZBWLH-AZVNHNRSSA-N qy5y9r7g0e Chemical compound C([C@H]12)OS(=O)OC[C@@H]1[C@]1(Cl)C(Cl)=C(Cl)[C@@]2(Cl)C1(Cl)Cl RDYMFSUJUZBWLH-AZVNHNRSSA-N 0.000 claims description 6
- CIPFDHFTBYJKQB-UHFFFAOYSA-N 1,2,3,4,5-pentachloro-6-(2,3,4,5,6-pentachlorophenoxy)benzene Chemical group ClC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1OC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl CIPFDHFTBYJKQB-UHFFFAOYSA-N 0.000 claims description 5
- IISBACLAFKSPIT-MAJJRYNQSA-N 1,2,4,5-tetradeuterio-3-deuteriooxy-6-[1,1,1,3,3,3-hexadeuterio-2-(2,3,5,6-tetradeuterio-4-deuteriooxyphenyl)propan-2-yl]benzene Chemical group [2H]C1=C([2H])C(O[2H])=C([2H])C([2H])=C1C(C([2H])([2H])[2H])(C([2H])([2H])[2H])C1=C([2H])C([2H])=C(O[2H])C([2H])=C1[2H] IISBACLAFKSPIT-MAJJRYNQSA-N 0.000 claims description 5
- 239000005740 Boscalid Substances 0.000 claims description 5
- SNGREZUHAYWORS-LLXNCONNSA-N O[13C](=O)[13C](F)(F)[13C](F)(F)[13C](F)(F)[13C](F)(F)[13C](F)(F)[13C](F)(F)[13C](F)(F)F Chemical compound O[13C](=O)[13C](F)(F)[13C](F)(F)[13C](F)(F)[13C](F)(F)[13C](F)(F)[13C](F)(F)[13C](F)(F)F SNGREZUHAYWORS-LLXNCONNSA-N 0.000 claims description 5
- ZFOZVQLOBQUTQQ-UHFFFAOYSA-N Tributyl citrate Chemical compound CCCCOC(=O)CC(O)(C(=O)OCCCC)CC(=O)OCCCC ZFOZVQLOBQUTQQ-UHFFFAOYSA-N 0.000 claims description 5
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 claims description 5
- 239000012964 benzotriazole Substances 0.000 claims description 5
- 125000006267 biphenyl group Chemical group 0.000 claims description 5
- 229940118790 boscalid Drugs 0.000 claims description 5
- WYEMLYFITZORAB-UHFFFAOYSA-N boscalid Chemical compound C1=CC(Cl)=CC=C1C1=CC=CC=C1NC(=O)C1=CC=CN=C1Cl WYEMLYFITZORAB-UHFFFAOYSA-N 0.000 claims description 5
- 150000002989 phenols Chemical class 0.000 claims description 5
- 239000000243 solution Substances 0.000 claims description 5
- VDIFKDMFGPIVCQ-UHFFFAOYSA-N (2-tert-butylphenyl) diphenyl phosphate Chemical compound CC(C)(C)C1=CC=CC=C1OP(=O)(OC=1C=CC=CC=1)OC1=CC=CC=C1 VDIFKDMFGPIVCQ-UHFFFAOYSA-N 0.000 claims description 4
- BTJPUDCSZVCXFQ-UHFFFAOYSA-N 2,4-diethylthioxanthen-9-one Chemical compound C1=CC=C2C(=O)C3=CC(CC)=CC(CC)=C3SC2=C1 BTJPUDCSZVCXFQ-UHFFFAOYSA-N 0.000 claims description 4
- NXQMCAOPTPLPRL-UHFFFAOYSA-N 2-(2-benzoyloxyethoxy)ethyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCCOCCOC(=O)C1=CC=CC=C1 NXQMCAOPTPLPRL-UHFFFAOYSA-N 0.000 claims description 4
- YEDUAINPPJYDJZ-UHFFFAOYSA-N 2-hydroxybenzothiazole Chemical compound C1=CC=C2SC(O)=NC2=C1 YEDUAINPPJYDJZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000005730 Azoxystrobin Substances 0.000 claims description 4
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 claims description 4
- NIQCNGHVCWTJSM-UHFFFAOYSA-N Dimethyl phthalate Chemical compound COC(=O)C1=CC=CC=C1C(=O)OC NIQCNGHVCWTJSM-UHFFFAOYSA-N 0.000 claims description 4
- WFDXOXNFNRHQEC-GHRIWEEISA-N azoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1OC1=CC(OC=2C(=CC=CC=2)C#N)=NC=N1 WFDXOXNFNRHQEC-GHRIWEEISA-N 0.000 claims description 4
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 claims description 4
- PLUDEAUQZKPAIN-UHFFFAOYSA-N bis(4-methylphenyl) hydrogen phosphate Chemical compound C1=CC(C)=CC=C1OP(O)(=O)OC1=CC=C(C)C=C1 PLUDEAUQZKPAIN-UHFFFAOYSA-N 0.000 claims description 4
- 210000004369 blood Anatomy 0.000 claims description 4
- 239000008280 blood Substances 0.000 claims description 4
- SBPBAQFWLVIOKP-UHFFFAOYSA-N chlorpyrifos Chemical compound CCOP(=S)(OCC)OC1=NC(Cl)=C(Cl)C=C1Cl SBPBAQFWLVIOKP-UHFFFAOYSA-N 0.000 claims description 4
- 230000007423 decrease Effects 0.000 claims description 4
- 230000003247 decreasing effect Effects 0.000 claims description 4
- DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 claims description 4
- ALOUNLDAKADEEB-UHFFFAOYSA-N dimethyl sebacate Chemical compound COC(=O)CCCCCCCCC(=O)OC ALOUNLDAKADEEB-UHFFFAOYSA-N 0.000 claims description 4
- MQHNKCZKNAJROC-UHFFFAOYSA-N dipropyl phthalate Chemical compound CCCOC(=O)C1=CC=CC=C1C(=O)OCCC MQHNKCZKNAJROC-UHFFFAOYSA-N 0.000 claims description 4
- JLYXXMFPNIAWKQ-GNIYUCBRSA-N gamma-hexachlorocyclohexane Chemical compound Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl JLYXXMFPNIAWKQ-GNIYUCBRSA-N 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 4
- GXELTROTKVKZBQ-UHFFFAOYSA-N n,n-dibenzylhydroxylamine Chemical compound C=1C=CC=CC=1CN(O)CC1=CC=CC=C1 GXELTROTKVKZBQ-UHFFFAOYSA-N 0.000 claims description 4
- FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims description 4
- RLBIQVVOMOPOHC-UHFFFAOYSA-N parathion-methyl Chemical compound COP(=S)(OC)OC1=CC=C([N+]([O-])=O)C=C1 RLBIQVVOMOPOHC-UHFFFAOYSA-N 0.000 claims description 4
- PCIUEQPBYFRTEM-UHFFFAOYSA-N perfluorodecanoic acid Chemical compound OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F PCIUEQPBYFRTEM-UHFFFAOYSA-N 0.000 claims description 4
- UZUFPBIDKMEQEQ-UHFFFAOYSA-N perfluorononanoic acid Chemical compound OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F UZUFPBIDKMEQEQ-UHFFFAOYSA-N 0.000 claims description 4
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 claims description 4
- ODCWYMIRDDJXKW-UHFFFAOYSA-N simazine Chemical compound CCNC1=NC(Cl)=NC(NCC)=N1 ODCWYMIRDDJXKW-UHFFFAOYSA-N 0.000 claims description 4
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 claims description 4
- ZDPHROOEEOARMN-UHFFFAOYSA-N undecanoic acid Chemical compound CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 claims description 4
- DUEPRVBVGDRKAG-HPRDVNIFSA-N (2,2-dimethyl-3h-1-benzofuran-7-yl) n-(trideuteriomethyl)carbamate Chemical compound [2H]C([2H])([2H])NC(=O)OC1=CC=CC2=C1OC(C)(C)C2 DUEPRVBVGDRKAG-HPRDVNIFSA-N 0.000 claims description 3
- KGANAERDZBAECK-UHFFFAOYSA-N (3-phenoxyphenyl)methanol Chemical compound OCC1=CC=CC(OC=2C=CC=CC=2)=C1 KGANAERDZBAECK-UHFFFAOYSA-N 0.000 claims description 3
- RLLPVAHGXHCWKJ-MJGOQNOKSA-N (3-phenoxyphenyl)methyl (1r,3s)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate Chemical compound CC1(C)[C@H](C=C(Cl)Cl)[C@H]1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-MJGOQNOKSA-N 0.000 claims description 3
- RGCVYEOTYJCNOS-UHFFFAOYSA-N (4-cyano-2-methylphenyl)boronic acid Chemical compound CC1=CC(C#N)=CC=C1B(O)O RGCVYEOTYJCNOS-UHFFFAOYSA-N 0.000 claims description 3
- ULGAVXUJJBOWOD-UHFFFAOYSA-N (4-tert-butylphenyl) diphenyl phosphate Chemical compound C1=CC(C(C)(C)C)=CC=C1OP(=O)(OC=1C=CC=CC=1)OC1=CC=CC=C1 ULGAVXUJJBOWOD-UHFFFAOYSA-N 0.000 claims description 3
- OYGQVDSRYXATEL-UHFFFAOYSA-N 1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoroheptane-1-sulfonic acid Chemical compound OS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F OYGQVDSRYXATEL-UHFFFAOYSA-N 0.000 claims description 3
- HCNHNBLSNVSJTJ-UHFFFAOYSA-N 1,1-Bis(4-hydroxyphenyl)ethane Chemical compound C=1C=C(O)C=CC=1C(C)C1=CC=C(O)C=C1 HCNHNBLSNVSJTJ-UHFFFAOYSA-N 0.000 claims description 3
- OWEYKIWAZBBXJK-UHFFFAOYSA-N 1,1-Dichloro-2,2-bis(4-hydroxyphenyl)ethylene Chemical compound C1=CC(O)=CC=C1C(=C(Cl)Cl)C1=CC=C(O)C=C1 OWEYKIWAZBBXJK-UHFFFAOYSA-N 0.000 claims description 3
- GYSCBCSGKXNZRH-UHFFFAOYSA-N 1-benzothiophene-2-carboxamide Chemical compound C1=CC=C2SC(C(=O)N)=CC2=C1 GYSCBCSGKXNZRH-UHFFFAOYSA-N 0.000 claims description 3
- IBFAIOMGVHPWRQ-UHFFFAOYSA-N 1-ethoxy-2,3-difluoro-4-[4-(4-propylcyclohexyl)phenyl]benzene Chemical group C1CC(CCC)CCC1C1=CC=C(C=2C(=C(F)C(OCC)=CC=2)F)C=C1 IBFAIOMGVHPWRQ-UHFFFAOYSA-N 0.000 claims description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 3
- YIVXMZJTEQBPQO-UHFFFAOYSA-N 2,4-DB Chemical compound OC(=O)CCCOC1=CC=C(Cl)C=C1Cl YIVXMZJTEQBPQO-UHFFFAOYSA-N 0.000 claims description 3
- LHPPDQUVECZQSW-UHFFFAOYSA-N 2-(benzotriazol-2-yl)-4,6-ditert-butylphenol Chemical compound CC(C)(C)C1=CC(C(C)(C)C)=CC(N2N=C3C=CC=CC3=N2)=C1O LHPPDQUVECZQSW-UHFFFAOYSA-N 0.000 claims description 3
- LLWADFLAOKUBDR-UHFFFAOYSA-N 2-methyl-4-chlorophenoxybutyric acid Chemical compound CC1=CC(Cl)=CC=C1OCCCC(O)=O LLWADFLAOKUBDR-UHFFFAOYSA-N 0.000 claims description 3
- MQWCQFCZUNBTCM-UHFFFAOYSA-N 2-tert-butyl-6-(3-tert-butyl-2-hydroxy-5-methylphenyl)sulfanyl-4-methylphenol Chemical compound CC(C)(C)C1=CC(C)=CC(SC=2C(=C(C=C(C)C=2)C(C)(C)C)O)=C1O MQWCQFCZUNBTCM-UHFFFAOYSA-N 0.000 claims description 3
- XMTQQYYKAHVGBJ-UHFFFAOYSA-N 3-(3,4-DICHLOROPHENYL)-1,1-DIMETHYLUREA Chemical compound CN(C)C(=O)NC1=CC=C(Cl)C(Cl)=C1 XMTQQYYKAHVGBJ-UHFFFAOYSA-N 0.000 claims description 3
- PUIYMUZLKQOUOZ-LIJFRPJRSA-N 3-(4-propan-2-ylphenyl)-1,1-bis(trideuteriomethyl)urea Chemical compound [2H]C([2H])([2H])N(C([2H])([2H])[2H])C(=O)NC1=CC=C(C(C)C)C=C1 PUIYMUZLKQOUOZ-LIJFRPJRSA-N 0.000 claims description 3
- SPVZAYWHHVLPBN-HWKANZROSA-N 3-[(e)-2-chloro-3,3,3-trifluoroprop-1-enyl]-2,2-dimethylcyclopropane-1-carboxylic acid Chemical compound CC1(C)C(\C=C(\Cl)C(F)(F)F)C1C(O)=O SPVZAYWHHVLPBN-HWKANZROSA-N 0.000 claims description 3
- VPWNQTHUCYMVMZ-UHFFFAOYSA-N 4,4'-sulfonyldiphenol Chemical compound C1=CC(O)=CC=C1S(=O)(=O)C1=CC=C(O)C=C1 VPWNQTHUCYMVMZ-UHFFFAOYSA-N 0.000 claims description 3
- WJCNZQLZVWNLKY-RHQRLBAQSA-N 4-(4,5,6,7-tetradeuterio-1h-benzimidazol-2-yl)-1,3-thiazole Chemical compound N=1C2=C([2H])C([2H])=C([2H])C([2H])=C2NC=1C1=CSC=N1 WJCNZQLZVWNLKY-RHQRLBAQSA-N 0.000 claims description 3
- BATCUENAARTUKW-UHFFFAOYSA-N 4-[(4-hydroxyphenyl)-diphenylmethyl]phenol Chemical compound C1=CC(O)=CC=C1C(C=1C=CC(O)=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 BATCUENAARTUKW-UHFFFAOYSA-N 0.000 claims description 3
- IISBACLAFKSPIT-WFGJKAKNSA-N 4-[1,1,1,3,3,3-hexadeuterio-2-(4-hydroxyphenyl)propan-2-yl]phenol Chemical compound C=1C=C(O)C=CC=1C(C([2H])([2H])[2H])(C([2H])([2H])[2H])C1=CC=C(O)C=C1 IISBACLAFKSPIT-WFGJKAKNSA-N 0.000 claims description 3
- IJWIRZQYWANBMP-UHFFFAOYSA-N 4-[2-(4-hydroxy-3-propan-2-ylphenyl)propan-2-yl]-2-propan-2-ylphenol Chemical compound C1=C(O)C(C(C)C)=CC(C(C)(C)C=2C=C(C(O)=CC=2)C(C)C)=C1 IJWIRZQYWANBMP-UHFFFAOYSA-N 0.000 claims description 3
- PVFQHGDIOXNKIC-UHFFFAOYSA-N 4-[2-[3-[2-(4-hydroxyphenyl)propan-2-yl]phenyl]propan-2-yl]phenol Chemical compound C=1C=CC(C(C)(C)C=2C=CC(O)=CC=2)=CC=1C(C)(C)C1=CC=C(O)C=C1 PVFQHGDIOXNKIC-UHFFFAOYSA-N 0.000 claims description 3
- RYUJRXVZSJCHDZ-UHFFFAOYSA-N 8-methylnonyl diphenyl phosphate Chemical compound C=1C=CC=CC=1OP(=O)(OCCCCCCCC(C)C)OC1=CC=CC=C1 RYUJRXVZSJCHDZ-UHFFFAOYSA-N 0.000 claims description 3
- NNKRUBFJSSBFSS-UHFFFAOYSA-N Bis-(1,3-dichloro-2-propyl) phosphate Chemical compound ClCC(CCl)OP(=O)(O)OC(CCl)CCl NNKRUBFJSSBFSS-UHFFFAOYSA-N 0.000 claims description 3
- ORAAZVDXWSKZHK-UHFFFAOYSA-N Bis-(1-chloro-2-propyl) phosphate Chemical compound CC(CCl)OP(O)(=O)OC(C)CCl ORAAZVDXWSKZHK-UHFFFAOYSA-N 0.000 claims description 3
- VOWWYDCFAISREI-UHFFFAOYSA-N Bisphenol AP Chemical compound C=1C=C(O)C=CC=1C(C=1C=CC(O)=CC=1)(C)C1=CC=CC=C1 VOWWYDCFAISREI-UHFFFAOYSA-N 0.000 claims description 3
- HTVITOHKHWFJKO-UHFFFAOYSA-N Bisphenol B Chemical compound C=1C=C(O)C=CC=1C(C)(CC)C1=CC=C(O)C=C1 HTVITOHKHWFJKO-UHFFFAOYSA-N 0.000 claims description 3
- GIXXQTYGFOHYPT-UHFFFAOYSA-N Bisphenol P Chemical compound C=1C=C(C(C)(C)C=2C=CC(O)=CC=2)C=CC=1C(C)(C)C1=CC=C(O)C=C1 GIXXQTYGFOHYPT-UHFFFAOYSA-N 0.000 claims description 3
- SDDLEVPIDBLVHC-UHFFFAOYSA-N Bisphenol Z Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)CCCCC1 SDDLEVPIDBLVHC-UHFFFAOYSA-N 0.000 claims description 3
- 239000005944 Chlorpyrifos Substances 0.000 claims description 3
- UCNVFOCBFJOQAL-UHFFFAOYSA-N DDE Chemical group C=1C=C(Cl)C=CC=1C(=C(Cl)Cl)C1=CC=C(Cl)C=C1 UCNVFOCBFJOQAL-UHFFFAOYSA-N 0.000 claims description 3
- GHVNFZFCNZKVNT-UHFFFAOYSA-N Decanoic acid Natural products CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 claims description 3
- JYFHYPJRHGVZDY-UHFFFAOYSA-N Dibutyl phosphate Chemical compound CCCCOP(O)(=O)OCCCC JYFHYPJRHGVZDY-UHFFFAOYSA-N 0.000 claims description 3
- 239000005947 Dimethoate Substances 0.000 claims description 3
- 239000005510 Diuron Substances 0.000 claims description 3
- 239000005574 MCPA Substances 0.000 claims description 3
- 239000005949 Malathion Substances 0.000 claims description 3
- XQVWYOYUZDUNRW-UHFFFAOYSA-N N-Phenyl-1-naphthylamine Chemical compound C=1C=CC2=CC=CC=C2C=1NC1=CC=CC=C1 XQVWYOYUZDUNRW-UHFFFAOYSA-N 0.000 claims description 3
- DRUKNYVQGHETPO-UHFFFAOYSA-N Nonanedioic acid dimethyl ester Natural products COC(=O)CCCCCCCC(=O)OC DRUKNYVQGHETPO-UHFFFAOYSA-N 0.000 claims description 3
- CGSLYBDCEGBZCG-UHFFFAOYSA-N Octicizer Chemical compound C=1C=CC=CC=1OP(=O)(OCC(CC)CCCC)OC1=CC=CC=C1 CGSLYBDCEGBZCG-UHFFFAOYSA-N 0.000 claims description 3
- VWGNQYSIWFHEQU-IBAUKUMTSA-N Oxychlordane Chemical compound ClC1=C(Cl)[C@]2(Cl)C3C(Cl)C4(Cl)OC4C3[C@@]1(Cl)C2(Cl)Cl VWGNQYSIWFHEQU-IBAUKUMTSA-N 0.000 claims description 3
- JKIJEFPNVSHHEI-UHFFFAOYSA-N Phenol, 2,4-bis(1,1-dimethylethyl)-, phosphite (3:1) Chemical compound CC(C)(C)C1=CC(C(C)(C)C)=CC=C1OP(OC=1C(=CC(=CC=1)C(C)(C)C)C(C)(C)C)OC1=CC=C(C(C)(C)C)C=C1C(C)(C)C JKIJEFPNVSHHEI-UHFFFAOYSA-N 0.000 claims description 3
- WHKUVVPPKQRRBV-UHFFFAOYSA-N Trasan Chemical compound CC1=CC(Cl)=CC=C1OCC(O)=O WHKUVVPPKQRRBV-UHFFFAOYSA-N 0.000 claims description 3
- PQYJRMFWJJONBO-UHFFFAOYSA-N Tris(2,3-dibromopropyl) phosphate Chemical compound BrCC(Br)COP(=O)(OCC(Br)CBr)OCC(Br)CBr PQYJRMFWJJONBO-UHFFFAOYSA-N 0.000 claims description 3
- DZONBDFKZXLORJ-UHFFFAOYSA-N [2,4-di(propan-2-yl)phenyl] diphenyl phosphate Chemical compound CC(C)C1=CC(C(C)C)=CC=C1OP(=O)(OC=1C=CC=CC=1)OC1=CC=CC=C1 DZONBDFKZXLORJ-UHFFFAOYSA-N 0.000 claims description 3
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 claims description 3
- MXWJVTOOROXGIU-UHFFFAOYSA-N atrazine Chemical compound CCNC1=NC(Cl)=NC(NC(C)C)=N1 MXWJVTOOROXGIU-UHFFFAOYSA-N 0.000 claims description 3
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 claims description 3
- 150000008366 benzophenones Chemical class 0.000 claims description 3
- SBPBAQFWLVIOKP-MWUKXHIBSA-N bis(1,1,2,2,2-pentadeuterioethoxy)-sulfanylidene-(3,5,6-trichloropyridin-2-yl)oxy-$l^{5}-phosphane Chemical compound [2H]C([2H])([2H])C([2H])([2H])OP(=S)(OC([2H])([2H])C([2H])([2H])[2H])OC1=NC(Cl)=C(Cl)C=C1Cl SBPBAQFWLVIOKP-MWUKXHIBSA-N 0.000 claims description 3
- RWCCWEUUXYIKHB-LHNTUAQVSA-N bis(2,3,4,5,6-pentadeuteriophenyl)methanone Chemical compound [2H]C1=C([2H])C([2H])=C([2H])C([2H])=C1C(=O)C1=C([2H])C([2H])=C([2H])C([2H])=C1[2H] RWCCWEUUXYIKHB-LHNTUAQVSA-N 0.000 claims description 3
- ALEROMXYYSQFLX-UHFFFAOYSA-N bis(4-methylpentyl) benzene-1,2-dicarboxylate Chemical compound CC(C)CCCOC(=O)C1=CC=CC=C1C(=O)OCCCC(C)C ALEROMXYYSQFLX-UHFFFAOYSA-N 0.000 claims description 3
- MQDJYUACMFCOFT-UHFFFAOYSA-N bis[2-(1-hydroxycyclohexyl)phenyl]methanone Chemical compound C=1C=CC=C(C(=O)C=2C(=CC=CC=2)C2(O)CCCCC2)C=1C1(O)CCCCC1 MQDJYUACMFCOFT-UHFFFAOYSA-N 0.000 claims description 3
- ZFVMWEVVKGLCIJ-UHFFFAOYSA-N bisphenol AF Chemical compound C1=CC(O)=CC=C1C(C(F)(F)F)(C(F)(F)F)C1=CC=C(O)C=C1 ZFVMWEVVKGLCIJ-UHFFFAOYSA-N 0.000 claims description 3
- FHIVAFMUCKRCQO-UHFFFAOYSA-N diazinon Chemical compound CCOP(=S)(OCC)OC1=CC(C)=NC(C(C)C)=N1 FHIVAFMUCKRCQO-UHFFFAOYSA-N 0.000 claims description 3
- OEBRKCOSUFCWJD-UHFFFAOYSA-N dichlorvos Chemical compound COP(=O)(OC)OC=C(Cl)Cl OEBRKCOSUFCWJD-UHFFFAOYSA-N 0.000 claims description 3
- 229950001327 dichlorvos Drugs 0.000 claims description 3
- VOWAEIGWURALJQ-ZZRPVTOQSA-N dicyclohexyl 3,4,5,6-tetradeuteriobenzene-1,2-dicarboxylate Chemical compound C1CCCCC1OC(=O)C1=C([2H])C([2H])=C([2H])C([2H])=C1C(=O)OC1CCCCC1 VOWAEIGWURALJQ-ZZRPVTOQSA-N 0.000 claims description 3
- JXSJBGJIGXNWCI-UHFFFAOYSA-N diethyl 2-[(dimethoxyphosphorothioyl)thio]succinate Chemical compound CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC JXSJBGJIGXNWCI-UHFFFAOYSA-N 0.000 claims description 3
- MCWXGJITAZMZEV-UHFFFAOYSA-N dimethoate Chemical compound CNC(=O)CSP(=S)(OC)OC MCWXGJITAZMZEV-UHFFFAOYSA-N 0.000 claims description 3
- ASMQGLCHMVWBQR-UHFFFAOYSA-M diphenyl phosphate Chemical compound C=1C=CC=CC=1OP(=O)([O-])OC1=CC=CC=C1 ASMQGLCHMVWBQR-UHFFFAOYSA-M 0.000 claims description 3
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 claims description 3
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 claims description 3
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 claims description 3
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 claims description 3
- XXOYNJXVWVNOOJ-UHFFFAOYSA-N fenuron Chemical compound CN(C)C(=O)NC1=CC=CC=C1 XXOYNJXVWVNOOJ-UHFFFAOYSA-N 0.000 claims description 3
- FQKUGOMFVDPBIZ-UHFFFAOYSA-N flusilazole Chemical compound C=1C=C(F)C=CC=1[Si](C=1C=CC(F)=CC=1)(C)CN1C=NC=N1 FQKUGOMFVDPBIZ-UHFFFAOYSA-N 0.000 claims description 3
- 230000002363 herbicidal effect Effects 0.000 claims description 3
- ZFSLODLOARCGLH-UHFFFAOYSA-N isocyanuric acid Chemical compound OC1=NC(O)=NC(O)=N1 ZFSLODLOARCGLH-UHFFFAOYSA-N 0.000 claims description 3
- PUIYMUZLKQOUOZ-UHFFFAOYSA-N isoproturon Chemical compound CC(C)C1=CC=C(NC(=O)N(C)C)C=C1 PUIYMUZLKQOUOZ-UHFFFAOYSA-N 0.000 claims description 3
- 229960002809 lindane Drugs 0.000 claims description 3
- 229960000453 malathion Drugs 0.000 claims description 3
- RYPQSGURZSTFSX-UHFFFAOYSA-N mono(2-ethyl-5-hydroxyhexyl) phthalate Chemical compound CC(O)CCC(CC)COC(=O)C1=CC=CC=C1C(O)=O RYPQSGURZSTFSX-UHFFFAOYSA-N 0.000 claims description 3
- YWTYJOPNNQFBPC-KHORGVISSA-N n-[1-[(6-chloropyridin-3-yl)methyl]-4,4,5,5-tetradeuterioimidazol-2-yl]nitramide Chemical compound [2H]C1([2H])C([2H])([2H])N=C(N[N+]([O-])=O)N1CC1=CC=C(Cl)N=C1 YWTYJOPNNQFBPC-KHORGVISSA-N 0.000 claims description 3
- LCCNCVORNKJIRZ-UHFFFAOYSA-N parathion Chemical compound CCOP(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 LCCNCVORNKJIRZ-UHFFFAOYSA-N 0.000 claims description 3
- YFSUTJLHUFNCNZ-UHFFFAOYSA-N perfluorooctane-1-sulfonic acid Chemical compound OS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F YFSUTJLHUFNCNZ-UHFFFAOYSA-N 0.000 claims description 3
- SNGREZUHAYWORS-UHFFFAOYSA-N perfluorooctanoic acid Chemical compound OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F SNGREZUHAYWORS-UHFFFAOYSA-N 0.000 claims description 3
- SIDINRCMMRKXGQ-UHFFFAOYSA-N perfluoroundecanoic acid Chemical compound OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F SIDINRCMMRKXGQ-UHFFFAOYSA-N 0.000 claims description 3
- RMNODSGCFHVNDC-UHFFFAOYSA-N phenyl bis(2-propan-2-ylphenyl) phosphate Chemical compound CC(C)C1=CC=CC=C1OP(=O)(OC=1C(=CC=CC=1)C(C)C)OC1=CC=CC=C1 RMNODSGCFHVNDC-UHFFFAOYSA-N 0.000 claims description 3
- GQJZORIDXGBCCT-UHFFFAOYSA-N phenyl bis(4-propan-2-ylphenyl) phosphate Chemical compound C1=CC(C(C)C)=CC=C1OP(=O)(OC=1C=CC(=CC=1)C(C)C)OC1=CC=CC=C1 GQJZORIDXGBCCT-UHFFFAOYSA-N 0.000 claims description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 3
- WXNIEINRHBIHRE-UHFFFAOYSA-M sodium;1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluorohexane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F WXNIEINRHBIHRE-UHFFFAOYSA-M 0.000 claims description 3
- BIWJNBZANLAXMG-OESJLNMISA-N trans-chlordane Chemical compound ClC1=C(Cl)[C@@]2(Cl)[C@@H]3C[C@H](Cl)[C@@H](Cl)[C@@H]3[C@]1(Cl)C2(Cl)Cl BIWJNBZANLAXMG-OESJLNMISA-N 0.000 claims description 3
- STCOOQWBFONSKY-UHFFFAOYSA-N tributyl phosphate Chemical compound CCCCOP(=O)(OCCCC)OCCCC STCOOQWBFONSKY-UHFFFAOYSA-N 0.000 claims description 3
- DQWPFSLDHJDLRL-UHFFFAOYSA-N triethyl phosphate Chemical compound CCOP(=O)(OCC)OCC DQWPFSLDHJDLRL-UHFFFAOYSA-N 0.000 claims description 3
- RXPQRKFMDQNODS-UHFFFAOYSA-N tripropyl phosphate Chemical compound CCCOP(=O)(OCCC)OCCC RXPQRKFMDQNODS-UHFFFAOYSA-N 0.000 claims description 3
- DQWPFSLDHJDLRL-NLBPYYKNSA-N tris(1,1,2,2,2-pentadeuterioethyl) phosphate Chemical compound [2H]C([2H])([2H])C([2H])([2H])OP(=O)(OC([2H])([2H])C([2H])([2H])[2H])OC([2H])([2H])C([2H])([2H])[2H] DQWPFSLDHJDLRL-NLBPYYKNSA-N 0.000 claims description 3
- ASLWPAWFJZFCKF-BXSQCBKHSA-N tris(1,3-dichloro-1,1,2,3,3-pentadeuteriopropan-2-yl) phosphate Chemical compound [2H]C([2H])(Cl)C([2H])(OP(=O)(OC([2H])(C([2H])([2H])Cl)C([2H])([2H])Cl)OC([2H])(C([2H])([2H])Cl)C([2H])([2H])Cl)C([2H])([2H])Cl ASLWPAWFJZFCKF-BXSQCBKHSA-N 0.000 claims description 3
- XZZNDPSIHUTMOC-KLHTYYPYSA-N tris(2,3,4,5,6-pentadeuteriophenyl) phosphate Chemical compound [2H]C1=C([2H])C([2H])=C([2H])C([2H])=C1OP(=O)(OC=1C(=C([2H])C([2H])=C([2H])C=1[2H])[2H])OC1=C([2H])C([2H])=C([2H])C([2H])=C1[2H] XZZNDPSIHUTMOC-KLHTYYPYSA-N 0.000 claims description 3
- WTLBZVNBAKMVDP-UHFFFAOYSA-N tris(2-butoxyethyl) phosphate Chemical compound CCCCOCCOP(=O)(OCCOCCCC)OCCOCCCC WTLBZVNBAKMVDP-UHFFFAOYSA-N 0.000 claims description 3
- HZZVNABLNATHQO-UHFFFAOYSA-N tris(3-propan-2-ylphenyl) phosphate Chemical compound CC(C)C1=CC=CC(OP(=O)(OC=2C=C(C=CC=2)C(C)C)OC=2C=C(C=CC=2)C(C)C)=C1 HZZVNABLNATHQO-UHFFFAOYSA-N 0.000 claims description 3
- ANVREEJNGJMLOV-UHFFFAOYSA-N tris(4-propan-2-ylphenyl) phosphate Chemical compound C1=CC(C(C)C)=CC=C1OP(=O)(OC=1C=CC(=CC=1)C(C)C)OC1=CC=C(C(C)C)C=C1 ANVREEJNGJMLOV-UHFFFAOYSA-N 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- ZXQYGBMAQZUVMI-RDDWSQKMSA-N (1S)-cis-(alphaR)-cyhalothrin Chemical compound CC1(C)[C@H](\C=C(/Cl)C(F)(F)F)[C@@H]1C(=O)O[C@@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 ZXQYGBMAQZUVMI-RDDWSQKMSA-N 0.000 claims description 2
- FTJBMYITMFAUCP-UHFFFAOYSA-N (3,5-dichlorophenyl)urea Chemical compound NC(=O)NC1=CC(Cl)=CC(Cl)=C1 FTJBMYITMFAUCP-UHFFFAOYSA-N 0.000 claims description 2
- OWICEWMBIBPFAH-UHFFFAOYSA-N (3-diphenoxyphosphoryloxyphenyl) diphenyl phosphate Chemical compound C=1C=CC=CC=1OP(OC=1C=C(OP(=O)(OC=2C=CC=CC=2)OC=2C=CC=CC=2)C=CC=1)(=O)OC1=CC=CC=C1 OWICEWMBIBPFAH-UHFFFAOYSA-N 0.000 claims description 2
- WCXDHFDTOYPNIE-RIYZIHGNSA-N (E)-acetamiprid Chemical compound N#C/N=C(\C)N(C)CC1=CC=C(Cl)N=C1 WCXDHFDTOYPNIE-RIYZIHGNSA-N 0.000 claims description 2
- HOKKPVIRMVDYPB-UVTDQMKNSA-N (Z)-thiacloprid Chemical compound C1=NC(Cl)=CC=C1CN1C(=N/C#N)/SCC1 HOKKPVIRMVDYPB-UVTDQMKNSA-N 0.000 claims description 2
- XYXJKPCGSGVSBO-UHFFFAOYSA-N 1,3,5-tris[(4-tert-butyl-3-hydroxy-2,6-dimethylphenyl)methyl]-1,3,5-triazinane-2,4,6-trione Chemical group CC1=CC(C(C)(C)C)=C(O)C(C)=C1CN1C(=O)N(CC=2C(=C(O)C(=CC=2C)C(C)(C)C)C)C(=O)N(CC=2C(=C(O)C(=CC=2C)C(C)(C)C)C)C1=O XYXJKPCGSGVSBO-UHFFFAOYSA-N 0.000 claims description 2
- PXMNMQRDXWABCY-UHFFFAOYSA-N 1-(4-chlorophenyl)-4,4-dimethyl-3-(1H-1,2,4-triazol-1-ylmethyl)pentan-3-ol Chemical compound C1=NC=NN1CC(O)(C(C)(C)C)CCC1=CC=C(Cl)C=C1 PXMNMQRDXWABCY-UHFFFAOYSA-N 0.000 claims description 2
- UKPTVLGWOKOZRG-UHFFFAOYSA-N 1-(4-ethylcyclohexyl)-4-[4-(trifluoromethoxy)phenyl]benzene Chemical group C1CC(CC)CCC1C1=CC=C(C=2C=CC(OC(F)(F)F)=CC=2)C=C1 UKPTVLGWOKOZRG-UHFFFAOYSA-N 0.000 claims description 2
- LQDARGUHUSPFNL-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)-3-(1,1,2,2-tetrafluoroethoxy)propyl]1,2,4-triazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(COC(F)(F)C(F)F)CN1C=NC=N1 LQDARGUHUSPFNL-UHFFFAOYSA-N 0.000 claims description 2
- WKBPZYKAUNRMKP-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)pentyl]1,2,4-triazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(CCC)CN1C=NC=N1 WKBPZYKAUNRMKP-UHFFFAOYSA-N 0.000 claims description 2
- YZLQPXLJLFVDEA-UHFFFAOYSA-N 1-chloro-2-(2-chlorophenyl)-4-(2,2-dichloroethenyl)benzene Chemical group ClC(Cl)=CC(C=C1)=CC(C(C=CC=C2)=C2Cl)=C1Cl YZLQPXLJLFVDEA-UHFFFAOYSA-N 0.000 claims description 2
- 239000012956 1-hydroxycyclohexylphenyl-ketone Substances 0.000 claims description 2
- LVDGGZAZAYHXEY-UHFFFAOYSA-N 2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,13-pentacosafluorotridecanoic acid Chemical compound OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F LVDGGZAZAYHXEY-UHFFFAOYSA-N 0.000 claims description 2
- RUDINRUXCKIXAJ-UHFFFAOYSA-N 2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,14-heptacosafluorotetradecanoic acid Chemical compound OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F RUDINRUXCKIXAJ-UHFFFAOYSA-N 0.000 claims description 2
- NCWPXDOVVTVZBC-UHFFFAOYSA-N 2,2,3,5,5,6-hexafluoro-3,6-bis(trifluoromethyl)-1,4-dioxane Chemical compound FC(F)(F)C1(F)OC(F)(F)C(F)(C(F)(F)F)OC1(F)F NCWPXDOVVTVZBC-UHFFFAOYSA-N 0.000 claims description 2
- JHYLOZKQMTWGPP-UHFFFAOYSA-N 2,9-bis[(3,5-ditert-butyl-4-hydroxyphenyl)methyl]decanedioic acid Chemical compound CC(C)(C)C1=C(O)C(C(C)(C)C)=CC(CC(CCCCCCC(CC=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)C(O)=O)C(O)=O)=C1 JHYLOZKQMTWGPP-UHFFFAOYSA-N 0.000 claims description 2
- OVSKIKFHRZPJSS-CBYSEHNBSA-N 2-(2,4-dichloro-3,5,6-trideuteriophenoxy)acetic acid Chemical compound [2H]c1c([2H])c(OCC(O)=O)c(Cl)c([2H])c1Cl OVSKIKFHRZPJSS-CBYSEHNBSA-N 0.000 claims description 2
- UFNOUKDBUJZYDE-UHFFFAOYSA-N 2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol Chemical compound C1=NC=NN1CC(O)(C=1C=CC(Cl)=CC=1)C(C)C1CC1 UFNOUKDBUJZYDE-UHFFFAOYSA-N 0.000 claims description 2
- UHGULLIUJBCTEF-UHFFFAOYSA-N 2-aminobenzothiazole Chemical compound C1=CC=C2SC(N)=NC2=C1 UHGULLIUJBCTEF-UHFFFAOYSA-N 0.000 claims description 2
- UTBVIMLZIRIFFR-UHFFFAOYSA-N 2-methylthio-1,3-benzothiazole Chemical compound C1=CC=C2SC(SC)=NC2=C1 UTBVIMLZIRIFFR-UHFFFAOYSA-N 0.000 claims description 2
- ACVHLWLOORYJEE-UHFFFAOYSA-N 2-o-cyclohexyl 1-o-(2-methylpropyl) benzene-1,2-dicarboxylate Chemical compound CC(C)COC(=O)C1=CC=CC=C1C(=O)OC1CCCCC1 ACVHLWLOORYJEE-UHFFFAOYSA-N 0.000 claims description 2
- ALKCLFLTXBBMMP-UHFFFAOYSA-N 3,7-dimethylocta-1,6-dien-3-yl hexanoate Chemical compound CCCCCC(=O)OC(C)(C=C)CCC=C(C)C ALKCLFLTXBBMMP-UHFFFAOYSA-N 0.000 claims description 2
- RQDJADAKIFFEKQ-UHFFFAOYSA-N 4-(4-chlorophenyl)-2-phenyl-2-(1,2,4-triazol-1-ylmethyl)butanenitrile Chemical compound C1=CC(Cl)=CC=C1CCC(C=1C=CC=CC=1)(C#N)CN1N=CN=C1 RQDJADAKIFFEKQ-UHFFFAOYSA-N 0.000 claims description 2
- RZCQJZFWJZHMPK-UHFFFAOYSA-N 4-(4-propoxyphenyl)benzonitrile Chemical compound C1=CC(OCCC)=CC=C1C1=CC=C(C#N)C=C1 RZCQJZFWJZHMPK-UHFFFAOYSA-N 0.000 claims description 2
- VSAWBBYYMBQKIK-UHFFFAOYSA-N 4-[[3,5-bis[(3,5-ditert-butyl-4-hydroxyphenyl)methyl]-2,4,6-trimethylphenyl]methyl]-2,6-ditert-butylphenol Chemical compound CC1=C(CC=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)C(C)=C(CC=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)C(C)=C1CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 VSAWBBYYMBQKIK-UHFFFAOYSA-N 0.000 claims description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 claims description 2
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 claims description 2
- XEFQLINVKFYRCS-UXHGNOADSA-N 5-chloro-2-(2,4-dichloro-3,5,6-trideuteriophenoxy)phenol Chemical compound [2H]C1=C(Cl)C([2H])=C([2H])C(OC=2C(=CC(Cl)=CC=2)O)=C1Cl XEFQLINVKFYRCS-UXHGNOADSA-N 0.000 claims description 2
- PZBQVZFITSVHAW-UHFFFAOYSA-N 5-chloro-2h-benzotriazole Chemical compound C1=C(Cl)C=CC2=NNN=C21 PZBQVZFITSVHAW-UHFFFAOYSA-N 0.000 claims description 2
- 239000005875 Acetamiprid Substances 0.000 claims description 2
- MOZDKDIOPSPTBH-UHFFFAOYSA-N Benzyl parahydroxybenzoate Chemical compound C1=CC(O)=CC=C1C(=O)OCC1=CC=CC=C1 MOZDKDIOPSPTBH-UHFFFAOYSA-N 0.000 claims description 2
- MWZFRUPLSZXIPT-UHFFFAOYSA-N CC(COC(C(=O)O)C)CC(C)Cl Chemical compound CC(COC(C(=O)O)C)CC(C)Cl MWZFRUPLSZXIPT-UHFFFAOYSA-N 0.000 claims description 2
- JWBOIMRXGHLCPP-UHFFFAOYSA-N Chloditan Chemical compound C=1C=CC=C(Cl)C=1C(C(Cl)Cl)C1=CC=C(Cl)C=C1 JWBOIMRXGHLCPP-UHFFFAOYSA-N 0.000 claims description 2
- 239000005757 Cyproconazole Substances 0.000 claims description 2
- YVGGHNCTFXOJCH-UHFFFAOYSA-N DDT Chemical compound C1=CC(Cl)=CC=C1C(C(Cl)(Cl)Cl)C1=CC=C(Cl)C=C1 YVGGHNCTFXOJCH-UHFFFAOYSA-N 0.000 claims description 2
- NDUPDOJHUQKPAG-UHFFFAOYSA-N Dalapon Chemical compound CC(Cl)(Cl)C(O)=O NDUPDOJHUQKPAG-UHFFFAOYSA-N 0.000 claims description 2
- 239000004641 Diallyl-phthalate Substances 0.000 claims description 2
- 239000005760 Difenoconazole Substances 0.000 claims description 2
- 239000005508 Dimethachlor Substances 0.000 claims description 2
- 239000005775 Fenbuconazole Substances 0.000 claims description 2
- 239000005776 Fenhexamid Substances 0.000 claims description 2
- ZTJORNVITHUQJA-UHFFFAOYSA-N Heptyl p-hydroxybenzoate Chemical class CCCCCCCOC(=O)C1=CC=C(O)C=C1 ZTJORNVITHUQJA-UHFFFAOYSA-N 0.000 claims description 2
- 239000005906 Imidacloprid Substances 0.000 claims description 2
- 239000005807 Metalaxyl Substances 0.000 claims description 2
- 241001465754 Metazoa Species 0.000 claims description 2
- 239000005916 Methomyl Substances 0.000 claims description 2
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 claims description 2
- 239000005813 Penconazole Substances 0.000 claims description 2
- 239000005923 Pirimicarb Substances 0.000 claims description 2
- 239000005820 Prochloraz Substances 0.000 claims description 2
- 239000005869 Pyraclostrobin Substances 0.000 claims description 2
- YSMRWXYRXBRSND-UHFFFAOYSA-N TOTP Chemical compound CC1=CC=CC=C1OP(=O)(OC=1C(=CC=CC=1)C)OC1=CC=CC=C1C YSMRWXYRXBRSND-UHFFFAOYSA-N 0.000 claims description 2
- 239000005839 Tebuconazole Substances 0.000 claims description 2
- 239000005840 Tetraconazole Substances 0.000 claims description 2
- 239000005940 Thiacloprid Substances 0.000 claims description 2
- 239000005941 Thiamethoxam Substances 0.000 claims description 2
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 claims description 2
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 claims description 2
- 239000005857 Trifloxystrobin Substances 0.000 claims description 2
- GTVWRXDRKAHEAD-UHFFFAOYSA-N Tris(2-ethylhexyl) phosphate Chemical compound CCCCC(CC)COP(=O)(OCC(CC)CCCC)OCC(CC)CCCC GTVWRXDRKAHEAD-UHFFFAOYSA-N 0.000 claims description 2
- XCSGPAVHZFQHGE-UHFFFAOYSA-N alachlor Chemical compound CCC1=CC=CC(CC)=C1N(COC)C(=O)CCl XCSGPAVHZFQHGE-UHFFFAOYSA-N 0.000 claims description 2
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 claims description 2
- 229940034794 benzylparaben Drugs 0.000 claims description 2
- NNXWIPHZHATIFE-UHFFFAOYSA-N bis(2-butoxyethyl) hydrogen phosphate Chemical compound CCCCOCCOP(O)(=O)OCCOCCCC NNXWIPHZHATIFE-UHFFFAOYSA-N 0.000 claims description 2
- ROPXFXOUUANXRR-YPKPFQOOSA-N bis(2-ethylhexyl) (z)-but-2-enedioate Chemical compound CCCCC(CC)COC(=O)\C=C/C(=O)OCC(CC)CCCC ROPXFXOUUANXRR-YPKPFQOOSA-N 0.000 claims description 2
- MGWAVDBGNNKXQV-KDWZCNHSSA-N bis(2-methylpropyl) 3,4,5,6-tetradeuteriobenzene-1,2-dicarboxylate Chemical compound [2H]C1=C([2H])C([2H])=C(C(=O)OCC(C)C)C(C(=O)OCC(C)C)=C1[2H] MGWAVDBGNNKXQV-KDWZCNHSSA-N 0.000 claims description 2
- JANBFCARANRIKJ-UHFFFAOYSA-N bis(3-methylbutyl) benzene-1,2-dicarboxylate Chemical compound CC(C)CCOC(=O)C1=CC=CC=C1C(=O)OCCC(C)C JANBFCARANRIKJ-UHFFFAOYSA-N 0.000 claims description 2
- PDLPMCXGPIVYQQ-UHFFFAOYSA-N bis(4-tert-butylphenyl) phenyl phosphate Chemical compound C1=CC(C(C)(C)C)=CC=C1OP(=O)(OC=1C=CC(=CC=1)C(C)(C)C)OC1=CC=CC=C1 PDLPMCXGPIVYQQ-UHFFFAOYSA-N 0.000 claims description 2
- ZWYAVGUHWPLBGT-UHFFFAOYSA-N bis(6-methylheptyl) decanedioate Chemical compound CC(C)CCCCCOC(=O)CCCCCCCCC(=O)OCCCCCC(C)C ZWYAVGUHWPLBGT-UHFFFAOYSA-N 0.000 claims description 2
- HORIEOQXBKUKGQ-UHFFFAOYSA-N bis(7-methyloctyl) cyclohexane-1,2-dicarboxylate Chemical compound CC(C)CCCCCCOC(=O)C1CCCCC1C(=O)OCCCCCCC(C)C HORIEOQXBKUKGQ-UHFFFAOYSA-N 0.000 claims description 2
- QUDWYFHPNIMBFC-UHFFFAOYSA-N bis(prop-2-enyl) benzene-1,2-dicarboxylate Chemical compound C=CCOC(=O)C1=CC=CC=C1C(=O)OCC=C QUDWYFHPNIMBFC-UHFFFAOYSA-N 0.000 claims description 2
- 125000006226 butoxyethyl group Chemical group 0.000 claims description 2
- 229940067596 butylparaben Drugs 0.000 claims description 2
- 239000006013 carbendazim Substances 0.000 claims description 2
- DUEPRVBVGDRKAG-UHFFFAOYSA-N carbofuran Chemical compound CNC(=O)OC1=CC=CC2=C1OC(C)(C)C2 DUEPRVBVGDRKAG-UHFFFAOYSA-N 0.000 claims description 2
- 239000013078 crystal Substances 0.000 claims description 2
- SEGLCEQVOFDUPX-UHFFFAOYSA-N di-(2-ethylhexyl)phosphoric acid Chemical compound CCCCC(CC)COP(O)(=O)OCC(CC)CCCC SEGLCEQVOFDUPX-UHFFFAOYSA-N 0.000 claims description 2
- 238000003745 diagnosis Methods 0.000 claims description 2
- UCVPKAZCQPRWAY-UHFFFAOYSA-N dibenzyl benzene-1,2-dicarboxylate Chemical compound C=1C=CC=C(C(=O)OCC=2C=CC=CC=2)C=1C(=O)OCC1=CC=CC=C1 UCVPKAZCQPRWAY-UHFFFAOYSA-N 0.000 claims description 2
- DFBKLUNHFCTMDC-PICURKEMSA-N dieldrin Chemical compound C([C@H]1[C@H]2[C@@]3(Cl)C(Cl)=C([C@]([C@H]22)(Cl)C3(Cl)Cl)Cl)[C@H]2[C@@H]2[C@H]1O2 DFBKLUNHFCTMDC-PICURKEMSA-N 0.000 claims description 2
- 229950006824 dieldrin Drugs 0.000 claims description 2
- NGPMUTDCEIKKFM-UHFFFAOYSA-N dieldrin Natural products CC1=C(Cl)C2(Cl)C3C4CC(C5OC45)C3C1(Cl)C2(Cl)Cl NGPMUTDCEIKKFM-UHFFFAOYSA-N 0.000 claims description 2
- BQYJATMQXGBDHF-UHFFFAOYSA-N difenoconazole Chemical compound O1C(C)COC1(C=1C(=CC(OC=2C=CC(Cl)=CC=2)=CC=1)Cl)CN1N=CN=C1 BQYJATMQXGBDHF-UHFFFAOYSA-N 0.000 claims description 2
- SCCDDNKJYDZXMM-UHFFFAOYSA-N dimethachlor Chemical compound COCCN(C(=O)CCl)C1=C(C)C=CC=C1C SCCDDNKJYDZXMM-UHFFFAOYSA-N 0.000 claims description 2
- NIQCNGHVCWTJSM-LNFUJOGGSA-N dimethyl 3,4,5,6-tetradeuteriobenzene-1,2-dicarboxylate Chemical compound [2H]C1=C([2H])C([2H])=C(C(=O)OC)C(C(=O)OC)=C1[2H] NIQCNGHVCWTJSM-LNFUJOGGSA-N 0.000 claims description 2
- VNGOYPQMJFJDLV-UHFFFAOYSA-N dimethyl benzene-1,3-dicarboxylate Chemical compound COC(=O)C1=CC=CC(C(=O)OC)=C1 VNGOYPQMJFJDLV-UHFFFAOYSA-N 0.000 claims description 2
- FBSAITBEAPNWJG-UHFFFAOYSA-N dimethyl phthalate Natural products CC(=O)OC1=CC=CC=C1OC(C)=O FBSAITBEAPNWJG-UHFFFAOYSA-N 0.000 claims description 2
- 229940014772 dimethyl sebacate Drugs 0.000 claims description 2
- 229960001826 dimethylphthalate Drugs 0.000 claims description 2
- DROMNWUQASBTFM-UHFFFAOYSA-N dinonyl benzene-1,2-dicarboxylate Chemical compound CCCCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCCCC DROMNWUQASBTFM-UHFFFAOYSA-N 0.000 claims description 2
- YKBZOVFACRVRJN-UHFFFAOYSA-N dinotefuran Chemical compound [O-][N+](=O)\N=C(/NC)NCC1CCOC1 YKBZOVFACRVRJN-UHFFFAOYSA-N 0.000 claims description 2
- 239000001177 diphosphate Substances 0.000 claims description 2
- 235000011180 diphosphates Nutrition 0.000 claims description 2
- 201000010099 disease Diseases 0.000 claims description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 2
- VDLGAVXLJYLFDH-UHFFFAOYSA-N fenhexamid Chemical compound C=1C=C(O)C(Cl)=C(Cl)C=1NC(=O)C1(C)CCCCC1 VDLGAVXLJYLFDH-UHFFFAOYSA-N 0.000 claims description 2
- FRCCEHPWNOQAEU-UHFFFAOYSA-N heptachlor Chemical compound ClC1=C(Cl)C2(Cl)C3C=CC(Cl)C3C1(Cl)C2(Cl)Cl FRCCEHPWNOQAEU-UHFFFAOYSA-N 0.000 claims description 2
- CKAPSXZOOQJIBF-UHFFFAOYSA-N hexachlorobenzene Chemical compound ClC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl CKAPSXZOOQJIBF-UHFFFAOYSA-N 0.000 claims description 2
- 229940056881 imidacloprid Drugs 0.000 claims description 2
- YWTYJOPNNQFBPC-UHFFFAOYSA-N imidacloprid Chemical compound [O-][N+](=O)\N=C1/NCCN1CC1=CC=C(Cl)N=C1 YWTYJOPNNQFBPC-UHFFFAOYSA-N 0.000 claims description 2
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 claims description 2
- 239000005910 lambda-Cyhalothrin Substances 0.000 claims description 2
- KLGMSAOQDHLCOS-UHFFFAOYSA-N mecarbam Chemical compound CCOC(=O)N(C)C(=O)CSP(=S)(OCC)OCC KLGMSAOQDHLCOS-UHFFFAOYSA-N 0.000 claims description 2
- UHXUZOCRWCRNSJ-QPJJXVBHSA-N methomyl Chemical compound CNC(=O)O\N=C(/C)SC UHXUZOCRWCRNSJ-QPJJXVBHSA-N 0.000 claims description 2
- ZQEIXNIJLIKNTD-UHFFFAOYSA-N methyl N-(2,6-dimethylphenyl)-N-(methoxyacetyl)alaninate Chemical compound COCC(=O)N(C(C)C(=O)OC)C1=C(C)C=CC=C1C ZQEIXNIJLIKNTD-UHFFFAOYSA-N 0.000 claims description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims description 2
- 229960002216 methylparaben Drugs 0.000 claims description 2
- YWWHKOHZGJFMIE-UHFFFAOYSA-N monoethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(O)=O YWWHKOHZGJFMIE-UHFFFAOYSA-N 0.000 claims description 2
- XOSNGXNHDRYFEF-UHFFFAOYSA-N monohexyl phthalate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1C(O)=O XOSNGXNHDRYFEF-UHFFFAOYSA-N 0.000 claims description 2
- CXJOEMLCEGZVPL-UHFFFAOYSA-N monoisopropyl phthalate Chemical compound CC(C)OC(=O)C1=CC=CC=C1C(O)=O CXJOEMLCEGZVPL-UHFFFAOYSA-N 0.000 claims description 2
- PKIYFBICNICNGJ-UHFFFAOYSA-N monooctyl phthalate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1C(O)=O PKIYFBICNICNGJ-UHFFFAOYSA-N 0.000 claims description 2
- FPGPRAKRYDSZAW-UHFFFAOYSA-N monopentyl phthalate Chemical compound CCCCCOC(=O)C1=CC=CC=C1C(O)=O FPGPRAKRYDSZAW-UHFFFAOYSA-N 0.000 claims description 2
- CXGONMQFMIYUJR-UHFFFAOYSA-N perfluorododecanoic acid Chemical compound OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F CXGONMQFMIYUJR-UHFFFAOYSA-N 0.000 claims description 2
- PXUULQAPEKKVAH-UHFFFAOYSA-N perfluorohexanoic acid Chemical compound OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F PXUULQAPEKKVAH-UHFFFAOYSA-N 0.000 claims description 2
- RRRXPPIDPYTNJG-UHFFFAOYSA-N perfluorooctanesulfonamide Chemical compound NS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F RRRXPPIDPYTNJG-UHFFFAOYSA-N 0.000 claims description 2
- CMPQUABWPXYYSH-UHFFFAOYSA-N phenyl phosphate Chemical compound OP(O)(=O)OC1=CC=CC=C1 CMPQUABWPXYYSH-UHFFFAOYSA-N 0.000 claims description 2
- LYXOWKPVTCPORE-UHFFFAOYSA-N phenyl-(4-phenylphenyl)methanone Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1C(=O)C1=CC=CC=C1 LYXOWKPVTCPORE-UHFFFAOYSA-N 0.000 claims description 2
- 150000003021 phthalic acid derivatives Chemical class 0.000 claims description 2
- YFGYUFNIOHWBOB-UHFFFAOYSA-N pirimicarb Chemical compound CN(C)C(=O)OC1=NC(N(C)C)=NC(C)=C1C YFGYUFNIOHWBOB-UHFFFAOYSA-N 0.000 claims description 2
- TVLSRXXIMLFWEO-UHFFFAOYSA-N prochloraz Chemical compound C1=CN=CN1C(=O)N(CCC)CCOC1=C(Cl)C=C(Cl)C=C1Cl TVLSRXXIMLFWEO-UHFFFAOYSA-N 0.000 claims description 2
- ISEUFVQQFVOBCY-UHFFFAOYSA-N prometon Chemical compound COC1=NC(NC(C)C)=NC(NC(C)C)=N1 ISEUFVQQFVOBCY-UHFFFAOYSA-N 0.000 claims description 2
- WJNRPILHGGKWCK-UHFFFAOYSA-N propazine Chemical compound CC(C)NC1=NC(Cl)=NC(NC(C)C)=N1 WJNRPILHGGKWCK-UHFFFAOYSA-N 0.000 claims description 2
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 claims description 2
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 claims description 2
- 229960003415 propylparaben Drugs 0.000 claims description 2
- HZRSNVGNWUDEFX-UHFFFAOYSA-N pyraclostrobin Chemical compound COC(=O)N(OC)C1=CC=CC=C1COC1=NN(C=2C=CC(Cl)=CC=2)C=C1 HZRSNVGNWUDEFX-UHFFFAOYSA-N 0.000 claims description 2
- JOOMJVFZQRQWKR-UHFFFAOYSA-N pyrazophos Chemical compound N1=C(C)C(C(=O)OCC)=CN2N=C(OP(=S)(OCC)OCC)C=C21 JOOMJVFZQRQWKR-UHFFFAOYSA-N 0.000 claims description 2
- PZTAGFCBNDBBFZ-UHFFFAOYSA-N tert-butyl 2-(hydroxymethyl)piperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCCCC1CO PZTAGFCBNDBBFZ-UHFFFAOYSA-N 0.000 claims description 2
- 239000004308 thiabendazole Substances 0.000 claims description 2
- WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 claims description 2
- 235000010296 thiabendazole Nutrition 0.000 claims description 2
- 229960004546 thiabendazole Drugs 0.000 claims description 2
- NWWZPOKUUAIXIW-FLIBITNWSA-N thiamethoxam Chemical compound [O-][N+](=O)\N=C/1N(C)COCN\1CC1=CN=C(Cl)S1 NWWZPOKUUAIXIW-FLIBITNWSA-N 0.000 claims description 2
- YXFVVABEGXRONW-UHFFFAOYSA-N toluene Substances CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 2
- 229960003500 triclosan Drugs 0.000 claims description 2
- WEAPVABOECTMGR-UHFFFAOYSA-N triethyl 2-acetyloxypropane-1,2,3-tricarboxylate Chemical compound CCOC(=O)CC(C(=O)OCC)(OC(C)=O)CC(=O)OCC WEAPVABOECTMGR-UHFFFAOYSA-N 0.000 claims description 2
- 239000001069 triethyl citrate Substances 0.000 claims description 2
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 claims description 2
- 235000013769 triethyl citrate Nutrition 0.000 claims description 2
- ONCZDRURRATYFI-TVJDWZFNSA-N trifloxystrobin Chemical compound CO\N=C(\C(=O)OC)C1=CC=CC=C1CO\N=C(/C)C1=CC=CC(C(F)(F)F)=C1 ONCZDRURRATYFI-TVJDWZFNSA-N 0.000 claims description 2
- JNXDCMUUZNIWPQ-UHFFFAOYSA-N trioctyl benzene-1,2,4-tricarboxylate Chemical compound CCCCCCCCOC(=O)C1=CC=C(C(=O)OCCCCCCCC)C(C(=O)OCCCCCCCC)=C1 JNXDCMUUZNIWPQ-UHFFFAOYSA-N 0.000 claims description 2
- XZZNDPSIHUTMOC-UHFFFAOYSA-N triphenyl phosphate Chemical compound C=1C=CC=CC=1OP(OC=1C=CC=CC=1)(=O)OC1=CC=CC=C1 XZZNDPSIHUTMOC-UHFFFAOYSA-N 0.000 claims description 2
- HQUQLFOMPYWACS-UHFFFAOYSA-N tris(2-chloroethyl) phosphate Chemical compound ClCCOP(=O)(OCCCl)OCCCl HQUQLFOMPYWACS-UHFFFAOYSA-N 0.000 claims description 2
- LIPMRGQQBZJCTM-UHFFFAOYSA-N tris(2-propan-2-ylphenyl) phosphate Chemical compound CC(C)C1=CC=CC=C1OP(=O)(OC=1C(=CC=CC=1)C(C)C)OC1=CC=CC=C1C(C)C LIPMRGQQBZJCTM-UHFFFAOYSA-N 0.000 claims description 2
- BCTKCHOESSAGCN-UHFFFAOYSA-N tris(3,4-dimethylphenyl) phosphate Chemical compound C1=C(C)C(C)=CC=C1OP(=O)(OC=1C=C(C)C(C)=CC=1)OC1=CC=C(C)C(C)=C1 BCTKCHOESSAGCN-UHFFFAOYSA-N 0.000 claims description 2
- LLPMAOBOEQFPRE-UHFFFAOYSA-N tris(3,5-dimethylphenyl) phosphate Chemical compound CC1=CC(C)=CC(OP(=O)(OC=2C=C(C)C=C(C)C=2)OC=2C=C(C)C=C(C)C=2)=C1 LLPMAOBOEQFPRE-UHFFFAOYSA-N 0.000 claims description 2
- LORSVOJSXMHDHF-UHFFFAOYSA-N tris(4-tert-butylphenyl) phosphate Chemical compound C1=CC(C(C)(C)C)=CC=C1OP(=O)(OC=1C=CC(=CC=1)C(C)(C)C)OC1=CC=C(C(C)(C)C)C=C1 LORSVOJSXMHDHF-UHFFFAOYSA-N 0.000 claims description 2
- KGRVJHAUYBGFFP-UHFFFAOYSA-N 2,2'-Methylenebis(4-methyl-6-tert-butylphenol) Chemical compound CC(C)(C)C1=CC(C)=CC(CC=2C(=C(C=C(C)C=2)C(C)(C)C)O)=C1O KGRVJHAUYBGFFP-UHFFFAOYSA-N 0.000 claims 2
- ICKWICRCANNIBI-UHFFFAOYSA-N 2,4-di-tert-butylphenol Chemical compound CC(C)(C)C1=CC=C(O)C(C(C)(C)C)=C1 ICKWICRCANNIBI-UHFFFAOYSA-N 0.000 claims 2
- AJPIUNPJBFBUKK-UHFFFAOYSA-N 2-isopropyl-6-methylpyrimidin-4-ol Chemical compound CC(C)C1=NC(C)=CC(O)=N1 AJPIUNPJBFBUKK-UHFFFAOYSA-N 0.000 claims 2
- DXYYSGDWQCSKKO-UHFFFAOYSA-N 2-methylbenzothiazole Chemical compound C1=CC=C2SC(C)=NC2=C1 DXYYSGDWQCSKKO-UHFFFAOYSA-N 0.000 claims 2
- DOZRDZLFLOODMB-UHFFFAOYSA-N 3,5-di-tert-Butyl-4-hydroxybenzaldehyde Chemical compound CC(C)(C)C1=CC(C=O)=CC(C(C)(C)C)=C1O DOZRDZLFLOODMB-UHFFFAOYSA-N 0.000 claims 2
- VVBLNCFGVYUYGU-UHFFFAOYSA-N 4,4'-Bis(dimethylamino)benzophenone Chemical compound C1=CC(N(C)C)=CC=C1C(=O)C1=CC=C(N(C)C)C=C1 VVBLNCFGVYUYGU-UHFFFAOYSA-N 0.000 claims 2
- NPFYZDNDJHZQKY-UHFFFAOYSA-N 4-Hydroxybenzophenone Chemical compound C1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 NPFYZDNDJHZQKY-UHFFFAOYSA-N 0.000 claims 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 claims 2
- IRIAEXORFWYRCZ-UHFFFAOYSA-N Butylbenzyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCC1=CC=CC=C1 IRIAEXORFWYRCZ-UHFFFAOYSA-N 0.000 claims 2
- KCXZNSGUUQJJTR-UHFFFAOYSA-N Di-n-hexyl phthalate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCC KCXZNSGUUQJJTR-UHFFFAOYSA-N 0.000 claims 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 2
- YZBOVSFWWNVKRJ-UHFFFAOYSA-N Monobutylphthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(O)=O YZBOVSFWWNVKRJ-UHFFFAOYSA-N 0.000 claims 2
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 claims 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 2
- MGWAVDBGNNKXQV-UHFFFAOYSA-N diisobutyl phthalate Chemical compound CC(C)COC(=O)C1=CC=CC=C1C(=O)OCC(C)C MGWAVDBGNNKXQV-UHFFFAOYSA-N 0.000 claims 2
- IDQHRQQSSQDLTR-UHFFFAOYSA-N diuron-desmethyl Chemical compound CNC(=O)NC1=CC=C(Cl)C(Cl)=C1 IDQHRQQSSQDLTR-UHFFFAOYSA-N 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- HEOCBCNFKCOKBX-RELGSGGGSA-N (1s,2e,4r)-4,7,7-trimethyl-2-[(4-methylphenyl)methylidene]bicyclo[2.2.1]heptan-3-one Chemical compound C1=CC(C)=CC=C1\C=C/1C(=O)[C@]2(C)CC[C@H]\1C2(C)C HEOCBCNFKCOKBX-RELGSGGGSA-N 0.000 claims 1
- SMYMJHWAQXWPDB-UHFFFAOYSA-N (2,4,5-trichlorophenoxy)acetic acid Chemical compound OC(=O)COC1=CC(Cl)=C(Cl)C=C1Cl SMYMJHWAQXWPDB-UHFFFAOYSA-N 0.000 claims 1
- DXGLGDHPHMLXJC-VIQYUKPQSA-N (2-hydroxy-4-methoxyphenyl)-(2,3,4,5,6-pentadeuteriophenyl)methanone Chemical compound OC1=C(C(=O)C2=C(C(=C(C(=C2[2H])[2H])[2H])[2H])[2H])C=CC(=C1)OC DXGLGDHPHMLXJC-VIQYUKPQSA-N 0.000 claims 1
- XMNDMAQKWSQVOV-UHFFFAOYSA-N (2-methylphenyl) diphenyl phosphate Chemical compound CC1=CC=CC=C1OP(=O)(OC=1C=CC=CC=1)OC1=CC=CC=C1 XMNDMAQKWSQVOV-UHFFFAOYSA-N 0.000 claims 1
- WXPWZZHELZEVPO-UHFFFAOYSA-N (4-methylphenyl)-phenylmethanone Chemical compound C1=CC(C)=CC=C1C(=O)C1=CC=CC=C1 WXPWZZHELZEVPO-UHFFFAOYSA-N 0.000 claims 1
- HNXDYNVXCUCKMS-UHFFFAOYSA-N 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonic acid;potassium Chemical compound [K].OS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F HNXDYNVXCUCKMS-UHFFFAOYSA-N 0.000 claims 1
- CCEKAJIANROZEO-ZBJDZAJPSA-N 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-N-(1,1,2,2,2-pentadeuterioethyl)octane-1-sulfonamide Chemical compound [2H]C([2H])([2H])C([2H])([2H])NS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F CCEKAJIANROZEO-ZBJDZAJPSA-N 0.000 claims 1
- SRMWNTGHXHOWBT-FIBGUPNXSA-N 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-N-(trideuteriomethyl)octane-1-sulfonamide Chemical compound C(NS(=O)(=O)C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)([2H])([2H])[2H] SRMWNTGHXHOWBT-FIBGUPNXSA-N 0.000 claims 1
- OFBWFHZWGNQDDR-ZBDRYARFSA-N 1,2,3,3a,4,4-hexadeuterio-5-methylbenzotriazole Chemical compound [2H]N1N([2H])C2=CC=C(C)C([2H])([2H])C2([2H])N1[2H] OFBWFHZWGNQDDR-ZBDRYARFSA-N 0.000 claims 1
- OPNUROKCUBTKLF-UHFFFAOYSA-N 1,2-bis(2-methylphenyl)guanidine Chemical compound CC1=CC=CC=C1N\C(N)=N\C1=CC=CC=C1C OPNUROKCUBTKLF-UHFFFAOYSA-N 0.000 claims 1
- OWRCNXZUPFZXOS-UHFFFAOYSA-N 1,3-diphenylguanidine Chemical compound C=1C=CC=CC=1NC(=N)NC1=CC=CC=C1 OWRCNXZUPFZXOS-UHFFFAOYSA-N 0.000 claims 1
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 claims 1
- FDNSXGJAVAUPJG-UHFFFAOYSA-N 1-[4-(4-butylcyclohexyl)cyclohexyl]-4-ethoxy-2,3-difluorobenzene Chemical compound C1CC(CCCC)CCC1C1CCC(C=2C(=C(F)C(OCC)=CC=2)F)CC1 FDNSXGJAVAUPJG-UHFFFAOYSA-N 0.000 claims 1
- QXDAODVIURYQBR-UHFFFAOYSA-N 1-[[2,6-difluoro-4-(4-propylphenyl)phenyl]-difluoromethoxy]-3,4,5-trifluoro-2-methylbenzene Chemical group CCCC1=CC=C(C=C1)C1=CC(F)=C(C(F)=C1)C(F)(F)OC1=CC(F)=C(F)C(F)=C1C QXDAODVIURYQBR-UHFFFAOYSA-N 0.000 claims 1
- CVUGPAFCQJIYDT-UHFFFAOYSA-N 1-chloro-2-[2,2,2-trichloro-1-(4-chlorophenyl)ethyl]benzene Chemical compound C1=CC(Cl)=CC=C1C(C(Cl)(Cl)Cl)C1=CC=CC=C1Cl CVUGPAFCQJIYDT-UHFFFAOYSA-N 0.000 claims 1
- KHDBEDDPFRHGCN-UHFFFAOYSA-N 1-ethenyl-4-(4-propylcyclohexyl)cyclohexane Chemical compound C1CC(CCC)CCC1C1CCC(C=C)CC1 KHDBEDDPFRHGCN-UHFFFAOYSA-N 0.000 claims 1
- BOAHGIPRRKDVQY-UHFFFAOYSA-N 1-ethoxy-2,3-difluoro-4-(4-propylcyclohexyl)benzene Chemical compound C1CC(CCC)CCC1C1=CC=C(OCC)C(F)=C1F BOAHGIPRRKDVQY-UHFFFAOYSA-N 0.000 claims 1
- RYPOSVPGRBGCKW-UHFFFAOYSA-N 1-ethoxy-2,3-difluoro-4-(4-propylphenyl)benzene Chemical compound C1=CC(CCC)=CC=C1C1=CC=C(OCC)C(F)=C1F RYPOSVPGRBGCKW-UHFFFAOYSA-N 0.000 claims 1
- DEFRYXBKOCRIJE-UHFFFAOYSA-N 1-ethoxy-4-[4-(4-ethylcyclohexyl)phenyl]-2,3-difluorobenzene Chemical compound FC1=C(F)C(OCC)=CC=C1C1=CC=C(C2CCC(CC)CC2)C=C1 DEFRYXBKOCRIJE-UHFFFAOYSA-N 0.000 claims 1
- BDFIJHWKUNMYCF-UHFFFAOYSA-N 1-hexoxy-4-phenylcyclohexa-2,4-diene-1-carbonitrile Chemical compound C1=CC(OCCCCCC)(C#N)CC=C1C1=CC=CC=C1 BDFIJHWKUNMYCF-UHFFFAOYSA-N 0.000 claims 1
- JMOYCPSDEMHCFG-UHFFFAOYSA-N 1-methoxy-4-(4-propylcyclohexyl)cyclohexane Chemical compound C1CC(CCC)CCC1C1CCC(OC)CC1 JMOYCPSDEMHCFG-UHFFFAOYSA-N 0.000 claims 1
- ZGBOHJUSTPZQPL-UHFFFAOYSA-N 1-methyl-4-(4-pentylphenyl)benzene Chemical group C1=CC(CCCCC)=CC=C1C1=CC=C(C)C=C1 ZGBOHJUSTPZQPL-UHFFFAOYSA-N 0.000 claims 1
- SDESCXGEQILYTQ-UHFFFAOYSA-N 1-methyl-4-[4-(4-propylcyclohexyl)cyclohexyl]benzene Chemical compound C1CC(CCC)CCC1C1CCC(C=2C=CC(C)=CC=2)CC1 SDESCXGEQILYTQ-UHFFFAOYSA-N 0.000 claims 1
- DLZBUNUDESZERL-UHFFFAOYSA-N 1-o-heptyl 6-o-nonyl hexanedioate Chemical compound CCCCCCCCCOC(=O)CCCCC(=O)OCCCCCCC DLZBUNUDESZERL-UHFFFAOYSA-N 0.000 claims 1
- IASLDLGGHXYCEO-UHFFFAOYSA-N 1-prop-1-enyl-4-(4-propylcyclohexyl)cyclohexane Chemical compound C1CC(CCC)CCC1C1CCC(C=CC)CC1 IASLDLGGHXYCEO-UHFFFAOYSA-N 0.000 claims 1
- LEZWWPYKPKIXLL-UHFFFAOYSA-N 1-{2-(4-chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl}imidazole Chemical compound C1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 LEZWWPYKPKIXLL-UHFFFAOYSA-N 0.000 claims 1
- KWVGIHKZDCUPEU-UHFFFAOYSA-N 2,2-dimethoxy-2-phenylacetophenone Chemical compound C=1C=CC=CC=1C(OC)(OC)C(=O)C1=CC=CC=C1 KWVGIHKZDCUPEU-UHFFFAOYSA-N 0.000 claims 1
- XIKIUQUXDNHBFR-DOGSKSIHSA-N 2,3,4,5-tetradeuterio-6-phenylmethoxycarbonylbenzoic acid Chemical compound OC(=O)C1=C([2H])C([2H])=C([2H])C([2H])=C1C(=O)OCC1=CC=CC=C1 XIKIUQUXDNHBFR-DOGSKSIHSA-N 0.000 claims 1
- HTQNYBBTZSBWKL-UHFFFAOYSA-N 2,3,4-trihydroxbenzophenone Chemical compound OC1=C(O)C(O)=CC=C1C(=O)C1=CC=CC=C1 HTQNYBBTZSBWKL-UHFFFAOYSA-N 0.000 claims 1
- HGUFODBRKLSHSI-UHFFFAOYSA-N 2,3,7,8-tetrachloro-dibenzo-p-dioxin Chemical compound O1C2=CC(Cl)=C(Cl)C=C2OC2=C1C=C(Cl)C(Cl)=C2 HGUFODBRKLSHSI-UHFFFAOYSA-N 0.000 claims 1
- FRGPBGWMABUJNC-UHFFFAOYSA-N 2,3-difluoro-1-methoxy-4-[4-(4-propylcyclohexyl)cyclohexyl]benzene Chemical compound C1CC(CCC)CCC1C1CCC(C=2C(=C(F)C(OC)=CC=2)F)CC1 FRGPBGWMABUJNC-UHFFFAOYSA-N 0.000 claims 1
- WGONOKAJJBMHGL-UHFFFAOYSA-N 2,3-difluoro-1-propoxy-4-[4-(4-propylcyclohexyl)cyclohexyl]benzene Chemical compound FC1=C(F)C(OCCC)=CC=C1C1CCC(C2CCC(CCC)CC2)CC1 WGONOKAJJBMHGL-UHFFFAOYSA-N 0.000 claims 1
- 239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 claims 1
- 239000003559 2,4,5-trichlorophenoxyacetic acid Substances 0.000 claims 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 claims 1
- MFZAXZRJGHLULL-UHFFFAOYSA-N 2,4-ditert-butyl-6-[2-(3,5-ditert-butyl-2-hydroxyphenyl)ethyl]phenol Chemical compound CC(C)(C)C1=CC(C(C)(C)C)=CC(CCC=2C(=C(C=C(C=2)C(C)(C)C)C(C)(C)C)O)=C1O MFZAXZRJGHLULL-UHFFFAOYSA-N 0.000 claims 1
- HNURKXXMYARGAY-UHFFFAOYSA-N 2,6-Di-tert-butyl-4-hydroxymethylphenol Chemical compound CC(C)(C)C1=CC(CO)=CC(C(C)(C)C)=C1O HNURKXXMYARGAY-UHFFFAOYSA-N 0.000 claims 1
- GJDRKHHGPHLVNI-UHFFFAOYSA-N 2,6-ditert-butyl-4-(diethoxyphosphorylmethyl)phenol Chemical compound CCOP(=O)(OCC)CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 GJDRKHHGPHLVNI-UHFFFAOYSA-N 0.000 claims 1
- VMZVBRIIHDRYGK-UHFFFAOYSA-N 2,6-ditert-butyl-4-[(dimethylamino)methyl]phenol Chemical compound CN(C)CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 VMZVBRIIHDRYGK-UHFFFAOYSA-N 0.000 claims 1
- VRJKCPFUTGSJEH-UHFFFAOYSA-N 2-(1,3-benzothiazol-2-yl)-4-[2-(1,3-benzothiazol-2-yl)morpholin-4-yl]sulfanylmorpholine Chemical compound C1=CC=C2SC(C3OCCN(C3)SN3CCOC(C3)C=3SC4=CC=CC=C4N=3)=NC2=C1 VRJKCPFUTGSJEH-UHFFFAOYSA-N 0.000 claims 1
- ZMWRRFHBXARRRT-UHFFFAOYSA-N 2-(benzotriazol-2-yl)-4,6-bis(2-methylbutan-2-yl)phenol Chemical compound CCC(C)(C)C1=CC(C(C)(C)CC)=CC(N2N=C3C=CC=CC3=N2)=C1O ZMWRRFHBXARRRT-UHFFFAOYSA-N 0.000 claims 1
- OLFNXLXEGXRUOI-UHFFFAOYSA-N 2-(benzotriazol-2-yl)-4,6-bis(2-phenylpropan-2-yl)phenol Chemical compound C=1C(N2N=C3C=CC=CC3=N2)=C(O)C(C(C)(C)C=2C=CC=CC=2)=CC=1C(C)(C)C1=CC=CC=C1 OLFNXLXEGXRUOI-UHFFFAOYSA-N 0.000 claims 1
- WXHVQMGINBSVAY-UHFFFAOYSA-N 2-(benzotriazol-2-yl)-4-tert-butylphenol Chemical compound CC(C)(C)C1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 WXHVQMGINBSVAY-UHFFFAOYSA-N 0.000 claims 1
- YJUHXJQZJUQYJJ-UHFFFAOYSA-N 2-[difluoro-(3,4,5-trifluorophenoxy)methyl]-1,3-difluoro-5-(4-propylphenyl)benzene Chemical group C1=CC(CCC)=CC=C1C1=CC(F)=C(C(F)(F)OC=2C=C(F)C(F)=C(F)C=2)C(F)=C1 YJUHXJQZJUQYJJ-UHFFFAOYSA-N 0.000 claims 1
- WVQBLGZPHOPPFO-UHFFFAOYSA-N 2-chloro-N-(2-ethyl-6-methylphenyl)-N-(1-methoxypropan-2-yl)acetamide Chemical compound CCC1=CC=CC(C)=C1N(C(C)COC)C(=O)CCl WVQBLGZPHOPPFO-UHFFFAOYSA-N 0.000 claims 1
- 125000001340 2-chloroethyl group Chemical group [H]C([H])(Cl)C([H])([H])* 0.000 claims 1
- FZZDDDNEJNJTID-UHFFFAOYSA-N 2-docosoxycarbonylbenzoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCOC(=O)C1=CC=CC=C1C(O)=O FZZDDDNEJNJTID-UHFFFAOYSA-N 0.000 claims 1
- SJEBAWHUJDUKQK-UHFFFAOYSA-N 2-ethylanthraquinone Chemical compound C1=CC=C2C(=O)C3=CC(CC)=CC=C3C(=O)C2=C1 SJEBAWHUJDUKQK-UHFFFAOYSA-N 0.000 claims 1
- KTALPKYXQZGAEG-UHFFFAOYSA-N 2-propan-2-ylthioxanthen-9-one Chemical compound C1=CC=C2C(=O)C3=CC(C(C)C)=CC=C3SC2=C1 KTALPKYXQZGAEG-UHFFFAOYSA-N 0.000 claims 1
- HXIQYSLFEXIOAV-UHFFFAOYSA-N 2-tert-butyl-4-(5-tert-butyl-4-hydroxy-2-methylphenyl)sulfanyl-5-methylphenol Chemical compound CC1=CC(O)=C(C(C)(C)C)C=C1SC1=CC(C(C)(C)C)=C(O)C=C1C HXIQYSLFEXIOAV-UHFFFAOYSA-N 0.000 claims 1
- DGQFNPWGWSSTMN-UHFFFAOYSA-N 2-tert-butyl-4-[4-(5-tert-butyl-4-hydroxy-2-methylphenyl)butyl]-5-methylphenol Chemical compound CC1=CC(O)=C(C(C)(C)C)C=C1CCCCC1=CC(C(C)(C)C)=C(O)C=C1C DGQFNPWGWSSTMN-UHFFFAOYSA-N 0.000 claims 1
- GPNYZBKIGXGYNU-UHFFFAOYSA-N 2-tert-butyl-6-[(3-tert-butyl-5-ethyl-2-hydroxyphenyl)methyl]-4-ethylphenol Chemical compound CC(C)(C)C1=CC(CC)=CC(CC=2C(=C(C=C(CC)C=2)C(C)(C)C)O)=C1O GPNYZBKIGXGYNU-UHFFFAOYSA-N 0.000 claims 1
- FDVCQFAKOKLXGE-UHFFFAOYSA-N 216978-79-9 Chemical compound C1CC(C)(C)C2=CC(C=O)=CC3=C2N1CCC3(C)C FDVCQFAKOKLXGE-UHFFFAOYSA-N 0.000 claims 1
- YEXOWHQZWLCHHD-UHFFFAOYSA-N 3,5-ditert-butyl-4-hydroxybenzoic acid Chemical compound CC(C)(C)C1=CC(C(O)=O)=CC(C(C)(C)C)=C1O YEXOWHQZWLCHHD-UHFFFAOYSA-N 0.000 claims 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 claims 1
- HCILJBJJZALOAL-UHFFFAOYSA-N 3-(3,5-ditert-butyl-4-hydroxyphenyl)-n'-[3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoyl]propanehydrazide Chemical compound CC(C)(C)C1=C(O)C(C(C)(C)C)=CC(CCC(=O)NNC(=O)CCC=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)=C1 HCILJBJJZALOAL-UHFFFAOYSA-N 0.000 claims 1
- RZRNAYUHWVFMIP-GDCKJWNLSA-N 3-oleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-GDCKJWNLSA-N 0.000 claims 1
- MRBKEAMVRSLQPH-UHFFFAOYSA-N 3-tert-butyl-4-hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1 MRBKEAMVRSLQPH-UHFFFAOYSA-N 0.000 claims 1
- IOJUPLGTWVMSFF-RHQRLBAQSA-N 4,5,6,7-tetradeuterio-1,3-benzothiazole Chemical compound [2H]C1=C([2H])C([2H])=C2SC=NC2=C1[2H] IOJUPLGTWVMSFF-RHQRLBAQSA-N 0.000 claims 1
- QRLSTWVLSWCGBT-UHFFFAOYSA-N 4-((4,6-bis(octylthio)-1,3,5-triazin-2-yl)amino)-2,6-di-tert-butylphenol Chemical compound CCCCCCCCSC1=NC(SCCCCCCCC)=NC(NC=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)=N1 QRLSTWVLSWCGBT-UHFFFAOYSA-N 0.000 claims 1
- UJAWGGOCYUPCPS-UHFFFAOYSA-N 4-(2-phenylpropan-2-yl)-n-[4-(2-phenylpropan-2-yl)phenyl]aniline Chemical compound C=1C=C(NC=2C=CC(=CC=2)C(C)(C)C=2C=CC=CC=2)C=CC=1C(C)(C)C1=CC=CC=C1 UJAWGGOCYUPCPS-UHFFFAOYSA-N 0.000 claims 1
- DLLIPJSMDJCZRF-UHFFFAOYSA-N 4-(4-ethylphenyl)benzonitrile Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C#N)C=C1 DLLIPJSMDJCZRF-UHFFFAOYSA-N 0.000 claims 1
- GPGGNNIMKOVSAG-UHFFFAOYSA-N 4-(4-octoxyphenyl)benzonitrile Chemical compound C1=CC(OCCCCCCCC)=CC=C1C1=CC=C(C#N)C=C1 GPGGNNIMKOVSAG-UHFFFAOYSA-N 0.000 claims 1
- RDISTOCQRJJICR-UHFFFAOYSA-N 4-(4-pentoxyphenyl)benzonitrile Chemical group C1=CC(OCCCCC)=CC=C1C1=CC=C(C#N)C=C1 RDISTOCQRJJICR-UHFFFAOYSA-N 0.000 claims 1
- 239000005213 4-Cyano-4'-pentyloxybiphenyl Substances 0.000 claims 1
- VLXNXMTVRWIUJZ-UHFFFAOYSA-N 4-Fluoro-3-phenoxybenzoic acid Chemical compound OC(=O)C1=CC=C(F)C(OC=2C=CC=CC=2)=C1 VLXNXMTVRWIUJZ-UHFFFAOYSA-N 0.000 claims 1
- YPCMHZWFVHZWAB-UHFFFAOYSA-N 4-[2-[4-(3-tert-butyl-4-hydroxy-5-methylphenyl)-3-carboxybutoxy]ethoxy]-2-[(3-tert-butyl-4-hydroxy-5-methylphenyl)methyl]butanoic acid Chemical compound CC(C)(C)C1=C(O)C(C)=CC(CC(CCOCCOCCC(CC=2C=C(C(O)=C(C)C=2)C(C)(C)C)C(O)=O)C(O)=O)=C1 YPCMHZWFVHZWAB-UHFFFAOYSA-N 0.000 claims 1
- 239000005242 4-[Difluoro(3,4,5-trifluorophenoxy)methyl]-3,5-difluoro-4'-propylbiphenyl Substances 0.000 claims 1
- UDQCDDZBBZNIFA-UHFFFAOYSA-N 4-methyl-1,3-dihydrobenzimidazole-2-thione Chemical compound CC1=CC=CC2=C1NC(=S)N2 UDQCDDZBBZNIFA-UHFFFAOYSA-N 0.000 claims 1
- PIIZYNQECPTVEO-UHFFFAOYSA-N 4-nitro-m-cresol Chemical compound CC1=CC(O)=CC=C1[N+]([O-])=O PIIZYNQECPTVEO-UHFFFAOYSA-N 0.000 claims 1
- ISAVYTVYFVQUDY-UHFFFAOYSA-N 4-tert-Octylphenol Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(O)C=C1 ISAVYTVYFVQUDY-UHFFFAOYSA-N 0.000 claims 1
- UWSMKYBKUPAEJQ-UHFFFAOYSA-N 5-Chloro-2-(3,5-di-tert-butyl-2-hydroxyphenyl)-2H-benzotriazole Chemical compound CC(C)(C)C1=CC(C(C)(C)C)=CC(N2N=C3C=C(Cl)C=CC3=N2)=C1O UWSMKYBKUPAEJQ-UHFFFAOYSA-N 0.000 claims 1
- LRUDIIUSNGCQKF-UHFFFAOYSA-N 5-methyl-1H-benzotriazole Chemical compound C1=C(C)C=CC2=NNN=C21 LRUDIIUSNGCQKF-UHFFFAOYSA-N 0.000 claims 1
- ZYMCJDAUBJFVSM-UHFFFAOYSA-N 6-methylheptyl 4-(dimethylamino)benzoate Chemical compound CC(C)CCCCCOC(=O)C1=CC=C(N(C)C)C=C1 ZYMCJDAUBJFVSM-UHFFFAOYSA-N 0.000 claims 1
- 239000005496 Chlorsulfuron Substances 0.000 claims 1
- XTJFFFGAUHQWII-UHFFFAOYSA-N Dibutyl adipate Chemical compound CCCCOC(=O)CCCCC(=O)OCCCC XTJFFFGAUHQWII-UHFFFAOYSA-N 0.000 claims 1
- PYGXAGIECVVIOZ-UHFFFAOYSA-N Dibutyl decanedioate Chemical compound CCCCOC(=O)CCCCCCCCC(=O)OCCCC PYGXAGIECVVIOZ-UHFFFAOYSA-N 0.000 claims 1
- VIZORQUEIQEFRT-UHFFFAOYSA-N Diethyl adipate Chemical compound CCOC(=O)CCCCC(=O)OCC VIZORQUEIQEFRT-UHFFFAOYSA-N 0.000 claims 1
- DKMROQRQHGEIOW-UHFFFAOYSA-N Diethyl succinate Chemical compound CCOC(=O)CCC(=O)OCC DKMROQRQHGEIOW-UHFFFAOYSA-N 0.000 claims 1
- UDSFAEKRVUSQDD-UHFFFAOYSA-N Dimethyl adipate Chemical compound COC(=O)CCCCC(=O)OC UDSFAEKRVUSQDD-UHFFFAOYSA-N 0.000 claims 1
- RRRXPPIDPYTNJG-LLXNCONNSA-N F[13C]([13C]([13C]([13C]([13C]([13C]([13C]([13C](F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(S(=O)(=O)N)F Chemical compound F[13C]([13C]([13C]([13C]([13C]([13C]([13C]([13C](F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(S(=O)(=O)N)F RRRXPPIDPYTNJG-LLXNCONNSA-N 0.000 claims 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 claims 1
- OKOBUGCCXMIKDM-UHFFFAOYSA-N Irganox 1098 Chemical compound CC(C)(C)C1=C(O)C(C(C)(C)C)=CC(CCC(=O)NCCCCCCNC(=O)CCC=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)=C1 OKOBUGCCXMIKDM-UHFFFAOYSA-N 0.000 claims 1
- PWWVAXIEGOYWEE-UHFFFAOYSA-N Isophenergan Chemical compound C1=CC=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 PWWVAXIEGOYWEE-UHFFFAOYSA-N 0.000 claims 1
- FLVIGYVXZHLUHP-UHFFFAOYSA-N N,N'-diethylthiourea Chemical compound CCNC(=S)NCC FLVIGYVXZHLUHP-UHFFFAOYSA-N 0.000 claims 1
- UTGQNNCQYDRXCH-UHFFFAOYSA-N N,N'-diphenyl-1,4-phenylenediamine Chemical compound C=1C=C(NC=2C=CC=CC=2)C=CC=1NC1=CC=CC=C1 UTGQNNCQYDRXCH-UHFFFAOYSA-N 0.000 claims 1
- FCSHMCFRCYZTRQ-UHFFFAOYSA-N N,N'-diphenylthiourea Chemical compound C=1C=CC=CC=1NC(=S)NC1=CC=CC=C1 FCSHMCFRCYZTRQ-UHFFFAOYSA-N 0.000 claims 1
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 claims 1
- ISRUGXGCCGIOQO-UHFFFAOYSA-N Rhoden Chemical compound CNC(=O)OC1=CC=CC=C1OC(C)C ISRUGXGCCGIOQO-UHFFFAOYSA-N 0.000 claims 1
- MVSANBPTBLEQMT-OTUNDXSFSA-N [2H]C(C([2H])([2H])C([2H])(C([2H])([2H])C1([2H])[2H])O)C1([2H])C(OC(C)(C)C)=O Chemical group [2H]C(C([2H])([2H])C([2H])(C([2H])([2H])C1([2H])[2H])O)C1([2H])C(OC(C)(C)C)=O MVSANBPTBLEQMT-OTUNDXSFSA-N 0.000 claims 1
- BEUGBYXJXMVRFO-UHFFFAOYSA-N [4-(dimethylamino)phenyl]-phenylmethanone Chemical compound C1=CC(N(C)C)=CC=C1C(=O)C1=CC=CC=C1 BEUGBYXJXMVRFO-UHFFFAOYSA-N 0.000 claims 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims 1
- UBNYRXMKIIGMKK-RMKNXTFCSA-N amiloxate Chemical compound COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-RMKNXTFCSA-N 0.000 claims 1
- 229960002709 amiloxate Drugs 0.000 claims 1
- 229940067597 azelate Drugs 0.000 claims 1
- WXNRYSGJLQFHBR-UHFFFAOYSA-N bis(2,4-dihydroxyphenyl)methanone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=C(O)C=C1O WXNRYSGJLQFHBR-UHFFFAOYSA-N 0.000 claims 1
- BJQHLKABXJIVAM-SAQXESPHSA-N bis(2-ethylhexyl) 3,4,5,6-tetradeuteriobenzene-1,2-dicarboxylate Chemical compound [2H]C1=C([2H])C([2H])=C(C(=O)OCC(CC)CCCC)C(C(=O)OCC(CC)CCCC)=C1[2H] BJQHLKABXJIVAM-SAQXESPHSA-N 0.000 claims 1
- SAOKZLXYCUGLFA-UHFFFAOYSA-N bis(2-ethylhexyl) adipate Chemical compound CCCCC(CC)COC(=O)CCCCC(=O)OCC(CC)CCCC SAOKZLXYCUGLFA-UHFFFAOYSA-N 0.000 claims 1
- SODJJEXAWOSSON-UHFFFAOYSA-N bis(2-hydroxy-4-methoxyphenyl)methanone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(OC)C=C1O SODJJEXAWOSSON-UHFFFAOYSA-N 0.000 claims 1
- UQRSMZHDWDMLDH-UHFFFAOYSA-N bis(2-tert-butylphenyl) phenyl phosphate Chemical compound CC(C)(C)C1=CC=CC=C1OP(=O)(OC=1C(=CC=CC=1)C(C)(C)C)OC1=CC=CC=C1 UQRSMZHDWDMLDH-UHFFFAOYSA-N 0.000 claims 1
- VYHBFRJRBHMIQZ-UHFFFAOYSA-N bis[4-(diethylamino)phenyl]methanone Chemical compound C1=CC(N(CC)CC)=CC=C1C(=O)C1=CC=C(N(CC)CC)C=C1 VYHBFRJRBHMIQZ-UHFFFAOYSA-N 0.000 claims 1
- RMXVHZFHSKRNJN-UHFFFAOYSA-N chlorourea Chemical compound NC(=O)NCl RMXVHZFHSKRNJN-UHFFFAOYSA-N 0.000 claims 1
- VJYIFXVZLXQVHO-UHFFFAOYSA-N chlorsulfuron Chemical compound COC1=NC(C)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CC=2)Cl)=N1 VJYIFXVZLXQVHO-UHFFFAOYSA-N 0.000 claims 1
- UCVPKAZCQPRWAY-ZZRPVTOQSA-N dibenzyl 3,4,5,6-tetradeuteriobenzene-1,2-dicarboxylate Chemical compound C=1C=CC=CC=1COC(=O)C1=C([2H])C([2H])=C([2H])C([2H])=C1C(=O)OCC1=CC=CC=C1 UCVPKAZCQPRWAY-ZZRPVTOQSA-N 0.000 claims 1
- JBSLOWBPDRZSMB-BQYQJAHWSA-N dibutyl (e)-but-2-enedioate Chemical compound CCCCOC(=O)\C=C\C(=O)OCCCC JBSLOWBPDRZSMB-BQYQJAHWSA-N 0.000 claims 1
- DOIRQSBPFJWKBE-ULDPCNCHSA-N dibutyl 3,4,5,6-tetradeuteriobenzene-1,2-dicarboxylate Chemical compound [2H]C1=C([2H])C([2H])=C(C(=O)OCCCC)C(C(=O)OCCCC)=C1[2H] DOIRQSBPFJWKBE-ULDPCNCHSA-N 0.000 claims 1
- 229940100539 dibutyl adipate Drugs 0.000 claims 1
- KCXZNSGUUQJJTR-LSQQNFJSSA-N dihexyl 3,4,5,6-tetradeuteriobenzene-1,2-dicarboxylate Chemical compound [2H]C1=C([2H])C([2H])=C(C(=O)OCCCCCC)C(C(=O)OCCCCCC)=C1[2H] KCXZNSGUUQJJTR-LSQQNFJSSA-N 0.000 claims 1
- MJOKHGMXPJXFTG-UHFFFAOYSA-N dihexyl nonanedioate Chemical compound CCCCCCOC(=O)CCCCCCCC(=O)OCCCCCC MJOKHGMXPJXFTG-UHFFFAOYSA-N 0.000 claims 1
- JUHFQCKQQLMGAB-UHFFFAOYSA-N diphenyl (4-propan-2-ylphenyl) phosphate Chemical compound C1=CC(C(C)C)=CC=C1OP(=O)(OC=1C=CC=CC=1)OC1=CC=CC=C1 JUHFQCKQQLMGAB-UHFFFAOYSA-N 0.000 claims 1
- FHESUNXRPBHDQM-UHFFFAOYSA-N diphenyl benzene-1,3-dicarboxylate Chemical compound C=1C=CC(C(=O)OC=2C=CC=CC=2)=CC=1C(=O)OC1=CC=CC=C1 FHESUNXRPBHDQM-UHFFFAOYSA-N 0.000 claims 1
- MQHNKCZKNAJROC-KDWZCNHSSA-N dipropyl 3,4,5,6-tetradeuteriobenzene-1,2-dicarboxylate Chemical compound [2H]C1=C([2H])C([2H])=C(C(=O)OCCC)C(C(=O)OCCC)=C1[2H] MQHNKCZKNAJROC-KDWZCNHSSA-N 0.000 claims 1
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 claims 1
- 229960003913 econazole Drugs 0.000 claims 1
- 229960004697 enzacamene Drugs 0.000 claims 1
- 229940075529 glyceryl stearate Drugs 0.000 claims 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 claims 1
- HCWNFKHKKHNSSL-UHFFFAOYSA-N mono(2-ethyl-5-oxohexyl) phthalate Chemical compound CC(=O)CCC(CC)COC(=O)C1=CC=CC=C1C(O)=O HCWNFKHKKHNSSL-UHFFFAOYSA-N 0.000 claims 1
- DJDSLBVSSOQSLW-UHFFFAOYSA-N mono(2-ethylhexyl) phthalate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1C(O)=O DJDSLBVSSOQSLW-UHFFFAOYSA-N 0.000 claims 1
- NTIWNFLUZQSLDR-UHFFFAOYSA-N mono-2-heptyl phthalate Chemical compound CCCCCC(C)OC(=O)C1=CC=CC=C1C(O)=O NTIWNFLUZQSLDR-UHFFFAOYSA-N 0.000 claims 1
- XIKIUQUXDNHBFR-UHFFFAOYSA-N monobenzyl phthalate Chemical compound OC(=O)C1=CC=CC=C1C(=O)OCC1=CC=CC=C1 XIKIUQUXDNHBFR-UHFFFAOYSA-N 0.000 claims 1
- RZRNAYUHWVFMIP-UHFFFAOYSA-N monoelaidin Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-UHFFFAOYSA-N 0.000 claims 1
- RNCMBSSLYOAVRT-UHFFFAOYSA-N monoisononyl phthalate Chemical compound CC(C)CCCCCCOC(=O)C1=CC=CC=C1C(O)=O RNCMBSSLYOAVRT-UHFFFAOYSA-N 0.000 claims 1
- VSHTWPWTCXQLQN-UHFFFAOYSA-N n-butylaniline Chemical compound CCCCNC1=CC=CC=C1 VSHTWPWTCXQLQN-UHFFFAOYSA-N 0.000 claims 1
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 claims 1
- FZUGPQWGEGAKET-UHFFFAOYSA-N parbenate Chemical compound CCOC(=O)C1=CC=C(N(C)C)C=C1 FZUGPQWGEGAKET-UHFFFAOYSA-N 0.000 claims 1
- YPJUNDFVDDCYIH-UHFFFAOYSA-N perfluorobutyric acid Chemical compound OC(=O)C(F)(F)C(F)(F)C(F)(F)F YPJUNDFVDDCYIH-UHFFFAOYSA-N 0.000 claims 1
- ZWBAMYVPMDSJGQ-UHFFFAOYSA-N perfluoroheptanoic acid Chemical compound OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F ZWBAMYVPMDSJGQ-UHFFFAOYSA-N 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims 1
- 229960003910 promethazine Drugs 0.000 claims 1
- VTGOHKSTWXHQJK-UHFFFAOYSA-N pyrimidin-2-ol Chemical compound OC1=NC=CC=N1 VTGOHKSTWXHQJK-UHFFFAOYSA-N 0.000 claims 1
- ULYIJZHWHDXAMG-UHFFFAOYSA-M sodium;1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-henicosafluorodecane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F ULYIJZHWHDXAMG-UHFFFAOYSA-M 0.000 claims 1
- VACCAVUAMIDAGB-UHFFFAOYSA-N sulfamethizole Chemical compound S1C(C)=NN=C1NS(=O)(=O)C1=CC=C(N)C=C1 VACCAVUAMIDAGB-UHFFFAOYSA-N 0.000 claims 1
- CCEKAJIANROZEO-UHFFFAOYSA-N sulfluramid Chemical compound CCNS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F CCEKAJIANROZEO-UHFFFAOYSA-N 0.000 claims 1
- 150000003852 triazoles Chemical class 0.000 claims 1
- 210000002381 plasma Anatomy 0.000 abstract description 37
- 238000004445 quantitative analysis Methods 0.000 abstract description 4
- 238000003672 processing method Methods 0.000 abstract description 2
- 238000000861 blow drying Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 7
- 239000011521 glass Substances 0.000 description 7
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 6
- 239000011159 matrix material Substances 0.000 description 6
- 238000012546 transfer Methods 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- BXNANOICGRISHX-IZUSZFKNSA-N 7-[bis(1,1,2,2,2-pentadeuterioethoxy)phosphinothioyloxy]-3-chloro-4-methylchromen-2-one Chemical group CC1=C(Cl)C(=O)OC2=CC(OP(=S)(OC([2H])([2H])C([2H])([2H])[2H])OC([2H])([2H])C([2H])([2H])[2H])=CC=C21 BXNANOICGRISHX-IZUSZFKNSA-N 0.000 description 4
- 238000010811 Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Methods 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 238000002203 pretreatment Methods 0.000 description 4
- 241001494479 Pecora Species 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 238000005040 ion trap Methods 0.000 description 3
- 239000004597 plastic additive Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 3
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 2
- WNTGYJSOUMFZEP-UHFFFAOYSA-N 2-(4-chloro-2-methylphenoxy)propanoic acid Chemical compound OC(=O)C(C)OC1=CC=C(Cl)C=C1C WNTGYJSOUMFZEP-UHFFFAOYSA-N 0.000 description 2
- KESQFSZFUCZCEI-UHFFFAOYSA-N 2-(5-nitropyridin-2-yl)oxyethanol Chemical compound OCCOC1=CC=C([N+]([O-])=O)C=N1 KESQFSZFUCZCEI-UHFFFAOYSA-N 0.000 description 2
- NUCFNMOPTGEHQA-UHFFFAOYSA-N 3-bromo-2h-pyrazolo[4,3-c]pyridine Chemical compound C1=NC=C2C(Br)=NNC2=C1 NUCFNMOPTGEHQA-UHFFFAOYSA-N 0.000 description 2
- LEUWBMAQQQENOO-UHFFFAOYSA-N 4-(4-chlorophenyl)-6-methyl-2-oxo-3,4-dihydro-1h-pyridine-5-carboxylic acid Chemical compound C1C(=O)NC(C)=C(C(O)=O)C1C1=CC=C(Cl)C=C1 LEUWBMAQQQENOO-UHFFFAOYSA-N 0.000 description 2
- XKJMBINCVNINCA-UHFFFAOYSA-N Alfalone Chemical compound CON(C)C(=O)NC1=CC=C(Cl)C(Cl)=C1 XKJMBINCVNINCA-UHFFFAOYSA-N 0.000 description 2
- 239000005573 Linuron Substances 0.000 description 2
- BQPNUOYXSVUVMY-UHFFFAOYSA-N [4-[2-(4-diphenoxyphosphoryloxyphenyl)propan-2-yl]phenyl] diphenyl phosphate Chemical compound C=1C=C(OP(=O)(OC=2C=CC=CC=2)OC=2C=CC=CC=2)C=CC=1C(C)(C)C(C=C1)=CC=C1OP(=O)(OC=1C=CC=CC=1)OC1=CC=CC=C1 BQPNUOYXSVUVMY-UHFFFAOYSA-N 0.000 description 2
- JLYXXMFPNIAWKQ-SHFUYGGZSA-N alpha-hexachlorocyclohexane Chemical compound Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H](Cl)[C@H]1Cl JLYXXMFPNIAWKQ-SHFUYGGZSA-N 0.000 description 2
- SAOKZLXYCUGLFA-QSIDXAOLSA-N bis(2-ethylhexyl) 2,2,3,3,4,4,5,5-octadeuteriohexanedioate Chemical compound [2H]C([2H])(C(=O)OCC(CC)CCCC)C([2H])([2H])C([2H])([2H])C([2H])([2H])C(=O)OCC(CC)CCCC SAOKZLXYCUGLFA-QSIDXAOLSA-N 0.000 description 2
- 238000007664 blowing Methods 0.000 description 2
- 239000000152 carbamate pesticide Substances 0.000 description 2
- BIWJNBZANLAXMG-IDTQJTQFSA-N cis-chlordane Chemical compound ClC1=C(Cl)[C@@]2(Cl)[C@@H]3C[C@@H](Cl)[C@@H](Cl)[C@@H]3[C@]1(Cl)C2(Cl)Cl BIWJNBZANLAXMG-IDTQJTQFSA-N 0.000 description 2
- JJXNVYMIYBNZQX-UHFFFAOYSA-N diphenyl (2-propan-2-ylphenyl) phosphate Chemical compound CC(C)C1=CC=CC=C1OP(=O)(OC=1C=CC=CC=1)OC1=CC=CC=C1 JJXNVYMIYBNZQX-UHFFFAOYSA-N 0.000 description 2
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 2
- DWNAQMUDCDVSLT-UHFFFAOYSA-N diphenyl phthalate Chemical compound C=1C=CC=C(C(=O)OC=2C=CC=CC=2)C=1C(=O)OC1=CC=CC=C1 DWNAQMUDCDVSLT-UHFFFAOYSA-N 0.000 description 2
- RZRNAYUHWVFMIP-HXUWFJFHSA-N glycerol monolinoleate Natural products CCCCCCCCC=CCCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-HXUWFJFHSA-N 0.000 description 2
- 239000000383 hazardous chemical Substances 0.000 description 2
- 231100000206 health hazard Toxicity 0.000 description 2
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 2
- WLGDAKIJYPIYLR-UHFFFAOYSA-M octane-1-sulfonate Chemical compound CCCCCCCCS([O-])(=O)=O WLGDAKIJYPIYLR-UHFFFAOYSA-M 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000002728 pyrethroid Substances 0.000 description 2
- 238000000275 quality assurance Methods 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- IROINLKCQGIITA-UHFFFAOYSA-N terbutryn Chemical compound CCNC1=NC(NC(C)(C)C)=NC(SC)=N1 IROINLKCQGIITA-UHFFFAOYSA-N 0.000 description 2
- HQUQLFOMPYWACS-LBTWDOQPSA-N tris(2-chloro-1,1,2,2-tetradeuterioethyl) phosphate Chemical compound [2H]C([2H])(Cl)C([2H])([2H])OP(=O)(OC([2H])([2H])C([2H])([2H])Cl)OC([2H])([2H])C([2H])([2H])Cl HQUQLFOMPYWACS-LBTWDOQPSA-N 0.000 description 2
- KPGXUAIFQMJJFB-UHFFFAOYSA-H tungsten hexachloride Chemical compound Cl[W](Cl)(Cl)(Cl)(Cl)Cl KPGXUAIFQMJJFB-UHFFFAOYSA-H 0.000 description 2
- RSJKGSCJYJTIGS-UHFFFAOYSA-N undecane Chemical compound CCCCCCCCCCC RSJKGSCJYJTIGS-UHFFFAOYSA-N 0.000 description 2
- ZXFXBSWRVIQKOD-CFKMXOCQSA-N (1R,2S,3R,5R,6S,7R,8S)-1,6,8,9,10,11,11-heptachloro-4-oxatetracyclo[6.2.1.02,7.03,5]undec-9-ene Chemical compound ClC1=C(Cl)[C@]2(Cl)[C@@H]3[C@H]4O[C@H]4[C@@H](Cl)[C@@H]3[C@@]1(Cl)C2(Cl)Cl ZXFXBSWRVIQKOD-CFKMXOCQSA-N 0.000 description 1
- LQTIAFFVNAYEGV-UHFFFAOYSA-N (2,4-dihydroxyphenyl)-phenylmethanone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1.OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 LQTIAFFVNAYEGV-UHFFFAOYSA-N 0.000 description 1
- SAPGTCDSBGMXCD-UHFFFAOYSA-N (2-chlorophenyl)-(4-fluorophenyl)-pyrimidin-5-ylmethanol Chemical compound C=1N=CN=CC=1C(C=1C(=CC=CC=1)Cl)(O)C1=CC=C(F)C=C1 SAPGTCDSBGMXCD-UHFFFAOYSA-N 0.000 description 1
- YKNCPXOFSKBINA-UHFFFAOYSA-N (2-hydroxy-4-methoxyphenyl)-phenylmethanone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1.OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 YKNCPXOFSKBINA-UHFFFAOYSA-N 0.000 description 1
- UETPRJJVZPVPQI-UHFFFAOYSA-N (2-propan-2-ylphenyl) dihydrogen phosphate Chemical compound CC(C)C1=CC=CC=C1OP(O)(O)=O UETPRJJVZPVPQI-UHFFFAOYSA-N 0.000 description 1
- ZMYFCFLJBGAQRS-IRXDYDNUSA-N (2R,3S)-epoxiconazole Chemical compound C1=CC(F)=CC=C1[C@@]1(CN2N=CN=C2)[C@H](C=2C(=CC=CC=2)Cl)O1 ZMYFCFLJBGAQRS-IRXDYDNUSA-N 0.000 description 1
- AFQJYYPIAZDTHT-UHFFFAOYSA-N (3,5-dimethylphenyl) dihydrogen phosphate Chemical compound CC1=CC(C)=CC(OP(O)(O)=O)=C1 AFQJYYPIAZDTHT-UHFFFAOYSA-N 0.000 description 1
- BYKFQXBTKULKMU-UHFFFAOYSA-N (4,4-diphenylcyclohexa-1,5-dien-1-yl)-phenylmethanone Chemical compound C=1C=CC=CC=1C(=O)C(C=C1)=CCC1(C=1C=CC=CC=1)C1=CC=CC=C1 BYKFQXBTKULKMU-UHFFFAOYSA-N 0.000 description 1
- STJANKPTIVPGNU-UHFFFAOYSA-N (4-hydroxyphenyl)-phenylmethanone Chemical compound OC1=CC=C(C(=O)C2=CC=CC=C2)C=C1.OC1=CC=C(C(=O)C2=CC=CC=C2)C=C1 STJANKPTIVPGNU-UHFFFAOYSA-N 0.000 description 1
- JNUCNIFVQZYOCP-UHFFFAOYSA-N (4-methylphenyl) dihydrogen phosphate Chemical compound CC1=CC=C(OP(O)(O)=O)C=C1 JNUCNIFVQZYOCP-UHFFFAOYSA-N 0.000 description 1
- BFVWABPNHXPWPS-UHFFFAOYSA-N (4-tert-butylphenyl) dihydrogen phosphate Chemical compound CC(C)(C)C1=CC=C(OP(O)(O)=O)C=C1 BFVWABPNHXPWPS-UHFFFAOYSA-N 0.000 description 1
- FABAOYOFJNAVHB-KVVVOXFISA-N (z)-octadec-9-enoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O FABAOYOFJNAVHB-KVVVOXFISA-N 0.000 description 1
- SRMWNTGHXHOWBT-UHFFFAOYSA-N 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-n-methyloctane-1-sulfonamide Chemical compound CNS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F SRMWNTGHXHOWBT-UHFFFAOYSA-N 0.000 description 1
- ZROXLDFZRPDCSV-UHFFFAOYSA-N 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane-1-sulfonic acid Chemical compound FC(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(S(=O)(=O)O)F.FC(C(C(C(C(C(C(C(S(=O)(=O)O)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F ZROXLDFZRPDCSV-UHFFFAOYSA-N 0.000 description 1
- ALFOANISZPLMRO-UHFFFAOYSA-N 1,2-diphenylethane-1,2-dione Chemical compound C=1C=CC=CC=1C(=O)C(=O)C1=CC=CC=C1.C=1C=CC=CC=1C(=O)C(=O)C1=CC=CC=C1 ALFOANISZPLMRO-UHFFFAOYSA-N 0.000 description 1
- JBQMAAJJRTWUPQ-UHFFFAOYSA-N 1,2-diphenylguanidine Chemical compound C1(=CC=CC=C1)NC(NC1=CC=CC=C1)=N.C1(=CC=CC=C1)NC(=N)NC1=CC=CC=C1 JBQMAAJJRTWUPQ-UHFFFAOYSA-N 0.000 description 1
- IZYUWBATGXUSIK-UHFFFAOYSA-N 1-(2-benzoyloxypropoxy)propan-2-yl benzoate Chemical compound C=1C=CC=CC=1C(=O)OC(C)COCC(C)OC(=O)C1=CC=CC=C1 IZYUWBATGXUSIK-UHFFFAOYSA-N 0.000 description 1
- VGPIBGGRCVEHQZ-UHFFFAOYSA-N 1-(biphenyl-4-yloxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-ol Chemical compound C1=NC=NN1C(C(O)C(C)(C)C)OC(C=C1)=CC=C1C1=CC=CC=C1 VGPIBGGRCVEHQZ-UHFFFAOYSA-N 0.000 description 1
- GIORNWYQFIWZNC-UHFFFAOYSA-N 1-N,4-N-diphenylbenzene-1,4-diamine Chemical compound C1(=CC=CC=C1)NC1=CC=C(C=C1)NC1=CC=CC=C1.C1(=CC=CC=C1)NC1=CC=C(C=C1)NC1=CC=CC=C1 GIORNWYQFIWZNC-UHFFFAOYSA-N 0.000 description 1
- PZBPKYOVPCNPJY-UHFFFAOYSA-N 1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]imidazole Chemical compound ClC1=CC(Cl)=CC=C1C(OCC=C)CN1C=NC=C1 PZBPKYOVPCNPJY-UHFFFAOYSA-N 0.000 description 1
- DFPYXQYWILNVAU-UHFFFAOYSA-N 1-hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1.C1=CC=C2N(O)N=NC2=C1 DFPYXQYWILNVAU-UHFFFAOYSA-N 0.000 description 1
- KKTRUNKYKDKMGC-UHFFFAOYSA-N 1-methyl-4-[4-(4-propylcyclohexyl)cyclohexyl]benzene Chemical compound C1CC(CCC)CCC1C1CCC(C=2C=CC(C)=CC=2)CC1.C1CC(CCC)CCC1C1CCC(C=2C=CC(C)=CC=2)CC1 KKTRUNKYKDKMGC-UHFFFAOYSA-N 0.000 description 1
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 description 1
- KYYLRFGDYLDEOZ-UHFFFAOYSA-N 2,2,3,3,4,4,4-heptafluorobutanoic acid Chemical compound FC(C(C(C(=O)O)(F)F)(F)F)(F)F.FC(C(C(C(=O)O)(F)F)(F)F)(F)F KYYLRFGDYLDEOZ-UHFFFAOYSA-N 0.000 description 1
- BYCNMZYQCQZYLG-UHFFFAOYSA-N 2,2-dimethoxy-1,2-diphenylethanone Chemical compound C=1C=CC=CC=1C(OC)(OC)C(=O)C1=CC=CC=C1.C=1C=CC=CC=1C(OC)(OC)C(=O)C1=CC=CC=C1 BYCNMZYQCQZYLG-UHFFFAOYSA-N 0.000 description 1
- OIVQVBDAMYDDEM-UHFFFAOYSA-N 2,3,3,3-tetrafluoro-2-[1,1,2,3,3,3-hexafluoro-2-(1,1,2,2,3,3,3-heptafluoropropoxy)propoxy]propanoic acid Chemical compound OC(=O)C(F)(C(F)(F)F)OC(F)(F)C(F)(C(F)(F)F)OC(F)(F)C(F)(F)C(F)(F)F OIVQVBDAMYDDEM-UHFFFAOYSA-N 0.000 description 1
- 239000002794 2,4-DB Substances 0.000 description 1
- ILLYVXDVYIMSTE-UHFFFAOYSA-N 2,4-ditert-butyl-6-(5-chlorobenzotriazol-2-yl)phenol Chemical compound C(C)(C)(C)C1=C(C(=CC(=C1)C(C)(C)C)N1N=C2C(=N1)C=CC(=C2)Cl)O.C(C)(C)(C)C2=C(C(=CC(=C2)C(C)(C)C)N2N=C1C(=N2)C=CC(=C1)Cl)O ILLYVXDVYIMSTE-UHFFFAOYSA-N 0.000 description 1
- KMJBUNZXLOWHLV-UHFFFAOYSA-N 2,4-ditert-butylphenol Chemical compound CC(C)(C)C1=CC=C(O)C(C(C)(C)C)=C1.CC(C)(C)C1=CC=C(O)C(C(C)(C)C)=C1 KMJBUNZXLOWHLV-UHFFFAOYSA-N 0.000 description 1
- ADTULIPIPGWVAA-UHFFFAOYSA-N 2,6-ditert-butyl-4-[(dimethylamino)methyl]phenol Chemical compound C(C)(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)CN(C)C.C(C)(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)CN(C)C ADTULIPIPGWVAA-UHFFFAOYSA-N 0.000 description 1
- BCGVBROPLUFASJ-UHFFFAOYSA-N 2-(2,4,5-trichlorophenoxy)acetic acid Chemical compound OC(=O)COC1=CC(Cl)=C(Cl)C=C1Cl.OC(=O)COC1=CC(Cl)=C(Cl)C=C1Cl BCGVBROPLUFASJ-UHFFFAOYSA-N 0.000 description 1
- HZJKXKUJVSEEFU-UHFFFAOYSA-N 2-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)hexanenitrile Chemical compound C=1C=C(Cl)C=CC=1C(CCCC)(C#N)CN1C=NC=N1 HZJKXKUJVSEEFU-UHFFFAOYSA-N 0.000 description 1
- GGOUUEMCWBTDMT-UHFFFAOYSA-N 2-(6-chloro-1,1,2,2,3,3,4,4,5,5,6,6-dodecafluorohexoxy)-1,1,2,2-tetrafluoroethanesulfonic acid Chemical compound OS(=O)(=O)C(F)(F)C(F)(F)OC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)Cl GGOUUEMCWBTDMT-UHFFFAOYSA-N 0.000 description 1
- SZVGIJOITCPDPM-UHFFFAOYSA-N 2-(8-chloro-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8-hexadecafluorooctoxy)-1,1,2,2-tetrafluoroethanesulfonic acid Chemical compound OS(=O)(=O)C(F)(F)C(F)(F)OC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)Cl SZVGIJOITCPDPM-UHFFFAOYSA-N 0.000 description 1
- QSRJVOOOWGXUDY-UHFFFAOYSA-N 2-[2-[2-[3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propanoyloxy]ethoxy]ethoxy]ethyl 3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propanoate Chemical compound CC(C)(C)C1=C(O)C(C)=CC(CCC(=O)OCCOCCOCCOC(=O)CCC=2C=C(C(O)=C(C)C=2)C(C)(C)C)=C1 QSRJVOOOWGXUDY-UHFFFAOYSA-N 0.000 description 1
- KODOIOCJZCCYHX-UHFFFAOYSA-N 2-acetylsulfanylethanesulfonic acid Chemical compound CC(=O)SCCS(O)(=O)=O KODOIOCJZCCYHX-UHFFFAOYSA-N 0.000 description 1
- SVFHHGXDLUSTKX-UHFFFAOYSA-N 2-aminoethanimidamide Chemical compound NCC(N)=N SVFHHGXDLUSTKX-UHFFFAOYSA-N 0.000 description 1
- ANHAEBWRQNIPEV-UHFFFAOYSA-N 2-chloroethyl dihydrogen phosphate Chemical compound OP(O)(=O)OCCCl ANHAEBWRQNIPEV-UHFFFAOYSA-N 0.000 description 1
- LIAWCKFOFPPVGF-UHFFFAOYSA-N 2-ethyladamantane Chemical compound C1C(C2)CC3CC1C(CC)C2C3 LIAWCKFOFPPVGF-UHFFFAOYSA-N 0.000 description 1
- LJKDOMVGKKPJBH-UHFFFAOYSA-N 2-ethylhexyl dihydrogen phosphate Chemical compound CCCCC(CC)COP(O)(O)=O LJKDOMVGKKPJBH-UHFFFAOYSA-N 0.000 description 1
- SRBCDRVMFOIVNR-UHFFFAOYSA-N 2-methyl-1,3-benzothiazole Chemical compound C1=CC=C2SC(C)=NC2=C1.C1=CC=C2SC(C)=NC2=C1 SRBCDRVMFOIVNR-UHFFFAOYSA-N 0.000 description 1
- OGFKELAGBSEHIU-UHFFFAOYSA-N 2-tert-butyl-4-methoxyphenol Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C(C(C)(C)C)=C1 OGFKELAGBSEHIU-UHFFFAOYSA-N 0.000 description 1
- XNGIFLGASWRNHJ-RHQRLBAQSA-N 3,4,5,6-tetradeuteriophthalic acid Chemical compound [2H]C1=C([2H])C([2H])=C(C(O)=O)C(C(O)=O)=C1[2H] XNGIFLGASWRNHJ-RHQRLBAQSA-N 0.000 description 1
- UPDBTGVHQJDXNH-UHFFFAOYSA-N 3,5-ditert-butyl-4-hydroxybenzoic acid Chemical compound C(C)(C)(C)C=1C=C(C(=O)O)C=C(C1O)C(C)(C)C.C(C)(C)(C)C=1C=C(C(=O)O)C=C(C1O)C(C)(C)C UPDBTGVHQJDXNH-UHFFFAOYSA-N 0.000 description 1
- MHKLKWCYGIBEQF-UHFFFAOYSA-N 4-(1,3-benzothiazol-2-ylsulfanyl)morpholine Chemical compound C1COCCN1SC1=NC2=CC=CC=C2S1 MHKLKWCYGIBEQF-UHFFFAOYSA-N 0.000 description 1
- WTOWZCUOYMKQPZ-UHFFFAOYSA-N 4-(4-octoxyphenyl)benzonitrile Chemical compound CCCCCCCCOc1ccc(cc1)-c1ccc(cc1)C#N.CCCCCCCCOc1ccc(cc1)-c1ccc(cc1)C#N WTOWZCUOYMKQPZ-UHFFFAOYSA-N 0.000 description 1
- GONPAIMDIMMKMK-UHFFFAOYSA-N 4-[3-carboxy-4-(3,5-ditert-butyl-4-hydroxyphenyl)butyl]sulfanyl-2-[(3,5-ditert-butyl-4-hydroxyphenyl)methyl]butanoic acid Chemical compound CC(C)(C)C1=C(O)C(C(C)(C)C)=CC(CC(CCSCCC(CC=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)C(O)=O)C(O)=O)=C1 GONPAIMDIMMKMK-UHFFFAOYSA-N 0.000 description 1
- MWTNHMQXSIWVJZ-UHFFFAOYSA-N 4-[4-[4-(4-ethylcyclohexyl)cyclohexyl]phenyl]-1,2-difluorobenzene Chemical group CCC1CCC(CC1)C1CCC(CC1)C1=CC=C(C=C1)C1=CC=C(F)C(F)=C1 MWTNHMQXSIWVJZ-UHFFFAOYSA-N 0.000 description 1
- BETABLJQRNJCFA-UHFFFAOYSA-N 4-amino-2-ethylbenzoic acid;ethyl 4-aminobenzoate Chemical compound CCOC(=O)C1=CC=C(N)C=C1.CCC1=CC(N)=CC=C1C(O)=O BETABLJQRNJCFA-UHFFFAOYSA-N 0.000 description 1
- CMGDVUCDZOBDNL-UHFFFAOYSA-N 4-methyl-2h-benzotriazole Chemical compound CC1=CC=CC2=NNN=C12 CMGDVUCDZOBDNL-UHFFFAOYSA-N 0.000 description 1
- MGLMEJLINAZYBG-UHFFFAOYSA-N 5-benzoyl-4-hydroxy-2-methoxybenzenesulfonic acid;hydrate Chemical compound O.C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 MGLMEJLINAZYBG-UHFFFAOYSA-N 0.000 description 1
- PCCSBWNGDMYFCW-UHFFFAOYSA-N 5-methyl-5-(4-phenoxyphenyl)-3-(phenylamino)-1,3-oxazolidine-2,4-dione Chemical compound O=C1C(C)(C=2C=CC(OC=3C=CC=CC=3)=CC=2)OC(=O)N1NC1=CC=CC=C1 PCCSBWNGDMYFCW-UHFFFAOYSA-N 0.000 description 1
- NVBPGQRYDRJSHH-UHFFFAOYSA-N 6-methylheptyl 2-cyano-3,3-diphenylprop-2-enoate Chemical compound C=1C=CC=CC=1C(=C(C#N)C(=O)OCCCCCC(C)C)C1=CC=CC=C1 NVBPGQRYDRJSHH-UHFFFAOYSA-N 0.000 description 1
- QZCLKYGREBVARF-UHFFFAOYSA-N Acetyl tributyl citrate Chemical compound CCCCOC(=O)CC(C(=O)OCCCC)(OC(C)=O)CC(=O)OCCCC QZCLKYGREBVARF-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- OYXLMBZLRFQOTD-UHFFFAOYSA-N C(C)(C)(C)C=1C=C(C=C(C1O)C(C)(C)C)CCC(=O)NNC(CCC1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C)=O.C(C)(C)(C)C=1C=C(C=C(C1O)C(C)(C)C)CCC(=O)NNC(CCC1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C)=O Chemical compound C(C)(C)(C)C=1C=C(C=C(C1O)C(C)(C)C)CCC(=O)NNC(CCC1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C)=O.C(C)(C)(C)C=1C=C(C=C(C1O)C(C)(C)C)CCC(=O)NNC(CCC1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C)=O OYXLMBZLRFQOTD-UHFFFAOYSA-N 0.000 description 1
- BIXNRGRTJGILCH-UHFFFAOYSA-N C(C)(C)C1=CC=2C(C3=CC=CC=C3SC2C=C1)=O.C(C)(C)C1=CC=2C(C3=CC=CC=C3SC2C=C1)=O Chemical compound C(C)(C)C1=CC=2C(C3=CC=CC=C3SC2C=C1)=O.C(C)(C)C1=CC=2C(C3=CC=CC=C3SC2C=C1)=O BIXNRGRTJGILCH-UHFFFAOYSA-N 0.000 description 1
- VWONYUGGFFCDIH-UHFFFAOYSA-N C(C)C(C(=O)O)(CCCC(=O)O)CC.C(CCCCC(=O)OCC)(=O)OCC Chemical compound C(C)C(C(=O)O)(CCCC(=O)O)CC.C(CCCCC(=O)OCC)(=O)OCC VWONYUGGFFCDIH-UHFFFAOYSA-N 0.000 description 1
- BOPFMROIKVHVPQ-UHFFFAOYSA-N C(C)C1=C(C(=O)O)C=CC(=C1)N(C)C.CN(C1=CC=C(C(=O)OCC)C=C1)C Chemical compound C(C)C1=C(C(=O)O)C=CC(=C1)N(C)C.CN(C1=CC=C(C(=O)OCC)C=C1)C BOPFMROIKVHVPQ-UHFFFAOYSA-N 0.000 description 1
- YRIBCMYGTPNNPO-UHFFFAOYSA-N C(C)C1=CC=2C(C3=CC=CC=C3C(C2C=C1)=O)=O.C(C)C1=CC=2C(C3=CC=CC=C3C(C2C=C1)=O)=O Chemical compound C(C)C1=CC=2C(C3=CC=CC=C3C(C2C=C1)=O)=O.C(C)C1=CC=2C(C3=CC=CC=C3C(C2C=C1)=O)=O YRIBCMYGTPNNPO-UHFFFAOYSA-N 0.000 description 1
- MWWANAURRFYIJF-UHFFFAOYSA-N C(C)N(C1=CC=C(C(=O)C2=CC=C(C=C2)N(CC)CC)C=C1)CC.C(C)N(C1=CC=C(C(=O)C2=CC=C(C=C2)N(CC)CC)C=C1)CC Chemical compound C(C)N(C1=CC=C(C(=O)C2=CC=C(C=C2)N(CC)CC)C=C1)CC.C(C)N(C1=CC=C(C(=O)C2=CC=C(C=C2)N(CC)CC)C=C1)CC MWWANAURRFYIJF-UHFFFAOYSA-N 0.000 description 1
- CHGIBPCWTKJVIX-UHFFFAOYSA-N C(C)NC(=S)NCC.C(C)NC(=S)NCC Chemical compound C(C)NC(=S)NCC.C(C)NC(=S)NCC CHGIBPCWTKJVIX-UHFFFAOYSA-N 0.000 description 1
- WPWMYXMQXAANIN-UHFFFAOYSA-N C(C1=C(C(=CC(=C1)C)C(C)(C)C)O)C1=C(C(=CC(=C1)C)C(C)(C)C)O.C(C1=C(C(=CC(=C1)C)C(C)(C)C)O)C1=C(C(=CC(=C1)C)C(C)(C)C)O Chemical compound C(C1=C(C(=CC(=C1)C)C(C)(C)C)O)C1=C(C(=CC(=C1)C)C(C)(C)C)O.C(C1=C(C(=CC(=C1)C)C(C)(C)C)O)C1=C(C(=CC(=C1)C)C(C)(C)C)O WPWMYXMQXAANIN-UHFFFAOYSA-N 0.000 description 1
- FMQNQXPPMJEFJN-UHFFFAOYSA-N C(CCC)(C1=C(C=C(C(=C1)C(C)(C)C)O)C)C1=C(C=C(C(=C1)C(C)(C)C)O)C.C(CCCC1=C(C=C(C(=C1)C(C)(C)C)O)C)C1=C(C=C(C(=C1)C(C)(C)C)O)C Chemical compound C(CCC)(C1=C(C=C(C(=C1)C(C)(C)C)O)C)C1=C(C=C(C(=C1)C(C)(C)C)O)C.C(CCCC1=C(C=C(C(=C1)C(C)(C)C)O)C)C1=C(C=C(C(=C1)C(C)(C)C)O)C FMQNQXPPMJEFJN-UHFFFAOYSA-N 0.000 description 1
- ZKWRZCGBAXPRNG-UHFFFAOYSA-N C(CCC)C(=C(/C(=O)O)CCCC)C(=O)O.C(C=CC(=O)OCCCC)(=O)OCCCC Chemical compound C(CCC)C(=C(/C(=O)O)CCCC)C(=O)O.C(C=CC(=O)OCCCC)(=O)OCCCC ZKWRZCGBAXPRNG-UHFFFAOYSA-N 0.000 description 1
- JKTNUPMEJUHPBY-UHFFFAOYSA-N C(CCC)C=1C(=C(C(C(=O)O)=CC1)C(=O)O)CC1=CC=CC=C1.C(C=1C(C(=O)OCC2=CC=CC=C2)=CC=CC1)(=O)OCCCC Chemical compound C(CCC)C=1C(=C(C(C(=O)O)=CC1)C(=O)O)CC1=CC=CC=C1.C(C=1C(C(=O)OCC2=CC=CC=C2)=CC=CC1)(=O)OCCCC JKTNUPMEJUHPBY-UHFFFAOYSA-N 0.000 description 1
- BPPVGCIATLIVTO-UHFFFAOYSA-N C(CCCC)OC1=CC=C(C=C1)C1=CC=C(C=C1)C#N.O(CCCCC)C1=CC=C(C=C1)C1=CC=C(C=C1)C#N Chemical group C(CCCC)OC1=CC=C(C=C1)C1=CC=C(C=C1)C#N.O(CCCCC)C1=CC=C(C=C1)C1=CC=C(C=C1)C#N BPPVGCIATLIVTO-UHFFFAOYSA-N 0.000 description 1
- CEVHXHNTDFMURO-UHFFFAOYSA-N C(CCCCCCC)SC1=NC(=NC(=N1)SCCCCCCCC)NC1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C.C(CCCCCCC)SC1=NC(=NC(=N1)SCCCCCCCC)NC1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C Chemical compound C(CCCCCCC)SC1=NC(=NC(=N1)SCCCCCCCC)NC1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C.C(CCCCCCC)SC1=NC(=NC(=N1)SCCCCCCCC)NC1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C CEVHXHNTDFMURO-UHFFFAOYSA-N 0.000 description 1
- VZVZXHLFYRNBCD-UHFFFAOYSA-N C1(=C(C=CC=C1)NC(NC1=C(C=CC=C1)C)=N)C.C1(=C(C=CC=C1)NC(NC1=C(C=CC=C1)C)=N)C Chemical compound C1(=C(C=CC=C1)NC(NC1=C(C=CC=C1)C)=N)C.C1(=C(C=CC=C1)NC(NC1=C(C=CC=C1)C)=N)C VZVZXHLFYRNBCD-UHFFFAOYSA-N 0.000 description 1
- CURPTLDEGOSQKP-UHFFFAOYSA-N C1(=CC=CC=C1)NC(=S)NC1=CC=CC=C1.C1(=CC=CC=C1)NC(=S)NC1=CC=CC=C1 Chemical compound C1(=CC=CC=C1)NC(=S)NC1=CC=CC=C1.C1(=CC=CC=C1)NC(=S)NC1=CC=CC=C1 CURPTLDEGOSQKP-UHFFFAOYSA-N 0.000 description 1
- SQVCTWVNFDHODK-UHFFFAOYSA-N CC(C)(C)CC(C)(C)C1=CC=C(O)C=C1.CC(C)(C)CC(C)(C)C1=CC=C(O)C=C1 Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(O)C=C1.CC(C)(C)CC(C)(C)C1=CC=C(O)C=C1 SQVCTWVNFDHODK-UHFFFAOYSA-N 0.000 description 1
- BJKOAZNVTOGGKF-UHFFFAOYSA-N CC1=CC=C(C(=O)C2=CC=CC=C2)C=C1.CC1=CC=C(C(=O)C2=CC=CC=C2)C=C1 Chemical compound CC1=CC=C(C(=O)C2=CC=CC=C2)C=C1.CC1=CC=C(C(=O)C2=CC=CC=C2)C=C1 BJKOAZNVTOGGKF-UHFFFAOYSA-N 0.000 description 1
- JGWRBYFSXLBCSI-UHFFFAOYSA-N CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1.CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1.CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 JGWRBYFSXLBCSI-UHFFFAOYSA-N 0.000 description 1
- XEBQAWWBEKQRMV-UHFFFAOYSA-N CC=1C(=C(C(=O)O)C=CC1)C(C1=CC=CC=C1)=O.COC(C1=C(C=CC=C1)C(C1=CC=CC=C1)=O)=O Chemical compound CC=1C(=C(C(=O)O)C=CC1)C(C1=CC=CC=C1)=O.COC(C1=C(C=CC=C1)C(C1=CC=CC=C1)=O)=O XEBQAWWBEKQRMV-UHFFFAOYSA-N 0.000 description 1
- BLPJJRCJESZTCC-UHFFFAOYSA-N CC=1C=C(C=CC1[N+](=O)[O-])O.CC=1C=C(C=CC1[N+](=O)[O-])O Chemical compound CC=1C=C(C=CC1[N+](=O)[O-])O.CC=1C=C(C=CC1[N+](=O)[O-])O BLPJJRCJESZTCC-UHFFFAOYSA-N 0.000 description 1
- RNANIZLIMGERTD-UHFFFAOYSA-N CN(C1=CC=C(C(=O)C2=CC=C(C=C2)N(C)C)C=C1)C.CN(C1=CC=C(C(=O)C2=CC=C(C=C2)N(C)C)C=C1)C Chemical compound CN(C1=CC=C(C(=O)C2=CC=C(C=C2)N(C)C)C=C1)C.CN(C1=CC=C(C(=O)C2=CC=C(C=C2)N(C)C)C=C1)C RNANIZLIMGERTD-UHFFFAOYSA-N 0.000 description 1
- 239000005493 Chloridazon (aka pyrazone) Substances 0.000 description 1
- 239000005647 Chlorpropham Substances 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- CYESCLHCWJKRKM-UHFFFAOYSA-N DCPU Natural products NC(=O)NC1=CC=C(Cl)C(Cl)=C1 CYESCLHCWJKRKM-UHFFFAOYSA-N 0.000 description 1
- QWDBCIAVABMJPP-UHFFFAOYSA-N Diisopropyl phthalate Chemical compound CC(C)OC(=O)C1=CC=CC=C1C(=O)OC(C)C QWDBCIAVABMJPP-UHFFFAOYSA-N 0.000 description 1
- 239000005767 Epoxiconazole Substances 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- XLYMOEINVGRTEX-ARJAWSKDSA-N Ethyl hydrogen fumarate Chemical compound CCOC(=O)\C=C/C(O)=O XLYMOEINVGRTEX-ARJAWSKDSA-N 0.000 description 1
- 239000005772 Famoxadone Substances 0.000 description 1
- ZLSWBLPERHFHIS-UHFFFAOYSA-N Fenoprop Chemical compound OC(=O)C(C)OC1=CC(Cl)=C(Cl)C=C1Cl ZLSWBLPERHFHIS-UHFFFAOYSA-N 0.000 description 1
- 239000005786 Flutolanil Substances 0.000 description 1
- CAWXEEYDBZRFPE-UHFFFAOYSA-N Hexazinone Chemical compound O=C1N(C)C(N(C)C)=NC(=O)N1C1CCCCC1 CAWXEEYDBZRFPE-UHFFFAOYSA-N 0.000 description 1
- 239000005795 Imazalil Substances 0.000 description 1
- 239000005797 Iprovalicarb Substances 0.000 description 1
- 239000005800 Kresoxim-methyl Substances 0.000 description 1
- NWUWYYSKZYIQAE-ZBFHGGJFSA-N L-(R)-iprovalicarb Chemical compound CC(C)OC(=O)N[C@@H](C(C)C)C(=O)N[C@H](C)C1=CC=C(C)C=C1 NWUWYYSKZYIQAE-ZBFHGGJFSA-N 0.000 description 1
- 239000005579 Metamitron Substances 0.000 description 1
- 239000005580 Metazachlor Substances 0.000 description 1
- RRVIAQKBTUQODI-UHFFFAOYSA-N Methabenzthiazuron Chemical compound C1=CC=C2SC(N(C)C(=O)NC)=NC2=C1 RRVIAQKBTUQODI-UHFFFAOYSA-N 0.000 description 1
- NTAHCMPOMKHKEU-AATRIKPKSA-N Methacrifos Chemical compound COC(=O)C(\C)=C\OP(=S)(OC)OC NTAHCMPOMKHKEU-AATRIKPKSA-N 0.000 description 1
- 239000005581 Metobromuron Substances 0.000 description 1
- WLFDQEVORAMCIM-UHFFFAOYSA-N Metobromuron Chemical compound CON(C)C(=O)NC1=CC=C(Br)C=C1 WLFDQEVORAMCIM-UHFFFAOYSA-N 0.000 description 1
- 239000005583 Metribuzin Substances 0.000 description 1
- 239000005811 Myclobutanil Substances 0.000 description 1
- UDCDOJQOXWCCSD-UHFFFAOYSA-N N,N-dimethyl-N'-p-tolylsulfamide Chemical compound CN(C)S(=O)(=O)NC1=CC=C(C)C=C1 UDCDOJQOXWCCSD-UHFFFAOYSA-N 0.000 description 1
- ZJMZZNVGNSWOOM-UHFFFAOYSA-N N-(butan-2-yl)-N'-ethyl-6-methoxy-1,3,5-triazine-2,4-diamine Chemical compound CCNC1=NC(NC(C)CC)=NC(OC)=N1 ZJMZZNVGNSWOOM-UHFFFAOYSA-N 0.000 description 1
- SIRJUKASRDPCRS-UHFFFAOYSA-N N=1N(N=C2C1C=CC=C2)C2=C(C(=CC(=C2)C(C)(C)CC)C(C)(C)CC)O.N=2N(N=C1C2C=CC=C1)C1=C(C(=CC(=C1)C(C)(C)CC)C(C)(C)CC)O Chemical compound N=1N(N=C2C1C=CC=C2)C2=C(C(=CC(=C2)C(C)(C)CC)C(C)(C)CC)O.N=2N(N=C1C2C=CC=C1)C1=C(C(=CC(=C1)C(C)(C)CC)C(C)(C)CC)O SIRJUKASRDPCRS-UHFFFAOYSA-N 0.000 description 1
- GEAMULNSXDTGLY-UHFFFAOYSA-N N=1N(N=C2C1C=CC=C2)C2=C(C(=CC(=C2)C(C)(C2=CC=CC=C2)C)C(C)(C)C2=CC=CC=C2)O.N=2N(N=C1C2C=CC=C1)C1=C(C(=CC(=C1)C(C)(C1=CC=CC=C1)C)C(C)(C)C1=CC=CC=C1)O Chemical compound N=1N(N=C2C1C=CC=C2)C2=C(C(=CC(=C2)C(C)(C2=CC=CC=C2)C)C(C)(C)C2=CC=CC=C2)O.N=2N(N=C1C2C=CC=C1)C1=C(C(=CC(=C1)C(C)(C1=CC=CC=C1)C)C(C)(C)C1=CC=CC=C1)O GEAMULNSXDTGLY-UHFFFAOYSA-N 0.000 description 1
- YLPKUPIZOXNPSS-UHFFFAOYSA-N OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F.OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F Chemical compound OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F.OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F YLPKUPIZOXNPSS-UHFFFAOYSA-N 0.000 description 1
- DYZLRGBRJROJDZ-UHFFFAOYSA-N OC1=C(C(=O)C2=C(C=C(C=C2)O)O)C=CC(=C1)O.OC1=C(C(=O)C2=C(C=C(C=C2)O)O)C=CC(=C1)O Chemical compound OC1=C(C(=O)C2=C(C=C(C=C2)O)O)C=CC(=C1)O.OC1=C(C(=O)C2=C(C=C(C=C2)O)O)C=CC(=C1)O DYZLRGBRJROJDZ-UHFFFAOYSA-N 0.000 description 1
- XYUZTEZXEXIDQO-UHFFFAOYSA-N P(=O)(OC1=C(C=C(C=C1)C(C)C)C(C)C)(OC1=C(C=C(C=C1)C(C)C)C(C)C)OC1=CC=CC=C1 Chemical compound P(=O)(OC1=C(C=C(C=C1)C(C)C)C(C)C)(OC1=C(C=C(C=C1)C(C)C)C(C)C)OC1=CC=CC=C1 XYUZTEZXEXIDQO-UHFFFAOYSA-N 0.000 description 1
- WTLBZVNBAKMVDP-WCCMSLRSSA-N P(=O)(O[13CH2][13CH2]OCCCC)(O[13CH2][13CH2]OCCCC)O[13CH2][13CH2]OCCCC Chemical compound P(=O)(O[13CH2][13CH2]OCCCC)(O[13CH2][13CH2]OCCCC)O[13CH2][13CH2]OCCCC WTLBZVNBAKMVDP-WCCMSLRSSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Substances CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- 239000005603 Prosulfocarb Substances 0.000 description 1
- JCBQILNLSOWJPY-UHFFFAOYSA-N S(C1=C(C(=CC(=C1)C)C(C)(C)C)O)C1=C(C(=CC(=C1)C)C(C)(C)C)O.S(C1=C(C(=CC(=C1)C)C(C)(C)C)O)C1=C(C(=CC(=C1)C)C(C)(C)C)O Chemical compound S(C1=C(C(=CC(=C1)C)C(C)(C)C)O)C1=C(C(=CC(=C1)C)C(C)(C)C)O.S(C1=C(C(=CC(=C1)C)C(C)(C)C)O)C1=C(C(=CC(=C1)C)C(C)(C)C)O JCBQILNLSOWJPY-UHFFFAOYSA-N 0.000 description 1
- TYUUFFZATQXQQW-UHFFFAOYSA-N S(C1=C(C=C(C(=C1)C(C)(C)C)O)C)C1=C(C=C(C(=C1)C(C)(C)C)O)C.S(C1=C(C=C(C(=C1)C(C)(C)C)O)C)C1=C(C=C(C(=C1)C(C)(C)C)O)C Chemical compound S(C1=C(C=C(C(=C1)C(C)(C)C)O)C)C1=C(C=C(C(=C1)C(C)(C)C)O)C.S(C1=C(C=C(C(=C1)C(C)(C)C)O)C)C1=C(C=C(C(=C1)C(C)(C)C)O)C TYUUFFZATQXQQW-UHFFFAOYSA-N 0.000 description 1
- OUNSASXJZHBGAI-UHFFFAOYSA-N Salithion Chemical compound C1=CC=C2OP(OC)(=S)OCC2=C1 OUNSASXJZHBGAI-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229930182692 Strobilurin Natural products 0.000 description 1
- HFYJGKLEJHNKAA-SAQXESPHSA-N [2H]C(C1(CCCCCC)C(O)=O)=C([2H])C([2H])=C([2H])C1(CCCCCC)C(O)=O Chemical compound [2H]C(C1(CCCCCC)C(O)=O)=C([2H])C([2H])=C([2H])C1(CCCCCC)C(O)=O HFYJGKLEJHNKAA-SAQXESPHSA-N 0.000 description 1
- RPCLHHPEYZXZHG-UHFFFAOYSA-N [4-(dimethylamino)phenyl]-phenylmethanone Chemical compound CN(C1=CC=C(C(=O)C2=CC=CC=C2)C=C1)C.CN(C1=CC=C(C(=O)C2=CC=CC=C2)C=C1)C RPCLHHPEYZXZHG-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- PXWUKZGIHQRDHL-UHFFFAOYSA-N atraton Chemical compound CCNC1=NC(NC(C)C)=NC(OC)=N1 PXWUKZGIHQRDHL-UHFFFAOYSA-N 0.000 description 1
- 229940089003 atryn Drugs 0.000 description 1
- 150000003851 azoles Chemical class 0.000 description 1
- JLYXXMFPNIAWKQ-CDRYSYESSA-N beta-hexachlorocyclohexane Chemical compound Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@H](Cl)[C@@H](Cl)[C@@H]1Cl JLYXXMFPNIAWKQ-CDRYSYESSA-N 0.000 description 1
- NODQIIIVHRULLK-UHFFFAOYSA-N bis(2-hydroxy-4-methoxyphenyl)methanone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(OC)C=C1O.OC1=CC(OC)=CC=C1C(=O)C1=CC=C(OC)C=C1O NODQIIIVHRULLK-UHFFFAOYSA-N 0.000 description 1
- NIXUKOBJIRJEPB-UHFFFAOYSA-N bis(2-methylpropyl) benzene-1,2-dicarboxylate Chemical compound CC(C)COC(=O)C1=CC=CC=C1C(=O)OCC(C)C.CC(C)COC(=O)C1=CC=CC=C1C(=O)OCC(C)C NIXUKOBJIRJEPB-UHFFFAOYSA-N 0.000 description 1
- UAFXUVUVOTXFND-UHFFFAOYSA-N bis(4-methylpentan-2-yl) benzene-1,2-dicarboxylate Chemical compound CC(C)CC(C)OC(=O)C1=CC=CC=C1C(=O)OC(C)CC(C)C UAFXUVUVOTXFND-UHFFFAOYSA-N 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
- WYKYKTKDBLFHCY-UHFFFAOYSA-N chloridazon Chemical compound O=C1C(Cl)=C(N)C=NN1C1=CC=CC=C1 WYKYKTKDBLFHCY-UHFFFAOYSA-N 0.000 description 1
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 1
- JXCGFZXSOMJFOA-UHFFFAOYSA-N chlorotoluron Chemical compound CN(C)C(=O)NC1=CC=C(C)C(Cl)=C1 JXCGFZXSOMJFOA-UHFFFAOYSA-N 0.000 description 1
- IVUXTESCPZUGJC-UHFFFAOYSA-N chloroxuron Chemical compound C1=CC(NC(=O)N(C)C)=CC=C1OC1=CC=C(Cl)C=C1 IVUXTESCPZUGJC-UHFFFAOYSA-N 0.000 description 1
- CWJSHJJYOPWUGX-UHFFFAOYSA-N chlorpropham Chemical compound CC(C)OC(=O)NC1=CC=CC(Cl)=C1 CWJSHJJYOPWUGX-UHFFFAOYSA-N 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- BXNANOICGRISHX-UHFFFAOYSA-N coumaphos Chemical compound CC1=C(Cl)C(=O)OC2=CC(OP(=S)(OCC)OCC)=CC=C21 BXNANOICGRISHX-UHFFFAOYSA-N 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229960002380 dibutyl phthalate Drugs 0.000 description 1
- VWNJWHZYBFGFKG-UHFFFAOYSA-N diethyl butanedioate 2,3-diethylbutanedioic acid Chemical compound C(C)C(C(C(=O)O)CC)C(=O)O.C(CCC(=O)OCC)(=O)OCC VWNJWHZYBFGFKG-UHFFFAOYSA-N 0.000 description 1
- MIBBAKOUMIHBQC-UHFFFAOYSA-N dihexadecan-8-yl hexanedioate Chemical compound CCCCCCCCC(CCCCCCC)OC(=O)CCCCC(=O)OC(CCCCCCC)CCCCCCCC MIBBAKOUMIHBQC-UHFFFAOYSA-N 0.000 description 1
- QZFBLKUILYLYAX-UHFFFAOYSA-N dihexyl benzene-1,2-dicarboxylate 3,4-dihexylphthalic acid Chemical compound C(CCCCC)C=1C(=C(C(C(=O)O)=CC1)C(=O)O)CCCCCC.C(C=1C(C(=O)OCCCCCC)=CC=CC1)(=O)OCCCCCC QZFBLKUILYLYAX-UHFFFAOYSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- ZXOYHFNGXIKXGI-UHFFFAOYSA-N dimethyl hexanedioate 2,2-dimethylhexanedioic acid Chemical compound COC(=O)CCCCC(=O)OC.CC(C)(CCCC(O)=O)C(O)=O ZXOYHFNGXIKXGI-UHFFFAOYSA-N 0.000 description 1
- QQVHEQUEHCEAKS-UHFFFAOYSA-N diundecyl benzene-1,2-dicarboxylate Chemical compound CCCCCCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCCCCCC QQVHEQUEHCEAKS-UHFFFAOYSA-N 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- AWZOLILCOUMRDG-UHFFFAOYSA-N edifenphos Chemical compound C=1C=CC=CC=1SP(=O)(OCC)SC1=CC=CC=C1 AWZOLILCOUMRDG-UHFFFAOYSA-N 0.000 description 1
- 238000000132 electrospray ionisation Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 231100000507 endocrine disrupting Toxicity 0.000 description 1
- DFBKLUNHFCTMDC-GKRDHZSOSA-N endrin Chemical compound C([C@@H]1[C@H]2[C@@]3(Cl)C(Cl)=C([C@]([C@H]22)(Cl)C3(Cl)Cl)Cl)[C@@H]2[C@H]2[C@@H]1O2 DFBKLUNHFCTMDC-GKRDHZSOSA-N 0.000 description 1
- IZHZFAQWVKBTSL-UHFFFAOYSA-N endrin ketone Chemical compound O=C1C2CC3C1C1(Cl)C(Cl)(C4(Cl)Cl)C3C2C4(Cl)C1Cl IZHZFAQWVKBTSL-UHFFFAOYSA-N 0.000 description 1
- 229960002125 enilconazole Drugs 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- WRWJHZAQLXGJQX-UHFFFAOYSA-N ethyl acetate;formic acid Chemical compound OC=O.CCOC(C)=O WRWJHZAQLXGJQX-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- DIRFUJHNVNOBMY-UHFFFAOYSA-N fenobucarb Chemical compound CCC(C)C1=CC=CC=C1OC(=O)NC DIRFUJHNVNOBMY-UHFFFAOYSA-N 0.000 description 1
- MXWAGQASUDSFBG-RVDMUPIBSA-N fluacrypyrim Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1COC1=CC(C(F)(F)F)=NC(OC(C)C)=N1 MXWAGQASUDSFBG-RVDMUPIBSA-N 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- PTCGDEVVHUXTMP-UHFFFAOYSA-N flutolanil Chemical compound CC(C)OC1=CC=CC(NC(=O)C=2C(=CC=CC=2)C(F)(F)F)=C1 PTCGDEVVHUXTMP-UHFFFAOYSA-N 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
- 235000019251 heptyl p-hydroxybenzoate Nutrition 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- ZOTBXTZVPHCKPN-HTXNQAPBSA-N kresoxim-methyl Chemical compound CO\N=C(\C(=O)OC)C1=CC=CC=C1COC1=CC=CC=C1C ZOTBXTZVPHCKPN-HTXNQAPBSA-N 0.000 description 1
- 238000000370 laser capture micro-dissection Methods 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- VHCNQEUWZYOAEV-UHFFFAOYSA-N metamitron Chemical compound O=C1N(N)C(C)=NN=C1C1=CC=CC=C1 VHCNQEUWZYOAEV-UHFFFAOYSA-N 0.000 description 1
- STEPQTYSZVCJPV-UHFFFAOYSA-N metazachlor Chemical compound CC1=CC=CC(C)=C1N(C(=O)CCl)CN1N=CC=C1 STEPQTYSZVCJPV-UHFFFAOYSA-N 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- DSRNRYQBBJQVCW-UHFFFAOYSA-N metoxuron Chemical compound COC1=CC=C(NC(=O)N(C)C)C=C1Cl DSRNRYQBBJQVCW-UHFFFAOYSA-N 0.000 description 1
- FOXFZRUHNHCZPX-UHFFFAOYSA-N metribuzin Chemical compound CSC1=NN=C(C(C)(C)C)C(=O)N1N FOXFZRUHNHCZPX-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- PMDKYLLIOLFQPO-UHFFFAOYSA-N monocyclohexyl phthalate Chemical compound OC(=O)C1=CC=CC=C1C(=O)OC1CCCCC1 PMDKYLLIOLFQPO-UHFFFAOYSA-N 0.000 description 1
- RZJSUWQGFCHNFS-UHFFFAOYSA-N monoisobutyl phthalate Chemical compound CC(C)COC(=O)C1=CC=CC=C1C(O)=O RZJSUWQGFCHNFS-UHFFFAOYSA-N 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 231100000189 neurotoxic Toxicity 0.000 description 1
- 230000002887 neurotoxic effect Effects 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical compound C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- YAGMLECKUBJRNO-UHFFFAOYSA-N octyl 4-(dimethylamino)benzoate Chemical compound CCCCCCCCOC(=O)C1=CC=C(N(C)C)C=C1 YAGMLECKUBJRNO-UHFFFAOYSA-N 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- CXZGQIAOTKWCDB-UHFFFAOYSA-N perfluoropentanoic acid Chemical compound OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F CXZGQIAOTKWCDB-UHFFFAOYSA-N 0.000 description 1
- 239000000447 pesticide residue Substances 0.000 description 1
- OQJWHRFLHJQLAQ-UHFFFAOYSA-N phenyl-(2,3,4-trihydroxyphenyl)methanone Chemical compound OC1=C(C(=C(C(=O)C2=CC=CC=C2)C=C1)O)O.OC1=C(C(=C(C(=O)C2=CC=CC=C2)C=C1)O)O OQJWHRFLHJQLAQ-UHFFFAOYSA-N 0.000 description 1
- IOUNQDKNJZEDEP-UHFFFAOYSA-N phosalone Chemical compound C1=C(Cl)C=C2OC(=O)N(CSP(=S)(OCC)OCC)C2=C1 IOUNQDKNJZEDEP-UHFFFAOYSA-N 0.000 description 1
- 210000004180 plasmocyte Anatomy 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- LVTHXRLARFLXNR-UHFFFAOYSA-M potassium;1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate Chemical compound [K+].[O-]S(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F LVTHXRLARFLXNR-UHFFFAOYSA-M 0.000 description 1
- OWQCHLFKOGVODW-UHFFFAOYSA-M potassium;2-(6-chloro-1,1,2,2,3,3,4,4,5,5,6,6-dodecafluorohexoxy)-1,1,2,2-tetrafluoroethanesulfonate Chemical compound [K+].[O-]S(=O)(=O)C(F)(F)C(F)(F)OC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)Cl OWQCHLFKOGVODW-UHFFFAOYSA-M 0.000 description 1
- BDKYEEMJFNONPU-UHFFFAOYSA-M potassium;2-(8-chloro-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8-hexadecafluorooctoxy)-1,1,2,2-tetrafluoroethanesulfonate Chemical compound [K+].[O-]S(=O)(=O)C(F)(F)C(F)(F)OC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)Cl BDKYEEMJFNONPU-UHFFFAOYSA-M 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000011027 product recovery Methods 0.000 description 1
- AAEVYOVXGOFMJO-UHFFFAOYSA-N prometryn Chemical compound CSC1=NC(NC(C)C)=NC(NC(C)C)=N1 AAEVYOVXGOFMJO-UHFFFAOYSA-N 0.000 description 1
- IXTOWLKEARFCCP-UHFFFAOYSA-N propan-2-yl 2-[methoxy-(propan-2-ylamino)phosphinothioyl]oxybenzoate Chemical group CC(C)NP(=S)(OC)OC1=CC=CC=C1C(=O)OC(C)C IXTOWLKEARFCCP-UHFFFAOYSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- VXPLXMJHHKHSOA-UHFFFAOYSA-N propham Chemical compound CC(C)OC(=O)NC1=CC=CC=C1 VXPLXMJHHKHSOA-UHFFFAOYSA-N 0.000 description 1
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 description 1
- NQLVQOSNDJXLKG-UHFFFAOYSA-N prosulfocarb Chemical compound CCCN(CCC)C(=O)SCC1=CC=CC=C1 NQLVQOSNDJXLKG-UHFFFAOYSA-N 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229940066675 ricinoleate Drugs 0.000 description 1
- 229940116351 sebacate Drugs 0.000 description 1
- MGLWZSOBALDPEK-UHFFFAOYSA-N simetryn Chemical compound CCNC1=NC(NCC)=NC(SC)=N1 MGLWZSOBALDPEK-UHFFFAOYSA-N 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- AIMUHNZKNFEZSN-UHFFFAOYSA-M sodium;decane-1-sulfonate Chemical compound [Na+].CCCCCCCCCCS([O-])(=O)=O AIMUHNZKNFEZSN-UHFFFAOYSA-M 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229940072958 tetrahydrofurfuryl oleate Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- ZXFXBSWRVIQKOD-UHFFFAOYSA-N trans-heptachlor epoxide Natural products ClC1=C(Cl)C2(Cl)C3C4OC4C(Cl)C3C1(Cl)C2(Cl)Cl ZXFXBSWRVIQKOD-UHFFFAOYSA-N 0.000 description 1
- 150000003918 triazines Chemical class 0.000 description 1
- 229940093635 tributyl phosphate Drugs 0.000 description 1
- DCTZJRUXIXPDJP-UHFFFAOYSA-N trihexyl 2-hydroxy-4-oxoheptane-1,2,3-tricarboxylate Chemical compound CCCCCCOC(=O)CC(O)(C(=O)OCCCCCC)C(C(=O)CCC)C(=O)OCCCCCC DCTZJRUXIXPDJP-UHFFFAOYSA-N 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
- G01N2030/062—Preparation extracting sample from raw material
Definitions
- the invention relates to the technical fields of environmental science and organic matter analysis, in particular to a targeted exposure group analysis method for environmental pollutants in blood plasma and its application.
- the human body is exposed to various chemical pollutants in daily life, such as plastic additives in plastic products, perfluorinated compounds in furniture products, pesticide residues in vegetables and fruits (organochlorine pesticides, organophosphorus pesticides), etc. These pollutants may enter the human body through ingestion, breathing, skin absorption, etc., and exposure of the human body to them will cause health hazards. Some pollutants have been shown to be neurotoxic, endocrine disrupting, and reproductively toxic.
- the primary purpose of the present invention is to overcome the shortcomings and deficiencies of the prior art, and provide a targeted exposure group analysis method for environmental pollutants in plasma.
- Another object of the present invention is to provide the application of the targeted exposure group analysis method for environmental pollutants in plasma.
- a method for analyzing targeted exposure groups of environmental pollutants in plasma comprising the steps of:
- extraction solvent I is the mixed solvent that contains the ethyl acetate of formic acid and n-hexane; Described extraction solvent II is ethyl acetate;
- step (3) Dry the extract obtained in step (2) with nitrogen, then add methanol to redissolve, freeze at -40 ⁇ 5°C, then freeze and centrifuge, and take the supernatant to obtain the pretreated sample;
- step (2) Add an internal standard to the pretreated sample obtained in step (2), and then use liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) and/or gas chromatography-tandem mass spectrometry (GC-MS /MS) for quantitative analysis of environmental pollutants.
- UPLC-MS/MS liquid chromatography-tandem mass spectrometry
- GC-MS /MS gas chromatography-tandem mass spectrometry
- the dosage of the recovery rate indicators described in step (1) is calculated by adding 0.5-20 ng of each recovery rate indicator per 200 ⁇ L of plasma.
- the recovery indicators described in step (1) include three 2-butoxy-[13C2]-ethyl) phosphate (Tris(2-butoxy-[13C2]-ethyl)phosphate), tri-n-butyl phosphate -d27(Tri-n-butyl phosphate-d27), Tris(2-chloroethyl)phosphate-d12(Tris(2-chloroethyl)phosphate-d12), Tris(1,3-dichloro-2-propyl ) phosphate-d15 (Tris(1,3-dichloro-2-propyl) phosphate-d15), triethyl phosphate-d15 (Triethylphosphate-d15), triphenyl phosphate-d15 (Triphenyl phosphate-d15), bis( Butoxyethyl) phosphate-d8(Bis(butoxyethyl)Phosphate-d8), bis(1,3-dichloro-2-propy
- the plasma described in step (1) is human or animal plasma; preferably human or sheep blood plasma; more preferably human plasma.
- the plasma described in step (1) is preferably obtained by centrifuging the collected blood, and taking the supernatant to obtain the required plasma.
- the centrifugation condition is: centrifuge at 3000rpm for 3 minutes.
- the added recovery indicator described in step (1) is the isotope-labeled compound of the measured target compound, which can effectively correct the loss of the compound in the pretreatment process; in the present invention, most of the target compounds have one-to-one correspondence
- the recovery indicator if the compound cannot be one-to-one, use the isotope label corresponding to the same type of compound.
- extraction solvent 1 described in step (2) is as follows: 298.2mL ethyl acetate, 198.8mL normal hexane and 3mL formic acid (ethyl acetate and normal hexane are by volume ratio 3:2, and formic acid accounts for 0.6 of extraction solvent 1 volume %).
- step (2) requires 360-degree rotation and vibration to make the extraction more complete.
- the number of repetitions described in step (2) is more than 2 times; preferably 2 times.
- centrifugation conditions described in step (2) are: centrifugation at 3000-4000rpm for more than 3min; preferably: centrifugation at 3000rpm for 3min, the purpose of centrifugation is to precipitate suspended matter and help to transfer the extractant.
- the freezing time described in step (3) is more than 12 hours.
- the conditions for the refrigerated centrifugation in step (3) are: centrifuge at -10°C and 15000rpm for more than 5min.
- step (3) the extract needs to be blown to near dryness and reconstituted with methanol for freezing.
- the purpose is to precipitate lipids, and then it is necessary to keep low temperature in a refrigerated centrifuge for refrigerated centrifugation.
- the purpose is to allow lipid precipitation to help The transfer of the supernatant, so as to achieve the purpose of removing lipids and reduce the matrix effect.
- the amount of the internal standard described in step (4) is calculated by adding 1-20 ng of each internal standard per 50 ⁇ L of the pretreated sample.
- the internal standard described in the step (4) includes internal standards of perfluorinated compounds, plasticizers (plastic additives), organochlorine pesticides, organophosphorus pesticides and liquid crystal monomers.
- the internal standard of the perfluoro compound is perfluoro-n-[13C8]octanoic acid (Perfluoro-n-[13C8]octanoic acid; M8PFOA).
- the positive mode internal standard of the plasticizer is coumaphos-d10 (coumaphos-d10), and the negative mode internal standard is bisphenol A-d16 (BisphenolA-d16; BPA-d16).
- the internal standard of the organochlorine pesticide is decachlorodiphenyl ether (DCDE).
- the positive mode internal standard of the organophosphorus pesticide is coumaphos-d10, and the negative mode internal standard is tert butyl paraben-d9.
- the internal standard of the liquid crystal monomer is decachlorodiphenyl ether (DCDE).
- step (4) The liquid chromatography-tandem mass spectrometry described in step (4) is carried out by using ultra-high performance liquid chromatography-tandem mass spectrometry.
- Adopt liquid chromatography-tandem mass spectrometry described in step (4) to carry out the pollutant of quantitative analysis to environmental pollutant and comprise organophosphates (OPEs), phthalates (PAEs) ), personal care products (PCPs), phenolic compounds, ultraviolet stabilizers (UV), photoinitiators, antioxidants (AO), plasticizers, perfluorinated compounds (PFCs), organophosphorus pesticides (OPs), pyrethroids Esters, neonicotinoid pesticides, carbamate pesticides, acidic herbicides, azole pesticides, triadimefon pesticides, urea pesticides, amides pesticides, methoxyacrylate fungicides and other insecticides at least one of .
- organophosphates OPEs
- PAEs phthalates
- PCPs personal care products
- PFCs perfluorinated compounds
- OPs organophosphorus pesticides
- the organophosphates include at least one of organophosphate diesters and organophosphate triesters.
- organophosphate diesters include bis-(1-chloro-2-propyl) phosphate (bis-(1-chloro-2-propyl) phosphate), diphenyl phosphate (Diphenyl phosphate) , dibutyl phosphate (Dibutyl phosphate), bis (1,3-dichloro-2-propyl) phosphate (Bis (1,3-dichloro-2-propyl) phosphate), two p-cresyl phosphate (di -p-tolyl-phosphate), bis(butoxyethyl)phosphate and bis(2-ethylhexyl)phosphate.
- organophosphate triesters include triethyl phosphate (Triethyl phosphate), three (2-chloroethyl) phosphate (Tris (2-chloroethyl) phosphate), tripropyl phosphate (Tripropyl phosphate) , Tetrakis (2-Chloroethyl) dichloroisopentyl diphosphate, Triphenyl phosphate, Tris (2,3-dibromopropyl) phosphate (Tris(2,3-dibromopropyl)phosphate), Tributylphosphate, Cresyldiphenylphosphate, Tris(2-butoxyethyl)phosphate (Tris(2-butoxyethyl) phosphate), Tricresyl phosphate, Resorcinol bis(diphenyl phosphate), 2-Ethylhexyl-diphenyl phosphate (2-Ethylhexyl), 2-Ethylhexyl
- the phthalic acid esters include at least one of phthalic acid monoesters and phthalic acid diesters.
- the phthalate monoesters include monoethyl phthalate, monoisopropyl phthalate, monoisobutyl phthalate ), mono-n-pentyl phthalate, monocyclohexyl phthalate, monohexylphthalate, monobenzyl phthalate (monobenzyl phthalate), mono-2-heptyl phthalate (mono-2-heptyl phthalate), monooctyl phthalate (monoctyl phthalate), monoethylhexyl phthalate (monoethylhexyl phthalate), Monoisononyl phthalate (monoisononyl phthalate), mono(2-ethyl-5-oxohexyl) phthalate (mono(2-ethyl-5-oxohexyl) phthalate), mono(2-ethyl-5-oxohexyl) phthalate 2-Ethyl-5-hydroxyhexyl) este
- the phthalate diesters include dimethyl isophthalate, dimethyl phthalate, diethyl phthalate , Diallyl phthalate, di-n-propyl phthalate, Diisopropyl phthalat, Diisobutyl phthalate Diisobutyl phthalate, dibutyl phthalate, isobutylcyclohexyl phthalate, diisopentyl phthalate, butyl phthalate Benzyl ester (butyl benzylphthalate), diphenyl isophthalate (diphenyl isophthalate), diphenyl phthalate (diphenylphthalate), dihexyl phthalate (dihexyl phthalate), diisohexyl phthalate ( diisohexylphthalate), bis(4-methyl-2-pentyl)phthalate, dibenzyl phthalate, diheptyl phthalate Diisoheptyl phthalate, dinonyl phthal
- the personal care products include methyl paraben, butyl Paraben, benzyl Paraben, ethyl paraben Ethylparaben, Propylparaben, Heptylparaben and Triclosan.
- the phenolic compound includes at least one of bisphenol analogues.
- Described bisphenol analog includes bisphenol A (bisphenol A), bisphenol E (bisphenol E), bisphenol B (bisphenol B), bisphenol C (bisphenol C), bisphenol AF (bisphenol AF), bisphenol F (bisphenol F), bisphenol M (bisphenol M), bisphenol P (bisphenol P), bisphenol G (bisphenol G), bisphenol Z (bisphenol Z), bisphenol S (bisphenol S), bisphenol AP (bisphenol AP), bisphenol BP (bisphenol BP) and bisphenol PH (bisphenol PH).
- the ultraviolet stabilizer includes at least one of benzophenones, benzothiazoles, benzotriazoles and other types of ultraviolet stabilizers.
- Benzophenone UV stabilizers include 2,4-dihydroxybenzophenone (2,4-dihydroxybenzophenone), 2,2',4,4'-tetrahydroxybenzophenone (2,2',4,4'-tetrahydroxybenzophenone), 2-hydroxy-4-methoxybenzophenone (2-hydroxy-4-methoxybenzophenone), 2-hydroxy-4-methoxybenzophenone-5-sulfone Acid benzophenone (2-hydroxy-4-methoxybenzophenone-5-sulfonic acid hydrate), 2,2'-dihydroxy-4,4'-dimethoxybenzophenone (2,2'-dihydroxy-4 ,4'-dimethoxybenzophenone), 2,2'-hydroxy-4-methoxybenzophenone (2,2'-dihydroxy-4-methoxybenzophenone), 4-hydroxybenzophenone (4-hydroxybenzophenone) and 2 ,3,4-trihydroxybenzophenone (2,3,4-trihydroxybenzophenone (2,3,4-trihydroxy
- Benzothiazoles UV stabilizers include 2-methylbenzothiazole (2-methylbenzothiazole), 2-benzothiazolyl-N-morpholinothioether (2-(morpholinothio)- benzothiazole), 2-(methylthio)benzothiazole), 2-aminobenzothiazole and 2-hydroxybenzothiazole.
- Described benzotriazole UV stabilizers include 1-hydroxybenzotriazole (1-hydroxybenzotriazole), 5-methyl-1-hydrogenbenzotriazole (5-methyl-1-hydrogenbenzotriazole), 5-chlorobenzotriazole (5-chloro-1-hydrogenbenzotriazole), 4-methyl-1-hydrobenzotriazole (4-methyl-1H-benzotriazole), 2-(2'-hydroxyl-5 '-Methylphenyl)benzotriazole (2-(2-Hydroxy-5-methylphenyl)benzotriazole), 2-(5-tert-butyl-2-hydroxyphenyl)benzotriazole (2-(5 -tert-butyl-2-hydroxyphenyl)benzotriazole) and 2-(2'-hydroxy-3',5'-di-tert-butylphenyl)-benzotriazole (2-(3,5-Di-tert-butyl-2-hydroxyphenyl-2-hydroxyphenyl)-
- UV stabilizers include 4-tert-butyl-4'-methoxydibenzoylmethane (4-tert-butyl-4'-methoxydibenzoylmethane), 4-methylbenzylidene 4-methylbenzylidene camphor, isoamyl4-methoxycinnamate, isooctyl 2-cyano-3,3-diphenylacrylate (2-ethylhexyl2-cyano-3,3- diphenyl-2-propenoate(liquid)), octyl dimethyl-p-aminobenzoic acid, Ethylhexyl methoxycinnamate, 2-(2H-benzotriazole -2-yl)-4,6-bis(1-methyl-1-phenylethyl)phenol (2-(2H-benzotriazol-2-yl)-4,6-bis(1-methyl-1-phenylethyl )phenol), 2,4-di
- Described photoinitiator comprises benzophenone (benzophenone), 4-methylbenzophenone (4-methylbenzophenone), 1-hydroxycyclohexylphenyl ketone (1-hydroxycyclohexylphenyl ketone), 4-phenyl 4-phenylbenzophenone/4-benzoylbiphenyl, 1,2-diphenyl-1,2-ethanedione (1,2-diphenyl-1,2-ethanedione), 2-ethylanthraquinone (2-ethylanthraquinone), methyl-2-(benzoyl)benzoate (methyl-2-(benzoyl)benzoate), 2,2-dimethoxy-2-phenylacetophenone (2,2-dimethoxy-2- phenylacetophenone), p-dimethylaminobenzophenone (4-(dimethylamino)benzophenone), 4,4'-bis(dimethylamino)benzophen
- the antioxidants include antioxidants detected in positive ion detection mode and negative ion detection mode.
- the antioxidants detected under negative ion detection mode include 3-tert-butyl-4-hydroxyanisole (3-tert-butyl-4-hydroxyanisole), 3,5-di-tert-butyl-4-hydroxybenzene Formaldehyde (3,5-di-tert-butyl-4-hydroxybenzoic acid), 3,5-di-tert-butyl-4-hydroxybenzoic acid (3,5-di-tert-butyl-4-hydroxybenzoic acid), 2, 6-di-tert-butyl-4-(hydroxymethyl)phenol (2,6-di-tert-butyl-4-(hydroxymethyl)phenol), 2,4-di-tert-butylphenol (2,4-di- tert-butylphenol), 4,4'-butylene bis(6-tert-butyl-m-cresol) (4,4'-butylidenebis(6-tert-butyl-m-cresol)), 4-(1,1 ,3,3-tetramethylbuty
- the antioxidants detected under the positive ion detection mode include 1,3-di-o-tolylguanidine (1,3-di-o-tolylguanidine), 1,3-diphenyl-2-thiourea (1, 3-diphenyl-2-thiourea), 2,2'-ethylene-bis(4,6-di-tert-butylphenol) (2,2'-ethylene-bis(4,6-di-tert-butylphenol) ), methyl-2-mercaptobenzimidazole (methyl-2-mercaptobenzimidazole), 11-methyldodecyl 3-[4-hydroxyl-3,5-bis(2-methyl-2-propanyl) Phenyl]propanoate (11-Methyldodecyl3-[4-hydroxy-3,5-bis(2-methyl-2-propanyl)phenyl]propanoate), dibenzylhydroxylamine, tri(4-tert-butyl -3-hydroxy-2,6-dimethylbenzyl
- plasticizers comprises diethyl succinate (diethyl succinate), dimethyl adipate (dimethyl adipate), diethyl adipate (diethyl adipate), dimethyl azelate ( dimethylazelate), 2,2,4-trimethyl-1,3-pentanediol diisobutyrate (2,2,4-trimethyl-1,3-pentanediol-diisobutyrate), dibutyl fumarate ( dibutyl fumarate), dimethylsebacate, isopropyl myristate, triethyl citrate, diethylene glycol dibenzoate, decyl Dibutylsebacate, Isopropyl palmitate, Acetyl triethylcitrate, n-Propyl oleate, Di(2-ethyl maleate) Hexyl) ester (Di(2-ethylhexyl) maleate), di
- the perfluorinated compounds include perfluoron-octanoic acid (Perfluoro-n-octanoic acid), perfluorooctane sulfonic acid (perfluorooctane sulfonic acid), perfluoron-butanoic acid (Perfluoro-n-butanoic acid), perfluoron-heptyl Perfluoro-n-heptanoic acid, Perfluoro-n-hexanoic acid, Perfluoro-n-decanoic acid, Perfluoro-n-dodecanoic acid ), Perfluoro-n-nonanoic acid, Perfluoro-n-undecanoic acid, Perfluoro-n-pentanoic acid, Perfluoro-n-decanoic acid Perfluoro-n-tetradecanoic acid, Perfluoro-n-tridecanoic acid, Potassium perfluoro-1-butanesul
- the organophosphorus pesticides include chlorpyrifos (dursban/chlorpyrifos), diazinon (diazinon), methyl parathion (parathion-methyl), parathion (parathion), malathion (malathion), dimethoate ( dimethoate), dichlorvos (dichlorvos), 3-methyl-4-nitrophenol (3-methyl-4-nitrophenol), coumaphos, dioxabenzofos, edifenphos, 2-isopropyl-6-methyl-4-pyrimidinol (2-isopropyl-6-methyl-4-pyrimidinol), isofenphos-methyl, mecarbam, insecticides (methacrifos ), phosalone, pyrazophos and p-Nitrophenol.
- Described pyrethroids include 3-phenoxybenzyl alcohol (3-PBA), 4-fluoro-3-phenoxybenzoic acid (4-fluoro-3-phenoxybenzoic acid), cis-3-(2- Chloro-3,3,3-trifluoro-1-propenyl)-2,2-dimethyl-cyclopropanecarboxylic acid (cis-3-(2-chloro-3,3,3-trifluoro-1-propenyl )-2,2-dimethyl-cyclopropanecarbox ylic acid) and Lambda-cyhalothrin.
- 3-phenoxybenzyl alcohol (3-PBA)
- 4-fluoro-3-phenoxybenzoic acid (4-fluoro-3-phenoxybenzoic acid)
- Lambda-cyhalothrin Lambda-c
- the neonicotinoid pesticides include Acetamiprid, Dinotefuran, Imidacloprid, Thiacloprid and Thiamethoxam.
- the carbamate pesticides include Carbendazim, Carbofuran, Chlorpropham, Fenobucarb, Iprovalicarb, Methomyl, anti Pirimicarb and Propham.
- the acidic herbicides include 2,4-dichlorophenoxybutyric acid (2,4-DB), 2,4,5-propionic acid (2,4,5-TP (Silvex)), 2,4 ,5-trichlorophenoxyacetic acid (2,4,5-trichlorophenoxyacetic acid), 2,4-dichlorprop, 2-methyl-4-chlorophenoxyacetic acid (MCPA), 2-methyl- 4-chloropentyloxypropionic acid (Mecoprop) and 2-methyl-4-chlorophenoxybutyric acid (MCPB).
- the azole pesticides include Bitertanol, Cyproconazole, Difenoconazole, Epoxiconazole, Fenbuconazole, Flusilazole (Flusilazole), Imazalil, Myclobutanil, Penconazole, Prochloraz, Tebuconazole, Tetraconazole, and Thiabendazole ).
- the triadimefon pesticides include Chloridazon, Hexazinone, Metamitron, Metribuzin, Atryn, Atraton ), atrazine, prometon, prometryn, propazine, secbumeton, simazine, simetryn and Terbutryn/prenane.
- the urea pesticides include Chloroxuron, Chlortoluron, 1-(3,4-dichlorophenyl)-3-methylurea (1-(3,4-dichlorophenyl)- 3-methylurea), 1-(3,5-dichlorophenyl)urea (DCPU), Methabenzthiazuron, Metobromuron, Metoxuron, Diuron ), 3-phenyl-1,1-dimethylurea (Fenuron), isoproturon (Isoproturon) and Linuron (Linuron).
- the amide pesticides include Alachlor, Dimethachlor, N,N-dimethylamino-N-toluene (DMST) and Fenhexamid.
- the methoxyacrylate fungicides include Azoxystrobin, Fluacrypyrim, Kresoxim-methyl, Pyraclostrobin and Trifloxystrobin .
- insecticides mentioned include Flutolanil, Boscalid, Famoxadone, Metalaxyl, Nuarimol, and procarbal (Prosulfocarb).
- step (4) The gas chromatography-tandem mass spectrometry described in step (4) is carried out by using gas chromatography-tandem mass spectrometry.
- the pollutants for quantitative analysis of environmental pollutants by gas chromatography-tandem mass spectrometry (GC-MS/MS) described in step (4) include at least one of organochlorine pesticides and liquid crystal monomers.
- the organochlorine pesticides include dichloropropionic acid (Aldrin), ALPHA-666 ( ⁇ -HCH), BETA-666 ( ⁇ -HCH), Lindane ( ⁇ -HCH (lindane)), ⁇ -6 66 ( ⁇ -HCH), ⁇ -666 ( ⁇ -HCH), cis-chlordane (cis-chlordane), trans-chlordane (trans-chlordane), oxy-chlordane (oxy-chlordane), 4,4-Didididi (p.p′-DDD), 2,2-bis(4-chlorophenyl)-1,1-dichloroethylene (p.p′-DDE), 2,2-bis(p-chlorobenzene base)-1,1,1-trichloroethane (p.p′-DDT), 1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane (o.p '-DDD), 3-o-chlor
- the liquid crystal monomers include 4-vinyl-4'-propyl-1,1'-bicyclohexyl (1-(4-propylcyclohexyl)-4-vinylcyclohexane), 1-methoxy-4-( 4-propylcyclohexyl) cyclohexane (1-methoxy-4-(4-propylcyclohexyl)cyclohexane), 1-(prop-1-enyl)-4-(4-propylcyclohexyl)cyclohexane ( 1-(prop-l-enyl)-4-(4-propylcyclohexyl)cyclohexane), 1-ethoxy-2,3-difluoro-4-(4-propylcyclohexyl)benzene (1-ethoxy-2 ,3-difluoro-4-(4-propylcyclohexyl)benzene), 4-methyl-4'-pentyl biphenyl (4-methyl-4'-
- Chromatographic conditions include:
- Mobile phase A 0.1% formic acid aqueous solution by volume fraction
- Chromatographic column C18 chromatographic column (preferably: Luna 2.5 ⁇ m C18(2)-HST 100 ⁇ 2.0mm);
- the initial volume percentage of mobile phase B is 40%; 0 ⁇ 2min, the volume percentage of mobile phase B rises from 40% to 70%; 2 ⁇ 8min, the volume percentage of mobile phase B rises to 100%; Keep at 100% for 13 minutes, the volume percentage of mobile phase B drops to 40% at 13-13.1 minutes; keep at 40% for 13.1-17 minutes;
- Mass spectrometry conditions include: electrospray ionization source, ion source temperature is 550°C; detection mode is positive ion detection mode;
- Atomization pressure nitrogen, the pressure is 55psi;
- Chromatographic conditions include:
- Chromatographic column C18 chromatographic column (preferably: ZORBAX Extended-C18 3.5 ⁇ m 100 ⁇ 2.1mm);
- the volume percentage of the initial mobile phase B is 10%; 0-0.5min keeps the number constant at 10%; 0.5-1min, the volume percentage of the mobile phase B rises from 10% to 50%; B volume fraction increased from 50% to 99%; 7-10min, kept at 99%; 10-10.1min, decreased from 99% to 10%, 10.1-12min, mobile phase B volume fraction remained at 10% ;
- Mass spectrometry conditions include: electrospray ion source, ion temperature is 550°C, detection mode is negative ion detection mode; atomization pressure: nitrogen, pressure 55psi;
- 3Plasticizers plasticizers
- benzothiazoles Benzothiazoles UV stabilizers
- benzotriazoles benzotriazoles UV stabilizers
- other UV stabilizers other UV stabilizers
- Chromatographic conditions include:
- Mobile phase A 0.1% formic acid aqueous solution by volume fraction
- Chromatographic column C18 chromatographic column (preferably: Luna 2.5 ⁇ m C18(2)-HST 100 ⁇ 2.0mm);
- initial mobile phase B volume percentage is 40%, 0-2min keeps 40% unchanged; 2-4min, mobile phase B volume percentage rises from 40% to 80%; 4-14min, mobile phase B volume percentage increases from 80% rises to 100%; 14-17min, the volume percentage of mobile phase B remains at 100%; 17-20min, the volume percentage of mobile phase B drops to 40%, 20-24min, the volume percentage of mobile phase B remains at 40% constant;
- Mass spectrometry conditions include: electrospray ion source, ion temperature is 550°C, detection mode is positive ion detection mode; atomization pressure: nitrogen, pressure 55psi;
- Chromatographic conditions include:
- Mobile phase A a volume fraction of 0.1% formic acid in water
- Chromatographic column RP18 chromatographic column (preferably: ACQUITY UPLC BEH Shield RP18, 1.7 ⁇ m, 100 ⁇ 2.1mm);
- initial mobile phase B volume percentage is 5%, 0-1min maintains at 5%; 1-3min mobile phase B volume fraction rises from 5% to 40%; 3-12min rises from 40% to 100%; 12 From 15 minutes to 15 minutes, keep 100% unchanged; from 15 to 15.1 minutes, the volume percentage of mobile phase B decreases from 100% to 5%; from 15.1 to 18 minutes, the volume percentage of mobile phase B remains unchanged at 5%;
- Mass spectrometry conditions include: electrospray ion source, ion temperature is 550°C, detection mode is negative ion detection mode; atomization pressure: nitrogen, pressure 55psi;
- Chromatographic conditions include:
- Chromatographic column RP18 chromatographic column, preferably: ACQUITY UPLC BEH Shield RP18, 1.7 ⁇ m, 100 ⁇ 2.1mm);
- initial mobile phase B volume percentage is 5%, 0 ⁇ 4min, rise from 5% to 35%; 4 ⁇ 7min, B phase volume fraction rises from 35% to 80%; 7 ⁇ 12min, rise from 80% to 100%; 12-14min keep 100% unchanged; 14-15min, mobile phase B volume percentage decreases from 100% to 5%; 15-20min, mobile phase B volume percentage remains unchanged at 5%;
- Mass spectrometry conditions include: electrospray ion source, ion temperature is 550°C, detection mode is negative ion detection mode; atomization pressure: nitrogen, pressure 55psi;
- Chromatographic conditions include:
- Mobile phase A 4mmol/L ammonium acetate aqueous solution
- Chromatographic column C18 chromatographic column, preferably: Luna 2.5 ⁇ m C18(2)-HST 100 ⁇ 2.0mm;
- the initial volume percentage of mobile phase B is 10%; 0-0.5min keeps 10% unchanged; 0.5-1min the volume percentage of mobile phase B increases from 10% to 50%, and 1-7min rises to 99%; From 7 to 10 minutes, it remained at 99%; from 10 to 10.1 minutes, the volume percentage of mobile phase B dropped rapidly to 10%; from 10.1 to 12 minutes, the volume percentage of mobile phase B remained unchanged at 10%;
- Mass spectrometry conditions include: electrospray ion source, ion temperature is 550°C, detection mode is negative ion detection mode; atomization pressure: nitrogen, pressure 55psi;
- Chromatographic conditions include:
- Chromatographic column RP18 chromatographic column, preferably: ACQUITY UPLC BEH Shield RP18, 1.7 ⁇ m; 100 ⁇ 2.1mm;
- initial mobile phase B volume percentage is 40%; 40% remains unchanged within 0-2min, mobile phase B volume percentage rises to 66% in 2-3min; rises to 77% in 3-12min; mobile phase in 12-14min B volume fraction rises from 70% to 100%, and remains unchanged at 100% for 14-16 minutes; quickly drops to 40% for 16-16.1 minutes; 16.1-22 mobile phase B volume fraction remains unchanged at 40%;
- Mass spectrometry conditions include: electrospray ion source, ion temperature is 550°C, detection mode is negative ion detection mode; atomization pressure: nitrogen, pressure 55psi;
- 8Organophosphorus pesticides Pyrethroids, Neonicotinoids, Carbamates, Acidherbicides, Azoles, Triazoles Ketone pesticides (Triazines/triazone), urea pesticides (Urea), amide pesticides (amide pesticides, Amide pesticides), methoxyacrylate fungicides (Strobilurins), other pesticides (Other Pesticides):
- Chromatographic conditions include:
- Chromatographic column C18 chromatographic column, preferably: Kinetex 2.6 ⁇ m C18 100*2.1mm; 00D4462-AN;
- the volume percentage of the initial mobile phase B is 2%; the volume percentage of the mobile phase B increases from 2% to 30% in 0-4min; the volume percentage of the mobile phase increases from 30% to 68% in 4-22min; 22-22.1 Min mobile phase B increased from 68% to 99%; 22.1 ⁇ 23min, kept at 99%; 23 ⁇ 23.1min, mobile phase B volume percentage decreased from 99% to 2%; 23.1 ⁇ 26min, kept 2% unchanged ;
- Mass spectrometry conditions electrospray ion source, ion temperature is 550°C, detection mode is negative ion detection mode; atomization pressure: nitrogen, pressure 55psi.
- step (4) The detection condition of gas chromatography-tandem mass spectrometry described in step (4) is as follows:
- Chromatographic conditions include:
- Injection port temperature 260°C;
- Heating program initial temperature is 60°C, keep for 1min; heat up to 300°C at a rate of 5°C/min, then keep for 9min;
- Mass spectrometry conditions electron bombardment ion source, ion source temperature is 230°C, quadrupole temperature is 150°C, solvent delay is 3min;
- Chromatographic conditions include:
- Injection port temperature 260°C;
- Heating program initial temperature 80°C, keep for 2.5min; then raise the temperature to 200°C at a rate of 25°C/min and keep for 1min; then rise to 250°C at a rate of 10°C/min and then rise to 285°C at a rate of 5°C/min , keep for 5min; finally rise to 300°C at the speed of 30°C/min, keep for 1min;
- Mass spectrometry conditions electron bombardment ion source, ion source temperature 230°C, quadrupole temperature 150°C, solvent delay 6min.
- the present invention has the following advantages and effects:
- the present invention provides a high-throughput and convenient method for targeted exposure group analysis of environmental pollutants in human plasma. This method can simultaneously detect various types of environmental pollutants in plasma, and the pre-treatment is convenient.
- the analysis time is short, the cost is low, the analysis efficiency can be improved to the greatest extent, and it can provide technical support for the follow-up observation and detection of the mixed effect of pollutants in the environment on human health.
- the method of the present invention can simultaneously analyze hundreds of different kinds of environmental pollutants in blood plasma, and the processing method is simple, time-consuming and efficient.
- the extract when the plasma sample is pretreated, the extract is blown to near dryness and redissolved with methanol for freezing to allow the lipid to separate out, and then it is necessary to keep the low temperature in a refrigerated centrifuge for refrigerated centrifugation to allow the lipid to precipitate It is helpful for the transfer of supernatant, so as to achieve the purpose of removing lipid, reduce matrix effect, and improve the recovery rate of standard addition.
- Fig. 1 is the comparison result graph of the recovery rate of standard addition of the method of the present invention and comparative example 1.
- the reagents, methods and equipment used in the present invention are conventional reagents, methods and equipment in the technical field.
- the test methods that do not indicate the specific experimental conditions in the following examples, usually follow the routine experimental conditions or the experimental conditions suggested by the manufacturer.
- the reagents and raw materials used in the present invention can be obtained commercially.
- the extraction solvent involved in the embodiment that is, the ethyl acetate and normal hexane in the mixed solvent containing 0.6% formic acid ethyl acetate and normal hexane are at least LC-MS level, and the volume ratio of ethyl acetate and normal hexane is 3: 2.
- Example 1 Targeted exposome analysis of environmental pollutants in human plasma
- a total of 377 standard compounds and 74 isotope-labeled chemical substances used as recovery indicators or internal standards were purchased from AccuStandard Company of the United States, Sigma-Aldrich Company of the United States, Wellington Laboratory of Canada and Toronto Research Chemicals of Canada; including 39 kinds Organophosphate esters (OPEs) (including organophosphate diesters and organophosphate triesters), 36 phthalates (PAEs) (including phthalate monoesters and phthalate diesters) , 7 kinds of personal care products (PCPs), 14 kinds of phenolic compounds (bisphenol analogues), 29 kinds of ultraviolet stabilizers (UV) (including benzophenones, benzothiazoles, benzotriazoles and other categories UV stabilizers), 15 photoinitiators, 34 antioxidants (AO) (including positive and negative ion detection modes), 31 plasticizers, 25 perfluorinated compounds (PFCs), 18 organophosphorus pesticides (OPs) , 24 kinds of organochlorine pesticides (
- the target analytes were determined by ultra-high performance liquid chromatography-mass spectrometer (5500Q Trap triple quadrupole-linear ion Trap mass spectrometer) and gas chromatography-tandem mass spectrometer (7890B-5970A).
- the instrument was purchased from AB Sciex Company in Toronto, Canada; the gas chromatography tandem mass spectrometer was purchased from Agilent Company in the United States; the nitrogen blowing instrument (12N-EvapTM) used in the experiment was purchased from Oganomation Company; the centrifuge was purchased from Hunan Xiangyi Company; the refrigerated centrifuge Purchased from Thermo Fisher Scientific; the oscillator was purchased from Kylin-Bell; the reagents used in the experiment were all LC-MS grade and purchased from Thermo Fisher Scientific.
- Plasma samples were collected at the Third affiliated Hospital of Sun Yat-Sen University (Guangzhou, China) and collected with blood collection tubes (BD, USA). The collected plasma was centrifuged at 3000rpm for three minutes to separate plasma and blood cells, and the supernatant was transferred to a glass bottle and stored at -80°C before analysis. A total of 10 volunteer plasma samples were collected in this experiment.
- organophosphate diester Phthalate recovery rate indicator 5ng organophosphate triesters recovery rate indicator 2ng, phthalic acid monoesters recovery rate indicator 2ng, phthalic acid diesters recovery rate indicator 1ng, personal care product recovery rate indicator Object 2ng, bisphenol analogue recovery indicator 2ng, benzophenone UV stabilizer recovery indicator 5ng, benzothiazole UV stabilizer recovery indicator 5ng, benzotriazole UV stabilizer recovery Indicator 5ng, other categories of UV stabilizer recovery indicator 5ng, photoinitiator recovery indicator 5ng, antioxidant recovery indicator 5ng, plasticizer recovery indicator 5ng, perfluorinated compound recovery indicator 0.5ng, organophosphorus pesticide Recovery rate indicator 5ng, organochlorine pesticide recovery rate indicator 20ng, pyrethroid recovery rate
- BPA-d16 bisphenol A-d16
- M8PFOA perfluorochemical internal standard perfluoro-n-[13C8]octanoic acid
- M8PFOA perfluoro-n-[13C8]octanoic acid
- DCDE Decachlorodiphenyl ether
- the target compounds were quantitatively analyzed on ultra-high performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) and gas chromatography-tandem mass spectrometry (GC-MS/MS), with a total of 8 analysis methods , the specific information is shown in Tables 2 and 3. in:
- the mass spectrometry conditions in LC-MS/MS include: electrospray ion source, ion temperature is 550°C, detection mode is shown in Table 2; atomization pressure: nitrogen, pressure position 55psi;
- the mass spectrometry conditions in GC-MS/MS include: electron bombardment ion source, ion source temperature of 230°C, quadrupole temperature of 150°C, solvent delay of 3min (organochlorine pesticide) or 6min (liquid crystal monomer).
- the quality assurance and quality control procedures tested the recovery of the program blank and recovery indicators, while matrix-spiked samples were analyzed.
- two laboratory program blanks were processed at the same time, and 200 ⁇ L of ultrapure water was used to replace the actual sample to prepare the program blank.
- the processing process was the same as that of the actual sample, and was repeated three times.
- the isotope standard recoveries of all samples were calculated by integrating with AB Sciex 5500 Q Trap triple quadrupole-linear ion trap mass spectrometer analysis software Analyst 1.6.3 software, ranging from 50% to 110%.
- Each type of compound was quantified using a standard curve with more than five concentration levels, and the correlation coefficient of the standard curve was greater than 0.995.
- the limit of quantification (LOQ) of the method is defined as the concentration of the compound corresponding to the response of 3 times or 10 times the standard deviation of the noise. If the calculated LOQ is lower than the background contamination value in the blank, use the highest blank Concentrations were used as LOQ.
- the LOQs of all compounds are shown in Table 1.
- the output rate is greater than 70%, of which perfluorooctanoic acid (PFOA), sodium perfluoro-1-heptane sulfonate (L-PFHxS), sodium perfluoro-1-hexanesulfonate (L-PFHpS), perfluoro-n-nonanoic acid (PFNA), perfluorooctanesulfonic acid (PFOS), perfluoron-decanoic acid (PFDA), perfluoron-undecanoic acid (PFUdA), 9-chlorohexadecafluoro-3-oxane-1 -Potassium sulfonate (9Cl-PF3ONS), 11-chloroeicosfluoro-3-oxetane-1-potassium sulfonate (11Cl-PF3OUdS) detection rate
- Step (2) was repeated for the second extraction, and the extraction solvent was changed to ethyl acetate for the third extraction, and three extracts were combined;
- the extract was blown to 1mL and then added with 3mL volume fraction of 0.6% aqueous formic acid for dilution, then concentrated to 3mL by nitrogen blowing, and the HLB column ( PRiME HLB 3cc (60mg) Extraction Cartridges) were placed on the SPE extraction device, and then the HLB column was pre-washed sequentially with 3mL methanol and 3mL water;
- the recovery indicator and internal standard added by the above method are the same as those used in Example 1, only the pretreatment method is different.
- Method 1 is the method used in Example 1, and Method 2 is the method used in Comparative Example 1.
- the recovery rate of standard addition in method 1 is mostly around 70-100%, which is relatively stable and meets the standard.
- the recovery rate of standard addition in method 2 is relatively scattered and unstable, and the recovery rate is relatively low compared to method 1. , and some compounds even had spiked recoveries of 0%. This result shows that method 2 has strong matrix interference, and overall, method 1 is significantly better than method 2.
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Disclosed in the present invention are a method for analyzing a targeted exposure group of environmental pollutants in blood plasma, and the use thereof. The method comprises the following steps: (1) adding a recovery indicator to plasma to obtain a mixture of the plasma and the recovery indicator; (2) adding a mixed solvent of ethyl acetate and n-hexane that contains formic acid to perform extraction, then adding ethyl acetate to perform extraction, and combining extraction solutions; (3) performing blow-drying on the extraction solution using nitrogen, then adding methanol for redissolution, then freezing and centrifuging same, and taking a supernatant to obtain a pretreated sample; (4) adding an internal standard to the pretreated sample, and then performing quantitative analysis on environmental pollutants by means of using a liquid chromatography-tandem mass spectrometry and/or a gas chromatography-tandem mass spectrometry. The method in the present invention can realize the simultaneous detection of hundreds of different types of environmental pollutants in plasma, has a simple and convenient processing method, a short analysis time and is low cost, and can maximize analytical efficiency.
Description
本申请要求于2021年07月27日提交中国专利局、申请号为202110849180.0、发明名称为“一种血浆中环境污染物靶向暴露组分析方法及其应用”的中国专利申请的优先权,其全部内容通过引用结合在本申请中。This application claims the priority of the Chinese patent application submitted to the China Patent Office on July 27, 2021, with the application number 202110849180.0, and the title of the invention is "A Method for Targeting Exposureome Analysis of Environmental Pollutants in Plasma and Its Application". The entire contents are incorporated by reference in this application.
本发明涉及环境科学及有机物分析技术领域,特别涉及一种血浆中环境污染物靶向暴露组分析方法及其应用。The invention relates to the technical fields of environmental science and organic matter analysis, in particular to a targeted exposure group analysis method for environmental pollutants in blood plasma and its application.
人体在日常生活中会接触到各种化学污染物,例如塑料用品中的塑料添加剂、家具用品中的全氟化合物、蔬菜水果中的残留的农药(有机氯农药、有机磷农药)等。而这些污染物可能通过摄食、呼吸、皮肤吸收等途径进入人体,人体暴露其中对健康产生危害。一些污染物已经被证实具有神经毒性,内分泌干扰性以及生殖毒性。The human body is exposed to various chemical pollutants in daily life, such as plastic additives in plastic products, perfluorinated compounds in furniture products, pesticide residues in vegetables and fruits (organochlorine pesticides, organophosphorus pesticides), etc. These pollutants may enter the human body through ingestion, breathing, skin absorption, etc., and exposure of the human body to them will cause health hazards. Some pollutants have been shown to be neurotoxic, endocrine disrupting, and reproductively toxic.
化学用品的使用促进了社会的发展,但同时也给环境造成了污染,以致对人体人健康产生危害。目前已有许多研究表明人体暴露于各种各样的环境污染物中,但人体血浆中的环境污染物的研究大多数都是关注单一或者一类的化合物,对于多种环境污染物的混合效应的研究比较缺乏,同时一些新型添加剂或环境污染物的暴露对人体产生的健康危害仍然未知,例如日常生活使用的手机和电脑等电子设备的屏幕中,一些液晶单体的释放也可能使人体暴露在其中产生危害。The use of chemicals promotes the development of society, but at the same time it also pollutes the environment, causing harm to human health. At present, many studies have shown that the human body is exposed to a variety of environmental pollutants, but most of the research on environmental pollutants in human plasma focuses on a single or a class of compounds, and the mixed effects of multiple environmental pollutants At the same time, the health hazards caused by the exposure of some new additives or environmental pollutants to the human body are still unknown. For example, the release of some liquid crystal monomers in the screens of electronic devices such as mobile phones and computers used in daily life may also expose the human body to harm in it.
要想实现研究多种化学污染物混合效应,前提是能同时检出血浆中的多种不同的环境污染物,因此亟需开发一种能快速检测到人体血液中不同的环境污染物的方法。由于当前一些检测方法前处理过程复杂、耗时久并且成本过高,检测化合物的种类单一,因此建立简便高效且成本低的人体血浆中环境污染物靶向暴露组分析方法很有必要,可以为后续评价各类环境污染物对人体的健康影响提供技术条件。In order to study the mixed effect of various chemical pollutants, the premise is that a variety of different environmental pollutants in plasma can be detected at the same time, so it is urgent to develop a method that can quickly detect different environmental pollutants in human blood. Due to the complex, time-consuming and high cost of the pretreatment process of some current detection methods, and the single type of detection compounds, it is necessary to establish a simple, efficient and low-cost targeted exposure group analysis method for environmental pollutants in human plasma. Provide technical conditions for follow-up evaluation of the impact of various environmental pollutants on human health.
发明内容Contents of the invention
本发明的首要目的在于克服现有技术的缺点与不足,提供一种血浆中环境污染物靶向暴露组分析方法。The primary purpose of the present invention is to overcome the shortcomings and deficiencies of the prior art, and provide a targeted exposure group analysis method for environmental pollutants in plasma.
本发明的另一目的在于提供所述血浆中环境污染物靶向暴露组分析方法的应用。Another object of the present invention is to provide the application of the targeted exposure group analysis method for environmental pollutants in plasma.
本发明的目的通过下述技术方案实现:The object of the present invention is achieved through the following technical solutions:
一种血浆中环境污染物靶向暴露组分析方法,包括如下步骤:A method for analyzing targeted exposure groups of environmental pollutants in plasma, comprising the steps of:
(1)将回收率指示物添加到血浆中,混合均匀,得到血浆和回收率指示物的混合物;(1) Add the recovery rate indicator to the plasma and mix evenly to obtain a mixture of the plasma and the recovery rate indicator;
(2)向步骤(1)中得到的血浆和回收率指示物的混合物中加入萃取溶剂I进行萃取,离心,取上清,重复此步骤1次以上;再加入萃取溶剂II进行萃取,得到萃取液;其中,所述萃取溶剂I为含有甲酸的乙酸乙酯和正己烷的混合溶剂;所述萃取溶剂II为乙酸乙酯;(2) Add extraction solvent I to the mixture of plasma and recovery indicator obtained in step (1) for extraction, centrifuge, take the supernatant, repeat this step more than 1 time; then add extraction solvent II for extraction to obtain the extracted Liquid; Wherein, described extraction solvent I is the mixed solvent that contains the ethyl acetate of formic acid and n-hexane; Described extraction solvent II is ethyl acetate;
(3)将步骤(2)中得到的萃取液用氮气吹干,然后加入甲醇复溶后,置于-40±5℃下进行冷冻,然后冷冻离心,取上清液,得到预处理后的样品;(3) Dry the extract obtained in step (2) with nitrogen, then add methanol to redissolve, freeze at -40±5°C, then freeze and centrifuge, and take the supernatant to obtain the pretreated sample;
(4)向步骤(2)中得到的预处理后的样品中加入内标,然后利用液相色谱-串联质谱法(UPLC-MS/MS)和/或气相色谱-串联质谱法(GC-MS/MS)对环境污染物进行定量分析。(4) Add an internal standard to the pretreated sample obtained in step (2), and then use liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) and/or gas chromatography-tandem mass spectrometry (GC-MS /MS) for quantitative analysis of environmental pollutants.
步骤(1)中所述的回收率指示物的用量为按每200μL血浆加入每种回收率指示物0.5~20ng计算。The dosage of the recovery rate indicators described in step (1) is calculated by adding 0.5-20 ng of each recovery rate indicator per 200 μL of plasma.
步骤(1)中所述的回收率指示物包括三2-丁氧基-[13C2]-乙基)磷酸酯(Tris(2-butoxy-[13C2]-ethyl)phosphate)、磷酸三正丁酯-d27(Tri-n-butyl phosphate-d27)、三(2-氯乙基)磷酸酯-d12(Tris(2-chloroethyl)phosphate-d12)、三(1,3-二氯-2-丙基)磷酸酯-d15(Tris(1,3-dichloro-2-propyl)phosphate-d15)、磷酸三乙酯-d15(Triethylphosphate-d15)、磷酸三苯酯-d15(Triphenyl phosphate-d15)、双(丁氧基乙基)磷酸酯-d8(Bis(butoxyethyl)Phosphate-d8)、双(1,3-二氯-2-丙基)磷酸酯-d10(Bis(1,3-dichloro-2-propyl)phosphate-d10)、双(2-乙基己基)磷酸酯-d34(Bis(2-ethylhexyl)phosphate-d34)、磷酸二丁酯-d18(Dibutyl phosphate-d18)、磷酸二邻甲苯酯-d14(Di-o-cresyl Phosphate-d14)、二对甲苯基磷酸酯-d14(Di-p-tolyl-phosphate(Di-p-cresylphosphate)-d14)、磷酸二苯酯-d10(Diphenyl phosphate-d10)、邻苯二甲酸二苄酯-d4(Dibenzyl phthalate-d4)、邻苯二甲酸二正丁酯-d4(Di-n-butyl phthalate-d4)、邻苯二甲酸二异丁酯-3,4,5,6-d4(Di-iso-butyl phthalate-3,4,5,6-d4)、邻苯二甲酸二环己酯-3,4,5,6-d4(Dicyclohexyl phthalate-3,4,5,6-d4)、双(2-乙基己基)邻苯二甲酸酯-3,4,5,6-d4(Bis(2-ethylhexyl)phthalate-3,4,5,6-d4)、邻苯二甲酸二乙酯-3,4,5,6-d4(Diethyl phthalate-3,4,5,6-d4)、邻苯二甲酸二正己酯-3,4,5,6-d4(Di-n-hexylphthalate-3,4,5,6-d4)、邻苯二甲酸二甲酯-3,4,5,6-d4(Dimethyl phthalate-3,4,5,6-d4)、邻苯二甲酸二正戊酯-3,4,5,6-d4(Di-n-pentyl phthalate-3,4,5,6-d4)、邻苯二甲酸二正丙酯-3,4,5,6-d4(Di-n-propyl phthalate-3,4,5,6-d4)、邻苯二甲酸单苄酯-d4(Mono-benzyl phthalate-d4)、邻苯二甲酸单正丁酯-d4(Mono-n-butyl phthalate-d4)、双(2-乙基己基)己二酸酯-d8(Bis(2-ethylhexyl)adipate-d8)、O-乙酰柠檬酸三丁酯-d3(Tributyl O-acetylcitrate-d3)、双酚A-d6(Bisphenol A-d6)、双酚S-C12(Bisphenol S-C12)、三氯生-d3(Triclosan-d3)、2,4-二羟基二苯甲酮-13C6(2,4-dihydroxybenzophenone-13C6)、苯并噻唑-d4(benzothiazole-d4)、1H-苯并三唑-(环-d4)(1H-benzotriazole-(ring-d4))、5-甲基苯并三唑-d6(5-Methy-benzotriazole-d6)、二苯甲酮-d10(Benzophenone-d10)、2-羟基-4-甲氧基二苯甲酮-d5(2-Hydroxy-4-methoxybenzophenone-d5)、全氟-n-[(13)C4]丁酸(Perfluoro-n-[(13)C4]butanoicacid)、全氟-n-[1,2-(13)C2]己酸(Perfluoro-n-[1,2-(13)C2]hexanoic acid)、全氟-1-己烷[(18)O2]磺酸钠(Sodium perfluoro-1-hexane[(18)O2]sulfonate)、全氟-n-[1,2,3,4-(13)C4]辛酸(Perfluoro-n-[1,2,3,4-(13)C4]octanoic acid)、全氟-n-[1,2,3,4,5-(13)C5]壬酸(Perfluoro-n-[1,2,3,4,5-(13)C5]nonanoic acid)、全氟钠-1-[1,2,3,4-(13)C4]辛磺酸盐(Sodiumperfluoro-1-[1,2,3,4-(13)C4]octanesulfonate)、全氟-n-[1,2-(13)C2]癸酸(Perfluoro-n-[1,2-(13)C2]decanoic acid)、全氟-n-[1,2-(13)C2]十一烷酸(Perfluoro-n-[1,2-(13)C2]undecanoic acid)、全氟-n-[1,2-(13)C2]十二烷酸(Perfluoro-n-[1,2-(13)C2]dodecanoic acid)、全氟-1-[13C8]辛烷磺酰胺(Perfluoro-1-[13C8]octanesulfonamide)、N-甲基-d3-全氟-1-辛烷磺酰胺(N-methyl-d3-perfluoro-1-octanesulfonamide)、N-乙基-d5-全氟-1-辛烷磺酰胺(N-ethyl-d5-perfluoro-1-octanesulfonamide)、1H,1H,2H,2H-全氟-1-[1,2-13C2]-辛烷磺酸钠(Sodium1H,1H,2H,2H-perfluoro-1-[1,2-13C2]-octane sulfonate(6:2))、毒死蜱d10(chlorpyrifos d10)、γ-1,2,3,4,5,6-六氯环己烷-d6(gamma-1,2,3,4,5,6-Hexachlorocyclohexane-d6)、反式氯菊酯d6(trans-permethrin d6)、啶虫脒-d3(Acetamiprid-d3)、吡虫啉 -d4(Imidacloprid-d4)、噻虫啉-d4(Thiacloprid-d4)、噻虫嗪-d3(Thiamethoxam-d3)、多菌灵d3(Carbendazim d3)、呋喃丹d3(Carbofuran d3)、2,4-二氯苯氧基-3,5,6-d3-乙酸(2,4-Dd3)、2,4'-二氯二苯基三氯乙烷-d8(2,4'-Dichlorodiphenyltrichloroethane-d8)、2-(4-氯-2-甲基苯氧基)丙酸-D3(Mecoprop d3)、噻苯达唑d4(Thiabendazole d4)、十氘代西玛嗪(Simazined10)、特丁草净-D5(Terbutryn d5)、氘代敌草隆-D6(Diuron d6)、异丙隆d6(Isoproturon d6)、异丙甲草胺d6(Metolachlor d6)、嘧菌酯d4(Azoxystrobin d4)和啶酰菌胺d4(Boscalid d4)中的至少一种。The recovery indicators described in step (1) include three 2-butoxy-[13C2]-ethyl) phosphate (Tris(2-butoxy-[13C2]-ethyl)phosphate), tri-n-butyl phosphate -d27(Tri-n-butyl phosphate-d27), Tris(2-chloroethyl)phosphate-d12(Tris(2-chloroethyl)phosphate-d12), Tris(1,3-dichloro-2-propyl ) phosphate-d15 (Tris(1,3-dichloro-2-propyl) phosphate-d15), triethyl phosphate-d15 (Triethylphosphate-d15), triphenyl phosphate-d15 (Triphenyl phosphate-d15), bis( Butoxyethyl) phosphate-d8(Bis(butoxyethyl)Phosphate-d8), bis(1,3-dichloro-2-propyl)phosphate-d10(Bis(1,3-dichloro-2-propyl ) phosphate-d10), bis(2-ethylhexyl) phosphate-d34 (Bis(2-ethylhexyl) phosphate-d34), dibutyl phosphate-d18 (Dibutyl phosphate-d18), di-o-cresyl phosphate-d14 (Di-o-cresyl Phosphate-d14), Diphenyl phosphate-d14 (Di-p-tolyl-phosphate(Di-p-cresylphosphate)-d14), Diphenyl phosphate-d10 (Diphenyl phosphate-d10) , Dibenzyl phthalate-d4 (Dibenzyl phthalate-d4), Di-n-butyl phthalate-d4 (Di-n-butyl phthalate-d4), Diisobutyl phthalate-3,4 ,5,6-d4(Di-iso-butyl phthalate-3,4,5,6-d4), dicyclohexyl phthalate-3,4,5,6-d4(Dicyclohexyl phthalate-3,4 ,5,6-d4), bis(2-ethylhexyl)phthalate-3,4,5,6-d4 (Bis(2-ethylhexyl)phthalate-3,4,5,6-d4 ), Diethyl phthalate-3,4,5,6-d4 (Diethyl phthalate-3,4,5,6-d4), Di-n-hexyl phthalate-3,4,5,6- d4(Di-n-hexylphthalate-3,4,5,6-d4), dimethyl phthalate-3,4,5,6-d4(Dimeth yl phthalate-3,4,5,6-d4), di-n-pentyl phthalate-3,4,5,6-d4 (Di-n-pentyl phthalate-3,4,5,6-d4) , Di-n-propyl phthalate-3,4,5,6-d4 (Di-n-propyl phthalate-3,4,5,6-d4), Monobenzyl phthalate-d4 (Mono- benzyl phthalate-d4), mono-n-butyl phthalate-d4 (Mono-n-butyl phthalate-d4), bis(2-ethylhexyl) adipate-d8 (Bis(2-ethylhexyl) adipate- d8), O-acetyl tributyl citrate-d3 (Tributyl O-acetylcitrate-d3), bisphenol A-d6 (Bisphenol A-d6), bisphenol S-C12 (Bisphenol S-C12), triclosan- d3 (Triclosan-d3), 2,4-dihydroxybenzophenone-13C6 (2,4-dihydroxybenzophenone-13C6), benzothiazole-d4 (benzothiazole-d4), 1H-benzotriazole-(ring- d4)(1H-benzotriazole-(ring-d4)), 5-methylbenzotriazole-d6(5-Methy-benzotriazole-d6), benzophenone-d10(Benzophenone-d10), 2-hydroxy- 4-methoxybenzophenone-d5 (2-Hydroxy-4-methoxybenzophenone-d5), perfluoro-n-[(13)C4]butanoic acid (Perfluoro-n-[(13)C4]butanoic acid), Perfluoro-n-[1,2-(13)C2]hexanoic acid (Perfluoro-n-[1,2-(13)C2]hexanoic acid), perfluoro-1-hexane[(18)O2]sulfonic acid Sodium perfluoro-1-hexane[(18)O2]sulfonate, Perfluoro-n-[1,2,3,4-(13)C4]octanoic acid (Perfluoro-n-[1,2,3, 4-(13)C4]octanoic acid), perfluoro-n-[1,2,3,4,5-(13)C5]nonanoic acid (Perfluoro-n-[1,2,3,4,5- (13)C5]nonanoic acid), sodium perfluoro-1-[1,2,3,4-(13)C4] octanesulfonate (Sodium perfluoro-1-[1,2,3,4-(13) C4]octanesulfonate), perfluoro-n -[1,2-(13)C2]decanoic acid (Perfluoro-n-[1,2-(13)C2]decanoic acid), perfluoro-n-[1,2-(13)C2]undecane Perfluoro-n-[1,2-(13)C2]undecanoic acid, Perfluoro-n-[1,2-(13)C2]dodecanoic acid (Perfluoro-n-[1,2-( 13) C2]dodecanoic acid), perfluoro-1-[13C8]octanesulfonamide (Perfluoro-1-[13C8]octanesulfonamide), N-methyl-d3-perfluoro-1-octanesulfonamide (N- methyl-d3-perfluoro-1-octanesulfonamide), N-ethyl-d5-perfluoro-1-octanesulfonamide (N-ethyl-d5-perfluoro-1-octanesulfonamide), 1H,1H,2H,2H-all Fluoro-1-[1,2-13C2]-octane sulfonate (Sodium1H,1H,2H,2H-perfluoro-1-[1,2-13C2]-octane sulfonate(6:2)), chlorpyrifos d10( chlorpyrifos d10), gamma-1,2,3,4,5,6-hexachlorocyclohexane-d6 (gamma-1,2,3,4,5,6-Hexachlorocyclohexane-d6), trans-permethrin d6(trans-permethrin d6), acetamiprid-d3(Acetamiprid-d3), imidacloprid-d4(Imidacloprid-d4), thiacloprid-d4(Thiacloprid-d4), thiamethoxam-d3(Thiamethoxam-d3), Carbendazim d3 (Carbendazim d3), carbofuran d3 (Carbofuran d3), 2,4-dichlorophenoxy-3,5,6-d3-acetic acid (2,4-Dd3), 2,4'-di Chlorodiphenyltrichloroethane-d8(2,4'-Dichlorodiphenyltrichloroethane-d8), 2-(4-chloro-2-methylphenoxy)propionic acid-D3(Mecoprop d3), Thiabendazole d4 (Thiabendazole d4), decadeuterated simazine (Simazined10), terbutryn-D5 (Terbutryn d5), deuterated diuron-D6 (Diuron d6), isoproturon d6 (Isoproturon d6), isopropyl methyl Metolachlor d6, Azoxystrobin d4 and Boscalid d At least one of 4 (Boscalid d4).
步骤(1)中所述的血浆为人或动物的血浆;优选为人或绵羊血血浆;更优选为人体血浆。The plasma described in step (1) is human or animal plasma; preferably human or sheep blood plasma; more preferably human plasma.
步骤(1)中所述的血浆优选通过如下方式获得:将采集的血液离心分离,取上清液,获得所需要的血浆。The plasma described in step (1) is preferably obtained by centrifuging the collected blood, and taking the supernatant to obtain the required plasma.
所述的离心的条件为:3000rpm下离心3分钟。The centrifugation condition is: centrifuge at 3000rpm for 3 minutes.
步骤(1)中所述的添加的回收率指示物为所测目标化合物的同位素标记的化合物,能有效的校正前处理过程中化合物的损失;本发明中,大部分目标化合物都具有一一对应的回收率指示物,无法一一对应的化合物则使用同类别化合物对应的同位素标。The added recovery indicator described in step (1) is the isotope-labeled compound of the measured target compound, which can effectively correct the loss of the compound in the pretreatment process; in the present invention, most of the target compounds have one-to-one correspondence For the recovery indicator, if the compound cannot be one-to-one, use the isotope label corresponding to the same type of compound.
步骤(2)中所述的萃取溶剂I的配方如下:298.2mL乙酸乙酯、198.8mL正己烷和3mL甲酸(乙酸乙酯和正己烷按体积比3:2,甲酸占萃取溶剂I体积的0.6%)。The formula of extraction solvent 1 described in step (2) is as follows: 298.2mL ethyl acetate, 198.8mL normal hexane and 3mL formic acid (ethyl acetate and normal hexane are by volume ratio 3:2, and formic acid accounts for 0.6 of extraction solvent 1 volume %).
步骤(2)中所述的萃取需要360度旋转震荡使得萃取更加充分。The extraction described in step (2) requires 360-degree rotation and vibration to make the extraction more complete.
步骤(2)中所述的重复的次数为2次以上;优选为2次。The number of repetitions described in step (2) is more than 2 times; preferably 2 times.
步骤(2)中所述的离心的条件为:3000~4000rpm下离心3min以上;优选为:3000rpm下离心3min,离心目的是沉淀悬浮物,有助于转移萃取剂。The centrifugation conditions described in step (2) are: centrifugation at 3000-4000rpm for more than 3min; preferably: centrifugation at 3000rpm for 3min, the purpose of centrifugation is to precipitate suspended matter and help to transfer the extractant.
步骤(3)中所述的冷冻的时间为12小时以上。The freezing time described in step (3) is more than 12 hours.
步骤(3)中所述的冷冻离心的条件为:-10℃、15000rpm条件下离心5min以上。The conditions for the refrigerated centrifugation in step (3) are: centrifuge at -10°C and 15000rpm for more than 5min.
步骤(3)中,需要将萃取液吹至近干用甲醇复溶后进行冷冻,目的是让脂质析出,然后需要在冷冻离心机中保持低温进行冷冻离心,目的是让脂质沉淀有助于上清液的转移,从而达到去除脂质的目的,减少基质效应。In step (3), the extract needs to be blown to near dryness and reconstituted with methanol for freezing. The purpose is to precipitate lipids, and then it is necessary to keep low temperature in a refrigerated centrifuge for refrigerated centrifugation. The purpose is to allow lipid precipitation to help The transfer of the supernatant, so as to achieve the purpose of removing lipids and reduce the matrix effect.
步骤(4)中所述的内标的用量为按每50μL预处理后的样品加入每种内标1~20ng计算。The amount of the internal standard described in step (4) is calculated by adding 1-20 ng of each internal standard per 50 μL of the pretreated sample.
步骤(4)中所述的内标包括全氟化合物,增塑剂(塑料添加剂),有机氯农药,有机磷农药和液晶单体的内标。The internal standard described in the step (4) includes internal standards of perfluorinated compounds, plasticizers (plastic additives), organochlorine pesticides, organophosphorus pesticides and liquid crystal monomers.
所述的全氟化合物的内标为全氟-n-[13C8]辛酸(Perfluoro-n-[13C8]octanoicacid;M8PFOA)。The internal standard of the perfluoro compound is perfluoro-n-[13C8]octanoic acid (Perfluoro-n-[13C8]octanoic acid; M8PFOA).
所述的增塑剂的正模式的内标为蝇毒磷-d10(coumaphos-d10),负模式的内标为双酚A-d16(BisphenolA-d16;BPA-d16)。The positive mode internal standard of the plasticizer is coumaphos-d10 (coumaphos-d10), and the negative mode internal standard is bisphenol A-d16 (BisphenolA-d16; BPA-d16).
所述的有机氯农药的内标为十氯二苯醚(Decachlorodiphenyl ether;DCDE)。The internal standard of the organochlorine pesticide is decachlorodiphenyl ether (DCDE).
所述的有机磷农药的正模式的内标为蝇毒磷-d10(coumaphos-d10),负模式的内标为对羟基苯甲酸叔丁酯-d9(tert butyl paraben-d9)。The positive mode internal standard of the organophosphorus pesticide is coumaphos-d10, and the negative mode internal standard is tert butyl paraben-d9.
所述的液晶单体的内标为十氯二苯醚(Decachlorodiphenyl ether;DCDE)。The internal standard of the liquid crystal monomer is decachlorodiphenyl ether (DCDE).
步骤(4)中所述的液相色谱-串联质谱法为采用超高效液相色谱-串联质谱联用仪进行。The liquid chromatography-tandem mass spectrometry described in step (4) is carried out by using ultra-high performance liquid chromatography-tandem mass spectrometry.
步骤(4)中所述的采用液相色谱-串联质谱法(UPLC-MS/MS)对环境污染物进行定量分析的污染物包括有机磷酸酯类(OPEs),邻苯二甲酸酯类 (PAEs),个人护理产品(PCPs),苯酚类化合物,紫外稳定剂(UV),光引发剂,抗氧化剂(AO),增塑剂,全氟化合物(PFCs),有机磷农药(OPs),拟除虫菊酯,新烟碱类农药,氨基甲酸酯类农药,酸性除草剂,唑类农药,三唑酮类农药,尿素类农药,酰胺类农药,甲氧基丙烯酸酯类杀菌剂和其他杀虫剂中的至少一种。Adopt liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) described in step (4) to carry out the pollutant of quantitative analysis to environmental pollutant and comprise organophosphates (OPEs), phthalates (PAEs) ), personal care products (PCPs), phenolic compounds, ultraviolet stabilizers (UV), photoinitiators, antioxidants (AO), plasticizers, perfluorinated compounds (PFCs), organophosphorus pesticides (OPs), pyrethroids Esters, neonicotinoid pesticides, carbamate pesticides, acidic herbicides, azole pesticides, triadimefon pesticides, urea pesticides, amides pesticides, methoxyacrylate fungicides and other insecticides at least one of .
所述的有机磷酸酯类(OPEs)包括有机磷酸二酯类和有机磷酸三酯类中的至少一种。The organophosphates (OPEs) include at least one of organophosphate diesters and organophosphate triesters.
所述的有机磷酸二酯类(Organophosphate diesters)包括双-(1-氯-2-丙基)磷酸酯(bis-(1-chloro-2-propyl)phosphate)、磷酸二苯酯(Diphenyl phosphate)、磷酸二丁酯(Dibutyl phosphate)、双(1,3-二氯-2-丙基)磷酸酯(Bis(1,3-dichloro-2-propyl)phosphate)、二对甲苯基磷酸酯(di-p-tolyl-phosphate)、双(丁氧基乙基)磷酸酯(bis(butoxyethyl)phosphate)和双(2-乙基己基)磷酸酯(bis(2-ethylhexyl)phosphate)。Described organophosphate diesters (Organophosphate diesters) include bis-(1-chloro-2-propyl) phosphate (bis-(1-chloro-2-propyl) phosphate), diphenyl phosphate (Diphenyl phosphate) , dibutyl phosphate (Dibutyl phosphate), bis (1,3-dichloro-2-propyl) phosphate (Bis (1,3-dichloro-2-propyl) phosphate), two p-cresyl phosphate (di -p-tolyl-phosphate), bis(butoxyethyl)phosphate and bis(2-ethylhexyl)phosphate.
所述的有机磷酸三酯类(Organophosphate triesters)包括磷酸三乙酯(Triethyl phosphate)、三(2-氯乙基)磷酸酯(Tris(2-chloroethyl)phosphate)、磷酸三丙酯(Tripropyl phosphate)、四(2-氯乙基)二氯异戊基二磷酸酯(Tetrakis(2-Chloroethyl)dichloroisopentyl diphosphate)、磷酸三苯酯(Triphenyl phosphate)、三(2,3-二溴丙基)磷酸酯(Tris(2,3-dibromopropyl)phosphate)、磷酸三丁酯(Tributylphosphate)、磷酸甲酚二苯酯(Cresyldiphenyl phosphate)、三(2-丁氧基乙基)磷酸酯(Tris(2-butoxyethyl)phosphate)、磷酸三甲苯酯(Tricresyl phosphate)、间苯二酚双(磷酸二苯酯)(Resorcinol bis(diphenyl phosphate))、2-乙基己基-二苯基磷酸酯(2-Ethylhexyl-diphenyl phosphate)、磷酸异癸基二苯酯(Isodecyl diphenyl phosphate)、三(3,5-二甲基苯基)磷酸酯(Tris(3,5-dimethylphenyl)phosphate)、双酚A双(磷酸二苯酯)(Bisphenol A bis(diphenyl phosphate))、三(2-异丙基苯基)磷酸酯(Tris(2-isopropylphenyl)phosphate)、三(2-乙基己基)磷酸酯(Tris(2-ethylhexyl)phosphate)、叔丁基苯基二苯基磷酸酯(t-butylphenyl diphenyl phosphate)、2-异丙基苯基二苯基磷酸酯(2-Isopropylphenyl diphenyl phosphate)、4-异丙基苯基二苯基磷酸酯(4-Isopropylphenyl diphenyl phosphate)、双(2-异丙基苯基)苯基磷酸酯(Bis(2-isopropylphenyl)phenyl phosphate)、2,4-二异丙基苯基二苯基磷酸酯(2,4-Diisopropylphenyl diphenyl phosphate)、双(4-异丙基苯基)苯基磷酸酯(Bis(4-isopropylphenyl)phenyl phosphate)、三(3,4-二甲基苯基)磷酸酯(Trsi(3,4-dimethyphenyl)phosphate)、三(4-叔丁基苯基)磷酸酯(Tris(4-tert-butylphenyl)phosphate)、双(2,4-二异丙基苯基)苯基磷酸酯(Bis(2,4-diisopropylphenyl)phenylphosphate)、三(3-异丙基苯基)磷酸酯(Tris(3-isopropylphenyl)phosphate)、三(4-异丙基苯基)磷酸酯(Tris(4-isopropylphenyl)phosphate)、2-叔丁基苯基二苯基磷酸酯(2-tert-Butylphenyl diphenyl phosphate)、4-叔丁基苯基二苯基磷酸酯(4-tert-Butylphenyl diphenyl phosphate)、双(2-叔丁基苯基)苯基磷酸酯(Bis(2-tert-butylphenyl)phenyl phosphate)和双(4-叔丁基苯基)苯基磷酸酯(Bis(4-tert-butylphenyl)phenyl phosphate)。Described organophosphate triesters (Organophosphate triesters) include triethyl phosphate (Triethyl phosphate), three (2-chloroethyl) phosphate (Tris (2-chloroethyl) phosphate), tripropyl phosphate (Tripropyl phosphate) , Tetrakis (2-Chloroethyl) dichloroisopentyl diphosphate, Triphenyl phosphate, Tris (2,3-dibromopropyl) phosphate (Tris(2,3-dibromopropyl)phosphate), Tributylphosphate, Cresyldiphenylphosphate, Tris(2-butoxyethyl)phosphate (Tris(2-butoxyethyl) phosphate), Tricresyl phosphate, Resorcinol bis(diphenyl phosphate), 2-Ethylhexyl-diphenyl phosphate (2-Ethylhexyl-diphenyl phosphate ), Isodecyl diphenyl phosphate (Isodecyl diphenyl phosphate), three (3,5-dimethylphenyl) phosphate (Tris (3,5-dimethylphenyl) phosphate), bisphenol A bis (diphenyl phosphate ) (Bisphenol A bis (diphenyl phosphate)), three (2-isopropylphenyl) phosphate (Tris (2-isopropylphenyl) phosphate), three (2-ethylhexyl) phosphate (Tris (2-ethylhexyl) phosphate), t-butylphenyl diphenyl phosphate (t-butylphenyl diphenyl phosphate), 2-isopropylphenyl diphenyl phosphate (2-Isopropylphenyl diphenyl phosphate), 4-isopropylphenyl diphenyl 4-Isopropylphenyl diphenyl phosphate, bis(2-isopropylphenyl)phenyl phosphate (Bis(2-isopropylphenyl)phenyl phosphate), 2,4-diisopropylphenyl diphenyl phosphate Esters (2,4-Diisopropylphenyl diphenyl phosphate ), bis(4-isopropylphenyl)phenyl phosphate (Bis(4-isopropylphenyl)phenyl phosphate), tris(3,4-dimethylphenyl)phosphate (Trsi(3,4-dimethylphenyl) phosphate), three (4-tert-butylphenyl) phosphate (Tris (4-tert-butylphenyl) phosphate), bis (2,4-diisopropylphenyl) phenyl phosphate (Bis (2,4 -diisopropylphenyl)phenylphosphate), Tris(3-isopropylphenyl)phosphate (Tris(3-isopropylphenyl)phosphate), Tris(4-isopropylphenyl)phosphate (Tris(4-isopropylphenyl)phosphate), 2-tert-butylphenyl diphenyl phosphate (2-tert-Butylphenyl diphenyl phosphate), 4-tert-butylphenyl diphenyl phosphate (4-tert-Butylphenyl diphenyl phosphate), bis(2-tert-butyl Bis(2-tert-butylphenyl)phenyl phosphate and Bis(4-tert-butylphenyl)phenyl phosphate.
所述的邻苯二甲酸酯类(PAEs)包括邻苯二甲酸单酯类和邻苯二甲酸二酯类中的至少一种。The phthalic acid esters (PAEs) include at least one of phthalic acid monoesters and phthalic acid diesters.
所述的邻苯二甲酸单酯类(Phthalate monoesters)包括邻苯二甲酸单乙酯(monoethyl phthalate)、邻苯二甲酸单异丙酯(monoisopropyl phthalate)、邻苯二甲酸单丁酯(monoisobutyl phthalate)、邻苯二甲酸单正戊酯(mono-n-pentyl phthalate)、邻苯二甲酸单环己酯(monocyclohexyl phthalate)、邻苯二甲酸单己基酯(monohexylphthalate)、邻苯二甲酸单苄酯(monobenzyl phthalate)、邻苯二甲酸单-2-庚酯(mono-2-heptyl phthalate)、邻苯二甲酸单辛酯(monooctyl phthalate)、邻苯二甲酸单乙基己基酯(monoethylhexyl phthalate)、邻苯二甲酸单异壬酯(monoisononyl phthalate)、邻苯二甲酸单(2-乙基-5-氧己基)酯(mono(2-ethyl-5-oxohexyl)phthalate)、邻苯二甲酸单(2-乙基-5-羟基己基)酯(mono(2-ethyl-5-hydroxyhexyl)phthalate)和单(2-乙基-5-羧基戊基)邻苯二甲酸酯(mono(2-ethyl-5carboxypentyl)phthalate)。The phthalate monoesters include monoethyl phthalate, monoisopropyl phthalate, monoisobutyl phthalate ), mono-n-pentyl phthalate, monocyclohexyl phthalate, monohexylphthalate, monobenzyl phthalate (monobenzyl phthalate), mono-2-heptyl phthalate (mono-2-heptyl phthalate), monooctyl phthalate (monoctyl phthalate), monoethylhexyl phthalate (monoethylhexyl phthalate), Monoisononyl phthalate (monoisononyl phthalate), mono(2-ethyl-5-oxohexyl) phthalate (mono(2-ethyl-5-oxohexyl) phthalate), mono(2-ethyl-5-oxohexyl) phthalate 2-Ethyl-5-hydroxyhexyl) ester (mono(2-ethyl-5-hydroxyhexyl) phthalate) and mono(2-ethyl-5-carboxypentyl) phthalate (mono(2-ethyl -5carboxypentyl)phthalate).
所述的邻苯二甲酸二酯类(Phthalate diesters)包括间苯二甲酸二甲酯(dimethyl isophthalate)、邻苯二甲酸二甲酯(dimethyl phthalate)、邻苯二甲酸二乙酯(diethyl phthalate)、邻苯二甲酸二烯丙酯(diallyl phthalate)、邻苯二甲酸二丙酯(di-n-propyl phthalate)、邻苯二甲酸二异丙酯(Diisopropyl phthalat)、邻苯二甲酸二异丁酯(diisobutyl phthalate)、邻苯二甲酸二丁酯(dibutyl phthalate)、邻苯二甲酸异丁环己酯(isobutylcyclohexyl phthalate)、邻苯二甲酸二异戊酯(diisopentyl phthalate)、邻苯二甲酸丁苄酯(butyl benzylphthalate)、间苯二甲酸二苯酯(diphenyl isophthalate)、邻苯二甲酸二苯酯(diphenylphthalate)、邻苯二甲酸二己酯(dihexyl phthalate)、邻苯二甲酸二异己酯(diisohexylphthalate)、邻苯二甲酸双-4-甲基-2-戊酯(bis(4-methyl-2-pentyl)phthalate)、邻苯二甲酸二苄酯(dibenzyl phthalate)、邻苯二甲酸二庚酯(diisoheptyl phthalate)、邻苯二甲酸二壬酯(dinonyl phthalate)、邻苯二甲酸二十二烷基酯(diundecyl phthalate)和己二酸二(2-乙基己基)酯(bis(2-ethylhexyl)adipate)。The phthalate diesters include dimethyl isophthalate, dimethyl phthalate, diethyl phthalate , Diallyl phthalate, di-n-propyl phthalate, Diisopropyl phthalat, Diisobutyl phthalate Diisobutyl phthalate, dibutyl phthalate, isobutylcyclohexyl phthalate, diisopentyl phthalate, butyl phthalate Benzyl ester (butyl benzylphthalate), diphenyl isophthalate (diphenyl isophthalate), diphenyl phthalate (diphenylphthalate), dihexyl phthalate (dihexyl phthalate), diisohexyl phthalate ( diisohexylphthalate), bis(4-methyl-2-pentyl)phthalate, dibenzyl phthalate, diheptyl phthalate Diisoheptyl phthalate, dinonyl phthalate, diundecyl phthalate and bis(2-ethylhexyl) adipate (bis(2-ethylhexyl) ) adipate).
所述的个人护理产品(Personal Care Products)类包括对羟基苯甲酸甲酯(methyl paraben)、对羟基苯甲酸丁酯(butyl Paraben)、对羟基苯甲酸苄酯(benzylParaben)、对羟基苯甲酸乙酯(ethylparaben)、对羟基苯甲酸丙酯(propylparaben)、正庚基对羟基苯甲酸酯(heptyl paraben)和三氯生(Triclosan)。The personal care products (Personal Care Products) include methyl paraben, butyl Paraben, benzyl Paraben, ethyl paraben Ethylparaben, Propylparaben, Heptylparaben and Triclosan.
所述的苯酚类化合物包括双酚类似物中的至少一种。The phenolic compound includes at least one of bisphenol analogues.
所述的双酚类似物包括双酚A(bisphenolA)、双酚E(bisphenol E)、双酚B(bisphenol B)、双酚C(bisphenol C)、双酚AF(bisphenol AF)、双酚F(bisphenol F)、双酚M(bisphenol M)、双酚P(bisphenol P)、双酚G(bisphenol G)、双酚Z(bisphenol Z)、双酚S(bisphenol S)、双酚AP(bisphenol AP)、双酚BP(bisphenol BP)和双酚PH(bisphenol PH)。Described bisphenol analog includes bisphenol A (bisphenol A), bisphenol E (bisphenol E), bisphenol B (bisphenol B), bisphenol C (bisphenol C), bisphenol AF (bisphenol AF), bisphenol F (bisphenol F), bisphenol M (bisphenol M), bisphenol P (bisphenol P), bisphenol G (bisphenol G), bisphenol Z (bisphenol Z), bisphenol S (bisphenol S), bisphenol AP (bisphenol AP), bisphenol BP (bisphenol BP) and bisphenol PH (bisphenol PH).
所述的紫外稳定剂(UV)包括苯甲酮类、苯并噻唑类、苯并三唑类以及其他类别的紫外稳定剂中的至少一种。The ultraviolet stabilizer (UV) includes at least one of benzophenones, benzothiazoles, benzotriazoles and other types of ultraviolet stabilizers.
所述的苯甲酮类紫外稳定剂(Benzophenone UV stabilizers)包括2,4-二羟基二苯甲酮(2,4-dihydroxybenzophenone)、2,2',4,4'-四羟基二苯甲酮(2,2',4,4'-tetrahydroxybenzophenone)、2-羟基-4-甲氧基苯并苯酮(2-hydroxy-4-methoxybenzophenone)、2-羟基-4-甲氧基-5-磺酸二苯甲酮(2-hydroxy-4-methoxybenzophenone-5-sulfonicacid hydrate)、2,2'-二羟基-4,4'-二甲氧基二苯甲酮(2,2'-dihydroxy-4,4'-dimethoxybenzophenone)、2,2'-羟基-4-甲氧基二苯甲酮(2,2’-dihydroxy-4-methoxybenzophenone)、4-羟基二苯甲酮(4-hydroxybenzophenone)和2,3,4-三羟基二苯甲酮(2,3,4-trihydroxybenzophenone)。Described benzophenone UV stabilizers (Benzophenone UV stabilizers) include 2,4-dihydroxybenzophenone (2,4-dihydroxybenzophenone), 2,2',4,4'-tetrahydroxybenzophenone (2,2',4,4'-tetrahydroxybenzophenone), 2-hydroxy-4-methoxybenzophenone (2-hydroxy-4-methoxybenzophenone), 2-hydroxy-4-methoxybenzophenone-5-sulfone Acid benzophenone (2-hydroxy-4-methoxybenzophenone-5-sulfonic acid hydrate), 2,2'-dihydroxy-4,4'-dimethoxybenzophenone (2,2'-dihydroxy-4 ,4'-dimethoxybenzophenone), 2,2'-hydroxy-4-methoxybenzophenone (2,2'-dihydroxy-4-methoxybenzophenone), 4-hydroxybenzophenone (4-hydroxybenzophenone) and 2 ,3,4-trihydroxybenzophenone (2,3,4-trihydroxybenzophenone).
所述的苯并噻唑类紫外稳定剂(Benzothiazoles UV stabilizers)包括2-甲基苯并噻唑(2-methylbenzothiazole)、2-苯并噻唑基-N-吗啉基硫醚(2-(morpholinothio)-benzothiazole)、2-甲硫基苯并噻唑(2-(methylthio)benzothiazole)、2-氨基苯并噻唑(2-aminobenzothiazole)和2-羟基苯并噻唑(2-hydroxybenzothiazole)。Described benzothiazole UV stabilizers (Benzothiazoles UV stabilizers) include 2-methylbenzothiazole (2-methylbenzothiazole), 2-benzothiazolyl-N-morpholinothioether (2-(morpholinothio)- benzothiazole), 2-(methylthio)benzothiazole), 2-aminobenzothiazole and 2-hydroxybenzothiazole.
所述的苯并三唑类紫外稳定剂(benzotriazoles UV stabilizers)包括1-羟基苯并三唑(1-hydroxy benzotriazole)、5-甲基苯并三氮唑(5-methyl-1-hydrogenbenzotriazole)、5-氯代苯并三氮唑(5-chloro-1-hydrogenbenzotriazole)、4-甲基-1-氢苯并三唑(4-methyl-1H-benzotriazole)、2-(2'-羟基-5'-甲基苯基)苯并三唑(2-(2-Hydroxy-5-methylphenyl)benzotriazole)、2-(5-叔丁基-2-羟苯基)苯并三唑(2-(5-tert-butyl-2-hydroxyphenyl)benzotriazole)和2-(2'-羟基-3',5'-二叔丁基苯基)-苯并三唑(2-(3,5-Di-tert-butyl-2-hydroxyphenyl)2H-benzotriazole)。Described benzotriazole UV stabilizers (benzotriazoles UV stabilizers) include 1-hydroxybenzotriazole (1-hydroxybenzotriazole), 5-methyl-1-hydrogenbenzotriazole (5-methyl-1-hydrogenbenzotriazole), 5-chlorobenzotriazole (5-chloro-1-hydrogenbenzotriazole), 4-methyl-1-hydrobenzotriazole (4-methyl-1H-benzotriazole), 2-(2'-hydroxyl-5 '-Methylphenyl)benzotriazole (2-(2-Hydroxy-5-methylphenyl)benzotriazole), 2-(5-tert-butyl-2-hydroxyphenyl)benzotriazole (2-(5 -tert-butyl-2-hydroxyphenyl)benzotriazole) and 2-(2'-hydroxy-3',5'-di-tert-butylphenyl)-benzotriazole (2-(3,5-Di-tert- butyl-2-hydroxyphenyl) 2H-benzotriazole).
所述的其他类别紫外稳定剂(other UV stabilizers)包括4-叔丁基-4'-甲氧基二苯甲酰甲烷(4-tert-butyl-4’-methoxydibenzoylmethane)、4-甲基苄亚基樟脑(4-methylbenzylidene camphor)、甲氧基肉桂酸异戊酯(isoamyl4-methoxycinnamate)、2-氰基-3,3-二苯基丙烯酸异辛酯(2-ethylhexyl2-cyano-3,3-diphenyl-2-propenoate(liquid))、对二甲氨基苯甲酸异辛酯(octyl dimethyl-p-aminobenzoic acid)、对甲氧基肉桂酸辛酯(Ethylhexyl methoxycinnamate)、2-(2H-苯并三唑-2-基)-4,6-双(1-甲基-1-苯乙基)苯酚(2-(2H-benzotriazol-2-yl)-4,6-bis(1-methyl-1-phenylethyl)phenol)、2,4-二叔丁基-6-(5-氯-2H-苯并三唑-2-基)苯酚(2,4-Di-tert-butyl-6-(5-chloro-2H-benzotriazol-2-yl)phenol)和2-(2H-苯并三唑-2-基)-4,6-二叔戊基苯酚(2-(2H-benzotriazol-2-yl)-4,6-di-tert-pentylphenol)。The other UV stabilizers (other UV stabilizers) include 4-tert-butyl-4'-methoxydibenzoylmethane (4-tert-butyl-4'-methoxydibenzoylmethane), 4-methylbenzylidene 4-methylbenzylidene camphor, isoamyl4-methoxycinnamate, isooctyl 2-cyano-3,3-diphenylacrylate (2-ethylhexyl2-cyano-3,3- diphenyl-2-propenoate(liquid)), octyl dimethyl-p-aminobenzoic acid, Ethylhexyl methoxycinnamate, 2-(2H-benzotriazole -2-yl)-4,6-bis(1-methyl-1-phenylethyl)phenol (2-(2H-benzotriazol-2-yl)-4,6-bis(1-methyl-1-phenylethyl )phenol), 2,4-di-tert-butyl-6-(5-chloro-2H-benzotriazol-2-yl)phenol (2,4-Di-tert-butyl-6-(5-chloro- 2H-benzotriazol-2-yl)phenol) and 2-(2H-benzotriazol-2-yl)-4,6-di-tert-amylphenol (2-(2H-benzotriazol-2-yl)-4, 6-di-tert-pentylphenol).
所述的光引发剂(photoinitiatorAdditives)包括苯甲酮(benzophenone)、4-甲基二苯甲酮(4-methylbenzophenone)、1-羟基环己基苯基甲酮(1-hydroxycyclohexylphenyl ketone)、4-苯基二苯甲酮(4-phenylbenzophenone/4-benzoylbiphenyl)、1,2-二苯基-1,2-乙二酮(1,2-diphenyl-1,2-ethanedione)、2-乙基蒽醌(2-ethylanthraquinone)、邻苯甲酰苯甲酸甲酯(methyl-2-(benzoyl)benzoate)、2,2-二甲氧基-2-苯基苯乙酮(2,2-dimethoxy-2-phenylacetophenone)、对二甲氨基二苯甲酮(4-(dimethylamino)benzophenone)、4,4'-双(二甲氨基)二苯甲酮(4,4'-bis(dimethylamino)benzophenone)、4,4'-双(二乙氨基)二苯甲酮(4,4'-bis(diethylamino)benzophenone)、4-氨基苯甲酸乙酯(ethyl-4-aminobenzoate)、4-二甲氨基苯甲酸乙酯(ethyl-4-dimethylaminobenzoate)、2-异丙基噻吨酮(2-isopropylthioxanthone)和2,4-二乙基噻吨酮(2,4-diethylthioxanthone/2,4-diethyl-9H-thioxanthen-9-one)。Described photoinitiator (photoinitiatorAdditives) comprises benzophenone (benzophenone), 4-methylbenzophenone (4-methylbenzophenone), 1-hydroxycyclohexylphenyl ketone (1-hydroxycyclohexylphenyl ketone), 4-phenyl 4-phenylbenzophenone/4-benzoylbiphenyl, 1,2-diphenyl-1,2-ethanedione (1,2-diphenyl-1,2-ethanedione), 2-ethylanthraquinone (2-ethylanthraquinone), methyl-2-(benzoyl)benzoate (methyl-2-(benzoyl)benzoate), 2,2-dimethoxy-2-phenylacetophenone (2,2-dimethoxy-2- phenylacetophenone), p-dimethylaminobenzophenone (4-(dimethylamino)benzophenone), 4,4'-bis(dimethylamino)benzophenone (4,4'-bis(dimethylamino)benzophenone), 4, 4'-bis(diethylamino)benzophenone (4,4'-bis(diethylamino)benzophenone), 4-aminobenzoic acid ethyl ester (ethyl-4-aminobenzoate), 4-dimethylaminobenzoic acid ethyl ester (ethyl-4-dimethylaminobenzoate), 2-isopropylthioxanthone (2-isopropylthioxanthone) and 2,4-diethylthioxanthone (2,4-diethylthioxanthone/2,4-diethyl-9H-thioxanthen-9 -one).
所述的抗氧化剂(antioxidants)包括在正离子检测模式和负离子检测模式下进行检测的抗氧化剂。The antioxidants (antioxidants) include antioxidants detected in positive ion detection mode and negative ion detection mode.
所述的在负离子检测模式下进行检测的抗氧化剂包括3-叔丁基-4-羟基茴香醚(3-tert-butyl-4-hydroxyanisole)、3,5-二叔丁基-4-羟基苯甲醛(3,5-di-tert-butyl-4-hydroxybenzaldehyde)、3,5-二叔丁基-4-羟基苯甲酸(3,5-di-tert-butyl-4-hydroxybenzoic acid)、2,6-二叔丁基-4-(羟甲基)苯酚(2,6-di-tert-butyl-4-(hydroxymethyl)phenol)、2,4-二叔丁基苯酚(2,4-di-tert-butylphenol)、4,4'-亚丁基双(6-叔丁基-间甲酚)(4,4'-butylidenebis(6-tert-butyl-m-cresol))、4-(1,1,3,3-四甲基丁基)苯酚(4-(1,1,3,3-tetra-methylbutyl)phenol)、2,2'-亚甲基双(4-乙基-6-叔丁基苯酚)(2,2'-methylenebis(4-ethyl-6-tert-butylphenol))、2,2'-亚甲基双(6-叔丁基-4-甲基苯酚)(2,2'-methylenebis(6-tert-butyl-4-methylphenol))、二乙基-3,5-二叔丁基-4-羟基苄基膦酸酯(diethyl-3,5-Di-tert-butyl-4-hydroxybenzylphosphonate)、2,2'-硫代双(6-叔丁 基-对甲酚)(2,2'-thiobis(6-tert-butyl-p-cresol))、1,2-双(3,5-二叔丁基-4-羟基氢化肉桂酰基)肼(1,2-bis(3,5-di-tert-butyl-4-hydroxyhydrocinnamoyl)hydrazine)和4,4'-硫代双(6-叔丁基-间甲酚)(4,4'-thiobis(6-tert-butyl-m-cresol))。The antioxidants detected under negative ion detection mode include 3-tert-butyl-4-hydroxyanisole (3-tert-butyl-4-hydroxyanisole), 3,5-di-tert-butyl-4-hydroxybenzene Formaldehyde (3,5-di-tert-butyl-4-hydroxybenzoic acid), 3,5-di-tert-butyl-4-hydroxybenzoic acid (3,5-di-tert-butyl-4-hydroxybenzoic acid), 2, 6-di-tert-butyl-4-(hydroxymethyl)phenol (2,6-di-tert-butyl-4-(hydroxymethyl)phenol), 2,4-di-tert-butylphenol (2,4-di- tert-butylphenol), 4,4'-butylene bis(6-tert-butyl-m-cresol) (4,4'-butylidenebis(6-tert-butyl-m-cresol)), 4-(1,1 ,3,3-tetramethylbutyl)phenol (4-(1,1,3,3-tetra-methylbutyl)phenol), 2,2'-methylenebis(4-ethyl-6-tert-butyl phenylphenol) (2,2'-methylenebis(4-ethyl-6-tert-butylphenol)), 2,2'-methylene bis(6-tert-butyl-4-methylphenol) (2,2' -methylenebis(6-tert-butyl-4-methylphenol)), diethyl-3,5-di-tert-butyl-4-hydroxybenzyl phosphonate (diethyl-3,5-Di-tert-butyl-4 -hydroxybenzylphosphonate), 2,2'-thiobis(6-tert-butyl-p-cresol) (2,2'-thiobis(6-tert-butyl-p-cresol)), 1,2-bis(3 ,5-di-tert-butyl-4-hydroxyhydrocinnamoyl)hydrazine (1,2-bis(3,5-di-tert-butyl-4-hydroxyhydrocinnamoyl)hydrazine) and 4,4'-thiobis(6 -tert-butyl-m-cresol) (4,4'-thiobis(6-tert-butyl-m-cresol)).
所述的在正离子检测模式下进行检测的抗氧化剂包括1,3-二邻甲苯胍(1,3-di-o-tolylguanidine)、1,3-二苯基-2-硫脲(1,3-diphenyl-2-thiourea)、2,2'-亚乙基-双(4,6-二叔丁基苯酚)(2,2'-ethylidene-bis(4,6-di-tert-butylphenol))、甲基-2-巯基苯并咪唑(methyl-2-mercaptobenzimidazole)、11-甲基十二烷基3-[4-羟基-3,5-双(2-甲基-2-丙烷基)苯基]丙酸酯(11-Methyldodecyl3-[4-hydroxy-3,5-bis(2-methyl-2-propanyl)phenyl]propanoate)、二苄基羟胺(dibenzylhydroxylamine)、三(4-叔丁基-3-羟基-2,6-二甲基苄基)异氰脲酸酯(Tris(4-tert-butyl-3-hydroxy-2,6-dimethylbenzyl)isocyanurate)、1,3,5-三甲基-2,4,6-三(3,5-二叔丁基-4-羟基苄基)苯(1,3,5-trimethyl-2,4,6-tris(3,5-di-tert-butyl-4-hydroxybenzyl)benzene)、2,6-二叔丁基-4-(二甲氨基-甲基)苯酚(2,6-Di-tert-butyl-4-(dimethylamino-methyl)phenol)、三(2,4-二叔丁基苯基)亚磷酸酯(tris(2,4-ditert-butylphenyl)phosphite)、磺基二基二-2,1-乙二基双[3-(4-羟基-3,5-双(2-甲基-2-丙烷基)苯基)丙酸酯](Sulfanediyldi-2,1-ethanediylbis[3-(4-hydroxy-3,5-bis(2-methyl-2-propanyl)phenyl)propanoate])、2,2'-硫代双(6-叔丁基-对甲酚)、N,N'-1,6-己二基双[3-[4-羟基-3,5-双(2-甲基-2-丙烷基)苯基]丙酰胺](N,N'-1,6-Hexanediylbis[3-[4-hydroxy-3,5-bis(2-methyl-2-propanyl)phenyl]propanamide])、1,2-乙二基双(氧-2,1-乙二基)双[3-[4-羟基-3-甲基-5-(2-甲基-2-丙烷基)苯基]丙酸酯](1,2-Ethanediylbis(oxy-2,1-ethanediyl)bis[3-[4-hydroxy-3-methyl-5-(2-methyl-2-propanyl)phenyl]propanoate])、1,6-己二基双[3-[4-羟基-3,5-双(2-甲基-2-丙烷基)苯基]丙酸酯](1,6-Hexanediylbis[3-[4-hydroxy-3,5-bis(2-methyl-2-propanyl)phenyl]propanoate])、4-[[4,6-双(辛基硫烷基)-1,3,5-三嗪-2-基]氨基]-2,6-二叔丁基苯酚(4-[[4,6-bis(octylsulfanyl)-1,3,5-triazin-2-yl]amino]-2,6-ditert-butylphenol)、n-苯基-1-萘胺(n-phenyl-1-naphthylamine)、双[4-(2-苯基-2-丙基)苯基]胺(bis[4-(2-phenyl-2-propyl)phenyl]amine)、N,N'-二苯基-1,4-苯二胺(N,N'-Diphenyl-1,4-benzenediamine)、(1,2-二氧代-1,2-乙二基)双(亚氨基-2,1-乙二基)双[3-[4-羟基-3,5-双(2-甲基-2-丙烷基)苯基]丙酸酯]((1,2-Dioxo-1,2-ethanediyl)bis(imino-2,1-ethanediyl)bis[3-[4-hydroxy-3,5-bis(2-methyl-2-propanyl)phenyl]propanoate])、N,N'-二乙基硫脲(N,N'-diethylthiourea)和1,3-二苯基胍(1,3-Diphenylguanidine)。The antioxidants detected under the positive ion detection mode include 1,3-di-o-tolylguanidine (1,3-di-o-tolylguanidine), 1,3-diphenyl-2-thiourea (1, 3-diphenyl-2-thiourea), 2,2'-ethylene-bis(4,6-di-tert-butylphenol) (2,2'-ethylene-bis(4,6-di-tert-butylphenol) ), methyl-2-mercaptobenzimidazole (methyl-2-mercaptobenzimidazole), 11-methyldodecyl 3-[4-hydroxyl-3,5-bis(2-methyl-2-propanyl) Phenyl]propanoate (11-Methyldodecyl3-[4-hydroxy-3,5-bis(2-methyl-2-propanyl)phenyl]propanoate), dibenzylhydroxylamine, tri(4-tert-butyl -3-hydroxy-2,6-dimethylbenzyl)isocyanurate (Tris(4-tert-butyl-3-hydroxy-2,6-dimethylbenzyl)isocyanurate), 1,3,5-trimethyl Base-2,4,6-tris(3,5-di-tert-butyl-4-hydroxybenzyl)benzene (1,3,5-trimethyl-2,4,6-tris(3,5-di-tert -butyl-4-hydroxybenzyl)benzene), 2,6-di-tert-butyl-4-(dimethylamino-methyl)phenol (2,6-Di-tert-butyl-4-(dimethylamino-methyl)phenol) , Tris (2,4-ditert-butylphenyl) phosphite (tris (2,4-ditert-butylphenyl) phosphite), sulfodi-2,1-ethylenediylbis[3-(4 -Hydroxy-3,5-bis(2-methyl-2-propanyl)phenyl)propionate](Sulfanediyldi-2,1-ethanediylbis[3-(4-hydroxy-3,5-bis(2- methyl-2-propanyl)phenyl)propanoate]), 2,2'-thiobis(6-tert-butyl-p-cresol), N,N'-1,6-hexanediylbis[3-[4 -Hexanediylbis[3-[4-hydroxy-3,5-bis( 2-methyl-2-propanyl)phenyl]propanamide]), 1,2-ethanediylbis(oxygen-2,1-ethanediyl)bis[3-[4- Hydroxy-3-methyl-5-(2-methyl-2-propanyl)phenyl]propionate](1,2-Ethanediylbis(oxy-2,1-ethanediyl)bis[3-[4-hydroxy -3-methyl-5-(2-methyl-2-propanyl)phenyl]propanoate]), 1,6-hexanediylbis[3-[4-hydroxy-3,5-bis(2-methyl-2 -Propanyl)phenyl]propanoate](1,6-Hexanediylbis[3-[4-hydroxy-3,5-bis(2-methyl-2-propanyl)phenyl]propanoate]), 4-[[4 ,6-bis(octylsulfanyl)-1,3,5-triazin-2-yl]amino]-2,6-di-tert-butylphenol (4-[[4,6-bis(octylsulfanyl) -1,3,5-triazin-2-yl]amino]-2,6-ditert-butylphenol), n-phenyl-1-naphthylamine (n-phenyl-1-naphthylamine), bis[4-(2 -Phenyl-2-propyl)phenyl]amine (bis[4-(2-phenyl-2-propyl)phenyl]amine), N,N'-diphenyl-1,4-phenylenediamine (N ,N'-Diphenyl-1,4-benzenediamine), (1,2-dioxo-1,2-ethanediyl)bis(imino-2,1-ethanediamine)bis[3-[4- Hydroxy-3,5-bis(2-methyl-2-propanyl)phenyl]propionate]((1,2-Dioxo-1,2-ethanediyl)bis(imino-2,1-ethanediyl)bis [3-[4-hydroxy-3,5-bis(2-methyl-2-propanyl)phenyl]propanoate]), N,N'-diethylthiourea (N,N'-diethylthiourea) and 1,3 - Diphenylguanidine (1,3-Diphenylguanidine).
所述的增塑剂(plasticizers)包括丁二酸二乙酯(diethyl succinate)、己二酸二甲酯(dimethyl adipate)、己二酸二乙酯(diethyl adipate)、壬二酸二甲酯(dimethylazelate)、2,2,4-三甲基-1,3-戊二醇二异丁酸酯(2,2,4-trimethyl-1,3-pentanediol-diisobutyrate)、富马酸二丁酯(dibutyl fumarate)、癸二酸二甲酯(dimethylsebacate)、肉豆蔻酸异丙酯(isopropyl myristate)、柠檬酸三乙酯(Triethyl citrate)、二甘醇二苯甲酸酯(Diethylene glycol dibenzoate)、癸二酸二丁酯(dibutylsebacate)、棕榈酸异丙酯(Isopropyl palmitate)、乙酰柠檬酸三乙酯(Acetyl triethylcitrate)、油酸丙酯(n-Propyl oleate)、马来酸二(2-乙基己基)酯(Di(2-ethylhexyl)maleate)、二苯甲酸二聚丙二醇酯(Oxydipropyl dibenzoate)、甘油单油酸酯(Glycerolmonooleate)、 壬二酸二己酯(Di-n-hexyl azelate)、硬脂酸甘油酯(Glycerolmonostearate)、柠檬酸三丁酯(Tributyl citrate)、(Z)-油酸-2-四氢呋喃甲酯(Tetrahydrofurfuryl oleate)、12-乙酰氧基-[R-(Z)]-9-烯-十八酸丁酯(n-Butylacetyl ricinoleate)、壬二酸二异辛酯(Diisooctyl azelate)、乙酰柠檬酸三正丁酯(acetyl tri-n-butyl citrate)、癸二酸二异辛酯(2-Ethylhexyl sebacate)、丁酰柠檬酸三正己酯(n-Butyryltri-n-hexyl citrate)、己二酸庚基壬基酯(di(n-heptyl,n-nonyl)adipate)、己二酸二丁酯(dibutyl adipate)、己二酸二异癸烷基酯(diisodecyladipate)、环己烷1,2-二甲酸二异壬基酯(di-isononyl cyclohexane-1,2-dicarboxylate)和偏苯三酸三辛酯(trioctyl trimellitate)。Described plasticizer (plasticizers) comprises diethyl succinate (diethyl succinate), dimethyl adipate (dimethyl adipate), diethyl adipate (diethyl adipate), dimethyl azelate ( dimethylazelate), 2,2,4-trimethyl-1,3-pentanediol diisobutyrate (2,2,4-trimethyl-1,3-pentanediol-diisobutyrate), dibutyl fumarate ( dibutyl fumarate), dimethylsebacate, isopropyl myristate, triethyl citrate, diethylene glycol dibenzoate, decyl Dibutylsebacate, Isopropyl palmitate, Acetyl triethylcitrate, n-Propyl oleate, Di(2-ethyl maleate) Hexyl) ester (Di(2-ethylhexyl) maleate), dipropylene glycol dibenzoate (Oxydipropyl dibenzoate), glycerol monooleate (Glycerolmonooleate), di-n-hexyl azelate (Di-n-hexyl azelate), hard Glycerolmonostearate, Tributyl citrate, (Z)-oleic acid-2-tetrahydrofurfuryl oleate, 12-acetoxy-[R-(Z)]-9 -ene-butyl octadecanoate (n-Butylacetyl ricinoleate), diisooctyl azelate (Diisooctyl azelate), acetyl tri-n-butyl citrate (acetyl tri-n-butyl citrate), diisooctyl sebacate 2-Ethylhexyl sebacate, n-Butyryltri-n-hexyl citrate, di(n-heptyl,n-nonyl) adipate, di(n-heptyl,n-nonyl) adipate dibutyl adipate, diisodecyl adipate, di-isononyl cyclohexane-1,2-dicarbox ylate) and trioctyl trimellitate.
所述的全氟化合物包括全氟正辛酸(Perfluoro-n-octanoic acid)、全氟辛烷磺酸(perfluorooctane sulfonic acid)、全氟正丁酸(Perfluoro-n-butanoic acid)、全氟正庚酸(Perfluoro-n-heptanoic acid)、全氟正己酸(Perfluoro-n-hexanoic acid)、全氟正癸酸(Perfluoro-n-decanoic acid)、全氟正十二烷酸(Perfluoro-n-dodecanoicacid)、全氟正壬酸(Perfluoro-n-nonanoic acid)、全氟正十一烷酸(Perfluoro-n-undecanoic acid)、全氟正戊酸(Perfluoro-n-pentanoic acid)、全氟正十四烷酸(Perfluoro-n-tetradecanoic acid)、全氟正十三烷酸(Perfluoro-n-tridecanoicacid)、全氟-1-丁烷磺酸钾(Potassium perfluoro-1-butanesulfonate)、全氟-1-癸烷磺酸钠(Sodium perfluoro-1-decanesulfonate)、全氟-1-庚烷磺酸钠(Sodium perfluoro-1-heptanesulfonate)、全氟-1-己磺酸钠(Sodium perfluoro-1-hexanesulfonate)、全氟-1-辛烷磺酰胺(Perfluoro-1-octanesulfonamide)、N-甲基全氟-1-辛磺酰胺(N-methylperfluoro-1-octansulfonamide)、N-乙基全氟-1-辛烷磺酰胺(N-ethylperfluoro-1-octanesulfonamide)、1H,1H,2H,2H-全氟己烷磺酸钠(4:2)(Sodium1H,1H,2H,2H-perfluorohexane sulfonate(4:2))、1H,1H,2H,2H-全氟辛烷磺酸钠(6:2)(Sodium1H,1H,2H,2H-perfluorooctane sulfonate(6:2))、1H,1H,2H,2H-全氟癸烷磺酸钠(8:2)(Sodium1H,1H,2H,2H-perfluorodecane sulfonate(8:2))、氯十六烷-氟-3-氧杂戊烷-1-磺酸钾(Potassium9-chlorohexadeca-fluoro-3-oxanonane-1-sulfonate)、11-氯二十碳氟-3-氧十一烷-1-磺酸钾(Potassium11-chloroeicosafluoro-3-oxaundecane-1-sulfonate)和全氟-2,5-二甲基-3,6-二恶烷酸(perfluoro-2,5-dimethyl-3,6-dioxanonanoic acid)。The perfluorinated compounds include perfluoron-octanoic acid (Perfluoro-n-octanoic acid), perfluorooctane sulfonic acid (perfluorooctane sulfonic acid), perfluoron-butanoic acid (Perfluoro-n-butanoic acid), perfluoron-heptyl Perfluoro-n-heptanoic acid, Perfluoro-n-hexanoic acid, Perfluoro-n-decanoic acid, Perfluoro-n-dodecanoic acid ), Perfluoro-n-nonanoic acid, Perfluoro-n-undecanoic acid, Perfluoro-n-pentanoic acid, Perfluoro-n-decanoic acid Perfluoro-n-tetradecanoic acid, Perfluoro-n-tridecanoic acid, Potassium perfluoro-1-butanesulfonate, Perfluoro-1 -Sodium perfluoro-1-decanesulfonate, Sodium perfluoro-1-heptanesulfonate, Sodium perfluoro-1-hexanesulfonate ), Perfluoro-1-octanesulfonamide, N-methylperfluoro-1-octansulfonamide, N-ethyl perfluoro-1- Octanesulfonamide (N-ethylperfluoro-1-octanesulfonamide), 1H,1H,2H,2H-perfluorohexane sulfonate (4:2) (Sodium1H,1H,2H,2H-perfluorohexane sulfonate(4:2) ), 1H,1H,2H,2H-sodium perfluorooctane sulfonate (6:2) (Sodium1H,1H,2H,2H-perfluorooctane sulfonate(6:2)), 1H,1H,2H,2H-perfluorooctane Sodium decane sulfonate (8:2) (Sodium1H,1H,2H,2H-perfluorodecane sulfonate(8:2)), chlorohexadecane-fluoro -3-oxapentane-1-sulfonate potassium (Potassium9-chlorohexadeca-fluoro-3-oxanonane-1-sulfonate), 11-chloroeicosane-3-oxoundecane-1-sulfonate potassium ( Potassium11-chloroeicosafluoro-3-oxaundecane-1-sulfonate) and perfluoro-2,5-dimethyl-3,6-dioxane acid (perfluoro-2,5-dimethyl-3,6-dioxanonanoic acid).
所述的有机磷农药包括毒死蜱(dursban/chlorpyrifos)、二嗪农(diazinon)、甲基对硫磷(parathion-methyl)、对硫磷(parathion)、马拉硫磷(malathion)、乐果(dimethoate)、敌敌畏(dichlorvos)、3-甲基-4-硝基苯酚(3-methyl-4-nitrophenol)、香豆磷(coumaphos)、二恶唑磷(dioxabenzofos)、杀灭磷(edifenphos)、2-异丙基-6-甲基-4-嘧啶醇(2-isopropyl-6-methyl-4-pyrimidinol)、异灭磷(isofenphos-methyl)、美卡巴姆(mecarbam)、杀虫剂(methacrifos)、磷酮(phosalone)、吡唑磷(pyrazophos)和对硝基苯酚(p-Nitrophenol)。The organophosphorus pesticides include chlorpyrifos (dursban/chlorpyrifos), diazinon (diazinon), methyl parathion (parathion-methyl), parathion (parathion), malathion (malathion), dimethoate ( dimethoate), dichlorvos (dichlorvos), 3-methyl-4-nitrophenol (3-methyl-4-nitrophenol), coumaphos, dioxabenzofos, edifenphos, 2-isopropyl-6-methyl-4-pyrimidinol (2-isopropyl-6-methyl-4-pyrimidinol), isofenphos-methyl, mecarbam, insecticides (methacrifos ), phosalone, pyrazophos and p-Nitrophenol.
所述的拟除虫菊酯包括3-苯氧基苄醇(3-PBA)、4-氟-3-苯氧基苯甲酸(4-fluoro-3-phenoxy benzoic acid)、顺-3-(2-氯-3,3,3-三氟-1-丙烯基)-2,2-二甲基-环丙烷羧酸(cis-3-(2-chloro-3,3,3-trifluoro-1-propenyl)-2,2-dimethyl-cyclopropanecarbox ylic acid)和高效氯氟氰菊酯(Lambda-cyhalothrin)。Described pyrethroids include 3-phenoxybenzyl alcohol (3-PBA), 4-fluoro-3-phenoxybenzoic acid (4-fluoro-3-phenoxybenzoic acid), cis-3-(2- Chloro-3,3,3-trifluoro-1-propenyl)-2,2-dimethyl-cyclopropanecarboxylic acid (cis-3-(2-chloro-3,3,3-trifluoro-1-propenyl )-2,2-dimethyl-cyclopropanecarbox ylic acid) and Lambda-cyhalothrin.
所述的新烟碱类农药包括啶虫脒(Acetamiprid)、呋虫胺(Dinotefuran)、吡虫啉(Imidacloprid)、噻虫啉(Thiacloprid)和噻虫嗪(Thiamethoxam)。The neonicotinoid pesticides include Acetamiprid, Dinotefuran, Imidacloprid, Thiacloprid and Thiamethoxam.
所述的氨基甲酸酯类农药包括多菌灵(Carbendazim)、呋喃丹 (Carbofuran)、氯丙胺(Chlorpropham)、非诺威(Fenobucarb)、异威威(Iprovalicarb)、灭多威(Methomyl)、抗蚜威(Pirimicarb)和苯胺灵(Propham)。The carbamate pesticides include Carbendazim, Carbofuran, Chlorpropham, Fenobucarb, Iprovalicarb, Methomyl, anti Pirimicarb and Propham.
所述的酸性除草剂包括2,4-二氯苯氧丁酸(2,4-DB)、2,4,5-涕丙酸(2,4,5-TP(Silvex))、2,4,5-三氯苯氧乙酸(2,4,5-trichlorophenoxyacetic acid)、2,4-滴丙酸(Dichlorprop)、2-甲基-4-氯苯氧乙酸(MCPA)、2-甲基-4-氯戊氧基丙酸(Mecoprop)和2-甲基-4-氯苯氧基丁酸(MCPB)。The acidic herbicides include 2,4-dichlorophenoxybutyric acid (2,4-DB), 2,4,5-propionic acid (2,4,5-TP (Silvex)), 2,4 ,5-trichlorophenoxyacetic acid (2,4,5-trichlorophenoxyacetic acid), 2,4-dichlorprop, 2-methyl-4-chlorophenoxyacetic acid (MCPA), 2-methyl- 4-chloropentyloxypropionic acid (Mecoprop) and 2-methyl-4-chlorophenoxybutyric acid (MCPB).
所述的唑类农药包括联苯三唑醇(Bitertanol)、环唑醇(Cyproconazole)、苯醚甲环唑(Difenoconazole)、氟环唑(Epoxiconazole)、芬布康唑(Fenbuconazole)、氟硅唑(Flusilazole)、抑菌灵(Imazalil)、丁苯胺(Myclobutanil)、戊康唑(Penconazole)、丙氯灵(Prochloraz)、戊唑醇(Tebuconazole)、四康唑(Tetraconazole)和噻菌灵(Thiabendazole)。The azole pesticides include Bitertanol, Cyproconazole, Difenoconazole, Epoxiconazole, Fenbuconazole, Flusilazole (Flusilazole), Imazalil, Myclobutanil, Penconazole, Prochloraz, Tebuconazole, Tetraconazole, and Thiabendazole ).
所述的三唑酮类农药包括氯唑草酮(Chloridazon)、己嗪酮(Hexazinone)、苯嗪草酮(Metamitron)、嗪草酮(Metribuzin)、苯胺(ametryn)、阿特拉顿(atraton)、阿特拉津(atrazine)、扑灭通(prometon)、扑草净(prometryn)、扑灭津(propazine)、仲丁通(secbumeton)、西玛津(simazine)、西草净(simetryn)和特丁净(terbutryn/prenane)。The triadimefon pesticides include Chloridazon, Hexazinone, Metamitron, Metribuzin, Atryn, Atraton ), atrazine, prometon, prometryn, propazine, secbumeton, simazine, simetryn and Terbutryn/prenane.
所述的尿素类农药包括氯磺隆(Chloroxuron)、氯脲酮(Chlortoluron)、1-(3,4-二氯苯基)-3-甲基脲(1-(3,4-dichlorophenyl)-3-methylurea)、1-(3,5-二氯苯基)脲(DCPU)、甲基苯噻隆(Methabenzthiazuron)、溴谷隆(Metobromuron)、甲氧隆(Metoxuron)、敌草隆(Diuron)、3-苯基-1,1-二甲基脲(Fenuron)、异丙隆(Isoproturon)和利谷隆(Linuron)。The urea pesticides include Chloroxuron, Chlortoluron, 1-(3,4-dichlorophenyl)-3-methylurea (1-(3,4-dichlorophenyl)- 3-methylurea), 1-(3,5-dichlorophenyl)urea (DCPU), Methabenzthiazuron, Metobromuron, Metoxuron, Diuron ), 3-phenyl-1,1-dimethylurea (Fenuron), isoproturon (Isoproturon) and Linuron (Linuron).
所述的酰胺类农药包括甲草胺(Alachlor)、二甲草胺(Dimethachlor)、N,N-二甲基氨基-N-甲苯(DMST)和环酰菌胺(Fenhexamid)。The amide pesticides include Alachlor, Dimethachlor, N,N-dimethylamino-N-toluene (DMST) and Fenhexamid.
所述的甲氧基丙烯酸酯类杀菌剂包括嘧菌酯(Azoxystrobin)、嘧螨酯(Fluacrypyrim)、醚菌酯(Kresoxim-methyl)、吡唑醚菌酯(Pyraclostrobin)和肟菌酯(Trifloxystrobin)。The methoxyacrylate fungicides include Azoxystrobin, Fluacrypyrim, Kresoxim-methyl, Pyraclostrobin and Trifloxystrobin .
所述的其他杀虫剂包括氟担菌宁(Flutolanil)、啶酰菌胺(Boscalid)、恶唑菌酮(Famoxadone)、甲霜灵(Metalaxyl)、氟苯嘧啶醇(Nuarimol)和苄草丹(Prosulfocarb)。Other insecticides mentioned include Flutolanil, Boscalid, Famoxadone, Metalaxyl, Nuarimol, and procarbal (Prosulfocarb).
步骤(4)中所述的气相色谱-串联质谱法为采用气相色谱-串联质谱联用仪进行。The gas chromatography-tandem mass spectrometry described in step (4) is carried out by using gas chromatography-tandem mass spectrometry.
步骤(4)中所述的采用气相色谱-串联质谱法(GC-MS/MS)对环境污染物进行定量分析的污染物包括有机氯农药和液晶单体中的至少一种。The pollutants for quantitative analysis of environmental pollutants by gas chromatography-tandem mass spectrometry (GC-MS/MS) described in step (4) include at least one of organochlorine pesticides and liquid crystal monomers.
所述的有机氯农药包括二氯丙酸(Aldrin)、ALPHA-六六六(α-HCH)、BETA-六六六(β-HCH)、林丹(γ-HCH(lindane))、δ-六六六(δ-HCH)、Ε-六六六(ε-HCH)、顺式A-氯丹(cis-chlordane)、反式氯丹(trans-chlordane)、氧氯丹(oxy-chlordane)、4,4-滴滴滴(p.p′-DDD)、2,2-双(4-氯苯基)-1,1-二氯乙烯(p.p′-DDE)、2,2-双(对氯苯基)-1,1,1-三氯乙烷(p.p′-DDT)、1-(2-氯苯基)-1-(4-氯苯基)-2,2-二氯乙烷(o.p′-DDD)、3-邻氯苯基-2-对氯苯基-1,1-二氯乙烯溶液(o.p′-DDE)、1,1,1-三氯-2-(2-氯苯基)-2-(4-氯苯基)乙烷(o.p′-DDT)、狄氏剂(Dieldrin)、alpha-硫丹(α-Endosulfan)、BETA-硫丹(β-Endosulfan)、安特灵(Endrin)、异狄氏剂酮(Endrin ketone)、七氯(Heptachlor)、内环氧七氯(Heptachlor-exo-epoxide)、六氯苯(Hexachlorobenzene)和吡唑草胺(Metazachlor)。The organochlorine pesticides include dichloropropionic acid (Aldrin), ALPHA-666 (α-HCH), BETA-666 (β-HCH), Lindane (γ-HCH (lindane)), δ-6 66 (δ-HCH), Ε-666 (ε-HCH), cis-chlordane (cis-chlordane), trans-chlordane (trans-chlordane), oxy-chlordane (oxy-chlordane), 4,4-Didididi (p.p′-DDD), 2,2-bis(4-chlorophenyl)-1,1-dichloroethylene (p.p′-DDE), 2,2-bis(p-chlorobenzene base)-1,1,1-trichloroethane (p.p′-DDT), 1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane (o.p '-DDD), 3-o-chlorophenyl-2-p-chlorophenyl-1,1-dichloroethylene solution (o.p'-DDE), 1,1,1-trichloro-2-(2-chlorobenzene base)-2-(4-chlorophenyl)ethane (o.p′-DDT), Dieldrin, alpha-Endosulfan (α-Endosulfan), BETA-Endosulfan (β-Endosulfan), Antetra Endrin, Endrin ketone, Heptachlor, Heptachlor-exo-epoxide, Hexachlorobenzene and Metazachlor.
所述的液晶单体包括4-乙烯基-4'-丙基-1,1'-联环己烷(1-(4-propylcyclohexyl)-4-vinylcyclohexane)、1-甲氧基-4-(4-丙基环己基)环己烷(1-methoxy-4-(4-propylcyclohexy1)cyclohexane)、1-(丙-1-烯基)-4-(4-丙基环己基)环己烷(1-(prop-l-enyl)-4-(4-propylcyclohexyl)cyclohexane)、1-乙氧基-2,3-二氟-4-(4-丙基环己基)苯 (1-ethoxy-2,3-difluoro-4-(4-propylcyclohexyl)benzene)、4-甲基-4'-戊基联苯(4-methyl-4'-pentylbiphenyl)、1-乙氧基-2,3-二氟-4-(4-丙基苯基)苯(1-ethoxy-2,3-difluoro-4-(4-propylphenyl)benzene)、4-(4-乙基环己基)-4'-(三氟甲氧基)联苯(4-(4-ethylcyclohexyl)-4'-(tnfluoromethoxy)biphenyl)、4-(4-甲基苯基)-4'-乙烯基-1,1'-双(环己基)(4-(4-methylphenyl)-4'-vinyl-1,1'-bi(cyclohexyl))、4-[二氟(3,4,5-三氟苯氧基)甲基]-3,5-二氟-4'-丙基联苯(4-[difluoro(3,4,5-trifluorophenoxy)methyl]-3,5-difluoro-4'-propylbiphenyl)、1-甲基-4-(4-(4-丙基环己基)环己基)苯(1-methyl-4-(4-(4-propylcyclohexyl)cyclohexyl)benzene)、4-[二氟(2-甲基-3,4,5-三氟苯氧基)甲基]-3,5-二氟-4'-丙基联苯(4-[difluoro(2-methyl-3,4,5-trifluorophenoxy)methyl]-3,5-difluoro-4'-propylbi phenyl)、2,3-二氟-1-甲氧基-4-(4-(4-丙基环己基)环己基)苯(2,3-difluoro-l-methoxy-4-(4-(4-propylcyclohexyl)cyclohexyl)benzene)、l-乙基-4-(4-(4丙基环己基)苯基)苯(l-ethyl-4-(4-(4propylcyclohexyl)phenyl)benzene)、2,3-二氟-1-乙氧基-4-(4-(4-乙基环己基)苯基)苯(2,3-difluoro-1-ethoxy-4-(4-(4-ethylcyclohexyl)phenyl)benzene)、4"-乙基-2'-氟-4-丙基-l,l':4',1"-三联苯(4"-ethyl-2'-fluoro-4-propyl-l,l':4',1"-terphenyl)、(4-乙氧基-2,3-二氟-4'-(4-丙基环己基)联苯)(4-ethoxy-2,3-difluoro-4'-(4-propylcyclohexyl)biphenyl)、2,3-二氟-1-丙氧基-4-(4-(4-丙基环己基)环己基)苯(2,3-difluoro-l-propoxy-4-(4-(4-propylcyclohexyl)cyclohexyl)benzene)、1-(4-(4-丁基环己基)环己基)-4-乙氧基-2,3-二氟苯(1-(4-(4-butylcyclohexyl)cyclohexyl)-4-ethoxy-2,3-difluorobenzene)、4-丁基-4"-乙基-2'-氟-l,l':4',1"-三联苯(4-butyl-4"-ethyl-2'-fluoro-l,l':4',1"-terphenyl)、3,4-二氟-4'-[4'-乙基-1,1'-双(环己基)-4-基]联苯(3,4-difluoro-4'-[4'-ethyl-1,1'-bi(cyclohexyl)-4-yl]biphenyl)、3,4-二氟-4'-丙基-l,l'-联苯(3,4-difluoro-4'-propyl-l,l'-Biphenyl)、4'-乙基联苯-4-甲腈(4'-ethylbiphenyl-4-carbonitril)、4'-丙氧基-4-联苯甲腈(4'-propoxy-4-biphenylcarbonitrfle)、4-丙基1-4'-[4-(三氟甲氧基)苯基]-1,1'-双环己基(4-propy1-4'-[4-(trifluoromethoxy)phenyl]-1,1'-bicyclohexyl)、4"-乙基-2',3,4,5-四氟-1,1':4',1"-三联苯(4"-ethyl-2',3,4,5-tetrafluoro-1,1':4',1"-terphenyl)、4-氰基-4'-戊氧基联苯(4-cyano-4'-pentyloxybiphenyl)、4-己氧基-4-联苯甲腈(4-hexyloxy-4-biphenylcarbonitrile)和4'-(辛氧基)-4-联苯甲腈(4'-(octyloxy)-4-biphenylcarbonitrile)。The liquid crystal monomers include 4-vinyl-4'-propyl-1,1'-bicyclohexyl (1-(4-propylcyclohexyl)-4-vinylcyclohexane), 1-methoxy-4-( 4-propylcyclohexyl) cyclohexane (1-methoxy-4-(4-propylcyclohexyl)cyclohexane), 1-(prop-1-enyl)-4-(4-propylcyclohexyl)cyclohexane ( 1-(prop-l-enyl)-4-(4-propylcyclohexyl)cyclohexane), 1-ethoxy-2,3-difluoro-4-(4-propylcyclohexyl)benzene (1-ethoxy-2 ,3-difluoro-4-(4-propylcyclohexyl)benzene), 4-methyl-4'-pentyl biphenyl (4-methyl-4'-pentylbiphenyl), 1-ethoxy-2,3-difluoro -4-(4-propylphenyl)benzene (1-ethoxy-2,3-difluoro-4-(4-propylphenyl)benzene), 4-(4-ethylcyclohexyl)-4'-(trifluoro Methoxy)biphenyl (4-(4-ethylcyclohexyl)-4'-(tnfluoromethoxy)biphenyl), 4-(4-methylphenyl)-4'-vinyl-1,1'-bis(cyclohexyl )(4-(4-methylphenyl)-4'-vinyl-1,1'-bi(cyclohexyl)), 4-[difluoro(3,4,5-trifluorophenoxy)methyl]-3, 5-difluoro-4'-propylbiphenyl (4-[difluoro(3,4,5-trifluorophenoxy)methyl]-3,5-difluoro-4'-propylbiphenyl), 1-methyl-4-(4 -(4-propylcyclohexyl)cyclohexyl)benzene (1-methyl-4-(4-(4-propylcyclohexyl)cyclohexyl)benzene), 4-[difluoro(2-methyl-3,4,5- Trifluorophenoxy)methyl]-3,5-difluoro-4'-propylbiphenyl (4-[difluoro(2-methyl-3,4,5-trifluorophenoxy)methyl]-3,5-difluoro -4'-propylbi phenyl), 2,3-difluoro-1-methoxy-4-(4-(4-propylcyclohexyl)cyclohexyl)benzene (2,3-difluoro-l-methoxy-4 -(4-(4-propylcyclohexyl)cyclohexyl)benzene), l-ethyl-4-(4-(4propane ylcyclohexyl)phenyl)benzene (l-ethyl-4-(4-(4propylcyclohexyl)phenyl)benzene), 2,3-difluoro-1-ethoxy-4-(4-(4-ethylcyclo Hexyl)phenyl)benzene (2,3-difluoro-1-ethoxy-4-(4-(4-ethylcyclohexyl)phenyl)benzene), 4"-ethyl-2'-fluoro-4-propyl-l, l':4',1"-terphenyl (4"-ethyl-2'-fluoro-4-propyl-l,l':4',1"-terphenyl), (4-ethoxy-2,3 -Difluoro-4'-(4-propylcyclohexyl)biphenyl)(4-ethoxy-2,3-difluoro-4'-(4-propylcyclohexyl)biphenyl), 2,3-difluoro-1-propane Oxygen-4-(4-(4-propylcyclohexyl)cyclohexyl)benzene (2,3-difluoro-l-propoxy-4-(4-(4-propylcyclohexyl)cyclohexyl)benzene), 1-(4 -(4-butylcyclohexyl)cyclohexyl)-4-ethoxy-2,3-difluorobenzene (1-(4-(4-butylcyclohexyl)cyclohexyl)-4-ethoxy-2,3-difluorobenzene), 4 -Butyl-4"-ethyl-2'-fluoro-l,l':4',1"-terphenyl (4-butyl-4"-ethyl-2'-fluoro-l,l':4' ,1"-terphenyl), 3,4-difluoro-4'-[4'-ethyl-1,1'-bis(cyclohexyl)-4-yl]biphenyl (3,4-difluoro-4' -[4'-ethyl-1,1'-bi(cyclohexyl)-4-yl]biphenyl), 3,4-difluoro-4'-propyl-l,l'-biphenyl (3,4-difluoro -4'-propyl-l, l'-Biphenyl), 4'-ethylbiphenyl-4-carbonitrile (4'-ethylbiphenyl-4-carbonitril), 4'-propoxy-4-biphenylcarbonitrile (4'-propoxy-4-biphenylcarbonitrfle), 4-propyl 1-4'-[4-(trifluoromethoxy)phenyl]-1,1'-bicyclohexyl (4-propy1-4'-[ 4-(trifluoromethoxy)phenyl]-1,1'-bicyclohexyl), 4"-ethyl-2',3,4,5-tetrafluoro-1,1':4',1"-terphenyl (4" -ethyl-2',3,4,5-tetraflu oro-1,1':4',1"-terphenyl), 4-cyano-4'-pentyloxybiphenyl (4-cyano-4'-pentyloxybiphenyl), 4-hexyloxy-4-biphenyl Carbonitrile (4-hexyloxy-4-biphenylcarbonitrile) and 4'-(octyloxy)-4-biphenylcarbonitrile (4'-(octyloxy)-4-biphenylcarbonitrile).
步骤(4)中所述的液相色谱-串联质谱法的检测条件如下:The detection condition of the liquid chromatography-tandem mass spectrometry described in step (4) is as follows:
①邻苯二甲酸二酯类(Phthalate diesters):① Phthalate diesters:
色谱条件包括:Chromatographic conditions include:
流动相A:体积分数为0.1%的甲酸水溶液;Mobile phase A: 0.1% formic acid aqueous solution by volume fraction;
流动相B:甲醇;Mobile phase B: Methanol;
色谱柱:C18色谱柱(优选为:Luna 2.5μm C18(2)-HST 100×2.0mm);Chromatographic column: C18 chromatographic column (preferably: Luna 2.5μm C18(2)-HST 100×2.0mm);
流速:0.2mL/min;Flow rate: 0.2mL/min;
柱温:40℃;Column temperature: 40°C;
洗脱程序:初始流动相B的体积百分含量为40%;0~2min,流动相B体积百分数从40%上升至70%;2~8min,流动相B体积百分数上升至100%;8~13min保持在100%不变,13~13.1min流动相B体积百分数降 至40%;13.1~17min,保持在40%不变;Elution procedure: the initial volume percentage of mobile phase B is 40%; 0~2min, the volume percentage of mobile phase B rises from 40% to 70%; 2~8min, the volume percentage of mobile phase B rises to 100%; Keep at 100% for 13 minutes, the volume percentage of mobile phase B drops to 40% at 13-13.1 minutes; keep at 40% for 13.1-17 minutes;
质谱条件包括:电喷雾离子源,离子源温度为550℃;检测模式为正离子检测模式;Mass spectrometry conditions include: electrospray ionization source, ion source temperature is 550°C; detection mode is positive ion detection mode;
雾化气压:氮气,压力为55psi;Atomization pressure: nitrogen, the pressure is 55psi;
②邻苯二甲酸单酯类(Phthalate monoesters),苯甲酮类紫外线稳定剂(Benzophenone UV stabilizers),双酚类似物(Bisphenol analogues)以及个人护理产品(Personal Care Products):② Phthalate monoesters, Benzophenone UV stabilizers, Bisphenol analogues and Personal Care Products:
色谱条件包括:Chromatographic conditions include:
流动相A:0.2mmol/L乙酸铵水溶液;Mobile phase A: 0.2mmol/L ammonium acetate aqueous solution;
流动相B:甲醇;Mobile phase B: Methanol;
色谱柱:C18色谱柱(优选为:ZORBAX Extended-C18 3.5μm 100×2.1mm);Chromatographic column: C18 chromatographic column (preferably: ZORBAX Extended-C18 3.5μm 100×2.1mm);
流速:0.2mL/min;Flow rate: 0.2mL/min;
柱温:40℃;Column temperature: 40°C;
洗脱程序:初始流动相B的体积百分数为10%;0~0.5min保持在10%数不变;0.5~1min,流动相B体积百分数从10%上升至50%;1~7min,流动相B体积分数从50%上升至99%;7~10min,保持在99%不变;10~10.1min,从99%下降到10%,10.1~12min,流动相B体积分数保持在10%不变;Elution procedure: the volume percentage of the initial mobile phase B is 10%; 0-0.5min keeps the number constant at 10%; 0.5-1min, the volume percentage of the mobile phase B rises from 10% to 50%; B volume fraction increased from 50% to 99%; 7-10min, kept at 99%; 10-10.1min, decreased from 99% to 10%, 10.1-12min, mobile phase B volume fraction remained at 10% ;
质谱条件包括:电喷雾离子源,离子温度为550℃,检测模式为负离子检测模式;雾化气压:氮气,压力位55psi;Mass spectrometry conditions include: electrospray ion source, ion temperature is 550°C, detection mode is negative ion detection mode; atomization pressure: nitrogen, pressure 55psi;
③增塑剂(plasticizers),苯并噻唑类(Benzothiazoles UV stabilizers)、苯并三唑(benzotriazoles UV stabilizers)类和其他类别紫外稳定剂(other UVstabilizers),光引发剂(photoinitiatorAdditives)以及在正离子检测模式下进行检测的抗氧化剂:③Plasticizers (plasticizers), benzothiazoles (Benzothiazoles UV stabilizers), benzotriazoles (benzotriazoles UV stabilizers) and other UV stabilizers (other UVstabilizers), photoinitiatorAdditives and positive ion detection Antioxidants detected in the mode:
色谱条件包括:Chromatographic conditions include:
流动相A:体积分数为0.1%的甲酸水溶液;Mobile phase A: 0.1% formic acid aqueous solution by volume fraction;
流动相B:甲醇;Mobile phase B: Methanol;
色谱柱:C18色谱柱(优选为:Luna 2.5μm C18(2)-HST 100×2.0mm);Chromatographic column: C18 chromatographic column (preferably: Luna 2.5μm C18(2)-HST 100×2.0mm);
流速:0.3mL/min;Flow rate: 0.3mL/min;
柱温:40℃;Column temperature: 40°C;
洗脱程序:初始流动相B体积百分数为40%,0~2min保持40%不变;2~4min,流动相B体积百分数由40%上升至80%;4~14min,流动相B体积百分数从80%上升至100%;14~17min,流动相B体积百分数保持在100%不变;17~20min,流动相B体积百分数下降至40%,20~24min,流动相B体积百分数保持在40%不变;Elution procedure: initial mobile phase B volume percentage is 40%, 0-2min keeps 40% unchanged; 2-4min, mobile phase B volume percentage rises from 40% to 80%; 4-14min, mobile phase B volume percentage increases from 80% rises to 100%; 14-17min, the volume percentage of mobile phase B remains at 100%; 17-20min, the volume percentage of mobile phase B drops to 40%, 20-24min, the volume percentage of mobile phase B remains at 40% constant;
质谱条件包括:电喷雾离子源,离子温度为550℃,检测模式为正离子检测模式;雾化气压:氮气,压力位55psi;Mass spectrometry conditions include: electrospray ion source, ion temperature is 550°C, detection mode is positive ion detection mode; atomization pressure: nitrogen, pressure 55psi;
④有机磷酸三酯类(Organophosphate triesters):④Organophosphate triesters:
色谱条件包括:Chromatographic conditions include:
流动相A:体积分数为0.1%甲酸水溶液;Mobile phase A: a volume fraction of 0.1% formic acid in water;
流动相B:甲醇;Mobile phase B: Methanol;
色谱柱:RP18色谱柱(优选为:ACQUITY UPLC BEH Shield RP18,1.7μm,100×2.1mm);Chromatographic column: RP18 chromatographic column (preferably: ACQUITY UPLC BEH Shield RP18, 1.7μm, 100×2.1mm);
流速:0.3mL/min;Flow rate: 0.3mL/min;
柱温:40℃;Column temperature: 40°C;
洗脱程序:初始流动相B体积百分数为5%,0~1min保持在5%;1~3min流动相B体积分数从5%上升至40%;3~12min从40%上升至100%;12~15min保持100%不变;15~15.1min,流动相B体积百分数从 100%降至5%;15.1~18min,流动相B体积分数保持在5%不变;Elution procedure: initial mobile phase B volume percentage is 5%, 0-1min maintains at 5%; 1-3min mobile phase B volume fraction rises from 5% to 40%; 3-12min rises from 40% to 100%; 12 From 15 minutes to 15 minutes, keep 100% unchanged; from 15 to 15.1 minutes, the volume percentage of mobile phase B decreases from 100% to 5%; from 15.1 to 18 minutes, the volume percentage of mobile phase B remains unchanged at 5%;
质谱条件包括:电喷雾离子源,离子温度为550℃,检测模式为负离子检测模式;雾化气压:氮气,压力位55psi;Mass spectrometry conditions include: electrospray ion source, ion temperature is 550°C, detection mode is negative ion detection mode; atomization pressure: nitrogen, pressure 55psi;
⑤有机磷酸二酯类(Organophosphate diesters):⑤Organophosphate diesters:
色谱条件包括:Chromatographic conditions include:
流动相A:0.2mmol/L乙酸铵水溶液;Mobile phase A: 0.2mmol/L ammonium acetate aqueous solution;
流动相B:甲醇;Mobile phase B: Methanol;
色谱柱:RP18色谱柱,优选为:ACQUITY UPLC BEH Shield RP18,1.7μm,100×2.1mm);Chromatographic column: RP18 chromatographic column, preferably: ACQUITY UPLC BEH Shield RP18, 1.7μm, 100×2.1mm);
流速:0.3mL/min;Flow rate: 0.3mL/min;
柱温:40℃;Column temperature: 40°C;
洗脱程序:初始流动相B体积百分数为5%,0~4min,从5%上升至35%;4~7min,B相体积分数从35%上升至80%;7~12min从80%升至100%;12~14min保持100%不变;14~15min,流动相B体积百分数从100%降至5%;15~20min,流动相B体积百分数保持在5%不变;Elution procedure: initial mobile phase B volume percentage is 5%, 0~4min, rise from 5% to 35%; 4~7min, B phase volume fraction rises from 35% to 80%; 7~12min, rise from 80% to 100%; 12-14min keep 100% unchanged; 14-15min, mobile phase B volume percentage decreases from 100% to 5%; 15-20min, mobile phase B volume percentage remains unchanged at 5%;
质谱条件包括:电喷雾离子源,离子温度为550℃,检测模式为负离子检测模式;雾化气压:氮气,压力位55psi;Mass spectrometry conditions include: electrospray ion source, ion temperature is 550°C, detection mode is negative ion detection mode; atomization pressure: nitrogen, pressure 55psi;
⑥在负离子检测模式下进行检测的抗氧化剂:⑥Antioxidants detected in negative ion detection mode:
色谱条件包括:Chromatographic conditions include:
流动相A:4mmol/L乙酸铵水溶液;Mobile phase A: 4mmol/L ammonium acetate aqueous solution;
流动相B:甲醇;Mobile phase B: Methanol;
色谱柱:C18色谱柱,优选为:Luna 2.5μm C18(2)-HST 100×2.0mm;Chromatographic column: C18 chromatographic column, preferably: Luna 2.5μm C18(2)-HST 100×2.0mm;
流速:0.2mL/min;Flow rate: 0.2mL/min;
柱温:40℃;Column temperature: 40°C;
洗脱程序:初始流动相B的体积百分数为10%;0~0.5min保持10%不变;0.5~1min流动相B的体积百分数从10%上升至50%,1~7min上升至99%;7~10min保持在99%不变;10~10.1min,流动相B体积百分数迅速下降至10%;10.1~12min流动相B体积分数保持10%不变;Elution procedure: the initial volume percentage of mobile phase B is 10%; 0-0.5min keeps 10% unchanged; 0.5-1min the volume percentage of mobile phase B increases from 10% to 50%, and 1-7min rises to 99%; From 7 to 10 minutes, it remained at 99%; from 10 to 10.1 minutes, the volume percentage of mobile phase B dropped rapidly to 10%; from 10.1 to 12 minutes, the volume percentage of mobile phase B remained unchanged at 10%;
质谱条件包括:电喷雾离子源,离子温度为550℃,检测模式为负离子检测模式;雾化气压:氮气,压力位55psi;Mass spectrometry conditions include: electrospray ion source, ion temperature is 550°C, detection mode is negative ion detection mode; atomization pressure: nitrogen, pressure 55psi;
⑦全氟化合物:⑦ Perfluorinated compounds:
色谱条件包括:Chromatographic conditions include:
流动相A:0.2mmol/L甲酸铵(pH=4);Mobile phase A: 0.2mmol/L ammonium formate (pH=4);
流动相B:甲醇;Mobile phase B: Methanol;
色谱柱:RP18色谱柱,优选为:ACQUITY UPLC BEH Shield RP18,1.7μm;100×2.1mm;Chromatographic column: RP18 chromatographic column, preferably: ACQUITY UPLC BEH Shield RP18, 1.7μm; 100×2.1mm;
流速:0.3mL/min;Flow rate: 0.3mL/min;
柱温:40℃;Column temperature: 40°C;
洗脱程序:初始流动相B体积百分数为40%;0~2min内保持40%不变,2~3min流动相B体积百分数上升至66%;3~12min上升至77%;12~14min流动相B体积分数由70%上升至100%,14~16min保持在100%不变;16~16.1min迅速降至40%;16.1~22流动相B体积分数保持在40%不变;Elution procedure: initial mobile phase B volume percentage is 40%; 40% remains unchanged within 0-2min, mobile phase B volume percentage rises to 66% in 2-3min; rises to 77% in 3-12min; mobile phase in 12-14min B volume fraction rises from 70% to 100%, and remains unchanged at 100% for 14-16 minutes; quickly drops to 40% for 16-16.1 minutes; 16.1-22 mobile phase B volume fraction remains unchanged at 40%;
质谱条件包括:电喷雾离子源,离子温度为550℃,检测模式为负离子检测模式;雾化气压:氮气,压力位55psi;Mass spectrometry conditions include: electrospray ion source, ion temperature is 550°C, detection mode is negative ion detection mode; atomization pressure: nitrogen, pressure 55psi;
⑧有机磷农药(organophosphorus pesticide),拟除虫菊酯(Pyrethroids),新烟碱类农药(Neonicotinoids),氨基甲酸酯类农药(Carbamates),酸性除草剂(Acidherbicides),唑类农药(Azoles),三唑酮类农药(Triazines/triazone),尿素类农药(Urea),酰胺类农药(酰胺杀虫剂,Amide pesticides),甲氧基丙烯酸酯类杀菌剂(Strobilurins),其他杀虫剂(Other Pesticides):⑧Organophosphorus pesticides, Pyrethroids, Neonicotinoids, Carbamates, Acidherbicides, Azoles, Triazoles Ketone pesticides (Triazines/triazone), urea pesticides (Urea), amide pesticides (amide pesticides, Amide pesticides), methoxyacrylate fungicides (Strobilurins), other pesticides (Other Pesticides):
色谱条件包括:Chromatographic conditions include:
流动相A:5mmol/L的乙酸铵溶液;Mobile phase A: 5mmol/L ammonium acetate solution;
流动相B:乙腈;Mobile phase B: acetonitrile;
色谱柱:C18色谱柱,优选为:Kinetex 2.6μm C18 100*2.1mm;00D4462-AN;Chromatographic column: C18 chromatographic column, preferably: Kinetex 2.6μm C18 100*2.1mm; 00D4462-AN;
流速:0.4mL/min;Flow rate: 0.4mL/min;
柱温:40℃;Column temperature: 40°C;
洗脱程序:初始流动相B的体积百分数为2%;0~4min流动相B体积百分数从宏观2%上升至30%;4~22min流动相体积百分数从30%上升至68%;22~22.1min流动相B从68%上升至99%;22.1~23min,保持在99%不变;23~23.1min,流动相B体积百分数从99%降至2%;23.1~26min,保持2%不变;Elution procedure: the volume percentage of the initial mobile phase B is 2%; the volume percentage of the mobile phase B increases from 2% to 30% in 0-4min; the volume percentage of the mobile phase increases from 30% to 68% in 4-22min; 22-22.1 Min mobile phase B increased from 68% to 99%; 22.1~23min, kept at 99%; 23~23.1min, mobile phase B volume percentage decreased from 99% to 2%; 23.1~26min, kept 2% unchanged ;
质谱条件:电喷雾离子源,离子温度为550℃,检测模式为负离子检测模式;雾化气压:氮气,压力位55psi。Mass spectrometry conditions: electrospray ion source, ion temperature is 550°C, detection mode is negative ion detection mode; atomization pressure: nitrogen, pressure 55psi.
步骤(4)中所述的气相色谱-串联质谱法的的检测条件如下:The detection condition of gas chromatography-tandem mass spectrometry described in step (4) is as follows:
⑨有机氯农药:⑨Organochlorine pesticides:
色谱条件包括:Chromatographic conditions include:
色谱柱:安捷伦HP-5MS色谱柱19091S-433(Agilent 19091S-433,HP-5MS,30m×0.250mm×0.25μm);Chromatographic column: Agilent HP-5MS chromatographic column 19091S-433 (Agilent 19091S-433, HP-5MS, 30m×0.250mm×0.25μm);
进样口温度:260℃;Injection port temperature: 260°C;
升温程序:起始温度60℃,保持1min;以5℃/min的速度升温至300℃后保持9min;Heating program: initial temperature is 60°C, keep for 1min; heat up to 300°C at a rate of 5°C/min, then keep for 9min;
质谱条件:电子轰击离子源,离子源温度为230℃,四极杆温度为150℃,溶剂延时3min;Mass spectrometry conditions: electron bombardment ion source, ion source temperature is 230°C, quadrupole temperature is 150°C, solvent delay is 3min;
⑩液晶单体:⑩Liquid crystal monomer:
色谱条件包括:Chromatographic conditions include:
色谱柱:安捷伦HP-5MS色谱柱19091S-433(Agilent 19091S-433,HP-5MS,30m×0.250mm×0.25μm);Chromatographic column: Agilent HP-5MS chromatographic column 19091S-433 (Agilent 19091S-433, HP-5MS, 30m×0.250mm×0.25μm);
进样口温度:260℃;Injection port temperature: 260°C;
升温程序:起始温度80℃,保持2.5min;然后以25℃/min的速度升温至200℃后保持1min;再以10℃/min速度升至250℃后以5℃/min升至285℃,保持5min;最后以30℃/min的速度升至300℃,保持1min;Heating program: initial temperature 80°C, keep for 2.5min; then raise the temperature to 200°C at a rate of 25°C/min and keep for 1min; then rise to 250°C at a rate of 10°C/min and then rise to 285°C at a rate of 5°C/min , keep for 5min; finally rise to 300℃ at the speed of 30℃/min, keep for 1min;
质谱条件:电子轰击离子源,离子源温度230℃,四极杆温度为150℃,溶剂延时6min。Mass spectrometry conditions: electron bombardment ion source, ion source temperature 230°C, quadrupole temperature 150°C, solvent delay 6min.
所述的血浆中环境污染物靶向暴露组分析方法在非疾病诊断治疗目的的分析血浆中环境污染物中的应用。The application of the targeted exposure group analysis method for environmental pollutants in plasma to the analysis of environmental pollutants in plasma for non-disease diagnosis and treatment purposes.
本发明相对于现有技术具有如下的优点及效果:Compared with the prior art, the present invention has the following advantages and effects:
(1)本发明提供了一种高通量且便捷的人体血浆中环境污染物靶向暴露组分析方法,该方法能实现同时检测血浆中多种类型各异的环境污染物,前处理方便,分析时间短,成本低,能够最大程度提高分析效率,可为后续观察和检测环境中的污染物的混合效应对人体健康的影响提供技术支持。(1) The present invention provides a high-throughput and convenient method for targeted exposure group analysis of environmental pollutants in human plasma. This method can simultaneously detect various types of environmental pollutants in plasma, and the pre-treatment is convenient. The analysis time is short, the cost is low, the analysis efficiency can be improved to the greatest extent, and it can provide technical support for the follow-up observation and detection of the mixed effect of pollutants in the environment on human health.
(2)本发明方法能够同时分析血浆中不同种类数百种环境污染物,处理方法简便,耗时短,效率高。(2) The method of the present invention can simultaneously analyze hundreds of different kinds of environmental pollutants in blood plasma, and the processing method is simple, time-consuming and efficient.
(3)本发明中对血浆样品进行预处理时,将萃取液吹至近干用甲醇复溶后进行冷冻,让脂质析出,然后需要在冷冻离心机中保持低温进行冷冻离心,让脂质沉淀有助于上清液的转移,从而达到去除脂质的目的,减少 基质效应,进而提高加标回收率。(3) In the present invention, when the plasma sample is pretreated, the extract is blown to near dryness and redissolved with methanol for freezing to allow the lipid to separate out, and then it is necessary to keep the low temperature in a refrigerated centrifuge for refrigerated centrifugation to allow the lipid to precipitate It is helpful for the transfer of supernatant, so as to achieve the purpose of removing lipid, reduce matrix effect, and improve the recovery rate of standard addition.
图1是本发明与对比例1的方法加标回收率对比结果图。Fig. 1 is the comparison result graph of the recovery rate of standard addition of the method of the present invention and comparative example 1.
下面结合实施例对本发明作进一步详细的描述,但本发明的实施方式不限于此。The present invention will be further described in detail below in conjunction with examples, but the embodiments of the present invention are not limited thereto.
除非特别说明,本发明采用的试剂、方法和设备为本技术领域常规试剂、方法和设备。下列实施例中未注明具体实验条件的试验方法,通常按照常规实验条件或按照制造厂所建议的实验条件。除非特别说明,本发明所用试剂和原材料均可通过市售获得。Unless otherwise specified, the reagents, methods and equipment used in the present invention are conventional reagents, methods and equipment in the technical field. For the test methods that do not indicate the specific experimental conditions in the following examples, usually follow the routine experimental conditions or the experimental conditions suggested by the manufacturer. Unless otherwise specified, the reagents and raw materials used in the present invention can be obtained commercially.
实施例中所涉及的萃取溶剂,即含0.6%甲酸的乙酸乙酯和正己烷的混合溶剂中的乙酸乙酯和正己烷至少为LC-MS级别,乙酸乙酯和正己烷体积比为3:2,用甲酸调节酸碱度(甲酸含量为0.6%);例如配置500mL萃取剂,乙酸乙酯用量为298.2mL,正己烷用量为198.8mL,甲酸用量为3mL。The extraction solvent involved in the embodiment, that is, the ethyl acetate and normal hexane in the mixed solvent containing 0.6% formic acid ethyl acetate and normal hexane are at least LC-MS level, and the volume ratio of ethyl acetate and normal hexane is 3: 2. Use formic acid to adjust the pH (formic acid content is 0.6%); for example, configure 500mL extractant, the amount of ethyl acetate is 298.2mL, the amount of n-hexane is 198.8mL, and the amount of formic acid is 3mL.
实施例1:人体血浆中环境污染物靶向暴露组分析Example 1: Targeted exposome analysis of environmental pollutants in human plasma
(1)试剂与材料(1) Reagents and materials
从美国AccuStandard公司、美国Sigma-Aldrich公司、加拿大惠灵顿实验室以及加拿大Toronto Research Chemicals公司购买共377种化合物的标准品、74种作为回收率指示物或者内标的同位素标记的化学物质;其中包括39种有机磷酸酯(OPEs)(包括有机磷酸二酯类和有机磷酸三酯类),36种邻苯二甲酸酯(PAEs)(包括邻苯二甲酸单酯类和邻苯二甲酸二酯类),7种个人护理产品(PCPs),14种苯酚类化合物(双酚类似物),29种紫外稳定剂(UV)(包括苯甲酮类、苯并噻唑类、苯并三唑类以及其他类别紫外稳定剂),15种光引发剂,34种抗氧化剂(AO)(包括正、负离子检测模式),31种增塑剂,25种全氟化合物(PFCs),18种有机磷农药(OPs),24种有机氯农药(OCPs),4种拟除虫菊酯,5种新烟碱类农药,8种氨基甲酸酯类农药,7种酸性除草剂,13种唑类农药,14种三唑酮类农药,11种尿素类农药,4种酰胺类农药(酰胺杀虫剂),5种甲氧基丙烯酸酯类杀菌剂,6种其他类型农药(其他杀虫剂),28种液晶单体(LCMs)。具体化合物的详细信息见表1。A total of 377 standard compounds and 74 isotope-labeled chemical substances used as recovery indicators or internal standards were purchased from AccuStandard Company of the United States, Sigma-Aldrich Company of the United States, Wellington Laboratory of Canada and Toronto Research Chemicals of Canada; including 39 kinds Organophosphate esters (OPEs) (including organophosphate diesters and organophosphate triesters), 36 phthalates (PAEs) (including phthalate monoesters and phthalate diesters) , 7 kinds of personal care products (PCPs), 14 kinds of phenolic compounds (bisphenol analogues), 29 kinds of ultraviolet stabilizers (UV) (including benzophenones, benzothiazoles, benzotriazoles and other categories UV stabilizers), 15 photoinitiators, 34 antioxidants (AO) (including positive and negative ion detection modes), 31 plasticizers, 25 perfluorinated compounds (PFCs), 18 organophosphorus pesticides (OPs) , 24 kinds of organochlorine pesticides (OCPs), 4 kinds of pyrethroids, 5 kinds of neonicotinoid pesticides, 8 kinds of carbamate pesticides, 7 kinds of acid herbicides, 13 kinds of azole pesticides, 14 kinds of triadimefon Pesticides, 11 kinds of urea pesticides, 4 kinds of amide pesticides (amide insecticides), 5 kinds of methoxyacrylate fungicides, 6 kinds of other types of pesticides (other insecticides), 28 kinds of liquid crystal monomers (LCMs ). Details of the specific compounds are listed in Table 1.
用超高效液相色谱质谱联用仪(5500Q Trap triple quadrupole-linear ion Trap mass spectrometer)和气相色谱串联质谱联用仪(7890B-5970A)对目标分析物进行测定,超高效液相色谱串联质谱联用仪器购置于加拿大多伦多AB Sciex公司;气相色谱串联质谱联用仪购置于美国安捷伦公司;实验所用氮吹仪(12N-EvapTM)购置于Oganomation公司;离心机购置于湖南湘仪公司;冷冻离心机购置于赛默飞世尔科技公司(ThermoFisher Scientific);振荡仪购置与Kylin-Bell公司;实验所用试剂均为LC-MS级别,购买于Thermo Fisher Scientific公司。The target analytes were determined by ultra-high performance liquid chromatography-mass spectrometer (5500Q Trap triple quadrupole-linear ion Trap mass spectrometer) and gas chromatography-tandem mass spectrometer (7890B-5970A). The instrument was purchased from AB Sciex Company in Toronto, Canada; the gas chromatography tandem mass spectrometer was purchased from Agilent Company in the United States; the nitrogen blowing instrument (12N-EvapTM) used in the experiment was purchased from Oganomation Company; the centrifuge was purchased from Hunan Xiangyi Company; the refrigerated centrifuge Purchased from Thermo Fisher Scientific; the oscillator was purchased from Kylin-Bell; the reagents used in the experiment were all LC-MS grade and purchased from Thermo Fisher Scientific.
表1定量检测的化合物Table 1 Quantitatively detected compounds
(2)样品采集(2) Sample collection
血浆样品采集于中山大学第三附属医院(中国广州),用采血管(美国BD公司)进行收集。收集后的血浆在3000rpm下离心三分钟将血浆和血细胞进行分离,取上清液即转移至玻璃瓶中,并在分析之前储存在-80℃下。本实验共采集10个志愿者的血浆样品。Plasma samples were collected at the Third Affiliated Hospital of Sun Yat-Sen University (Guangzhou, China) and collected with blood collection tubes (BD, USA). The collected plasma was centrifuged at 3000rpm for three minutes to separate plasma and blood cells, and the supernatant was transferred to a glass bottle and stored at -80°C before analysis. A total of 10 volunteer plasma samples were collected in this experiment.
(3)样品前处理与仪器分析(3) Sample pretreatment and instrumental analysis
①取200μL样品于15mL玻璃离心管中,加入回收率指示物(200μL血浆中每种回收率指示物的加入量为0.5~20ng,本实验具体加入回收率指示物的用量如下:有机磷酸二酯类回收率指示物5ng、有机磷酸三酯类回收率指示物2ng、邻苯二甲酸单酯类回收率指示物2ng、邻苯二甲酸二酯类回收率指示物1ng、个人护理产品回收率指示物2ng、双酚类似物回收率指示物2ng、苯甲酮类紫外线稳定剂类回收率指示5ng、苯并噻唑类紫外线稳定剂类回收率指示5ng、苯并三唑类紫外稳定剂类回收率指示5ng、其他类别紫外稳定剂类回收率指示5ng、光引发剂回收率指示5ng、抗氧化剂回收率指示5ng、增塑剂回收率指示5ng、全氟化合物回收率指示物0.5ng、有机磷农药回收率指示物5ng、有机氯农药回收率指示物20ng、拟除虫菊酯回收率指示物5ng、新烟碱类农药回收率指示物5ng、氨基甲酸酯类农药回收率指示物5ng、酸性除草剂回收率指示物5ng、唑类农药回收率指示物5ng、三唑酮类回收率指示物5ng、尿素类农药回收 率指示物5ng、酰胺杀虫剂回收率指示物5ng、甲氧基丙烯酸酯类杀菌剂回收率指示物5ng、其他杀虫剂回收率指示物5ng、液晶单体回收率指示物20ng),混匀后在离心管内加入3mL萃取溶剂,然后将混合物旋转震荡5min后再在3000rpm下离心3min,取上清液转移至另一个玻璃离心管中,再重复上述步骤两次;其中,前两次萃取溶剂为含0.6%(v/v)甲酸的乙酸乙酯和正己烷的混合溶剂(乙酸乙酯:正己烷=3:2,体积比),第三次萃取剂为乙酸乙酯(3mL);①Take 200 μL of the sample into a 15 mL glass centrifuge tube, and add the recovery indicator (the amount of each recovery indicator in 200 μL plasma is 0.5-20 ng, and the specific amount of the recovery indicator added in this experiment is as follows: organophosphate diester Phthalate recovery rate indicator 5ng, organophosphate triesters recovery rate indicator 2ng, phthalic acid monoesters recovery rate indicator 2ng, phthalic acid diesters recovery rate indicator 1ng, personal care product recovery rate indicator Object 2ng, bisphenol analogue recovery indicator 2ng, benzophenone UV stabilizer recovery indicator 5ng, benzothiazole UV stabilizer recovery indicator 5ng, benzotriazole UV stabilizer recovery Indicator 5ng, other categories of UV stabilizer recovery indicator 5ng, photoinitiator recovery indicator 5ng, antioxidant recovery indicator 5ng, plasticizer recovery indicator 5ng, perfluorinated compound recovery indicator 0.5ng, organophosphorus pesticide Recovery rate indicator 5ng, organochlorine pesticide recovery rate indicator 20ng, pyrethroid recovery rate indicator 5ng, neonicotinoid pesticide recovery rate indicator 5ng, carbamate pesticide recovery rate indicator 5ng, acid herbicide recovery Rate indicator 5ng, azole pesticide recovery rate indicator 5ng, triadimefolone recovery rate indicator 5ng, urea pesticide recovery rate indicator 5ng, amide insecticide recovery rate indicator 5ng, methoxyacrylate bactericidal Insecticide recovery indicator 5ng, other insecticide recovery indicator 5ng, liquid crystal monomer recovery indicator 20ng), after mixing, add 3mL extraction solvent into the centrifuge tube, then rotate the mixture for 5min and then centrifuge at 3000rpm 3min, the supernatant was transferred to another glass centrifuge tube, and the above steps were repeated twice; wherein, the first two extraction solvents were a mixed solvent of ethyl acetate containing 0.6% (v/v) formic acid and normal hexane ( Ethyl acetate:n-hexane=3:2, volume ratio), the third extractant is ethyl acetate (3mL);
②合并后的萃取液氮吹至近干后再加入50μL甲醇复溶,然后转移到1.5mL离心管中,-40℃下冷冻一晚后在冷冻离心机-10℃、15000rpm条件下离心5min,转移上清液至1.5mL进样瓶,加入内标(每种内标的用量为1~20ng,本实验中的内标用量如下:正模式内标蝇毒磷(coumaphos-d10)用量1ng、负模式内标双酚A-d16(BPA-d16)用量5ng、全氟化合物内标全氟-n-[13C8]辛酸(Perfluoro-n-[13C8]octanoic acid(M8PFOA))用量1ng、内标十氯二苯醚(Decachlorodiphenyl ether(DCDE))用量为20ng)(内标见表1)待进样分析。②The combined extracts were blown to nearly dry, then added 50 μL of methanol to redissolve, then transferred to a 1.5 mL centrifuge tube, frozen overnight at -40°C, centrifuged at -10°C, 15,000 rpm for 5 min in a refrigerated centrifuge, transferred Add the supernatant to a 1.5mL injection bottle, add internal standard (the amount of each internal standard is 1~20ng, the amount of internal standard in this experiment is as follows: the amount of internal standard coumaphos-d10 in positive mode is 1ng, and the amount of internal standard in negative mode is 1ng. The amount of internal standard bisphenol A-d16 (BPA-d16) is 5ng, the amount of perfluorochemical internal standard perfluoro-n-[13C8]octanoic acid (Perfluoro-n-[13C8]octanoic acid (M8PFOA)) is 1ng, the internal standard of decachloro The amount of diphenyl ether (Decachlorodiphenyl ether (DCDE)) is 20ng) (internal standard see Table 1) to be injected and analyzed.
目标化合物均在超高效液相色谱-串联质谱联用仪(UPLC-MS/MS)和气相色谱-串联质谱联用仪(GC-MS/MS)上对样品进行定量分析,共8种分析方法,具体信息如表2和3所示。其中:The target compounds were quantitatively analyzed on ultra-high performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) and gas chromatography-tandem mass spectrometry (GC-MS/MS), with a total of 8 analysis methods , the specific information is shown in Tables 2 and 3. in:
LC-MS/MS中的质谱条件包括:电喷雾离子源,离子温度为550℃,检测模式见表2;雾化气压:氮气,压力位55psi;The mass spectrometry conditions in LC-MS/MS include: electrospray ion source, ion temperature is 550°C, detection mode is shown in Table 2; atomization pressure: nitrogen, pressure position 55psi;
GC-MS/MS中的质谱条件包括:电子轰击离子源,离子源温度为230℃,四极杆温度为150℃,溶剂延时3min(有机氯农药)或6min(液晶单体)。The mass spectrometry conditions in GC-MS/MS include: electron bombardment ion source, ion source temperature of 230°C, quadrupole temperature of 150°C, solvent delay of 3min (organochlorine pesticide) or 6min (liquid crystal monomer).
表2化合物LC-MS/MS信息(柱温:40℃)Table 2 Compound LC-MS/MS information (column temperature: 40°C)
表3化合物GC-MS/MS信息(进样口温度:260℃)Table 3 Compound GC-MS/MS information (injection port temperature: 260°C)
(4)质量保证和质量控制(4) Quality assurance and quality control
质量保证和质量控制程序检测了程序空白和回收率指示物的回收率,同时对基质加标样品进行了分析。每处理10个不同血浆样品时同时处理两个实验室程序空白,用200μL超纯水替代实际样品来制备程序空白,处理过程与实际样品相同,三次重复。用AB Sciex 5500 Q Trap triple quadrupole-linear ion trap mass spectrometer分析软件Analyst 1.6.3软件积分计算所有样品的同位素标回收率为50~110%。The quality assurance and quality control procedures tested the recovery of the program blank and recovery indicators, while matrix-spiked samples were analyzed. When processing 10 different plasma samples, two laboratory program blanks were processed at the same time, and 200 μL of ultrapure water was used to replace the actual sample to prepare the program blank. The processing process was the same as that of the actual sample, and was repeated three times. The isotope standard recoveries of all samples were calculated by integrating with AB Sciex 5500 Q Trap triple quadrupole-linear ion trap mass spectrometer analysis software Analyst 1.6.3 software, ranging from 50% to 110%.
将标准品加入五份绵羊血血浆中(中国广州未来生物技术有限公司),每种标准品加入量为1~10ng,本实验中的标准品的具体加入量如下:有机磷酸二酯类5ng、有机磷酸三酯类2ng、邻苯二甲酸单酯类2ng、邻苯二甲酸二酯类1ng、个人护理产品2ng、双酚类似物2.5ng、苯甲酮类紫外线稳定剂5ng、苯并噻唑类紫外稳定剂5ng、苯并三唑类紫外稳定剂5ng、其他类别紫外稳定剂2ng、光引发剂5ng、抗氧化剂5ng、增塑剂5ng、全氟化合物2ng、有机磷农药2ng、有机氯农药3.5ng、拟除虫菊酯2ng、新烟碱类2ng、氨基甲酸酯类农药2ng、酸性除草剂2ng、唑类农药2ng、三唑酮类农药2ng、尿素类农药2ng、酰胺杀虫剂2ng、甲氧基丙烯酸酯类农药2ng、其他杀虫剂2ng、液晶单体10ng,用上述步骤(3)相同的前处理方法处理(三次重复),用AB Sciex 5500 Q Trap triple quadrupole-linear ion trap mass spectrometer分析软件Analyst 1.6.3软件积分计算获得目标化合物的平均回收率和基质效应:所有目标化合物的平均回收率范围在71~98%,基质效应在96~120%范围内。Add the standard product into five parts of sheep blood plasma (China Guangzhou Future Biotechnology Co., Ltd.), the amount of each standard product added is 1-10 ng, the specific added amount of the standard product in this experiment is as follows: Organophosphate triesters 2ng, phthalic acid monoesters 2ng, phthalic acid diesters 1ng, personal care products 2ng, bisphenol analogs 2.5ng, benzophenone UV stabilizers 5ng, benzothiazoles UV stabilizer 5ng, benzotriazole UV stabilizer 5ng, other types of UV stabilizer 2ng, photoinitiator 5ng, antioxidant 5ng, plasticizer 5ng, perfluorinated compound 2ng, organophosphorus pesticide 2ng, organochlorine pesticide 3.5 ng, pyrethroids 2ng, neonicotinoids 2ng, carbamate pesticides 2ng, acidic herbicides 2ng, azole pesticides 2ng, triadimefon pesticides 2ng, urea pesticides 2ng, amide insecticides 2ng, methoxy 2ng of acrylate pesticides, 2ng of other insecticides, and 10ng of liquid crystal monomers were treated with the same pretreatment method as in step (3) above (three repetitions), and analyzed by AB Sciex 5500 Q Trap triple quadrupole-linear ion trap mass spectrometer The average recovery rate and matrix effect of the target compound were calculated by software Analyst 1.6.3 software integration: the average recovery rate of all target compounds was in the range of 71-98%, and the matrix effect was in the range of 96-120%.
每类化合物用五个以上浓度水平的标准曲线进行定量,标准曲线的相关系数大于0.995。方法定量限(limit of quantification,LOQ)即检出限定义为3倍或10倍于噪声标准方差的响应所对应的化合物浓度,若计算得出LOQ低于空白中的背景污染值,使用最高空白浓度作为LOQ。具体所有化合物的LOQ如表1所示。Each type of compound was quantified using a standard curve with more than five concentration levels, and the correlation coefficient of the standard curve was greater than 0.995. The limit of quantification (LOQ) of the method is defined as the concentration of the compound corresponding to the response of 3 times or 10 times the standard deviation of the noise. If the calculated LOQ is lower than the background contamination value in the blank, use the highest blank Concentrations were used as LOQ. The LOQs of all compounds are shown in Table 1.
(5)分析结果(5) Analysis results
总共所测化合物为377种,共有40种化合物检出率大于50%,其中有32种化合物的检出率大于70%;全氟化合物检测出种类最多,25种全氟化合物中,13种检出率大于70%,其中全氟辛酸(PFOA)、全氟-1-庚烷磺酸钠(L-PFHxS)、全氟-1-己烷磺酸钠(L-PFHpS)、全氟正壬烷酸(PFNA)、全氟辛烷磺酸(PFOS)、全氟正癸酸(PFDA)、全氟正十一烷酸(PFUdA)、9-氯十六氟-3-氧杂环己烷-1-磺酸钾(9Cl-PF3ONS)、11-氯二十氟-3-氧杂环丁烷-1-磺酸钾(11Cl-PF3OUdS)检出率为100%;塑料添加剂中邻苯二甲酸酯检出种类最多,但检出浓度最高的是增塑剂类中的甘油单油酸(GMO),浓度范围为127~10914ng/mL;农药类别只有有机氯农药检出,其中α-六氯环己烷(α-HCH)和4,4'-滴滴涕(p,p′-DDE)检出率为100%。具体化合物检出信息如表4所示。A total of 377 compounds were detected, and the detection rate of 40 compounds was greater than 50%, of which 32 compounds were more than 70%. The output rate is greater than 70%, of which perfluorooctanoic acid (PFOA), sodium perfluoro-1-heptane sulfonate (L-PFHxS), sodium perfluoro-1-hexanesulfonate (L-PFHpS), perfluoro-n-nonanoic acid (PFNA), perfluorooctanesulfonic acid (PFOS), perfluoron-decanoic acid (PFDA), perfluoron-undecanoic acid (PFUdA), 9-chlorohexadecafluoro-3-oxane-1 -Potassium sulfonate (9Cl-PF3ONS), 11-chloroeicosfluoro-3-oxetane-1-potassium sulfonate (11Cl-PF3OUdS) detection rate is 100%; phthalic acid in plastic additives The most types of esters were detected, but the highest detection concentration was glycerol monooleic acid (GMO) in the plasticizer category, with a concentration range of 127-10914ng/mL; only organochlorine pesticides were detected in the pesticide category, of which α-hexachloro The detection rate of cyclohexane (α-HCH) and 4,4'-DDT (p,p'-DDE) was 100%. The specific compound detection information is shown in Table 4.
表4化合物检出信息Table 4 Compound detection information
对比例1Comparative example 1
按照实施例1步骤(2)中的方法采集样品,然后按如下方法进行检测:Collect samples according to the method in embodiment 1 step (2), then detect as follows:
(1)取200μL血浆,置于15mL玻璃离心管中,加入回收率指示物混合均匀;(1) Take 200 μL of plasma, put it in a 15mL glass centrifuge tube, add recovery indicator and mix well;
(2)向离心管中加入3mL体积比为3:2的乙酸乙酯和正己烷的萃取溶剂(含0.6%(v/v)甲酸),旋转震荡5min后,在3000rpm下离心3min,取上清液转移至另一个玻璃离心管内;(2) Add 3 mL of ethyl acetate and n-hexane extraction solvent (containing 0.6% (v/v) formic acid) with a volume ratio of 3:2 to the centrifuge tube, rotate and shake for 5 min, centrifuge at 3000 rpm for 3 min, and take the Transfer the supernatant to another glass centrifuge tube;
(3)第二次萃取重复步骤(2),第三次萃取将萃取溶剂换成乙酸乙酯,合并三次萃取液;(3) Step (2) was repeated for the second extraction, and the extraction solvent was changed to ethyl acetate for the third extraction, and three extracts were combined;
(4)在缓慢的氮气流下将萃取液吹至1mL后加入3mL体积分数为0.6%的甲酸水溶液稀释,然后氮吹浓缩至3mL,把HLB柱(
PRiME HLB 3cc(60mg)Extraction Cartridges)放置在SPE萃取装置上,然后用3mL甲醇、3mL水依次预洗HLB柱;
(4) Under the slow nitrogen flow, the extract was blown to 1mL and then added with 3mL volume fraction of 0.6% aqueous formic acid for dilution, then concentrated to 3mL by nitrogen blowing, and the HLB column ( PRiME HLB 3cc (60mg) Extraction Cartridges) were placed on the SPE extraction device, and then the HLB column was pre-washed sequentially with 3mL methanol and 3mL water;
(5)然后转移稀释液到HLB柱,再用3mL体积分数为2%的甲酸水溶液去除干扰,等溶剂流完后,再加入3mL甲醇水洗脱,用玻璃管接住洗脱液氮吹至50μL转移至进样瓶,加入内标待上样;(5) Then transfer the diluent to the HLB column, and then use 3mL of formic acid aqueous solution with a volume fraction of 2% to remove the interference. After the solvent flows out, add 3mL of methanol water to elute, and use a glass tube to catch the eluent and blow it with nitrogen. Transfer 50 μL to the injection bottle, add internal standard and wait for sample loading;
(6)在超高效液相色谱-串联质谱联用仪(UPLC-MS/MS)和气相色谱-串联质谱联用仪(GC-MS/MS)下对样品进行定量分析,方法如实施例1步骤(3)(表2、表3)。(6) Quantitatively analyze the sample under ultra-high performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) and gas chromatography-tandem mass spectrometry (GC-MS/MS), the method is as in Example 1 Step (3) (Table 2, Table 3).
上述方法所加的回收率指示物以及内标与实施例1所用相同,只有前处理的方法不同。The recovery indicator and internal standard added by the above method are the same as those used in Example 1, only the pretreatment method is different.
用上述前处理方法进行基质加标实验,取6份绵羊血血浆(中国广州未来生物技术有限公司),置于15mL玻璃离心管,其中5份中,每种目标化合物的加入量为2~10ng,具体加入量如下:有机磷酸二酯类5ng、有机磷酸三酯类2ng、邻苯二甲酸单酯类2ng、邻苯二甲酸二酯类1ng、个人护理产品2ng、双酚类似物2.5ng、苯甲酮类紫外线稳定剂5ng、苯并噻唑类紫外稳定剂5ng、苯并三唑类紫外稳定剂5ng、其他类型紫外稳定剂2ng、光引发剂5ng、抗氧化剂5ng、增塑剂5ng、全氟化合物2ng、有机磷农药2ng、有机氯农药3.5ng、拟除虫菊酯2ng、新烟碱类农药2ng、氨基甲酸酯类农药2ng、酸性除草剂2ng、唑类农药2ng、三唑酮类农药2ng、尿素类农药2ng、酰胺杀虫剂2ng、甲氧基丙烯酸酯类农药2ng、其他杀虫剂2ng、液晶单体10ng,另一份作为空白对照,然后全部加入回收率指示物混匀,后续按上述步骤进行前处理和进样分析(三次重复)。Use the above pretreatment method to carry out the matrix spike experiment, take 6 parts of sheep blood plasma (Guangzhou Future Biotechnology Co., Ltd., China), and put them in 15mL glass centrifuge tubes, and in 5 parts, the amount of each target compound added is 2-10ng , the specific dosage is as follows: 5 ng of organic phosphate diesters, 2 ng of organic phosphate triesters, 2 ng of phthalic acid monoesters, 1 ng of phthalic acid diesters, 2 ng of personal care products, 2.5 ng of bisphenol analogues, Benzophenone UV stabilizer 5ng, benzothiazole UV stabilizer 5ng, benzotriazole UV stabilizer 5ng, other types of UV stabilizer 2ng, photoinitiator 5ng, antioxidant 5ng, plasticizer 5ng, all Fluorine compound 2ng, organophosphorus pesticide 2ng, organochlorine pesticide 3.5ng, pyrethroid 2ng, neonicotinoid pesticide 2ng, carbamate pesticide 2ng, acid herbicide 2ng, azole pesticide 2ng, triadimefon pesticide 2ng , urea pesticides 2ng, amide pesticides 2ng, methoxyacrylate pesticides 2ng, other pesticides 2ng, liquid crystal monomer 10ng, the other part was used as a blank control, and then all were added to the recovery indicator and mixed evenly. Pretreatment and injection analysis were performed according to the above steps (three repetitions).
结果如图1所示:方法一为实施例1所用方法,方法二为对比例1所用方法。如图所示,方法一的加标回收率大部分在70~100%左右,比较稳定且符合标准,方法二的加标回收率则比较分散不稳定,且回收率相对方法一来说比较低,有些化合物甚至加标回收率为0%。此结果说明方法二的基质干扰较强,综合来看,方法一明显优于方法二。The results are shown in Figure 1: Method 1 is the method used in Example 1, and Method 2 is the method used in Comparative Example 1. As shown in the figure, the recovery rate of standard addition in method 1 is mostly around 70-100%, which is relatively stable and meets the standard. The recovery rate of standard addition in method 2 is relatively scattered and unstable, and the recovery rate is relatively low compared to method 1. , and some compounds even had spiked recoveries of 0%. This result shows that method 2 has strong matrix interference, and overall, method 1 is significantly better than method 2.
上述实施例为本发明较佳的实施方式,但本发明的实施方式并不受上述实施例的限制,其他的任何未背离本发明的精神实质与原理下所作的改变、修饰、替代、组合、简化,均应为等效的置换方式,都包含在本发明的保护范围之内。The above-mentioned embodiment is a preferred embodiment of the present invention, but the embodiment of the present invention is not limited by the above-mentioned embodiment, and any other changes, modifications, substitutions, combinations, Simplifications should be equivalent replacement methods, and all are included in the protection scope of the present invention.
Claims (11)
- 一种血浆中环境污染物靶向暴露组分析方法,其特征在于,包括如下步骤:A targeted exposure group analysis method for environmental pollutants in plasma, characterized in that it comprises the following steps:(1)将回收率指示物添加到血浆中,混合均匀,得到血浆和回收率指示物的混合物;(1) Add the recovery rate indicator to the plasma and mix evenly to obtain a mixture of the plasma and the recovery rate indicator;(2)向步骤(1)中得到的血浆和回收率指示物的混合物中加入萃取溶剂I进行萃取,离心,取上清,重复此步骤1次以上;再加入萃取溶剂II进行萃取,得到萃取液;其中,所述萃取溶剂I为含有甲酸的乙酸乙酯和正己烷的混合溶剂;所述萃取溶剂II为乙酸乙酯;(2) Add extraction solvent I to the mixture of plasma and recovery indicator obtained in step (1) for extraction, centrifuge, take the supernatant, repeat this step more than 1 time; then add extraction solvent II for extraction to obtain the extracted Liquid; Wherein, described extraction solvent I is the mixed solvent that contains the ethyl acetate of formic acid and n-hexane; Described extraction solvent II is ethyl acetate;(3)将步骤(2)中得到的萃取液用氮气吹干,然后加入甲醇复溶后,置于-40±5℃下进行冷冻,然后冷冻离心,取上清液,得到预处理后的样品;(3) Dry the extract obtained in step (2) with nitrogen, then add methanol to redissolve, freeze at -40±5°C, then freeze and centrifuge, and take the supernatant to obtain the pretreated sample;(4)向步骤(3)中得到的预处理后的样品中加入内标,然后利用液相色谱-串联质谱法和/或气相色谱-串联质谱法对环境污染物进行定量分析。(4) adding an internal standard to the pretreated sample obtained in step (3), and then quantitatively analyzing the environmental pollutants by using liquid chromatography-tandem mass spectrometry and/or gas chromatography-tandem mass spectrometry.
- 根据权利要求1所述的血浆中环境污染物靶向暴露组分析方法,其特征在于:步骤(1)中所述的回收率指示物的用量为按每200μL血浆加入每种回收率指示物0.5~20ng计算;The targeted exposure group analysis method for environmental pollutants in plasma according to claim 1, characterized in that: the amount of the recovery rate indicator described in step (1) is to add 0.5% of each recovery rate indicator per 200 μL of plasma. ~20ng calculation;步骤(2)中所述的萃取溶剂I的配方如下:298.2mL乙酸乙酯、198.8mL正己烷和3mL甲酸;The formula of extraction solvent I described in step (2) is as follows: 298.2mL ethyl acetate, 198.8mL n-hexane and 3mL formic acid;步骤(4)中所述的内标的用量为按每50μL预处理后的样品加入每种内标1~20ng计算。The amount of the internal standard described in step (4) is calculated by adding 1-20 ng of each internal standard per 50 μL of the pretreated sample.
- 根据权利要求1所述的血浆中环境污染物靶向暴露组分析方法,其特征在于:The targeted exposure group analysis method for environmental pollutants in plasma according to claim 1, characterized in that:步骤(3)中所述的冷冻的时间为12小时以上;The freezing time described in step (3) is more than 12 hours;步骤(3)中所述的冷冻离心的条件为:-10℃、15000rpm条件下离心5min以上。The conditions for the refrigerated centrifugation in step (3) are: centrifuge at -10°C and 15000rpm for more than 5min.
- 根据权利要求1所述的血浆中环境污染物靶向暴露组分析方法,其特征在于:The targeted exposure group analysis method for environmental pollutants in plasma according to claim 1, characterized in that:步骤(4)中所述的利用液相色谱-串联质谱法对环境污染物进行定量分析的污染物包括有机磷酸酯类,邻苯二甲酸酯类,个人护理产品,苯酚类化合物,紫外稳定剂,光引发剂,抗氧化剂,增塑剂,全氟化合物,有机磷农药,拟除虫菊酯,新烟碱类农药,氨基甲酸酯类农药,酸性除草剂,唑类农药,三唑酮类农药,尿素类农药,酰胺类农药,甲氧基丙烯酸酯类杀菌剂和其他杀虫剂中的至少一种;The pollutants that utilize liquid chromatography-tandem mass spectrometry described in step (4) to quantitatively analyze environmental pollutants include organophosphates, phthalates, personal care products, phenolic compounds, UV stabilizers , photoinitiators, antioxidants, plasticizers, perfluorinated compounds, organophosphorus pesticides, pyrethroids, neonicotinoid pesticides, carbamate pesticides, acidic herbicides, azole pesticides, triadimefon pesticides, At least one of urea pesticides, amide pesticides, methoxyacrylate fungicides and other insecticides;步骤(4)中所述的利用气相色谱-串联质谱法对环境污染物进行定量分析的污染物包括有机氯农药和液晶单体中的至少一种。The pollutants that are quantitatively analyzed by gas chromatography-tandem mass spectrometry in the step (4) include at least one of organochlorine pesticides and liquid crystal monomers.
- 根据权利要求4所述的血浆中环境污染物靶向暴露组分析方法,其特征在于:The targeted exposure group analysis method for environmental pollutants in plasma according to claim 4, characterized in that:所述的有机磷酸酯类包括有机磷酸二酯类和有机磷酸三酯类中的至少一种;The organophosphates include at least one of organophosphate diesters and organophosphate triesters;所述的有机磷酸二酯类包括双-(1-氯-2-丙基)磷酸酯、磷酸二苯酯、磷酸二丁酯、双(1,3-二氯-2-丙基)磷酸酯、二对甲苯基磷酸酯、双(丁氧基乙基)磷酸酯和双(2-乙基己基)磷酸酯;The organic phosphoric acid diesters include bis-(1-chloro-2-propyl) phosphate, diphenyl phosphate, dibutyl phosphate, bis(1,3-dichloro-2-propyl) phosphate , di-p-cresyl phosphate, bis(butoxyethyl) phosphate and bis(2-ethylhexyl) phosphate;所述的有机磷酸三酯类包括磷酸三乙酯、三(2-氯乙基)磷酸酯、磷酸三丙酯、四(2-氯乙基)二氯异戊基二磷酸酯、磷酸三苯酯、三(2,3-二溴丙基)磷酸酯、磷酸三丁酯、磷酸甲酚二苯酯、三(2-丁氧基乙基)磷酸酯、磷 酸三甲苯酯、间苯二酚双(磷酸二苯酯)、2-乙基己基-二苯基磷酸酯、磷酸异癸基二苯酯、三(3,5-二甲基苯基)磷酸酯、双酚A双(磷酸二苯酯)、三(2-异丙基苯基)磷酸酯、三(2-乙基己基)磷酸酯、叔丁基苯基二苯基磷酸酯、2-异丙基苯基二苯基磷酸酯、4-异丙基苯基二苯基磷酸酯、双(2-异丙基苯基)苯基磷酸酯、2,4-二异丙基苯基二苯基磷酸酯、双(4-异丙基苯基)苯基磷酸酯、三(3,4-二甲基苯基)磷酸酯、三(4-叔丁基苯基)磷酸酯、双(2,4-二异丙基苯基)苯基磷酸酯、三(3-异丙基苯基)磷酸酯、三(4-异丙基苯基)磷酸酯、2-叔丁基苯基二苯基磷酸酯、4-叔丁基苯基二苯基磷酸酯、双(2-叔丁基苯基)苯基磷酸酯和双(4-叔丁基苯基)苯基磷酸酯;Described organophosphate triesters include triethyl phosphate, tri(2-chloroethyl) phosphate, tripropyl phosphate, tetrakis(2-chloroethyl) dichloroisoamyl diphosphate, triphenyl phosphate ester, tris(2,3-dibromopropyl) phosphate, tributyl phosphate, cresol diphenyl phosphate, tris(2-butoxyethyl) phosphate, tricresyl phosphate, resorcinol Bis(diphenyl phosphate), 2-ethylhexyl-diphenyl phosphate, isodecyl diphenyl phosphate, tris(3,5-dimethylphenyl) phosphate, bisphenol A bis(diphenyl phosphate phenyl ester), tris(2-isopropylphenyl) phosphate, tris(2-ethylhexyl) phosphate, tert-butylphenyl diphenyl phosphate, 2-isopropylphenyl diphenyl phosphate ester, 4-isopropylphenyl diphenyl phosphate, bis(2-isopropylphenyl)phenyl phosphate, 2,4-diisopropylphenyl diphenyl phosphate, bis(4- Isopropylphenyl) phenyl phosphate, tris(3,4-dimethylphenyl) phosphate, tris(4-tert-butylphenyl) phosphate, bis(2,4-diisopropylphenyl) Base) phenyl phosphate, tris (3-isopropylphenyl) phosphate, tris (4-isopropylphenyl) phosphate, 2-tert-butylphenyl diphenyl phosphate, 4-tert-butyl phenyl diphenyl phosphate, bis(2-tert-butylphenyl)phenyl phosphate and bis(4-tert-butylphenyl)phenyl phosphate;所述的邻苯二甲酸酯类包括邻苯二甲酸单酯类和邻苯二甲酸二酯类中的至少一种;The phthalic acid esters include at least one of phthalic acid monoesters and phthalic acid diesters;所述的邻苯二甲酸单酯类包括邻苯二甲酸单乙酯、邻苯二甲酸单异丙酯、邻苯二甲酸单丁酯、邻苯二甲酸单正戊酯、邻苯二甲酸单环己酯、邻苯二甲酸单己基酯、邻苯二甲酸单苄酯、邻苯二甲酸单-2-庚酯、邻苯二甲酸单辛酯、邻苯二甲酸单乙基己基酯、邻苯二甲酸单异壬酯、邻苯二甲酸单(2-乙基-5-氧己基)酯、邻苯二甲酸单(2-乙基-5-羟基己基)酯和单(2-乙基-5-羧基戊基)邻苯二甲酸酯;The phthalic acid monoesters include monoethyl phthalate, monoisopropyl phthalate, monobutyl phthalate, mono-n-pentyl phthalate, mono-phthalate Cyclohexyl phthalate, monohexyl phthalate, monobenzyl phthalate, mono-2-heptyl phthalate, monooctyl phthalate, monoethylhexyl phthalate, ortho Mono-isononyl phthalate, mono(2-ethyl-5-oxohexyl) phthalate, mono(2-ethyl-5-hydroxyhexyl) phthalate and mono(2-ethyl-5-hydroxyhexyl) phthalate -5-carboxypentyl)phthalate;所述的邻苯二甲酸二酯类包括邻苯二甲酸二甲酯、邻苯二甲酸二乙酯、邻苯二甲酸二烯丙酯、邻苯二甲酸二丙酯、邻苯二甲酸二异丙酯、邻苯二甲酸二异丁酯、邻苯二甲酸二丁酯、邻苯二甲酸异丁环己酯、邻苯二甲酸二异戊酯、邻苯二甲酸丁苄酯、邻苯二甲酸二苯酯、邻苯二甲酸二己酯、邻苯二甲酸二异己酯、邻苯二甲酸双-4-甲基-2-戊酯、邻苯二甲酸二苄酯、邻苯二甲酸二庚酯、邻苯二甲酸二壬酯和邻苯二甲酸二十二烷基酯;The phthalic acid diesters include dimethyl phthalate, diethyl phthalate, diallyl phthalate, dipropyl phthalate, diisophthalate Propyl ester, diisobutyl phthalate, dibutyl phthalate, isobutylcyclohexyl phthalate, diisoamyl phthalate, butyl benzyl phthalate, phthalate Diphenyl formate, dihexyl phthalate, diisohexyl phthalate, bis-4-methyl-2-pentyl phthalate, dibenzyl phthalate, di-phthalate Heptyl, dinonyl phthalate and behenyl phthalate;所述的个人护理产品包括对羟基苯甲酸甲酯、对羟基苯甲酸丁酯、对羟基苯甲酸苄酯、对羟基苯甲酸乙酯、对羟基苯甲酸丙酯、正庚基对羟基苯甲酸酯和三氯生;Said personal care products include methylparaben, butylparaben, benzylparaben, ethylparaben, propylparaben, n-heptylparaben esters and triclosan;所述的苯酚类化合物包括双酚类似物中的至少一种;The phenolic compound includes at least one of bisphenol analogues;所述的双酚类似物包括双酚A、双酚E、双酚B、双酚C、双酚AF、双酚F、双酚M、双酚P、双酚G、双酚Z、双酚S、双酚AP、双酚BP和双酚PH;The bisphenol analogs include bisphenol A, bisphenol E, bisphenol B, bisphenol C, bisphenol AF, bisphenol F, bisphenol M, bisphenol P, bisphenol G, bisphenol Z, bisphenol S, bisphenol AP, bisphenol BP and bisphenol PH;所述的紫外稳定剂包括苯甲酮类、苯并噻唑类、苯并三唑类以及其他类别的紫外稳定剂中的至少一种;The ultraviolet stabilizer includes at least one of benzophenones, benzothiazoles, benzotriazoles and other types of ultraviolet stabilizers;所述的苯甲酮类紫外稳定剂包括2,4-二羟基二苯甲酮、2,2',4,4'-四羟基二苯甲酮、2-羟基-4-甲氧基苯并苯酮、2-羟基-4-甲氧基-5-磺酸二苯甲酮、2,2'-二羟基-4,4'-二甲氧基二苯甲酮、2,2'-羟基-4-甲氧基二苯甲酮、4-羟基二苯甲酮和2,3,4-三羟基二苯甲酮;Described benzophenone UV stabilizer includes 2,4-dihydroxybenzophenone, 2,2',4,4'-tetrahydroxybenzophenone, 2-hydroxy-4-methoxybenzo Benzophenone, 2-hydroxy-4-methoxy-5-sulfonic acid benzophenone, 2,2'-dihydroxy-4,4'-dimethoxybenzophenone, 2,2'-hydroxy - 4-methoxybenzophenone, 4-hydroxybenzophenone and 2,3,4-trihydroxybenzophenone;所述的苯并噻唑类紫外稳定剂包括2-甲基苯并噻唑、2-苯并噻唑基-N-吗啉基硫醚、2-甲硫基苯并噻唑、2-氨基苯并噻唑和2-羟基苯并噻唑;Described benzothiazole UV stabilizer includes 2-methylbenzothiazole, 2-benzothiazolyl-N-morpholinyl sulfide, 2-methylthiobenzothiazole, 2-aminobenzothiazole and 2-Hydroxybenzothiazole;所述的苯并三唑类紫外稳定剂包括1-羟基苯并三唑、5-甲基苯并三氮唑、5-氯代苯并三氮唑、4-甲基-1-氢苯并三唑、2-(2'-羟基-5'-甲基苯基)苯并三唑、2-(5-叔丁基-2-羟苯基)苯并三唑和2-(2'-羟基-3',5'-二叔丁基苯基)-苯并三唑;Described benzotriazole UV stabilizer includes 1-hydroxybenzotriazole, 5-methylbenzotriazole, 5-chlorobenzotriazole, 4-methyl-1-hydrobenzotriazole Triazole, 2-(2'-hydroxy-5'-methylphenyl)benzotriazole, 2-(5-tert-butyl-2-hydroxyphenyl)benzotriazole and 2-(2'- Hydroxy-3',5'-di-tert-butylphenyl)-benzotriazole;所述的其他类别紫外稳定剂包括4-叔丁基-4'-甲氧基二苯甲酰甲烷、4-甲基苄亚基樟脑、甲氧基肉桂酸异戊酯、2-氰基-3,3-二苯基丙烯酸异辛酯、对二甲氨基苯甲酸异辛酯、对甲氧基肉桂酸辛酯、2-(2H-苯并三唑-2-基)-4,6-双(1-甲基-1-苯乙基)苯酚、2,4-二叔丁基-6-(5-氯-2H-苯并三唑-2-基)苯酚和2-(2H-苯并三唑-2-基)-4,6-二叔戊基苯酚;Other classes of UV stabilizers mentioned include 4-tert-butyl-4'-methoxydibenzoylmethane, 4-methylbenzylidene camphor, isoamyl methoxycinnamate, 2-cyano- 3,3-Diphenylisooctyl acrylate, isooctyl p-dimethylaminobenzoate, octyl p-methoxycinnamate, 2-(2H-benzotriazol-2-yl)-4,6-bis (1-methyl-1-phenethyl)phenol, 2,4-di-tert-butyl-6-(5-chloro-2H-benzotriazol-2-yl)phenol and 2-(2H-benzo Triazol-2-yl)-4,6-di-tert-amylphenol;所述的光引发剂包括苯甲酮、4-甲基二苯甲酮、1-羟基环己基苯基甲酮、4-苯基二苯甲酮、1,2-二苯基-1,2-乙二酮、2-乙基蒽醌、邻苯甲酰苯 甲酸甲酯、2,2-二甲氧基-2-苯基苯乙酮、对二甲氨基二苯甲酮、4,4'-双(二甲氨基)二苯甲酮、4,4'-双(二乙氨基)二苯甲酮、4-氨基苯甲酸乙酯、4-二甲氨基苯甲酸乙酯、2-异丙基噻吨酮和2,4-二乙基噻吨酮;Described photoinitiator comprises benzophenone, 4-methyl benzophenone, 1-hydroxycyclohexyl phenyl ketone, 4-phenyl benzophenone, 1,2-diphenyl-1,2 -Ethylenedione, 2-ethylanthraquinone, methyl phthaloylbenzoate, 2,2-dimethoxy-2-phenylacetophenone, p-dimethylaminobenzophenone, 4,4 '-Bis(dimethylamino)benzophenone, 4,4'-bis(diethylamino)benzophenone, ethyl 4-aminobenzoate, ethyl 4-dimethylaminobenzoate, 2-iso Propylthioxanthone and 2,4-diethylthioxanthone;所述的抗氧化剂包括在正离子检测模式和负离子检测模式下进行检测的抗氧化剂;The antioxidants include antioxidants detected in positive ion detection mode and negative ion detection mode;所述的在负离子检测模式下进行检测的抗氧化剂包括3-叔丁基-4-羟基茴香醚、3,5-二叔丁基-4-羟基苯甲醛、3,5-二叔丁基-4-羟基苯甲酸、2,6-二叔丁基-4-(羟甲基)苯酚、2,4-二叔丁基苯酚、4,4'-亚丁基双(6-叔丁基-间甲酚)、4-(1,1,3,3-四甲基丁基)苯酚、2,2'-亚甲基双(4-乙基-6-叔丁基苯酚)、2,2'-亚甲基双(6-叔丁基-4-甲基苯酚)、二乙基-3,5-二叔丁基-4-羟基苄基膦酸酯、2,2'-硫代双(6-叔丁基-对甲酚)、1,2-双(3,5-二叔丁基-4-羟基氢化肉桂酰基)肼和4,4'-硫代双(6-叔丁基-间甲酚);The antioxidants detected under negative ion detection mode include 3-tert-butyl-4-hydroxyanisole, 3,5-di-tert-butyl-4-hydroxybenzaldehyde, 3,5-di-tert-butyl- 4-Hydroxybenzoic acid, 2,6-di-tert-butyl-4-(hydroxymethyl)phenol, 2,4-di-tert-butylphenol, 4,4'-butylenebis(6-tert-butyl-m- cresol), 4-(1,1,3,3-tetramethylbutyl)phenol, 2,2'-methylenebis(4-ethyl-6-tert-butylphenol), 2,2' -Methylenebis(6-tert-butyl-4-methylphenol), diethyl-3,5-di-tert-butyl-4-hydroxybenzylphosphonate, 2,2'-thiobis( 6-tert-butyl-p-cresol), 1,2-bis(3,5-di-tert-butyl-4-hydroxyhydrocinnamoyl)hydrazine and 4,4'-thiobis(6-tert-butyl- m-cresol);所述的在正离子检测模式下进行检测的抗氧化剂包括1,3-二邻甲苯胍、1,3-二苯基-2-硫脲、2,2'-亚乙基-双(4,6-二叔丁基苯酚)、甲基-2-巯基苯并咪唑、11-甲基十二烷基3-[4-羟基-3,5-双(2-甲基-2-丙烷基)苯基]丙酸酯、二苄基羟胺、三(4-叔丁基-3-羟基-2,6-二甲基苄基)异氰脲酸酯、1,3,5-三甲基-2,4,6-三(3,5-二叔丁基-4-羟基苄基)苯、2,6-二叔丁基-4-(二甲氨基-甲基)苯酚、三(2,4-二叔丁基苯基)亚磷酸酯、磺基二基二-2,1-乙二基双[3-(4-羟基-3,5-双(2-甲基-2-丙烷基)苯基)丙酸酯]、2,2'-硫代双(6-叔丁基-对甲酚)、N,N'-1,6-己二基双[3-[4-羟基-3,5-双(2-甲基-2-丙烷基)苯基]丙酰胺]、1,2-乙二基双(氧-2,1-乙二基)双[3-[4-羟基-3-甲基-5-(2-甲基-2-丙烷基)苯基]丙酸酯]、1,6-己二基双[3-[4-羟基-3,5-双(2-甲基-2-丙烷基)苯基]丙酸酯]、4-[[4,6-双(辛基硫烷基)-1,3,5-三嗪-2-基]氨基]-2,6-二叔丁基苯酚、n-苯基-1-萘胺、双[4-(2-苯基-2-丙基)苯基]胺、N,N'-二苯基-1,4-苯二胺、(1,2-二氧代-1,2-乙二基)双(亚氨基-2,1-乙二基)双[3-[4-羟基-3,5-双(2-甲基-2-丙烷基)苯基]丙酸酯]、N,N'-二乙基硫脲和1,3-二苯基胍;The antioxidants detected in the positive ion detection mode include 1,3-di-o-tolylguanidine, 1,3-diphenyl-2-thiourea, 2,2'-ethylene-bis(4, 6-di-tert-butylphenol), methyl-2-mercaptobenzimidazole, 11-methyldodecyl 3-[4-hydroxy-3,5-bis(2-methyl-2-propanyl) Phenyl]propionate, dibenzylhydroxylamine, tris(4-tert-butyl-3-hydroxy-2,6-dimethylbenzyl)isocyanurate, 1,3,5-trimethyl- 2,4,6-tris(3,5-di-tert-butyl-4-hydroxybenzyl)benzene, 2,6-di-tert-butyl-4-(dimethylamino-methyl)phenol, tris(2, 4-di-tert-butylphenyl)phosphite, sulfodiyldi-2,1-ethanediylbis[3-(4-hydroxy-3,5-bis(2-methyl-2-propanyl) )phenyl)propionate], 2,2'-thiobis(6-tert-butyl-p-cresol), N,N'-1,6-hexanediylbis[3-[4-hydroxy- 3,5-bis(2-methyl-2-propanyl)phenyl]propionamide], 1,2-ethanediylbis(oxy-2,1-ethanediyl)bis[3-[4-hydroxy -3-methyl-5-(2-methyl-2-propanyl)phenyl]propionate], 1,6-hexanediylbis[3-[4-hydroxy-3,5-bis(2 -methyl-2-propanyl)phenyl]propionate], 4-[[4,6-bis(octylsulfanyl)-1,3,5-triazin-2-yl]amino]- 2,6-di-tert-butylphenol, n-phenyl-1-naphthylamine, bis[4-(2-phenyl-2-propyl)phenyl]amine, N,N'-diphenyl-1 ,4-Phenylenediamine, (1,2-dioxo-1,2-ethanediyl)bis(imino-2,1-ethanediyl)bis[3-[4-hydroxyl-3,5- Bis(2-methyl-2-propanyl)phenyl]propionate], N,N'-diethylthiourea and 1,3-diphenylguanidine;所述的增塑剂包括丁二酸二乙酯、己二酸二甲酯、己二酸二乙酯、壬二酸二甲酯、2,2,4-三甲基-1,3-戊二醇二异丁酸酯、富马酸二丁酯、癸二酸二甲酯、肉豆蔻酸异丙酯、柠檬酸三乙酯、二甘醇二苯甲酸酯、癸二酸二丁酯、棕榈酸异丙酯、乙酰柠檬酸三乙酯、油酸丙酯、马来酸二(2-乙基己基)酯、二苯甲酸二聚丙二醇酯、甘油单油酸酯、壬二酸二己酯、硬脂酸甘油酯、柠檬酸三丁酯、(Z)-油酸-2-四氢呋喃甲酯、12-乙酰氧基-[R-(Z)]-9-烯-十八酸丁酯、壬二酸二异辛酯、乙酰柠檬酸三正丁酯、癸二酸二异辛酯、丁酰柠檬酸三正己酯、己二酸庚基壬基酯、己二酸二丁酯、己二酸二异癸烷基酯、环己烷1,2-二甲酸二异壬基酯和偏苯三酸三辛酯;The plasticizer includes diethyl succinate, dimethyl adipate, diethyl adipate, dimethyl azelate, 2,2,4-trimethyl-1,3-pentane Glycol Diisobutyrate, Dibutyl Fumarate, Dimethyl Sebacate, Isopropyl Myristate, Triethyl Citrate, Diethylene Glycol Dibenzoate, Dibutyl Sebacate , Isopropyl Palmitate, Acetyl Triethyl Citrate, Propyl Oleate, Di(2-Ethylhexyl) Maleate, Dipropylene Glycol Dibenzoate, Glyceryl Monooleate, Azelaic Acid Di Hexyl ester, glyceryl stearate, tributyl citrate, (Z)-oleic acid-2-tetrahydrofuryl methyl ester, 12-acetoxy-[R-(Z)]-9-ene-octadecanoic acid butyl Esters, di-isooctyl azelate, tri-n-butyl acetyl citrate, di-iso-octyl sebacate, tri-n-hexyl butyryl citrate, heptylnonyl adipate, dibutyl adipate, Diisodecyl adipate, diisononyl cyclohexane 1,2-dicarboxylate and trioctyl trimellitate;所述的全氟化合物包括全氟正辛酸、全氟辛烷磺酸、全氟正丁酸、全氟正庚酸、全氟正己酸、全氟正癸酸、全氟正十二烷酸、全氟正壬酸、全氟正十一烷酸、全氟正戊酸、全氟正十四烷酸、全氟正十三烷酸、全氟-1-丁烷磺酸钾、全氟-1-癸烷磺酸钠、全氟-1-庚烷磺酸钠、全氟-1-己磺酸钠、全氟-1-辛烷磺酰胺、N-甲基全氟-1-辛磺酰胺、N-乙基全氟-1-辛烷磺酰胺、1H,1H,2H,2H-全氟己烷磺酸钠(4:2)、1H,1H,2H,2H-全氟辛烷磺酸钠(6:2)、1H,1H,2H,2H-全氟癸烷磺酸钠(8:2)、氯十六烷-氟-3-氧杂戊烷-1-磺酸钾、11-氯二十碳氟-3-氧十一烷-1-磺酸钾和全氟-2,5-二甲基-3,6-二恶烷酸;The perfluorinated compounds include perfluoron-octanoic acid, perfluorooctanesulfonic acid, perfluoron-butyric acid, perfluoron-heptanoic acid, perfluoron-hexanoic acid, perfluoron-decanoic acid, perfluoron-dodecanoic acid, Perfluoro-n-nonanoic acid, perfluoro-n-undecanoic acid, perfluoro-n-valeric acid, perfluoro-n-tetradecanoic acid, perfluoro-n-tridecanoic acid, perfluoro-1-butanesulfonic acid potassium, perfluoro- Sodium 1-decanesulfonate, sodium perfluoro-1-heptanesulfonate, sodium perfluoro-1-hexanesulfonate, perfluoro-1-octanesulfonamide, N-methylperfluoro-1-octanesulfonate Amide, N-ethylperfluoro-1-octanesulfonamide, 1H,1H,2H,2H-sodium perfluorohexanesulfonate (4:2), 1H,1H,2H,2H-perfluorooctanesulfonate sodium perfluorodecane sulfonate (6:2), sodium 1H,1H,2H,2H-perfluorodecanesulfonate (8:2), potassium chlorohexadecane-fluoro-3-oxopentane-1-sulfonate, 11 - Potassium chloroeicosafluoro-3-oxoundecane-1-sulfonate and perfluoro-2,5-dimethyl-3,6-dioxane acid;所述的有机磷农药包括毒死蜱、二嗪农、甲基对硫磷、对硫磷、马拉硫磷、乐果、敌敌畏、3-甲基-4-硝基苯酚、香豆磷、二恶唑磷、杀灭磷、2-异丙基-6-甲基-4-嘧啶醇、异灭磷、美卡巴姆、杀虫剂、磷酮、吡唑磷和对硝基苯酚;The organophosphorus pesticides include chlorpyrifos, diazinon, methyl parathion, parathion, malathion, dimethoate, dichlorvos, 3-methyl-4-nitrophenol, coumarin, dioxin Azophos, methazol, 2-isopropyl-6-methyl-4-pyrimidinol, isofenfos, mecarbam, insecticides, phosphonone, pyrazophos, and p-nitrophenol;所述的拟除虫菊酯包括3-苯氧基苄醇、4-氟-3-苯氧基苯甲酸、顺-3-(2-氯-3,3,3-三氟-1-丙烯基)-2,2-二甲基-环丙烷羧酸和高效氯氟氰菊酯;The pyrethroids include 3-phenoxybenzyl alcohol, 4-fluoro-3-phenoxybenzoic acid, cis-3-(2-chloro-3,3,3-trifluoro-1-propenyl) - 2,2-Dimethyl-cyclopropanecarboxylic acid and lambda-cyhalothrin;所述的新烟碱类农药包括啶虫脒、呋虫胺、吡虫啉、噻虫啉和噻虫嗪;The neonicotinoid pesticides include acetamiprid, dinotefuran, imidacloprid, thiacloprid and thiamethoxam;所述的氨基甲酸酯类农药包括多菌灵、呋喃丹、氯丙胺、非诺威、异威威、灭多威、抗蚜威和苯胺灵;The carbamate pesticides include carbendazim, carbofuran, chlorpromine, fenovir, isocarb, methomyl, pirimicarb and phenhydramine;所述的酸性除草剂包括2,4-二氯苯氧丁酸、2,4,5-涕丙酸、2,4,5-三氯苯氧乙酸、2,4-滴丙酸、2-甲基-4-氯苯氧乙酸、2-甲基-4-氯戊氧基丙酸和2-甲基-4-氯苯氧基丁酸;Described acidic herbicide comprises 2,4-dichlorophenoxybutyric acid, 2,4,5-nylpropionic acid, 2,4,5-trichlorophenoxyacetic acid, 2,4-dipropionic acid, 2- Methyl-4-chlorophenoxyacetic acid, 2-methyl-4-chloropentyloxypropionic acid and 2-methyl-4-chlorophenoxybutyric acid;所述的唑类农药包括联苯三唑醇、环唑醇、苯醚甲环唑、氟环唑、芬布康唑、氟硅唑、抑菌灵、丁苯胺、戊康唑、丙氯灵、戊唑醇、四康唑和噻菌灵;The azole pesticides include bifendazole, cyproconazole, difenoconazole, econazole, fenbuconazole, flusilazole, fenzazolin, butylaniline, penconazole, prochloraz , tebuconazole, tetraconazole and thiabendazole;所述的三唑酮类农药包括氯唑草酮、己嗪酮、苯嗪草酮、嗪草酮、苯胺、阿特拉顿、阿特拉津、扑灭通、扑草净、扑灭津、仲丁通、西玛津、西草净和特丁净;The triadimefon pesticides include chlorfentrazone, hexazone, fenmetrione, metrizone, aniline, atrazine, atrazine, prometon, promethazine, propazine, Dingtong, Simazine, Xicaojing and Terdingjing;所述的尿素类农药包括氯磺隆、氯脲酮、1-(3,4-二氯苯基)-3-甲基脲、1-(3,5-二氯苯基)脲、甲基苯噻隆、溴谷隆、甲氧隆、敌草隆、3-苯基-1,1-二甲基脲、异丙隆和利谷隆;The urea pesticides include chlorsulfuron, chlorourea, 1-(3,4-dichlorophenyl)-3-methylurea, 1-(3,5-dichlorophenyl)urea, methyl Benzhiuron, Broglucuron, Methoxyuron, Diuron, 3-Phenyl-1,1-Dimethylurea, Isoproturon, and Riguron;所述的酰胺类农药包括甲草胺、二甲草胺、N,N-二甲基氨基-N-甲苯和环酰菌胺;The amide pesticides include alachlor, dimethachlor, N,N-dimethylamino-N-toluene and fenhexamid;所述的甲氧基丙烯酸酯类杀菌剂包括嘧菌酯、嘧螨酯、醚菌酯、吡唑醚菌酯和肟菌酯;The methoxyacrylate fungicides include azoxystrobin, pyrimaben, kysstrobin, pyraclostrobin and trifloxystrobin;所述的其他杀虫剂包括氟担菌宁、啶酰菌胺、恶唑菌酮、甲霜灵、氟苯嘧啶醇和苄草丹;The other insecticides mentioned include flunobendonin, boscalid, oxaflucondone, metalaxyl, pyrimidol and procarbal;所述的有机氯农药包括二氯丙酸、ALPHA-六六六、BETA-六六六、林丹、δ-六六六、Ε-六六六、顺式A-氯丹、反式氯丹、氧氯丹、4,4-滴滴滴、2,2-双(4-氯苯基)-1,1-二氯乙烯、2,2-双(对氯苯基)-1,1,1-三氯乙烷、1-(2-氯苯基)-1-(4-氯苯基)-2,2-二氯乙烷、3-邻氯苯基-2-对氯苯基-1,1-二氯乙烯溶液、1,1,1-三氯-2-(2-氯苯基)-2-(4-氯苯基)乙烷、狄氏剂、alpha-硫丹、BETA-硫丹、安特灵、异狄氏剂酮、七氯、内环氧七氯、六氯苯和吡唑草胺;The organochlorine pesticides include dichloropropionic acid, ALPHA-666, BETA-666, lindane, δ-666, Ε-666, cis-A-chlordane, trans-chlordane, Oxychlordane, 4,4-Dididi, 2,2-bis(4-chlorophenyl)-1,1-dichloroethylene, 2,2-bis(p-chlorophenyl)-1,1,1 -Trichloroethane, 1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane, 3-o-chlorophenyl-2-p-chlorophenyl-1 , 1-dichloroethylene solution, 1,1,1-trichloro-2-(2-chlorophenyl)-2-(4-chlorophenyl)ethane, dieldrin, alpha-endosulfan, BETA- Endosulfan, Antralin, Endrinone, Heptachlor, Endoepoxide, Hexachlorobenzene, and Metafenac;所述的液晶单体包括4-乙烯基-4'-丙基-1,1'-联环己烷、1-甲氧基-4-(4-丙基环己基)环己烷、1-(丙-1-烯基)-4-(4-丙基环己基)环己烷、1-乙氧基-2,3-二氟-4-(4-丙基环己基)苯、4-甲基-4'-戊基联苯、1-乙氧基-2,3-二氟-4-(4-丙基苯基)苯、4-(4-乙基环己基)-4'-(三氟甲氧基)联苯、4-(4-甲基苯基)-4'-乙烯基-1,1'-双(环己基)、4-[二氟(3,4,5-三氟苯氧基)甲基]-3,5-二氟-4'-丙基联苯、1-甲基-4-(4-(4-丙基环己基)环己基)苯、4-[二氟(2-甲基-3,4,5-三氟苯氧基)甲基]-3,5-二氟-4'-丙基联苯、2,3-二氟-1-甲氧基-4-(4-(4-丙基环己基)环己基)苯、l-乙基-4-(4-(4丙基环己基)苯基)苯、2,3-二氟-1-乙氧基-4-(4-(4-乙基环己基)苯基)苯、4"-乙基-2'-氟-4-丙基-l,l':4',1"-三联苯、(4-乙氧基-2,3-二氟-4'-(4-丙基环己基)联苯)、2,3-二氟-1-丙氧基-4-(4-(4-丙基环己基)环己基)苯、1-(4-(4-丁基环己基)环己基)-4-乙氧基-2,3-二氟苯、4-丁基-4"-乙基-2'-氟-l,l':4',1"-三联苯、3,4-二氟-4'-[4'-乙基-1,1'-双(环己基)-4-基]联苯、3,4-二氟-4'-丙基-l,l'-联苯、4'-乙基联苯-4-甲腈、4'-丙氧基-4-联苯甲腈、4-丙基1-4'-[4-(三氟甲氧基)苯基]-1,1'-双环己基、4"-乙基-2',3,4,5-四氟-1,1':4',1"-三联苯、4-氰基-4'-戊氧基联苯、4-己氧基-4-联苯甲腈和4'-(辛氧基)-4-联苯甲腈。The liquid crystal monomers include 4-vinyl-4'-propyl-1,1'-bicyclohexane, 1-methoxy-4-(4-propylcyclohexyl)cyclohexane, 1- (Prop-1-enyl)-4-(4-propylcyclohexyl)cyclohexane, 1-ethoxy-2,3-difluoro-4-(4-propylcyclohexyl)benzene, 4- Methyl-4'-pentylbiphenyl, 1-ethoxy-2,3-difluoro-4-(4-propylphenyl)benzene, 4-(4-ethylcyclohexyl)-4'- (Trifluoromethoxy)biphenyl, 4-(4-methylphenyl)-4'-vinyl-1,1'-bis(cyclohexyl), 4-[difluoro(3,4,5- Trifluorophenoxy)methyl]-3,5-difluoro-4'-propylbiphenyl, 1-methyl-4-(4-(4-propylcyclohexyl)cyclohexyl)benzene, 4- [Difluoro(2-methyl-3,4,5-trifluorophenoxy)methyl]-3,5-difluoro-4'-propylbiphenyl, 2,3-difluoro-1-methyl Oxy-4-(4-(4-propylcyclohexyl)cyclohexyl)benzene, l-ethyl-4-(4-(4-propylcyclohexyl)phenyl)benzene, 2,3-difluoro- 1-ethoxy-4-(4-(4-ethylcyclohexyl)phenyl)benzene, 4"-ethyl-2'-fluoro-4-propyl-l,l':4',1" -Terphenyl, (4-ethoxy-2,3-difluoro-4'-(4-propylcyclohexyl)biphenyl), 2,3-difluoro-1-propoxy-4-(4 -(4-Propylcyclohexyl)cyclohexyl)benzene, 1-(4-(4-butylcyclohexyl)cyclohexyl)-4-ethoxy-2,3-difluorobenzene, 4-butyl-4" -Ethyl-2'-fluoro-l,l':4',1"-terphenyl, 3,4-difluoro-4'-[4'-ethyl-1,1'-bis(cyclohexyl) -4-yl]biphenyl, 3,4-difluoro-4'-propyl-l,l'-biphenyl, 4'-ethylbiphenyl-4-carbonitrile, 4'-propoxy-4 -Biphenylcarbonitrile, 4-propyl 1-4'-[4-(trifluoromethoxy)phenyl]-1,1'-bicyclohexyl, 4"-ethyl-2',3,4, 5-tetrafluoro-1,1':4',1"-terphenyl, 4-cyano-4'-pentyloxybiphenyl, 4-hexyloxy-4-biphenylcarbonitrile and 4'-( octyloxy)-4-biphenylcarbonitrile.
- 根据权利要求4或5所述的血浆中环境污染物靶向暴露组分析方法,其特征在于:所述邻苯二甲酸酯类替换为间苯二甲酸二甲酯、间苯二甲酸二苯酯和己二酸二(2-乙基己基)酯。The targeted exposure group analysis method for environmental pollutants in plasma according to claim 4 or 5, characterized in that: the phthalates are replaced by dimethyl isophthalate and diphenyl isophthalate and bis(2-ethylhexyl) adipate.
- 根据权利要求1或2所述的血浆中环境污染物靶向暴露组分析方法,其特征在于:The targeted exposure group analysis method for environmental pollutants in plasma according to claim 1 or 2, characterized in that:步骤(1)中所述的回收率指示物包括三2-丁氧基-[13C2]-乙基)磷酸酯、磷酸三正丁酯-d27、三(2-氯乙基)磷酸酯-d12、三(1,3-二氯-2-丙基)磷酸酯-d15、磷酸三乙酯-d15、磷酸三苯酯-d15、双(丁氧基乙基)磷酸酯-d8、双(1,3-二氯-2-丙基)磷酸酯-d10、双(2-乙基己基)磷酸酯-d34、磷酸二丁酯-d18、磷酸二邻甲苯酯-d14、二对甲苯基磷酸酯-d14、磷酸二苯酯-d10、邻苯二甲酸二苄酯-d4、邻苯二甲酸二正丁酯-d4、邻苯二甲酸二异丁酯-3,4,5,6-d4、邻苯二甲酸二环己酯-3,4,5,6-d4、双(2-乙基己基)邻苯二甲酸酯-3,4,5,6-d4、邻苯二甲酸二乙酯-3,4,5,6-d4、邻苯二甲酸二正己酯-3,4,5,6-d4、邻苯二甲酸二甲酯-3,4,5,6-d4、邻苯二甲酸二正戊酯-3,4,5,6-d4、邻苯二甲酸二正丙酯-3,4,5,6-d4、邻苯二甲酸单苄酯-d4、邻苯二甲酸单正丁酯-d4、双(2-乙基己基)己二酸酯-d8、O-乙酰柠檬酸三丁酯-d3、双酚A-d6、双酚S-C12、三氯生-d3、2,4-二羟基二苯甲酮-13C6、苯并噻唑-d4、1H-苯并三唑-(环-d4)、5-甲基苯并三唑-d6、二苯甲酮-d10、2-羟基-4-甲氧基二苯甲酮-d5、全氟-n-[(13)C4]丁酸、全氟-n-[1,2-(13)C2]己酸、全氟-1-己烷[(18)O2]磺酸钠、全氟-n-[1,2,3,4-(13)C4]辛酸、全氟-n-[1,2,3,4,5-(13)C5]壬酸、全氟钠-1-[1,2,3,4-(13)C4]辛磺酸盐、全氟-n-[1,2-(13)C2]癸酸、全氟-n-[1,2-(13)C2]十一烷酸、全氟-n-[1,2-(13)C2]十二烷酸、全氟-1-[13C8]辛烷磺酰胺、N-甲基-d3-全氟-1-辛烷磺酰胺、N-乙基-d5-全氟-1-辛烷磺酰胺、1H,1H,2H,2H-全氟-1-[1,2-13C2]-辛烷磺酸钠、毒死蜱d10、γ-1,2,3,4,5,6-六氯环己烷-d6、反式氯菊酯d6、啶虫脒-d3、吡虫啉-d4、噻虫啉-d4、噻虫嗪-d3、多菌灵d3、呋喃丹d3、2,4-二氯苯氧基-3,5,6-d3-乙酸、2,4′-二氯二苯基三氯乙烷-d8、2-(4-氯-2-甲基苯氧基)丙酸-D3、噻苯达唑d4、十氚代西玛嗪、特丁草净-D5、氚代敌草隆-D6、异丙隆d6、异丙甲草胺d6、嘧菌酯d4和啶酰菌胺d4中的至少一种。The recovery indicators described in step (1) include three 2-butoxy-[13C2]-ethyl) phosphate, tri-n-butyl phosphate-d27, three (2-chloroethyl) phosphate-d12 , Tris(1,3-dichloro-2-propyl) phosphate-d15, triethyl phosphate-d15, triphenyl phosphate-d15, bis(butoxyethyl) phosphate-d8, bis(1 , 3-dichloro-2-propyl) phosphate-d10, bis(2-ethylhexyl) phosphate-d34, dibutyl phosphate-d18, di-o-cresyl phosphate-d14, 2-p-cresyl phosphate -d14, diphenyl phosphate-d10, dibenzyl phthalate-d4, di-n-butyl phthalate-d4, diisobutyl phthalate-3,4,5,6-d4, Dicyclohexyl phthalate-3,4,5,6-d4, bis(2-ethylhexyl)phthalate-3,4,5,6-d4, diethyl phthalate Ester-3,4,5,6-d4, di-n-hexyl phthalate-3,4,5,6-d4, dimethyl phthalate-3,4,5,6-d4, o-phthalate Di-n-pentyl dicarboxylate-3,4,5,6-d4, di-n-propyl phthalate-3,4,5,6-d4, monobenzyl phthalate-d4, phthalic acid Mono-n-butyl ester-d4, bis(2-ethylhexyl)adipate-d8, O-acetyl tributyl citrate-d3, bisphenol A-d6, bisphenol S-C12, triclosan-d3 , 2,4-dihydroxybenzophenone-13C6, benzothiazole-d4, 1H-benzotriazole-(ring-d4), 5-methylbenzotriazole-d6, benzophenone-d10 , 2-hydroxy-4-methoxybenzophenone-d5, perfluoro-n-[(13)C4]butanoic acid, perfluoro-n-[1,2-(13)C2]hexanoic acid, perfluoro-n-[1,2-(13)C2]hexanoic acid, Fluoro-1-hexane[(18)O2]sodium sulfonate, perfluoro-n-[1,2,3,4-(13)C4]octanoic acid, perfluoro-n-[1,2,3,4 , 5-(13)C5]nonanoic acid, perfluorosodium-1-[1,2,3,4-(13)C4]octylsulfonate, perfluoro-n-[1,2-(13)C2 ]decanoic acid, perfluoro-n-[1,2-(13)C2]undecanoic acid, perfluoro-n-[1,2-(13)C2]dodecanoic acid, perfluoro-1-[ 13C8] Octanesulfonamide, N-methyl-d3-perfluoro-1-octanesulfonamide, N-ethyl-d5-perfluoro-1-octanesulfonamide, 1H, 1H, 2H, 2H-perfluoro Fluoro-1-[1,2-13C2]-octane sulfonate sodium, chlorpyrifos d10, γ-1,2,3,4,5,6-hexachlorocyclohexane-d6, trans-permethrin d6, Acetamiprid-d3, imidacloprid-d4, thiacloprid-d4, thiamethoxam-d3, carbendazim d3, carbofuran d3, 2,4-dichlorophenoxy-3,5,6-d3-acetic acid , 2,4'-dichlorodiphenyltrichloroethane-d8, 2-(4-chloro-2-methylphenoxy)propionic acid-D3, thiabendazole d4, decatritium simazine Terding At least one of turfone-D5, diuron-D6 tritiated, isoproturon d6, metolachlor d6, azoxystrobin d4 and boscalid d4.
- 根据权利要求1或4所述的血浆中环境污染物靶向暴露组分析方法,其特征在于:The targeted exposure group analysis method for environmental pollutants in plasma according to claim 1 or 4, characterized in that:步骤(4)中所述的内标包括全氟化合物、增塑剂、有机氯农药、有机磷农药和液晶单体的内标;The internal standard described in step (4) comprises the internal standard of perfluorinated compound, plasticizer, organochlorine pesticide, organophosphorus pesticide and liquid crystal monomer;所述的全氟化合物的内标为全氟-n-[13C8]辛酸;The internal standard of the perfluorinated compound is perfluoro-n-[13C8] octanoic acid;所述的增塑剂的正模式的内标为蝇毒磷-d10,负模式的内标为双酚A-d16;The internal standard of the positive mode of the plasticizer is musphos-d10, and the internal standard of the negative mode is bisphenol A-d16;所述的有机氯农药的内标为十氯二苯醚;The internal standard of the organochlorine pesticide is decachlorodiphenyl ether;所述的有机磷农药的正模式的内标为蝇毒磷-d10,负模式的内标为对羟基苯甲酸叔丁酯-d9;The internal standard of the positive mode of the organophosphorus pesticide is muscarin-d10, and the internal standard of the negative mode is tert-butyl p-hydroxybenzoate-d9;所述的液晶单体的内标为十氯二苯醚。The internal standard of the liquid crystal monomer is decachlorodiphenyl ether.
- 根据权利要求1或4所述的血浆中环境污染物靶向暴露组分析方法,其特征在于:The targeted exposure group analysis method for environmental pollutants in plasma according to claim 1 or 4, characterized in that:步骤(4)中所述的液相色谱-串联质谱法的检测条件如下:The detection condition of the liquid chromatography-tandem mass spectrometry described in step (4) is as follows:①邻苯二甲酸二酯类:① Phthalic acid diesters:色谱条件包括:Chromatographic conditions include:流动相A:体积分数为0.1%的甲酸水溶液;Mobile phase A: 0.1% formic acid aqueous solution by volume fraction;流动相B:甲醇;Mobile phase B: Methanol;色谱柱:C18色谱柱;Chromatographic column: C18 chromatographic column;流速:0.2mL/min;Flow rate: 0.2mL/min;柱温:40℃;Column temperature: 40°C;洗脱程序:初始流动相B的体积百分含量为40%;0~2min,流动相B体积百分数从40%上升至70%;2~8min,流动相B体积百分数上升至100%;8~13min保持在100%不变,13~13.1min流动相B体积百分数降至40%;13.1~17min,保持在40%不变;Elution procedure: the initial volume percentage of mobile phase B is 40%; 0~2min, the volume percentage of mobile phase B rises from 40% to 70%; 2~8min, the volume percentage of mobile phase B rises to 100%; Keep at 100% for 13 minutes, the volume percentage of mobile phase B drops to 40% at 13-13.1 minutes; keep at 40% for 13.1-17 minutes;质谱条件包括:电喷雾离子源,离子源温度为550℃;检测模式为正离子检测模式;雾化气压;氮气,压力为55psi;The mass spectrometry conditions include: electrospray ion source, the ion source temperature is 550°C; the detection mode is positive ion detection mode; atomization air pressure; nitrogen, the pressure is 55psi;②邻苯二甲酸单酯类,苯甲酮类紫外线稳定剂,双酚类似物以及个人护理产品:② Phthalic acid monoesters, benzophenone UV stabilizers, bisphenol analogues and personal care products:色谱条件包括:Chromatographic conditions include:流动相A:0.2mmol/L乙酸铵水溶液;Mobile phase A: 0.2mmol/L ammonium acetate aqueous solution;流动相B:甲醇;Mobile phase B: Methanol;色谱柱:C18色谱柱;Chromatographic column: C18 chromatographic column;流速:0.2mL/min;Flow rate: 0.2mL/min;柱温:40℃;Column temperature: 40°C;洗脱程序:初始流动相B的体积百分数为10%;0~0.5min保持在10%数不变;0.5~1min,流动相B体积百分数从10%上升至50%;1~7min,流动相B体积分数从50%上升至99%;7~10min,保持在99%不变;10~10.1min,从99%下降到10%,10.1~12min,流动相B体积分数保持在10%不变;Elution procedure: the volume percentage of the initial mobile phase B is 10%; 0-0.5min keeps the number constant at 10%; 0.5-1min, the volume percentage of the mobile phase B rises from 10% to 50%; B volume fraction increased from 50% to 99%; 7-10min, kept at 99%; 10-10.1min, decreased from 99% to 10%, 10.1-12min, mobile phase B volume fraction remained at 10% ;质谱条件包括:电喷雾离子源,离子温度为550℃,检测模式为负离子检测模式;雾化气压:氮气,压力位55psi;Mass spectrometry conditions include: electrospray ion source, ion temperature is 550°C, detection mode is negative ion detection mode; atomization pressure: nitrogen, pressure 55psi;③增塑剂,苯并噻唑类、苯并三唑类和其他类别紫外稳定剂,光引发剂以及在正离子检测模式下进行检测的抗氧化剂:③Plasticizers, benzothiazoles, benzotriazoles and other UV stabilizers, photoinitiators and antioxidants detected in positive ion detection mode:色谱条件包括:Chromatographic conditions include:流动相A:体积分数为0.1%的甲酸水溶液;Mobile phase A: 0.1% formic acid aqueous solution by volume fraction;流动相B:甲醇;Mobile phase B: Methanol;色谱柱:C18色谱柱;Chromatographic column: C18 chromatographic column;流速:0.3mL/min;Flow rate: 0.3mL/min;柱温:40℃;Column temperature: 40°C;洗脱程序:初始流动相B体积百分数为40%,0~2min保持40%不变;2~4min,流动相B体积百分数由40%上升至80%;4~14min,流动相B体积百分数从80%上升至100%;14~17min,流动相B体积百分数保持在100%不变;17~20min,流动相B体积百分数下降至40%,20~24min,流动相B体积百分数保持在40%不变;Elution procedure: initial mobile phase B volume percentage is 40%, 0-2min keeps 40% unchanged; 2-4min, mobile phase B volume percentage rises from 40% to 80%; 4-14min, mobile phase B volume percentage increases from 80% rises to 100%; 14-17min, the volume percentage of mobile phase B remains at 100%; 17-20min, the volume percentage of mobile phase B drops to 40%, 20-24min, the volume percentage of mobile phase B remains at 40% constant;质谱条件包括:电喷雾离子源,离子温度为550℃,检测模式为正离子检测模式;雾化气压:氮气,压力位55psi;Mass spectrometry conditions include: electrospray ion source, ion temperature is 550°C, detection mode is positive ion detection mode; atomization pressure: nitrogen, pressure 55psi;④有机磷酸三酯类:④Organophosphate triesters:色谱条件包括:Chromatographic conditions include:流动相A:体积分数为0.1%甲酸水溶液;Mobile phase A: a volume fraction of 0.1% formic acid in water;流动相B:甲醇;Mobile phase B: Methanol;色谱柱:RP18色谱柱;Chromatographic column: RP18 chromatographic column;流速:0.3mL/min;Flow rate: 0.3mL/min;柱温:40℃;Column temperature: 40°C;洗脱程序:初始流动相B体积百分数为5%,0~1min保持在5%;1~3min流动相B体积分数从5%上升至40%;3~12min从40%上升至100%;12~15min保持100%不变;15~15.1min,流动相B体积百分数从100%降至5%;15.1~18min,流动相B体积分数保持在5%不变;Elution procedure: initial mobile phase B volume percentage is 5%, 0-1min maintains at 5%; 1-3min mobile phase B volume fraction rises from 5% to 40%; 3-12min rises from 40% to 100%; 12 From 15 minutes to 15 minutes, keep 100% unchanged; from 15 to 15.1 minutes, the volume percentage of mobile phase B decreases from 100% to 5%; from 15.1 to 18 minutes, the volume percentage of mobile phase B remains unchanged at 5%;质谱条件包括:电喷雾离子源,离子温度为550℃,检测模式为负离子检测模式;雾化气压:氮气,压力位55psi;Mass spectrometry conditions include: electrospray ion source, ion temperature is 550°C, detection mode is negative ion detection mode; atomization pressure: nitrogen, pressure 55psi;⑤有机磷酸二酯类:⑤Organophosphate diesters:色谱条件包括:Chromatographic conditions include:流动相A:0.2mmol/L乙酸铵水溶液;Mobile phase A: 0.2mmol/L ammonium acetate aqueous solution;流动相B:甲醇;Mobile phase B: Methanol;A子检测模式;雾化气压:氮气,压力位55psi:A sub-detection mode; atomization pressure: nitrogen, pressure 55psi:色谱柱:RP18色谱柱;Chromatographic column: RP18 chromatographic column;流速:0.3mL/min;Flow rate: 0.3mL/min;柱温:40℃;Column temperature: 40°C;洗脱程序:初始流动相B体积百分数为5%,0~4min,从5%上升至35%;4~7min,B相体积分数从35%上升至80%;7~12min从80%升至100%;12~14min保持100%不变;14~15min,流动相B体积百分数从100%降至5%;15~20min,流动相B体积百分数保持在5%不变;Elution procedure: initial mobile phase B volume percentage is 5%, 0~4min, rise from 5% to 35%; 4~7min, B phase volume fraction rises from 35% to 80%; 7~12min, rise from 80% to 100%; 12-14min keep 100% unchanged; 14-15min, mobile phase B volume percentage decreases from 100% to 5%; 15-20min, mobile phase B volume percentage remains unchanged at 5%;质谱条件包括:电喷雾离子源,离子温度为550℃,检测模式为负离子检测模式;雾化气压:氮气,压力位55psi:Mass spectrometry conditions include: electrospray ion source, ion temperature is 550°C, detection mode is negative ion detection mode; atomization pressure: nitrogen, pressure position 55psi:⑥在负离子检测模式下进行检测的抗氧化剂:⑥Antioxidants detected in negative ion detection mode:色谱条件包括:Chromatographic conditions include:流动相A:4mmol/L乙酸铵水溶液;Mobile phase A: 4mmol/L ammonium acetate aqueous solution;流动相B:甲醇;Mobile phase B: Methanol;色谱柱:C18色谱柱;Chromatographic column: C18 chromatographic column;流速:0.2mL/min;Flow rate: 0.2mL/min;柱温:40℃;Column temperature: 40°C;洗脱程序:初始流动相B的体积百分数为10%;0~0.5min保持10%不变;0.5~1min流动相B的体积百分数从10%上升至50%,1~7min上升至99%;7~10min保持在99%不变;10~10.1min,流动相B体积百分数迅速下降至10%;10.1~12min流动相B体积分数保持10%不变;Elution procedure: the initial volume percentage of mobile phase B is 10%; 0-0.5min keeps 10% unchanged; 0.5-1min the volume percentage of mobile phase B increases from 10% to 50%, and 1-7min rises to 99%; From 7 to 10 minutes, it remained at 99%; from 10 to 10.1 minutes, the volume percentage of mobile phase B dropped rapidly to 10%; from 10.1 to 12 minutes, the volume percentage of mobile phase B remained unchanged at 10%;质谱条件包括:电喷雾离子源,离子温度为550℃,检测模式为负离子检测模式;雾化气压:氮气,压力位55psi;⑦全氟化合物:Mass spectrometry conditions include: electrospray ion source, ion temperature of 550°C, detection mode of negative ion detection mode; atomization pressure: nitrogen, pressure position 55psi; ⑦ perfluorinated compounds:色谱条件包括:Chromatographic conditions include:流动相A:0.2mmol/L甲酸铵;Mobile phase A: 0.2mmol/L ammonium formate;流动相B:甲醇;Mobile phase B: Methanol;色谱柱:RP18色谱柱;Chromatographic column: RP18 chromatographic column;流速:0.3mL/min;Flow rate: 0.3mL/min;柱温:40℃;Column temperature: 40°C;洗脱程序:初始流动相B体积百分数为40%;0~2min内保持40%不变,2~3min流动相B体积百分数上升至66%;3~12min上升至77%;12~14min流动相B体积分数由70%上升至100%,14~16min保持在100%不变;16~16.1min迅速降至40%;16.1~22流动相B体积分数保持在40%不变;Elution procedure: initial mobile phase B volume percentage is 40%; 40% remains unchanged within 0-2min, mobile phase B volume percentage rises to 66% in 2-3min; rises to 77% in 3-12min; mobile phase in 12-14min B volume fraction rises from 70% to 100%, and remains unchanged at 100% for 14-16 minutes; quickly drops to 40% for 16-16.1 minutes; 16.1-22 mobile phase B volume fraction remains unchanged at 40%;质谱条件包括:电喷雾离子源,离子温度为550℃,检测模式为负离子检测模式;雾化气压:氮气,压力位55psi;Mass spectrometry conditions include: electrospray ion source, ion temperature is 550°C, detection mode is negative ion detection mode; atomization pressure: nitrogen, pressure 55psi;⑧有机磷农药,拟除虫菊酯,新烟碱类农药,氨基甲酸酯类农药,酸性除草剂,唑类农药,三唑酮类农药,尿素类农药,酰胺类农药,甲氧基丙烯酸酯类杀菌剂,其他杀虫剂:⑧Organophosphorus pesticides, pyrethroids, neonicotinoid pesticides, carbamate pesticides, acidic herbicides, azole pesticides, triadimefon pesticides, urea pesticides, amide pesticides, methoxyacrylate fungicides pesticides, other insecticides:流动相A:5mmol/L的乙酸铵溶液;Mobile phase A: 5mmol/L ammonium acetate solution;流动相B:乙腈;Mobile phase B: acetonitrile;色谱柱:C18色谱柱;Chromatographic column: C18 chromatographic column;流速:0.4mL/min;Flow rate: 0.4mL/min;柱温:40℃;Column temperature: 40°C;洗脱程序:初始流动相B的体积百分数为2%;0~4min流动相B体积百分数从宏观2%上升至30%;4~22min流动相体积百分数从30%上升至68%;22~22.1min流动相B从68%上升至99%;22.1~23min,保持在99%不变;23~23.1min,流动相B体积百分数从99%降至2%;23.1~26min,保持2%不变;Elution procedure: the volume percentage of the initial mobile phase B is 2%; the volume percentage of the mobile phase B increases from 2% to 30% in 0-4min; the volume percentage of the mobile phase increases from 30% to 68% in 4-22min; 22-22.1 Min mobile phase B increased from 68% to 99%; 22.1~23min, kept at 99%; 23~23.1min, mobile phase B volume percentage decreased from 99% to 2%; 23.1~26min, kept 2% unchanged ;质谱条件:电喷雾离子源,离子温度为550℃,检测模式为负离子检测模式;雾化气压:氮气,压力位55psi;Mass spectrometry conditions: electrospray ion source, ion temperature is 550°C, detection mode is negative ion detection mode; atomization pressure: nitrogen, pressure 55psi;步骤(4)中所述的气相色谱-串联质谱法的的检测条件如下:The detection condition of gas chromatography-tandem mass spectrometry described in step (4) is as follows:⑨有机氯农药:⑨Organochlorine pesticides:色谱条件包括:Chromatographic conditions include:色谱柱:安捷伦HP-5MS色谱柱19091S-433;Chromatographic column: Agilent HP-5MS chromatographic column 19091S-433;进样口温度:260℃;Injection port temperature: 260°C;升温程序:起始温度60℃,保持1min;以5℃/min的速度升温至300℃后保持9min;Heating program: initial temperature is 60°C, keep for 1min; heat up to 300°C at a rate of 5°C/min, then keep for 9min;质谱条件:电子轰击离子源,离子源温度为230℃,四极杆温度为150℃,溶剂延时3min;Mass spectrometry conditions: electron bombardment ion source, ion source temperature is 230°C, quadrupole temperature is 150°C, solvent delay is 3min;⑩液晶单体:⑩Liquid crystal monomer:色谱条件包括:Chromatographic conditions include:色谱柱:安捷伦HP-5MS色谱柱19091S-433;Chromatographic column: Agilent HP-5MS chromatographic column 19091S-433;进样口温度:260℃;Injection port temperature: 260°C;升温程序:起始温度80℃,保持2.5min;然后以25℃/min的速度升温至200℃后保持1min;再以10℃/min速度升至250℃后以5℃/min升至285℃,保持5min;最后以30℃/min的速度升至300℃,保持1minHeating program: initial temperature 80°C, keep for 2.5min; then raise the temperature to 200°C at a rate of 25°C/min and keep for 1min; then rise to 250°C at a rate of 10°C/min and then rise to 285°C at a rate of 5°C/min , hold for 5min; finally rise to 300°C at a speed of 30°C/min, hold for 1min质谱条件:电子轰击离子源,离子源温度230℃,四极杆温度为150℃,溶剂延时6min。Mass spectrometry conditions: electron bombardment ion source, ion source temperature 230°C, quadrupole temperature 150°C, solvent delay 6min.
- 根据权利要求1所述的血浆中环境污染物靶向暴露组分析方法,其特征在于:The targeted exposure group analysis method for environmental pollutants in plasma according to claim 1, characterized in that:步骤(1)中所述的血浆为人的血浆或动物的血浆;The plasma described in step (1) is human plasma or animal plasma;步骤(1)中所述的血浆通过如下方式获得:将采集的血液离心分离,取上清液,获得所需要的血浆;The plasma described in step (1) is obtained by centrifuging the collected blood, and taking the supernatant to obtain the required plasma;所述的离心的条件为:3000rpm下离心3分钟;The centrifugation condition is: centrifugation at 3000rpm for 3 minutes;步骤(2)中所述的重复的次数为2次以上;The number of repetitions described in step (2) is more than 2 times;步骤(2)中所述的离心的条件为:3000~4000rpm下离心3min以上;The centrifugation conditions described in step (2) are: centrifugation at 3000-4000rpm for more than 3min;步骤(4)中所述的液相色谱-串联质谱法为采用超高效液相色谱-串联质谱联用仪进行;The liquid chromatography-tandem mass spectrometry described in the step (4) is carried out by adopting ultra-high performance liquid chromatography-tandem mass spectrometry;步骤(4)中所述的气相色谱-串联质谱法为采用气相色谱-串联质谱联用仪进行。The gas chromatography-tandem mass spectrometry described in step (4) is carried out by using gas chromatography-tandem mass spectrometry.
- 权利要求1~10任一项所述的血浆中环境污染物靶向暴露组分析方法在非疾病诊断治疗目的的分析血浆中环境污染物中的应用。Application of the targeted exposome analysis method for environmental pollutants in plasma according to any one of claims 1 to 10 in the analysis of environmental pollutants in plasma for non-disease diagnosis and treatment purposes.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110849180.0A CN113671068B (en) | 2021-07-27 | 2021-07-27 | Method for analyzing environmental pollutant targeted exposure group in blood plasma and application thereof |
CN202110849180.0 | 2021-07-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023005682A1 true WO2023005682A1 (en) | 2023-02-02 |
Family
ID=78540258
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2022/105848 WO2023005682A1 (en) | 2021-07-27 | 2022-07-15 | Method for analyzing targeted exposure group of environmental pollutants in plasma, and use thereof |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN113671068B (en) |
WO (1) | WO2023005682A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116183782A (en) * | 2023-04-26 | 2023-05-30 | 北京建工环境修复股份有限公司 | Quantitative detection method of 8 perfluorinated compound substitutes based on alkali-assisted ionization |
CN116429951A (en) * | 2023-06-12 | 2023-07-14 | 湖南凯莱谱生物科技有限公司 | Kit, method and composition for simultaneously measuring contents of 11 benzoate substances and chlorine-containing antibacterial agents in human blood |
CN116840388A (en) * | 2023-07-05 | 2023-10-03 | 上海交通大学医学院附属新华医院 | Method for detecting perfluoro and polyfluoroalkyl substances in follicular fluid |
CN117310031A (en) * | 2023-09-26 | 2023-12-29 | 东莞理工学院 | Method for detecting halogenated organic pollutants in animal food |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113671068B (en) * | 2021-07-27 | 2023-01-24 | 暨南大学 | Method for analyzing environmental pollutant targeted exposure group in blood plasma and application thereof |
CN115201384B (en) * | 2022-09-16 | 2022-12-06 | 生态环境部华南环境科学研究所(生态环境部生态环境应急研究所) | Method for evaluating and detecting exposure risk of multiple pollutants in hair of large-scale crowd |
CN115656393B (en) * | 2022-12-27 | 2023-04-11 | 安徽医科大学 | Method for simultaneously detecting contents of multiple plastic additives in vegetables |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109839451A (en) * | 2017-11-29 | 2019-06-04 | 复旦大学 | Rapid analysis method while perfluorinated compound, phenolic compound and estrogen in a kind of blood |
CN110806451A (en) * | 2019-10-16 | 2020-02-18 | 生态环境部南京环境科学研究所 | Method for measuring content of phosphodiester metabolites of OPEs in plasma |
CN112379013A (en) * | 2020-10-28 | 2021-02-19 | 华中科技大学 | Method for detecting semi-volatile organic compounds in blood |
CN112986416A (en) * | 2021-02-03 | 2021-06-18 | 暨南大学 | Multi-component large-flux detection method for plastic additive in atmospheric particulates |
CN113671068A (en) * | 2021-07-27 | 2021-11-19 | 暨南大学 | Method for analyzing environmental pollutant targeting exposure component in blood plasma and application thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5952235A (en) * | 1997-04-14 | 1999-09-14 | Case Western Reserve University | Detection of teratogen exposure |
WO2005039381A2 (en) * | 2003-05-05 | 2005-05-06 | Drug Risk Solutions, L.L.C. | Compositions and processes for analysis of pharmacologic agents in biological samples |
CN106442772A (en) * | 2016-09-05 | 2017-02-22 | 司法部司法鉴定科学技术研究所 | Method for detecting and analyzing anticoagulant rodenticides in blood |
CN109738537B (en) * | 2019-01-17 | 2021-07-20 | 暨南大学 | Method for simultaneously extracting various residual medicines in environmental water |
-
2021
- 2021-07-27 CN CN202110849180.0A patent/CN113671068B/en active Active
-
2022
- 2022-07-15 WO PCT/CN2022/105848 patent/WO2023005682A1/en unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109839451A (en) * | 2017-11-29 | 2019-06-04 | 复旦大学 | Rapid analysis method while perfluorinated compound, phenolic compound and estrogen in a kind of blood |
CN110806451A (en) * | 2019-10-16 | 2020-02-18 | 生态环境部南京环境科学研究所 | Method for measuring content of phosphodiester metabolites of OPEs in plasma |
CN112379013A (en) * | 2020-10-28 | 2021-02-19 | 华中科技大学 | Method for detecting semi-volatile organic compounds in blood |
CN112986416A (en) * | 2021-02-03 | 2021-06-18 | 暨南大学 | Multi-component large-flux detection method for plastic additive in atmospheric particulates |
CN113671068A (en) * | 2021-07-27 | 2021-11-19 | 暨南大学 | Method for analyzing environmental pollutant targeting exposure component in blood plasma and application thereof |
Non-Patent Citations (2)
Title |
---|
BO YANNA;LI RONG;ZHANG PENGJIE;LIN QINBAO;ZHANG XIANCHEN;CHEN LISI;HU YIGUANG;HUANG ZHIQIANG: "Determination of 31 phthalate esters in baked foods and plastic packaging materials by high performance chromatography-tandem mass spectrometry", CHINESE JOURNAL OF CHROMATOGRAPHY, vol. 34, no. 9, 8 September 2016 (2016-09-08), pages 868 - 879, XP093028318, ISSN: 1000-8713, DOI: 10.3724/SP.J.1123.2016.05008 * |
ZHAO RANRAN: "Correlation Analysis on Phthalates Exposure and Missed Abortion", CHINESE MASTER'S THESES FULL-TEXT DATABASE, no. 8, 1 August 2019 (2019-08-01), pages 1 - 89, XP093028309, ISSN: 1674-0246 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116183782A (en) * | 2023-04-26 | 2023-05-30 | 北京建工环境修复股份有限公司 | Quantitative detection method of 8 perfluorinated compound substitutes based on alkali-assisted ionization |
CN116183782B (en) * | 2023-04-26 | 2023-07-28 | 北京建工环境修复股份有限公司 | Quantitative detection method of 8 perfluorinated compound substitutes based on alkali-assisted ionization |
CN116429951A (en) * | 2023-06-12 | 2023-07-14 | 湖南凯莱谱生物科技有限公司 | Kit, method and composition for simultaneously measuring contents of 11 benzoate substances and chlorine-containing antibacterial agents in human blood |
CN116429951B (en) * | 2023-06-12 | 2023-08-29 | 湖南凯莱谱生物科技有限公司 | Kit, method and composition for simultaneously measuring contents of 11 benzoate substances and chlorine-containing antibacterial agents in human blood |
CN116840388A (en) * | 2023-07-05 | 2023-10-03 | 上海交通大学医学院附属新华医院 | Method for detecting perfluoro and polyfluoroalkyl substances in follicular fluid |
CN117310031A (en) * | 2023-09-26 | 2023-12-29 | 东莞理工学院 | Method for detecting halogenated organic pollutants in animal food |
Also Published As
Publication number | Publication date |
---|---|
CN113671068A (en) | 2021-11-19 |
CN113671068B (en) | 2023-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2023005682A1 (en) | Method for analyzing targeted exposure group of environmental pollutants in plasma, and use thereof | |
Schettgen et al. | New gas chromatographic–mass spectrometric method for the determination of urinary pyrethroid metabolites in environmental medicine | |
Jahnke et al. | Trace analysis of per-and polyfluorinated alkyl substances in various matrices—how do current methods perform? | |
Seccia et al. | Multiresidue determination of nicotinoid insecticide residues in drinking water by liquid chromatography with electrospray ionization mass spectrometry | |
Sardans et al. | Ecological metabolomics: overview of current developments and future challenges | |
Van Leeuwen et al. | Advances in the gas chromatographic determination of persistent organic pollutants in the aquatic environment | |
Shih et al. | Detection of metabolites of toxic alkylmethylphosphonates in biological samples | |
Čajka et al. | Use of automated direct sample introduction with analyte protectants in the GC–MS analysis of pesticide residues | |
Martin et al. | Peer reviewed: analytical challenges hamper perfluoroalkyl research | |
Fernando et al. | Comprehensive analysis of the Great Lakes top predator fish for novel halogenated organic contaminants by GC× GC-HR-ToF mass spectrometry | |
Likas et al. | Rapid gas chromatographic method for the determination of famoxadone, trifloxystrobin and fenhexamid residues in tomato, grape and wine samples | |
Caldas et al. | A vortex-assisted MSPD method for the extraction of pesticide residues from fish liver and crab hepatopancreas with determination by GC–MS | |
Serodio et al. | Development of a stir-bar-sorptive extraction–liquid desorption–large-volume injection capillary gas chromatographic–mass spectrometric method for pyrethroid pesticides in water samples | |
Cequier et al. | Determination of emerging halogenated flame retardants and polybrominated diphenyl ethers in serum by gas chromatography mass spectrometry | |
Liao et al. | Simultaneous analysis of chlorpyrifos and cypermethrin in cord blood plasma by online solid-phase extraction coupled with liquid chromatography–heated electrospray ionization tandem mass spectrometry | |
Dirtu et al. | Analytical methods for selected emerging contaminants in human matrices—a review | |
Kienhuis et al. | Liquid chromatography–tandem mass spectrometric analysis of surface and waste water with atmospheric pressure chemical ionisation: II. Applications | |
Washington et al. | Analysis of perfluorinated carboxylic acids in soils II: optimization of chromatography and extraction | |
Chen et al. | Simultaneous determination of trifloxystrobin and trifloxystrobin acid residue in rice and soil by a modified quick, easy, cheap, effective, rugged, and safe method using ultra high performance liquid chromatography with tandem mass spectrometry | |
Mochalski et al. | Measurement of isoprene solubility in water, human blood and plasma by multiple headspace extraction gas chromatography coupled with solid phase microextraction | |
Nixon et al. | Evaluation of a tunable bandpass reaction cell for an inductively coupled plasma mass spectrometer for the determination of chromium and vanadium in serum and urine | |
Uroz et al. | Monitoring of 6-chloronicotinic acid in human urine by gas chromatography-tandem mass spectrometry as indicator of exposure to the pesticide imidacloprid | |
Piedra et al. | Screening of antifouling pesticides in sea water samples at low ppt levels by GC-MS and LC-MS | |
Brase et al. | Enhanced Sensitivity for the analysis of perfluoroethercarboxylic acids using LC–ESI–MS/MS: Effects of probe position, mobile phase additive, and capillary voltage | |
US11596144B2 (en) | Method of detecting an insect infestation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22848287 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |